Beruflich Dokumente
Kultur Dokumente
L. H. Gade D. Darensbourg
Universität Heidelberg Texas A & M University
Germany College Station, Texas, USA
M. L. H. Green H. B. Gray
University of Oxford California Institute of Technology
Oxford, United Kingdom Pasadena, California, USA
A. E. Merbach P. A. Lay
Laboratoire de Chimie et Bioanorganique EFPL, University of Sydney
Lausanne, Switzerland Sydney, Australia
P. J. Sadler J. Reedijk
University of Warwick Leiden University
Warwick, England Leiden, The Netherlands
K. Wieghardt Y. Sasaki
Max-Planck-Institut Hokkaido University
Mülheim, Germany Sapporo, Japan
Academic Press is an imprint of Elsevier
50 Hampshire Street, 5th Floor, Cambridge, MA 02139, United States
525 B Street, Suite 1800, San Diego, CA 92101-4495, United States
The Boulevard, Langford Lane, Kidlington, Oxford, OX5 1GB, United Kingdom
125 London Wall, London, EC2Y 5AS, United Kingdom
No part of this publication may be reproduced or transmitted in any form or by any means,
electronic or mechanical, including photocopying, recording, or any information storage and
retrieval system, without permission in writing from the publisher. Details on how to seek
permission, further information about the Publisher’s permissions policies and our
arrangements with organizations such as the Copyright Clearance Center and the Copyright
Licensing Agency, can be found at our website: www.elsevier.com/permissions.
This book and the individual contributions contained in it are protected under copyright by
the Publisher (other than as may be noted herein).
Notices
Knowledge and best practice in this field are constantly changing. As new research and
experience broaden our understanding, changes in research methods, professional practices,
or medical treatment may become necessary.
Practitioners and researchers must always rely on their own experience and knowledge in
evaluating and using any information, methods, compounds, or experiments described
herein. In using such information or methods they should be mindful of their own safety and
the safety of others, including parties for whom they have a professional responsibility.
To the fullest extent of the law, neither the Publisher nor the authors, contributors, or editors,
assume any liability for any injury and/or damage to persons or property as a matter of
products liability, negligence or otherwise, or from any use or operation of any methods,
products, instructions, or ideas contained in the material herein.
ISBN: 978-0-12-812834-3
ISSN: 0898-8838
RALPH G. WILKINS
Ralph Wilkins, born in 1927, grew up in the Southampton area of England.
He attended the University of Southampton and received his BSc and PhD
degrees in Chemistry there. He conducted research at the ICI research
laboratories in Welwyn for 3 years, followed by postdoctoral research with
Arthur Adamson at the University of Southern California. Afterwards he
was appointed as a Lecturer and subsequently as a Senior Lecturer at the
University of Sheffield. In 1962 he began a year as a Visiting Professor at
the Max Planck Institute in G€ ottingen, Germany, with Manfred Eigen.
During this time results, gathered principally from reports of ultrasonic
absorption experiments in G€ ottingen, temperature-jump relaxation exper-
iments in G€ ottingen and MIT, stopped-flow experiments in Sheffield, and
NMR spectroscopy water-exchange experiments in Berkeley, led to
the formulation of what became known as the Eigen–Wilkins mechanism
for transition metal complex formation. At that time these experimental
methods were relatively novel. Ralph Wilkins was then appointed to a
Professorship of Chemistry at the State University of New York in Buffalo,
and some years later as Professor and Chairman of the Department of
Chemistry at the State University of New Mexico in Las Cruces. His
research interests expanded to include bioinorganic chemistry and many
publications in this area, including books cited below, ensued. Completed
during a Visiting Professorship at the University of Warwick, United
Kingdom, in 1991, “Kinetics and Mechanism of Reactions of Transition
Metal Complexes” was a revised version of his earlier classic work, “The
Study of Kinetics and Mechanisms of Transition Metal Complexes,” pub-
lished in 1974. Other books include “Inorganic Chemistry in Biology”
(with P.C. Wilkins), in 1997, and in 2003, “The Role of Calcium and
Comparable Cations in Animal Behaviour,” also with P.C. Wilkins. In
retirement Ralph has extended his interests, beyond the highs and lows
of the England national cricket team, to genetics, and this has culminated
in the very recent appearance, Spring 2017, of “Animal Genetics for
v
vi Dedication
Andres G. Algarra
Instituto de Biomoleculas (INBIO), Facultad de Ciencias, Universidad de Cádiz, Polı́gono
Universitario Campus Rio San Pedro, Puerto Real, Spain
Gabriel Aullón
Secció de Quı́mica Inorgànica, Facultat de Quı́mica, Universitat de Barcelona, Barcelona,
Spain
Manuel G. Basallote
Instituto de Biomoleculas (INBIO), Facultad de Ciencias, Universidad de Cádiz, Polı́gono
Universitario Campus Rio San Pedro, Puerto Real, Spain
Gábor Beller
University of Debrecen, Debrecen, Hungary
Anna Company
Grup de Quı́mica Bioinspirada, Supramolecular i Catàlisi (QBIS-CAT), Institut de Quı́mica
Computacional i Catàlisi (IQCC), Universitat de Girona, Girona, Catalonia, Spain
Miquel Costas
Grup de Quı́mica Bioinspirada, Supramolecular i Catàlisi (QBIS-CAT), Institut de Quı́mica
Computacional i Catàlisi (IQCC), Universitat de Girona, Girona, Catalonia, Spain
Margarita Crespo
Secció de Quı́mica Inorgànica, Facultat de Quı́mica, Universitat de Barcelona, Barcelona,
Spain
Janusz M. Da˛browski
Faculty of Chemistry, Jagiellonian University, Kraków, Poland
Sam P. de Visser
Manchester Institute of Biotechnology, School of Chemical Engineering and Analytical
Science, The University of Manchester, Manchester, United Kingdom
István Fábián
University of Debrecen, Debrecen, Hungary
Abayomi S. Faponle
Manchester Institute of Biotechnology, School of Chemical Engineering and Analytical
Science, The University of Manchester, Manchester, United Kingdom; Faculty of Basic
Medical Sciences, Obafemi Awolowo College of Health Science, Olabisi Onabanjo
University, Ogun State, Nigeria
Yuichi Himeda
Research Institute of Energy Frontier, National Institute for Advanced Industrial Science and
Technology, Tsukuba, Japan
Deogratius Jaganyi
School of Chemistry and Physics, University of KwaZulu-Natal, Scottsville,
Pietermaritzburg, South Africa
xi
xii Contributors
Jesús Jover
Secció de Quı́mica Inorgànica, Facultat de Quı́mica, Universitat de Barcelona, Barcelona,
Spain
József Kalmár
MTA-DE Homogeneous Catalysis and Reaction Mechanisms Research Group, University
of Debrecen, Debrecen, Hungary
Hajime Kawanami
Research Institute for Chemical Process Technology, National Institute for Advanced
Industrial Science and Technology, Sendai, Japan
Gábor Laurenczy
cole Polytechnique Federale de Lausanne
Institut des Sciences et Ingenierie Chimiques, E
(EPFL), Lausanne, Switzerland
Allen Mambanda
School of Chemistry and Physics, University of KwaZulu-Natal, Scottsville,
Pietermaritzburg, South Africa
Juan P. Marcolongo
Facultad de Ciencias Exactas y Naturales and INQUIMAE, Universidad de Buenos Aires/
CONICET, Ciudad Universitaria, Buenos Aires, Argentina
Manuel Martı́nez
Secció de Quı́mica Inorgànica, Facultat de Quı́mica, Universitat de Barcelona, Barcelona,
Spain
Jose A. Olabe
Facultad de Ciencias Exactas y Naturales and INQUIMAE, Universidad de Buenos Aires/
CONICET, Ciudad Universitaria, Buenos Aires, Argentina
Joan Serrano-Plana
Grup de Quı́mica Bioinspirada, Supramolecular i Catàlisi (QBIS-CAT), Institut de Quı́mica
Computacional i Catàlisi (IQCC), Universitat de Girona, Girona, Catalonia, Spain
Leonardo D. Slep
Facultad de Ciencias Exactas y Naturales and INQUIMAE, Universidad de Buenos Aires/
CONICET, Ciudad Universitaria, Buenos Aires, Argentina
Alexander B. Sorokin
Institut de Recherches sur la Catalyse et l’Environnement de Lyon IRCELYON, UMR
5256, CNRS—Universite Lyon 1, Villeurbanne cedex, France
Mária Szabó
University of Debrecen, Debrecen, Hungary
Ari Zeida
Facultad de Ciencias Exactas y Naturales and INQUIMAE, Universidad de Buenos Aires/
CONICET, Ciudad Universitaria, Buenos Aires, Argentina
PREFACE
xiii
xiv Preface
Contents
1. Introduction 2
2. General Considerations 3
3. Selected Reactions of Oxychlorine Species 6
4. Kinetics of the Oxidation Reactions of Peroxo Compounds 22
5. The Photon as a Reactant 35
6. Selected Kinetic Studies on Heterogeneous Systems 49
7. Concluding remarks 55
Acknowledgments 57
References 57
Abstract
Redox reactions of simple inorganic species exhibit an amazingly rich variety of complex
kinetic phenomena. Typically, these reactions are interpreted on the basis of multistep
kinetic models which postulate the formation and subsequent fast reactions of reactive
intermediates. The main purpose of this chapter is to demonstrate the challenges asso-
ciated with mechanistic studies on complex redox reactions, and to offer selected exam-
ples how the complexities can be handled with currently available experimental and
computational methods. Clear arguments are presented to demonstrate that the stoi-
chiometries of these reactions are kinetically controlled. It is shown that in order to
understand the intimate details of these systems, the stoichiometry as a function of
reaction time, the final stoichiometry and the kinetic properties need to be studied
under as broad experimental conditions as possible. Furthermore, thorough character-
ization of the reactive intermediates is the key to in-depth understanding of the mech-
anism. The importance of photoinitiation and kinetic coupling between photochemical
and thermally activated reaction steps is also demonstrated in several systems. The sur-
vey of the literature results confirms that simultaneous and critical evaluation of all
1. INTRODUCTION
Redox reactions in aqueous solution exhibit a large variety both in
terms of kinetics and stoichiometry. The basic principles of simple electron
transfer processes are well established and there is a great number of publi-
cations which illustrate the excellent agreement between theoretical models,
most prominently the Marcus–Hush theory (1,2), and experimental data.
Complementary one-electron transfer processes are typically characterized
with straightforward second-order rate expressions which are first order
for both reactants. Simultaneous transfer of two or more electrons is less
likely, thus, complementary two-electron transfer reactions frequently
imply atom transfer. This may introduce some complications in the kinetic
features of such systems. By definition, noncomplementary redox reactions
proceed via the formation of one or more intermediates and require multi-
step kinetic models for the interpretation of the experimental data. Apart
from the redox steps, these models also include the equilibrium reactions
between the components (3). Depending on the relative rates of the indi-
vidual reaction steps simple or complex kinetic features may arise. Ulti-
mately some of these systems show nonlinear dynamic behavior under
specific experimental conditions.
Earlier, technical limitations prevented the assessment of the intimate
details of many complex redox processes. Recent developments in experi-
mental and computational methodologies opened new avenues in this field.
Quite often old but well-established principles are used; however, the per-
formance of the instruments is boosted by new technical improvements. In
other cases new approaches have been introduced. The advent of these
developments is that more reliable and larger experimental datasets, than
before, have become accessible on a routine basis. This, obviously, led to
the postulation of better defined kinetic models, and in many cases impor-
tant details of complicated reaction mechanisms have been explored. The
use of new methods is not without risks, because blind trust in sometimes
indirect pieces of information may lead to biased or wrong conclusions.
The Kinetics and Mechanism of Complex Redox Reactions 3
2. GENERAL CONSIDERATIONS
Complex redox reactions exhibit individual properties and sometimes
the same or very similar kinetic models are not suitable for the interpretation
of the results even in strongly related reactive systems. The complexity of the
kinetic behavior is always associated with a network of individual reaction
steps, illustrated in Scheme 1.
In these systems, first the reactants produce one or more reactive inter-
mediates. At least one such a step is required to initiate the overall process.
The initiation step(s) may quickly diminish, or be operative over the whole
course of the reaction.
The reactive intermediates open a series of new reaction paths by
reacting with each other and/or the reactants. Quite often the intermediates
are regenerated in cyclic processes. For example, in catalytic systems the
active form of the catalyst reacts with one or more reactants and eventually
a sequence of reactions leads to the regeneration of the catalyst. In other
cases, a reactive intermediate accelerates its own formation and an autocat-
alytic pattern arises. The interplay of the competing reaction paths ultimately
leads to the formation of the products.
In earlier studies, typically a relatively simple and forthright approach was
used to develop kinetic models for complex redox reactions. The experi-
mental conditions were simplified by introducing various approximations
and the results were evaluated by simplified rate expressions. It was assumed
that additional reactions do not interfere with the individual reaction step
R1 l1 P1
R2 l2 P2
Rp lp Pp
studied, often without testing the validity of this assumption. In other words,
kinetic coupling between the reaction steps was neglected. Consequently,
biased results were obtained for the rate constants, and the combination
of the corresponding data led to false conclusions. Kinetic studies on ozone
(O3) decomposition in aqueous solution serve as examples for this problem.
Because of its relevance in practical applications—such as water treatment
technologies, advanced oxidation processes (AOPs), preparative organic
chemistry, etc.—the kinetics and mechanism of this reaction have exten-
sively been studied. Two reasonably well-detailed kinetic models have been
developed for the interpretation of various aspects of aqueous ozone decom-
position (4–8). Most of the chain carrier radicals are the same in these models
but there are marked differences in the number of reaction steps and their
rate constants. The models were assembled using experimental data and ear-
lier literature results published on the reactions of the reactive intermediates.
Simulations on the basis of the proposed models could not reproduce the
experimental observations and led to the conclusion that none of them is
suitable for quantitative interpretation of aqueous ozone decomposition
(9). This failure was attributed to the following shortcoming of the proposed
models. The significance of several reaction steps was overestimated and the
approximations introduced during the evaluation of the individual kinetic
parameters led to a skewed set of rate constants. The calculations also dem-
onstrated the need for further experimental work and more accurate kinetic
parameters.
The fate of a complex redox reaction is determined by the competition
of parallel and subsequent reaction paths, in other words, by their relative
kinetic weights which may significantly change over the course of a reaction.
Thus, the stoichiometry of the reaction is controlled by the kinetics and it
may change as a function of reaction time. Exploring the intimate details of
these reactions requires the identification and thorough description of the
reactive intermediates. The inherent complication is that once the reactive
intermediates are formed they are typically involved in fast subsequent reac-
tion steps and present at very low concentration levels. These transient spe-
cies can be detected, if at all, by using specific experimental techniques.
Perhaps the most obvious example for this problem is the quantification
of the hydroxyl radical in solution. This species is an extremely powerful
oxidant which quickly reacts with a large variety of substrates (10). It can
be generated by different experimental methods but detected only via its fast
reaction with specific agents. However, introducing additional reactants
The Kinetics and Mechanism of Complex Redox Reactions 5
into a reactive system may complicate the kinetics even further. Indirect
detection of a reactive intermediate species always implies various approx-
imations with obvious uncertainties transferred into the final conclusions. In
some cases, direct observation and characterization of these species may be
feasible. This requires meticulous experimental work which pays off in bet-
ter defined kinetic models.
As an example, aqueous ozone decomposition serves as an excellent
example again. The formation and consecutive decay of the ozonide, super-
oxide, and carbonate ion radicals could be detected directly in this system
(11–13). These species have outmost importance in the overall process
and the characteristic kinetic traces were recorded under various experimen-
tal conditions. Simultaneous evaluation of all experimental data was instru-
mental in exploring the specific details of the mechanism. Discrepancies in
the literature data regarding the rate constant of the initiation step were
resolved and a comprehensive kinetic model was worked out which is suit-
able to explain the kinetic observations in the absence, as well as in the pres-
ence of hydrogen peroxide (a well-known catalyst of the reaction) and
carbonate ion (an inhibitor).
In subsequent parts of this chapter, we will cover selected topics in
mechanistic studies. The reactions of simple oxidants such as oxychlorine
species (Section 3) and peroxo compounds (Section 4) are discussed for
two reasons. First of all, these species have great practical significance in
AOPs, environmental chemistry, and biological systems. Exploring the
kinetics of the relevant reactions is of enormous importance in understand-
ing the behavior of these oxidants under a variety of conditions. On the
other hand, handling the mechanistic challenges associated with these sys-
tems has broader implications in reaction kinetics. In Section 5, it will be
demonstrated that the photon can be used as a reactant to control the for-
mation of several key intermediates in a complex reactive system. This
offers an unique experimental tool for mechanistic studies. Recent instru-
mental developments in this direction also opened new ways for studying
the kinetics of surface processes. It will be shown in Section 6 that the
methods used for mechanistic studies in homogeneous systems can effi-
ciently be adapted to explore heterogeneous reactions. Comprehensive
kinetic models for redox reactions coupled with adsorption processes
and diffusion phenomena in the confined space of high-porosity materials
lead to a new approach for the interpretation of heterogeneous catalytic
and photoinitiated processes.
6 Mária Szabó et al.
whitening agent in the pulp and textile industries. Chlorine dioxide offers
several advantages over chlorine, most importantly because it does not gen-
erate harmful chlorinated byproducts (18). The main disadvantage associated
with the use of ClO2 is its instability at high pressure. This prevents the trans-
portation of ClO2 in gaseous phase and technological applications are
designed to accommodate in situ preparation of this species. Several methods
exist for generating ClO2. Industrially, the reduction of chlorate ion with
methanol or other agents in sulfuric acid is used (19). For the preparation
of pure chlorine dioxide, metalloporphyrin catalyzed oxidation of chlorite
ion was reported by Collman et al. (20). The formation of chlorine dioxide
was also found during the decomposition and oxidation reactions of ClO2 ,
as will be discussed later in this section.
Chlorine dioxide is stable under acidic conditions but undergoes decom-
position in alkaline solution. As demonstrated in Fig. 1, the experimental
3
0.3
First order
104 [CIO2] (M)
0.2
Second order
Mixed order
2 0.1
104 [CIO2] (M)
0.0
0 2000 4000
Time (s)
Second order
First order
Mixed order
0
0 1000 2000 3000 4000 5000
Time (s)
Fig. 1 Regression analysis of kinetic traces for the decomposition of ClO2 by testing the
validities of first-, second-, and mixed-order rate expressions. [ClO2] ¼ 0.37 mM;
[NaOH] ¼ 0.40 M; T ¼ 25.0°C; I ¼ 1.0 M. Reprinted with permission from Odeh, I. N.;
Francisco, J. S.; Margerum, D. W. Inorg. Chem. 2002, 41, 6500–6506. Copyright 2002,
American Chemical Society.
8 Mária Szabó et al.
kinetic traces can be fitted with the mixed-order rate expression for ClO2
given in Eq. (2) (21):
½ClO2
¼ ka, obs ½ClO2 + kb, obs ½ClO2 2 (2)
dt
On the basis of the concentration dependencies of the first- and second-
order rate constants, and the final stoichiometry a detailed kinetic model was
proposed (Scheme 2).
The model postulates three parallel pathways, two of which (a and c) lead
to the formation of ClO2 and ClO3 , respectively, in a 1:1 ratio. The third
pathway (b) provides reasonable explanation for the deviation from this stoi-
chiometry by hypothesizing the formation of O2.
The catalytic decomposition and oxidation of ClO2 by hypochlorite
ion exhibit composite pH-dependent stoichiometric features (21a). The
corresponding reactions are given as follows:
of this system is that regardless of the actual stoichiometry, the same rate law
applies to the entire pH range studied, i.e., the reaction is strictly first order
both in ClO2 and OCl (Eq. 5):
d½ClO2
¼ k½ClO2 ½OCl (5)
dt
These observations are consistent with a kinetic model in which the rate-
determining step is followed by two major competing reaction paths leading
to different products as a function of pH (21a). Further details of this reaction
were explored in a subsequent study (22).
Thiols play an essential role in protecting cells from oxidative damage by
reactive organic species and the removal of these reducing agents from bio-
logical systems has detrimental effects. For example, during bacteria disinfec-
tion, ClO2 penetrates into the membrane, it oxidizes thiols to disulfides and
causes the death of the bacterium. According to literature data, ClO2 is also
able to oxidize amino acids and the fastest reactions were found with cyste-
ine, tyrosine, and tryptophan (23,24). Within this group, cysteine is the most
reactive amino acid due to the highly nucleophilic thiol group (25). During
the oxidation of cysteine with ClO2 and ClO2 in acidic medium, cysteic
acid (CSO3H) was reported as the main product by Darkwa et al. (26) The
kinetic traces were simulated on the basis of a 28-step kinetic model. Con-
sidering the uncertainties associated with this kind of evaluation of the
kinetic data, the proposed rate constants should be termed as ambiguous
at best.
The oxidation reactions of ClO2 involve the formation of lower oxi-
dation state oxychlorine species which, in turn, may quickly react with
the substrates. A thorough study on the oxidation of cysteine (HCS) and
glutathione by Ison et al. (Scheme 3) serves as an excellent example for this
feature (27).
According to pH-dependent experiments, the deprotonated form of the
substrate is reactive in this system. The rate-determining step is a single elec-
tron transfer from CS to chlorine dioxide which forms chlorite ion and a
cysteinyl radical. The overall second-order reaction is first order in each
reactant and the same rate expression applies to the entire pH range,
although the stoichiometry is pH dependent. It implies again that after
the formation of a common intermediate, which is the cysteinyl–ClO2
adduct, the products are formed via two concurrent pH-dependent paths.
The low pH pathway proceeds via the formation of HOCl and produces
cysteic acid, while cysteine is the main product of the high pH pathway.
10 Mária Szabó et al.
+H CO2–
3N
S•
Fast + ClO2
+H CO2–
3N
O O
S Cl
Cysteinyl-ClO2 adduct
Low pH pathway H 2O CS– High pH pathway
HOCl ClO2–
+H CO2–
3N
It was shown that chlorite ion oxidizes HCS about six orders of magnitude
slower than ClO2. This difference in the reactivities was interpreted by
assuming that different mechanisms are operative in these reactions, i.e.,
the oxidation with ClO2 proceeds via oxygen transfer as opposed to single
electron transfer with ClO2. The oxidations of glutathione (GSH) and HCS
show close resemblance leading to the conclusion that the thiol group is the
main reactive site of GSH as well (27).
The oxidation of tryptophan (Trp) by ClO2 was investigated by Stewart
and coworkers using HPLC, UV spectrophotometric, stopped-flow, and
The Kinetics and Mechanism of Complex Redox Reactions 11
ESI–MS methods (28). It was confirmed that one Trp consumes two ClO2
while HOCl and ClO2 are formed in a 1:1 ratio. In spite of the relatively
simple stoichiometry regarding the reactants and inorganic products, a broad
array of organic species is formed.
Very diverse kinetic features are associated with the chemistry of chlorite
ion. This species is relatively stable under alkaline conditions but it decom-
poses erratically in neutral solution probably because of the presence of
minute amounts of impurities which may act as catalysts. Under acidic con-
ditions, ClO2 decomposes spontaneously or in catalytic reactions and pro-
duces ClO3 , ClO2, and Cl (16). The stoichiometry of this reaction is
strongly dependent on the concentration ratios of the reactants, the concen-
tration of the catalyst and the pH. It was demonstrated earlier that the com-
bination of classical, stopped-flow, and quenched stopped-flow experiments
can provide invaluable information on the iron(III) catalyzed decomposition
of chlorous acid (29,30) and the same kind of experiments may prove to be
useful in other systems, too.
Chlorite ion is a key reactant in many reactive systems exhibiting unique,
nonlinear dynamic features. Perhaps chlorite-driven reactions form the big-
gest group of the family of oscillation reactions. The first such system was the
ClO2 I reaction which has the most well-established mechanism (31).
Nowadays, such reactions are used for designing propagation fronts (32–34).
In general, very complex multistep kinetic models are proposed for the
interpretation of these phenomena but sometimes important details are
not clarified. Thus, exploring the details of the subsystems is of utmost
importance.
It is well established that HOCl is an important intermediate in the reac-
tions of chlorite ion, and the formation of ClO2 is due to the
HOCl ClO2 reaction in many cases. The most detailed kinetic study
on this subsystem was reported by Kormanyos et al. (35) In this case, the for-
mation of ClO2 was monitored by systematically changing the reactant con-
centrations and pH. A detailed kinetic model (Scheme 4) was developed by
simultaneously fitting all kinetic traces.
This model provides an excellent interpretation of the experimental
results (Fig. 2).
The reaction of chlorite ion with reducing sulfur compounds quite often
shows complexities rarely found in other systems. In the chlorite–thiosulfate
ion reaction, later called “crazy clock” reaction, Orbán and coworkers
observed periodic and aperiodic oscillations (36,37) and Maselko and Epstein
reported chaos in a continuously stirred tank reactor (38). In batch reactors,
12 Mária Szabó et al.
this process is very sensitive to the stirring rate due to fluctuations (39). The
kinetics and mechanism of the chlorite–thiosulfate ion reaction are quite
complicated because the intermediates and the products can react with
the reactants and also with each other. In other words, the main reaction
includes several subsystems, such as the redox reactions between chlorite–
hypochlorous acid, thiosulfate ion–chlorine dioxide, tetrathionate ion–
hypochlorous acid, tetrathionate ion–chlorine dioxide and the decomposition
of chlorous acid. In the following paragraphs, we give a brief overview of
these processes.
The above reactions have been studied by Horváth et al. in great detail. In
the ClO2 S2 O3 2 system, they observed sigmoidal kinetic traces in the
excess of thiosulfate ion which indicates that autocatalysis is operative in this
reaction. Tetrathionate and chlorite ions are the main products of this pro-
cess but Cl and SO4 2 are also formed. It was proposed that the initial step
is the irreversible formation of the S2 O3 ClO2 •2 radical and the reaction
proceeds via the formation of the S4 O6 •3 radical. A 10-step mechanism
was postulated and the corresponding rate constants were estimated by
The Kinetics and Mechanism of Complex Redox Reactions 13
0.5
0.4
Absorbance at 360 nm
0.5
0.3
0.4
0.3
0.2
0.2
0.1
0.1 0
0 10 20 30 40
0
0 50 100 150 200 250 300
Time (s)
Fig. 2 Formation of chlorine dioxide in HOCl excess as a function of [Cl]0.
[HOCl]0 ¼ 3.00 mM, ½ClO2 0 ¼ 0:568 mM, pH 5.55; [Cl]0 (mM) ¼ 0 (●), 1.0 (□), 2.0
(▲), 4.0 (♦), 8.0 (■). The inset shows the enlarged first section of the traces. Reprinted
with permission from Kormanyos, B.; Nagypal, I.; Peintler, G.; Horvath, A. K. Inorg. Chem.
2008, 47, 7914–7920. Copyright 2008, American Chemical Society.
fitting more than 130 kinetic traces simultaneously (40). Excellent agree-
ment between the measured and calculated data seemed to validate the
model (Fig. 3).
In a subsequent study, Pan and Stanbury confirmed the experimental
observations reported by Horváth and Nagypál and made an attempt to pro-
vide an alternative interpretation for the autocatalytic nature of the reaction.
These authors confirmed that L-methionine suppresses the autocatalysis.
A detailed kinetic model was proposed which postulates the formation of
HOCl and SO3 2 as chain carriers in this system. The formation of ClO
was also proposed. The formation of a Cl(II) intermediate was postulated
in many reactions of oxychlorine species earlier. In aqueous solution, such
an intermediate could not be detected directly before, however, a great
number of mechanistic studies on the redox reactions of oxychlorine species
corroborate its existence. The kinetic effect of L-methionine was interpreted
by considering that this compound is an extremely efficient and selective
scavenger of HOCl and as such terminates the chain reaction (41).
14 Mária Szabó et al.
1.2
0.9
Absorbance
0.6
0.3
0.0
0.00 0.05 0.10 0.15
Time (s)
Fig. 3 Experimental and fitted kinetic traces on the basis of the kinetic model proposed
by Horváth and Nagypál (40). S2 O3 2 0 ¼ 1:55 103 M, pH 9.27; [ClO2]0
104 M ¼ 5.34 (●), 7.39 (□), 9.35 (▲), 11.0 (◊). Reprinted with permission from Horváth, A. K.;
Nagypál, I. J. Phys. Chem. A 1998, 102, 7267–7272. Copyright 1998, American Chemical
Society.
It is important to note that the two papers discussed earlier report the
same kinetic features of the ClO2 =S2 O3 2 system, yet, the proposed models
are markedly different. In a broader context, this is an inherent problem
associated with mechanistic studies on complex redox reactions. When a
large set of kinetic traces is collected by systematically changing the concen-
trations and concentration ratios of the reactants under a wide range of
experimentally accessible conditions, a multistep kinetic model may fit
the data exceptionally well. However, new experimental observations
may provide insight into further details of the mechanism and the combina-
tion of the old and new results may require substantial refinement or even
reconstruction of the kinetic model.
The chlorite–tetrathionate reaction exhibits complex kinetic patterns
leading to exotic nonlinear dynamic phenomena such as oscillation (37)
and has outstanding importance in some of the reactive systems featuring
spatiotemporal pattern formation and propagating fronts (42–45). Alkaline
decomposition of the tetrathionate ion leads to the formation of thiosulfate,
sulfite, and trithionate, thus the reactions of these ions with chlorite ion also
contribute to the overall process in the ClO2 =S4 O6 2 system. Kinetic
results on the ClO2 =S2 O3 2 reaction were reported by Nagypal and
The Kinetics and Mechanism of Complex Redox Reactions 15
Epstein (39), while Huff Hartz et al. studied the ClO2 =S2 O3 2 reac-
tion (46). In contrast to tetrathionate, trithionate is stable in alkaline aqueous
solution (47) and does not react with ClO2 . However, the formation of a
considerable amount of ClO2 was reported in the ClO2 =S3 O6 2 system
under slightly acidic conditions. It was also confirmed that ClO2 slowly dis-
appeared in excess trithionate (48). A systematic study on the
ClO2 =S3 O6 2 reaction revealed that the actual stoichiometry depends
on the concentration of the reactants and pH and always can be given as
the linear combination of the following two limiting stoichiometries:
Accordingly, a 38-step kinetic model was proposed for this system recently.
It was shown that fast equilibria (e.g., acid–base reactions) and 12 fast reac-
tions with 30 fitted parameters are suitable to describe 367 experimental
kinetic traces with high precision (51).
The common feature of the previously discussed reactions of ClO2 and
ClO2 is that only the concentration change of chlorine dioxide could be
followed quantitatively. This species has a characteristic, relatively strong
absorbance band in the UV–vis region which overlaps other spectral effects
and practically excludes the detection of absorbance contributions from
other components. This may introduce some ambiguity in the evaluation
of the kinetics when the formation of ClO2 is followed because kinetic pro-
files of a product may not contain sufficient information on the initial part of
a complex reaction. However, this problem is greatly eliminated if the reac-
tions are studied in a broad range of initial concentrations and concentration
ratios of the reactants, as it was carried out in the cited studies. In fact, the
results unequivocally indicated the formation of various transient species
which cannot be detected directly but are required for coherent interpreta-
tion of the experimental observations.
In manganese porphyrin catalyzed alkane oxidations with ClO2 , the
existence of two pathways was confirmed which involve the formation of
O2 and a high-valent manganese(V)–oxo intermediate (52). Recently, sev-
eral other reports have indicated that various transition metal complexes may
have interesting catalytic effects on the reactions of chlorite ions. Thus, cat-
alytic formation of ClO2 was observed in the presence of manganese por-
phyrin (53) and ruthenium bisphenanthroline complexes (54).
Catalytic decomposition of chlorite ion in the presence of water-soluble
iron (55,56) and manganese porphyrins (57,58) was studied under close to
neutral pH conditions in detail. In the case of the iron complexes, the dis-
proportionation of ClO2 produces Cl and ClO3 in a 1:2 ratio.
A moderate yield of O2 was also observed in the presence of the fluorinated
[FeIII(TF4TMAP)]+ complex. DFT calculations are consistent with the for-
mation of a FeIV oxo compound and chlorine monoxide in these systems (59).
In contrast, manganese complexes assist the conversion of ClO2 into ClO2.
Kinetic models postulate the formation of higher oxidation state MnIV and
MnV oxo intermediates in these systems. The catalytic cycle is initiated by oxy-
gen transfer between ClO2 and the catalyst and subsequent reactions include
electron transfer and proton-coupled electron transfer steps (Scheme 5). The
proposed model was validated by simulating the kinetic traces.
Hypochlorous acid is the simplest oxo-acid of chlorine which is involved
in fast equilibria with OCl and also with Cl2 under acidic conditions in the
The Kinetics and Mechanism of Complex Redox Reactions 17
ClO2– ClO–
k1
OH2 + O +
k2
ClO– Cl–
MnIII MnV
ClO3–
k6 ClO2–
ClO2 k–3
k–4 ClO2
k3
k4
O
–
ClO2
ClO2 IV
Mn
+ 2H+
Scheme 5 Kinetic model for the decomposition of ClO2 in the presence of a water-
soluble manganese porphyrine. Reprinted with permission from Hicks, S. D.; Xiong, S.;
Bougher, C. J.; Medvedev, G. A.; Caruthers, J.; Abu-Omar, M. M. J. Porphyrins Phthalocya-
nines 2015, 19, 492–499. Copyright 2015, World Scientific Publishing Company.
presence of Cl. HOCl is a much stronger oxidizing agent than its conjugate
base form, therefore, the oxidation reactions of the HOCl/ClO couple
show marked pH dependencies. These reactions typically follow straightfor-
ward kinetics, and complicated kinetic patterns are rarely observed. As an
exception, the oxidation of pyruvic acid to acetic acid should be mentioned
(60). In this system, a simple 1:1 stoichiometry was confirmed for the entire
pH region, moreover, the reaction is strictly first order in both reactants
above pH 2.5. The entropy of activation is consistent with an oxygen atom
transfer mechanism which is also supported by DFT calculations. Unexpect-
edly, stopped-flow kinetic traces under pH 2.5 show two distinct first-order
phases. It was confirmed that this complexity is caused by the hydration reac-
tion of the substrate which is a fast preequilibrium to the oxidation step.
In recent years, biological relevance of HOCl has generated vast interest
in its redox chemistry. In water treatment technologies, the formation of
chlorinated products is of primary concern (18). In biological systems,
HOCl is formed by nucleophiles in the myeloperoxidase/H2O2/chloride
ion system (61,62) as part of the defense mechanism against pathogens. With
amino compounds, it produces N-chloro-amines (63–67). The formation of
these species is very fast, and the corresponding second-order rate constants
18 Mária Szabó et al.
are within the range 104–108 M1 s1. Earlier studies on the formation of
N-chloramines from ammonia and amino acids revealed that the main reac-
tion path occurs between the deprotonated amine and HOCl as shown in
Eqs. (10)–(12) (62,68–73).
R NH2 + HOCl ¼ R NHCl + H2 O (10)
R NHCl + HOCl ¼ R NCl2 + H2 O (11)
NHCl2 + 2HOCl ¼ NCl3 + H2 O (12)
2NCl3 + 3H2 O ¼ N2 + 3HOCl + 3Cl + 3H + (13)
In water treatment processes, the chlorinating agent is present in excess,
thus, di- or trichlorinated amines are produced (Eqs. 11 and 12) (18). In
addition breakpoint chlorination occurs, i.e., ammonia is completely oxi-
dized leading to the formation of gaseous nitrogen (Eq. 13). In living sys-
tems, the amino acids and peptides are in excess over HOCl and only
N-monochloramines are formed (Eq. 10).
In all of these systems, HOCl is a precursor of the N-chloro species
which are able to penetrate into the cells and cause oxidative stress leading
to cell death. N-chloroamines are not stable in aqueous solution, according
to earlier studies they decompose to ammonia, carbon dioxide, chloride ion,
and carboxyl products (66,74). However, a survey of the literature reveals
contradictions in previous results and indicates the complexity of these reac-
tions (67,75–78). Recently, we have reinvestigated the kinetics of the
decomposition of N-chloroglycine (MCG) under alkaline conditions and
demonstrated that a simple kinetic approach may be misleading in this sys-
tem (79). Our spectrophotometric results were consistent with fast forma-
tion of this molecule (λmax ¼ 255 nm) followed by considerably slower
decomposition. Kinetic measurements were performed by mixing OCl
and glycine which was always used in excess. MCG formed immediately
upon mixing the reactants, and its decay could be monitored conveniently
by UV–vis spectrophotometry. While single exponential kinetic traces were
observed above 250 nm, the experiments indicated the formation of an
intermediate at lower wavelengths (Fig. 4).
The faster of the two first-order steps could be assigned to the decom-
position of MCG. The corresponding rate constant is linearly dependent on
the hydroxide ion concentration. The second step is pH independent and
corresponds to the transformation of an intermediate. The rate constants
did not change upon increasing the concentration of excess glycine, but
the final absorbance increased, indicating that glycine is involved in a side
reaction after the rate-determining step. The formation of ammonia was also
confirmed using the Nessler-test (80).
The Kinetics and Mechanism of Complex Redox Reactions 19
0.9
A 228 nm 0.6
0.3
0.0
0 2500 5000
t (s)
Fig. 4 Kinetic traces for the decomposition of N-chloroglycine (MCG) under alkaline
conditions and at excess glycine concentrations at 228 nm. [MCG]0 ¼ 3.00 103 M,
[OH] ¼ 0.054 M, and [Gly]0 ¼ 1.50 103 (◊), 3.00 103 (□), 1.20 102 ( ),
2.70 102 (△); I ¼ 1.0 M (NaClO4), T ¼ 25.0°C. Reprinted with permission from Szabó, M.;
Baranyai, Z.; Somsák, L.; Fábián, I. Chem. Res. Toxicol. 2015, 28, 1282–1291. Copyright
2015, American Chemical Society.
P1b GLY
P1a t (s)
P4 P2b P3b
P3a P2a
¥
7370
1804
453
I1b I1a
152
MCG
0
9.0 8.5 8.0 4.2 4.0 3.8 3.6 3.4 3.2
(ppm) (ppm)
Fig. 5 1H NMR spectra recorded at various reaction times during the decomposition of
MCG. [Gly]0 ¼ 1.00 102 M, [MCG]0 ¼ 1.00 102 M, [OH] ¼ 0.054 M, T ¼ 25.0°C.
Reprinted with permission from Szabó, M.; Baranyai, Z.; Somsák, L.; Fábián, I. Chem.
Res. Toxicol. 2015, 28, 1282–1291. Copyright 2015, American Chemical Society.
A
3.2
1.6
MCG
0.0
0 2500 5000
t (s)
B
4.8
I1
Intensity × 10−5 (a.u.)
3.2
1.6
I2
0.0
0 2500 5000
t (s)
C
1.5
P1a
Intensity × 10−6 (a.u.)
1.0
P1b
0.5
0.0
0 2500 5000
t (s)
Fig. 6 The intensities of the 1H NMR peaks as a function of time during the decompo-
sition of MCG. [Gly]0 ¼ 1.00 102 M, [MCG]0 ¼ 1.00 102 M, [OH] ¼ 0.054 M,
T ¼ 25.0°C. Reprinted with permission from Szabó, M.; Baranyai, Z.; Somsák, L.; Fábián, I.
Chem. Res. Toxicol. 2015, 28, 1282–1291. Copyright 2015, American Chemical Society.
The Kinetics and Mechanism of Complex Redox Reactions 21
Peaks P1 and P2 are assigned to the trans and cis forms of the main prod-
uct, N-formylglycine. In separate experiments, we also demonstrated that
glyoxalic acid, a potential byproduct in this system, immediately reacts
with glycine and forms a Shiff base (P3). Peak P4 belongs to the formate
ion which appears 2 h after starting the reaction. On the basis of 1H
NMR experiments with the pure compound, the intermediate (I1) of
the reaction was identified as N-oxalylglycine. The formation of this spe-
cies is responsible for the noted increase of final absorbance of the kinetic
traces as a function of glycine excess.
Earlier, it was assumed that the decomposition of N-chloroamino
acids proceeds by the Grob-fragmentation which is a concerted process
(62,68,75,81–83). In the case of N-chloroglycine, formaldehyde was
reported as one of the main products. Our results confirm a different mech-
anism outlined in Scheme 6. The reaction is initiated with the formation of
a carbanion which is consistent with the noted OH dependence of the first
exponential step of the kinetic traces. Once the imine is formed, the reac-
tion may proceed via two parallel pathways. Pathway II is included only to
Scheme 6 The outline of the mechanism of the decomposition of MCG. Reprinted with
permission from Szabó, M.; Baranyai, Z.; Somsák, L.; Fábián, I. Chem. Res. Toxicol. 2015, 28,
1282–1291. Copyright 2015, American Chemical Society.
22 Mária Szabó et al.
demonstrate that the main product could form via formaldehyde as inter-
mediate, but direct experimental evidence does not confirm its existence.
In contrast, pathway III must be operative in order to account for all the
observations in this system. The second kinetic step is assigned to slow
transformation of N-oxalylglycine to MCG. Perhaps the most exciting
aspect of these studies is that direct experimental evidence confirms the
existence of these two species, which have been shown to possess biological
activities.
S2 O8 2 ! 2SO4 • (14)
Both H2O2 and S2 O8 2 are frequently used in AOPs for generating free
radicals. However, these oxidants are rarely efficient in degrading organic
pollutants when employed on their own. Peroxomonosulfate ion (PMS)
is often used as an environmentally friendly replacement of the aforemen-
tioned peroxo species. Its main advantage over hydrogen peroxide is its eas-
ier handling and higher stability. Although PMS has a lower standard
potential, E°ðHSO5 =HSO4 Þ ¼ 1:82 V (89), than PDS, that is still suffi-
ciently high to oxidize various substrates. Many reactions of PMS proceed
faster than those of S2 O8 2 .
Peroxomonosulfate ion, primarily used in its monoprotonated form
(HSO5 ), is the anion of Caro’s acid (peroxomonosulfuric acid, H2SO5).
Potassium peroxomonosulfate is commercially available in the form of a sta-
ble triple salt (2KHSO5KHSO4K2SO4) which is called Oxone. In recent
decades, the use of PMS has increased rapidly in both industrial applications
and fundamental research. The main reasons behind its popularity are several
favorable features such as stability, simple handling, nontoxic nature, good
solubility in water, versatility of the reagent, and low cost. Its oxidation
byproducts (typically sulfate ion) do not pose a threat to aquatic life and con-
sidered environment friendly. These properties make PMS attractive for
large-scale applications.
Apart from its wide industrial and consumer utilizations (such as decol-
orizing agent in denture cleansers, microetchant in electronics, shock oxi-
dizer for swimming pools, repulping agent in papermaking, or oxidizer in
wool treatment), the use of PMS finds ever growing applications in organic
(90,91) and environmental chemistry (92). Interestingly, PMS was proven
to be readily applicable in both fields despite the fact that their objectives are
24 Mária Szabó et al.
O
RCHO
R OR
RCH2JOH
R3CJOH R2NOH
RCOR
R3CJH
O R 3N
Phenol Halogenation
PMS RJX
R R 3P
O
R
NO2 RSR
O R3PKO
R R R
R O
RSO2R
R R
Scheme 7 Examples of the organic oxidation reactions with PMS.
The Kinetics and Mechanism of Complex Redox Reactions 25
1.0
HSO5−
kapp/kref
0.5
I−
Br−
CI−
SO52−
0.0
2.0 5.0 8.0
pH
Fig. 7 pH dependencies of the normalized apparent second-order rate constants deter-
mined in the reactions between PMS– and various halide ions. Medium: 0.10 M NaClO4
(Br, I), 1.0 M NaClO4 (Cl); T ¼ 25.0°C; kref ¼ 2.06 103 M1 s1 (Cl), 7.0 101
M1 s1 (Br), 1.41 103 M1 s1 (I). The absolute values of the kapp rate constant var-
ied by orders of magnitudes for different halides, therefore the y-axis was normalized by
dividing by kref to facilitate comparison of the three curves. Reprinted with permission
from Lente, G.; Kalmár, J.; Baranyai, Z.; Kun, A.; Kek, I.; Bajusz, D.; Takács, M.; Veres, L.;
Fábián, I. Inorg. Chem. 2009, 48, 1763–1773. Copyright 2009, American Chemical Society.
(kapp) drops sharply in the pH region 7–10 (Fig. 7). This observation can be
interpreted by two parallel oxidation pathways with the acidic and basic
forms of the oxidant which are in fast acid–base equilibrium with each other.
The pH dependence clearly shows that SO5 2 is a considerably less active
oxidant than HSO5 . A similar property was observed during the oxidation
of SCN (102) and 1,10-phenanthroline (104).
In the reaction of PMS with SCN, further oxidation of the primary
product, hypothiocyanite ion (OSCN), also takes place and the rate con-
stant of the second step is about an order of magnitude higher than that of the
first one (Eqs. (20 and 21):
Scheme 8 Kinetic model for the initial stage of the oxidation FeLn 2 + with PMS, where
L is an N-heteroaromatic ligand (109).
30 Mária Szabó et al.
0.6
A (510 nm)
0.3
0.0
0.0 4.0 8.0
t (h)
Fig. 8 Kinetic trace detected in the reaction between PMS and FeðphenÞ3 2 + . [PMS]0 ¼
h i
11.4 mM; FeðphenÞ3 2 + ¼ 75:3 μM; [H2SO4] ¼ 1.01 102 M; T ¼ 25.0°C; path length ¼
0
1.0 cm.
Scheme 9 Kinetic model for the disproportionation of FeðphenÞ3 3 + (S1 and S2) and the
catalytic role of phenO (S3 and S4) (110).
The N-oxidations of the ligands bipy and tpy are significantly slower
than those of the corresponding Fe(II) complexes and most likely this is
the reason why bipyO and tpyO play no apparent role in the redox processes
between PMS and the corresponding complexes.
The PMS FeðbipyÞ3 2 + system bears no unusual features other than the
adduct formation, whereas the PMS FeðtpyÞ2 2 + oxidation reaction shows
autocatalysis.
The independent study on the oxidation of phen by PMS presented fur-
ther unique features. For a long time, the di-N-oxide derivative of phen
(phenO2) was considered a nonexistent compound due to the rigid planar
structure of phen and the limited space in the bay area of the molecule
(114,115). However, at last, the di-N-oxide was prepared by using the mix-
ture of F2, H2O, and CH3CN (116), but it still remained the prevailing
opinion that phenO2 cannot be produced by the use of peroxo compounds.
We have shown that the stepwise oxidation of phen by PMS results in
the formation of phenO, which is oxidized further to 1,10-
phenanthroline-N,N0 -dioxide (phenO2) in neutral aqueous solution. The
overall oxidation features a complex pH dependence: the pH significantly
32 Mária Szabó et al.
affects the rate of the reaction and also controls the number of feasible oxi-
dation steps. Under strongly acidic conditions, a one-step process occurs and
HphenO+ (the protonated mono-N-oxide) is the sole product of the reac-
tion, which is protected from further oxidation steps by an intramolecular
hydrogen bond (Scheme 11). The rate of the mono-N-oxidation shows a
maximum value close to the neutral pH region. Such pH dependence
can be interpreted by considering that the protonation of the substrate gives
less opportunity for the oxidative attack on the nitrogen atom under acidic
conditions. Under basic conditions, the deprotonation of HSO5 deceler-
ates the oxidation because SO5 2 is much less reactive than the mono-
protonated form, in a similar manner to the oxidation reactions of halide
ions (101) and thiocyanate ion (102).
In nearly neutral medium, the mono-N-oxide (HphenO+) undergoes
deprotonation (pKa ¼ 7.3), which opens additional paths for the oxidation.
A multiphase kinetic pattern was found under such conditions (Scheme 11).
Singular value decomposition analysis of the spectra indicated the presence
of five absorbing species (117). At appropriately selected wavelengths, four
well-defined phases can be identified in the overall reaction, which are
clearly separated by three extrema in the kinetic traces (Fig. 9). Thus, the
new absorbing components are produced in consecutive processes. When
the oxidant is used in excess, the maxima and minima of the curves practi-
cally occur at the same reaction time when the initial phen concentration is
varied. This unique feature proves that the reaction order with respect to the
limiting reactant, phen, and its derivatives produced in the consecutive steps
N N O
k1H
+ H +
N PMS N H
PMS
Hphen+ HphenO+
N k1 N k2 N
O
k3 k4
Intermediate Products
O
N PMS N O PMS N PMS PMS
Fig. 9 Normalized kinetic curves recorded under different initial concentration of phen.
εapp is obtained by subtracting the nearly constant contribution of PMS from the
detected absorbance and the division of the residual curves by the total concentration
of phen. [PMS]0 ¼ 9.77 mM; [phen]0 ¼ 7.62 μM; 12.7 μM; 25.4 μM; 38.1 μM; 50.8 μM and
76.2 μM; [phosphate]tot ¼ 1.01 101 M; pH 6.7; T ¼ 25.0°C, λ ¼ 243 nm; path length
1.0 cm. Reprinted with permission from Beller, G.; Szabó, M.; Lente, G.; Fábián, I. J. Org.
Chem. 2016, 81, 5345–5353. Copyright 2016, American Chemical Society.
is one. Otherwise the positions of the extrema would change with [phen]0.
As expected in such a situation, the normalized kinetic traces are practically
identical within the limits of experimental error (Fig. 9).
The kinetic model for this system is rather complex and a comprehensive
evaluation method was used which solves numerically the corresponding
differential equation system and simultaneously fits the kinetic traces by
using a nonlinear least squares algorithm (107).
Several reports are found in the literature on the syntheses of N-oxides by
the conversion of the derivatives of pyridine (118,119), pyrazine (120,121),
quinoxaline (121), or tetrazole (122). However, only limited kinetic infor-
mation is available for these reactions (104,123). As shown here, kinetic and
mechanistic information about organic transformations very often could
help in systematically fine tuning the initial conditions (concentrations of
the reactants, pH, temperature, etc.) in order to design experimental proto-
cols for synthetic purposes.
Quite interestingly, PMS is often used for modeling oxidation reactions
of H2O2, although the two oxidants show distinct features. As noted earlier,
hydrogen peroxide is the most common precursor of the OH• radical which
reacts very rapidly, typically at diffusion controlled rates with the substrates.
34 Mária Szabó et al.
In contrast, the hydroxyl radical is rarely formed from PMS and the reactions
of this oxidant proceed mainly via oxygen atom transfer steps, although one-
electron radical type reactions are also possible including the formation of
SO4 • as a reactive intermediate.
The reactions of H2O2 with iron-containing complexes are frequently
used for modeling O2 activation in biochemical processes (124). In these
biomimetic studies, the iron complexes act as synthetic model compounds
of heme or nonheme enzymes. When H2O2 reacts with an iron(III)complex
(LFeIII), very often the first step of the catalytic cycle is the formation of a
hydroperoxo intermediate (LFeIII–OOH). This species can decompose
via distinct pathways to give oxidants such as OH• or OOH• radicals or
high-valent iron complexes (LFeIV¼O or LFeV¼O). On the other hand,
when PMS is used as an oxidant, the formation of hydroperoxo species is
highly unlikely and catalytic cycles more often involve the formation of
high-valent iron-oxo transient species (125–128).
The oxidation of 2,4,6-trichlorophenol (TCP) with H2O2 and PMS
catalyzed by a water-soluble iron(III) porphyrin Fe(TPPS)+, where
TPPS ¼ meso-tetra(4-sulfonatophenyl)porphine, serves as an excellent
example to demonstrate this principle (125,129). It was found that in the
Fe(TPPS)+–H2O2–TCP system, the more active form of the catalyst is
the corresponding iron(III)hydroperoxo complex (Fe(TPPS)–OOH+).
The transformation of the catalyst into a much less active form was also
observed. The latter species was proposed to be an FeV oxo complex, which
is produced in a heterolytic O–O bond cleavage. Thorough understanding
of the mechanisms of such catalytic oxidations requires detailed studies on
the reaction of the catalyst and the oxidant in the absence of the substrate.
In the absence of TCP, the oxidation of Fe(TPPS)+ by H2O2 shows
multiphase kinetics and the first detectable intermediate is the FeV oxo spe-
cies (125). Most likely the hydroperoxo complex forms, too, but it might be
a very short-lived intermediate, which undergoes fast O–O bond cleavage.
At H2O2 excess, the iron(V) complex is further oxidized to give an inter-
mediate (Int) which is likely to contain a high-valent iron-oxo center and
a hydroxyl group. The final products of the reaction are the iron(III) com-
plex of the biliverdin analog formed from TPPS and 4-sulfobenzoic acid
(P1 and P2 in Scheme 12). The further oxidation steps are responsible for
the unusual kinetic phenomena observed during the catalytic oxidation of
TCP and the degradation of the catalyst.
In the case of PMS, the formation of a hydroperoxo species is unlikely.
Although the catalytic activity of the iron(V) oxo complex toward TCP is a
The Kinetics and Mechanism of Complex Redox Reactions 35
O H2O2 H2O2
H2O2
Fe(TPPS)+ Fe(TPPS)–OOH+ FeV(TPPS)+ Int P 1 + P2
O OH
Cl Cl Cl Cl
+ HCl
O Cl
DCQ TCP
Scheme 12 Fe(TPPS)+ catalyzed oxidation of TCP in the presence of excess H2O2.
O
PMS PMS PMS
Fe(TPPS)+ FeV(TPPS)+ Int P1 + P2
O OH
Cl Cl Cl Cl
+ HCl
O Cl
DCQ TCP
Scheme 13 Fe(TPPS)+ catalyzed oxidation of TCP in the presence of excess PMS.
mixing the reactants, and the concentrations of the transient species are
determined by the kinetics of the individual reactions steps. To some extent,
the steady-state concentrations of the intermediates can be varied by chang-
ing the experimental conditions. For example, changing the concentration
ratios of the reactants will alter the relative kinetic significance of the com-
peting reaction paths and also the concentration profiles of the intermedi-
ates. Thus, there is a possibility to affect the dominant reaction paths and
to separate the kinetic roles of the intermediates. However, there are only
limited options to utilize concentration-dependent studies, because the rate
of each reaction step is altered as a function of the initial concentrations of
the reactants. Photoinitiation may be useful to overcome this problem.
Earlier we found unexpected kinetic phenomena in diode array UV–vis
spectrophotometers (130). In these instruments, a relatively high energy
undispersed light beam enters the sample. If the chemical system contains
light sensitive species, the incoming light may trigger photoinitiated pro-
cesses. As shown in Scheme 14, such an instrument can be used as a
photoreactor.
The intensity and the spectral range of the entering light beam can be
controlled mainly by putting optical filters in the light path. The progress
of the reaction can be monitored spectrophotometrically by the same instru-
ment. This experimental setup was proven to be very valuable in studying
several complex processes as shown in the following examples.
The oxidation of 2,4,6-trichlorophenol (TCP) is often used to model the
efficiency of AOPs. When hydrogen peroxide is used as an oxidizing agent,
the reaction is slow and requires the use of some catalysts. The kinetics can
conveniently be studied by following the formation of Cl as a final product
using direct potentiometry. Lente and Espenson demonstrated that even the
fluorescent room light of a laboratory can accelerate the oxidation of TCP
by H2O2 and KHSO5 using Fe(TPPS)+ as a catalyst. (131) It was shown that
Diode array
D lamp Slit
Light
ð25Þ
DCQ → DCQ
* 1 * 3 (S2)
intersystem crossing step. This species reacts with water producing DCQw
which is either an adduct or a transition state for the subsequent two path-
ways, the competition of which defines the final product distribution.
Diode array spectrophotometers could also be used to explore crucial
details of the autoxidation of sulfur(IV) in aqueous solution. This reaction
is one of the main sources of acid rain formation and is also important in
industrial processes such as flue gas desulfurization. For this reason, the
kinetics and the mechanism of this reaction were extensively studied under
a variety of conditions (133). There seems to be an agreement that sulfur(IV)
is not oxidized directly by O2 because this reaction is spin forbidden. Thus,
the autoxidation is always initiated by the direct reaction between sulfur(IV)
and an oxidant which acts as a catalyst. Various mechanisms were proposed
for these reactions which include radical, nonradical, or the combination of
these two types of reactions. Several transition metal ions catalyze the autox-
idation and, in a general sense, the kinetic model found in the iron(III) cat-
alyzed autoxidation (134) applies to many other cases. This model is based
on a redox cycle which involves the metal ion (Scheme 16). The model
specifies HSO3 as the reactive form of S(IV) but it can be any other form
of S(IV) depending on the pH.
First the sulfite ion radical, SO3 • is formed which readily produces the
peroxomonosulfate ion radical, SO5 • , with O2. In fact, this reaction should
be considered as the activation step of dioxygen because SO5 • is an
extremely reactive oxidant which is involved in various subsequent reaction
steps. A radical type chain reaction commences which regenerates the
oxidized form of the catalyst and yields the final product, SO4 2 =HSO4 . As
it was demonstrated earlier, complex formation and protolytic equilibria
may complicate the kinetics of the reaction further (134). The steady-state
concentrations of the reactive intermediates in this system depend on the
experimental conditions in a very complex way and predictions regarding
the significance of the individual reaction paths are uncertain.
Spectral changes at the characteristic spectral band of sulfur(IV) confirm a
slow concentration decay under continuous illumination in a diode array
spectrophotometer in the presence of dissolved oxygen (Fig. 10) (112).
This observation clearly confirmed that the autoxidation of sulfur(IV)
can be driven by light. The following sequence of reactions was proposed
for the interpretation of the experimental results. (The formula H2OSO2
is used in the equations because it is the dominant form of sulfur(IV) under
the acidic conditions applied.)
0.9
15 min
0.6
A
0.3
0.0
240 270 300 330
l (nm)
Fig. 10 Autoxidation of sulfur(IV) during continuous irradiation in a HP-8453 spectro-
photometer. [S(IV)] ¼ 2.00 mM; [O2] ¼ 0.23 mM; [H2SO4] ¼ 0.50 M; path length 1.0 cm;
V ¼ 2.00 cm3; T ¼ 25.0°C. Reprinted with permission from Kerezsi, I.; Lente, G.; Fabian, I. Dal-
ton Trans. 2006, 955–960. Copyright 2006, The Royal Society of Chemistry.
40 Mária Szabó et al.
0.4
c
A (276 nm)
a b
0.3
0.2
0 100 200
t (s)
Fig. 11 Kinetic traces measured in a diode array instrument during the photoinitiated
autoxidation of sulfite ion. [Ce3+] ¼ 0.50 mM; [S(IV)] ¼ 1.00 mM; [O2] ¼ 0.19 mM (a and b),
0.22 mM (c); [H2SO4] ¼ 0.10 M; path length 1.0 cm; V ¼ 3.00 cm3; T ¼ 25.0°C; ti ¼ 5 s;
td ¼ 0 s (a), 5 s (b), 15 s (c); λ ¼ 276 nm. Reprinted with permission from Kerezsi, I.;
Lente, G.; Fabian, I. J. Am. Chem. Soc. 2005, 127, 4785–4793. Copyright 2005, American
Chemical Society.
The Kinetics and Mechanism of Complex Redox Reactions 41
Ce3+ O2
SO3−
.
Initiation: SO2
SO5−
.
Ce3+ + hn Ce4+
SO2
HSO4−
SO4−
.
Ce3+ HSO4−
2−
S2O8 Termination
Scheme 17 Kinetic model for the photoinitiated Ce(III)-catalyzed autoxidation of
sulfur(IV). Reprinted with permission from Kerezsi, I.; Lente, G.; Fabian, I. J. Am. Chem.
Soc. 2005, 127, 4785–4793. Copyright 2005, American Chemical Society.
1.0
0.5
0.0
0 5 10 15
ti (s)
Fig. 12 Fraction of the Ce(III) catalyzed autoxidation of S(IV) occurring in the dark (Q) as
a function of illumination time (ti) during experiments with intermittent dark periods.
Solid line: best fit to the model outlined in Scheme 17. [Ce3+] ¼ 0.50 mM; [S(IV)] ¼
1.00 mM; [H2SO4] 0.10 M; V ¼ 3.00 cm3; T ¼ 25.0°C; td ¼ 90 s. Reprinted with permission
from Kerezsi, I.; Lente, G.; Fabian, I. J. Am. Chem. Soc. 2005, 127, 4785–4793. Copyright
2005, American Chemical Society.
transfer between H2OSO2 and I. Such a reaction was proposed before in a
related system (112). Reactions S1–S3 (Scheme 18) are the initiation steps in
this process. They are written as nonelementary reactions because their inti-
mate details could not be explored. However, it is quite possible that these
reactions include a hydrated electron and a superoxide radical.
It was assumed that the consumption of O2 in the initiation reactions is
negligible compared to that in the chain-carrying steps, and Eq. (30) was
derived using the long-chain approach.
vffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
u
u aI NI + aS NS k2S4 ½I 2 ðp1 ½SðIVÞ + p1 ½I ½SðIVÞÞ2
u
v¼t
kS10 ðp1 ½SðIVÞ + p1 ½I ½SðIVÞÞ2 + kS11 kS4 ½I 2 ðp1 ½SðIVÞ + p1 ½I ½SðIVÞÞ + kS11 kS4 ½I 4
(30)
where NI and NS are the absorbed photon count per unit volume for iodide
ion and S(IV), respectively, while αI and αS are the corresponding quantum
efficiencies. Parameters p1 and p2 are given as follows:
I + HSO3 → SO3 + I + H
• − •− − +
v5b= kS5b[I ][HSO3 ]
• − (S5b)
I2 + I2 → I3 + I
•− •− − − v12= kS12[I2•−]2 (S12)
7.5
v0 (mM/s)
5.0
2.5
0.0
0.0 0.2 0.4 0.6
[I−] (mM)
Fig. 13 The initial rate as a function of iodide ion concentration in the photoinitiated
and iodide-catalyzed autoxidation of sulfur(IV). The solid lines show the best fit on
the basis of the proposed model (Scheme 18). [S(IV)] ¼ 3.00 (■), 2.00 (♦), 1.00 (▲),
and 0.70 mM (●); [H2SO4] ¼ 0.575 M; V ¼ 3.00 cm3; T ¼ 25.0°C. Reprinted with permission
from Kerezsi, I.; Lente, G.; Fabian, I. Inorg. Chem. 2007, 46, 4230–4238. Copyright 2007,
American Chemical Society.
10.0
v0 (µM/s)
5.0
0.0
0.0 1.0 2.0
pH
Fig. 14 The initial rate as a function of pH in the photoinitiated and iodide-catalyzed
autoxidation of sulfur(IV). The solid line shows the best fit on the basis of the proposed
model (Scheme 18). [S(IV)]) ¼ 2.00 mM; [I] ¼ 0.20 mM; μ ¼ 1.0 M (Na,H)ClO4;
V ¼ 3.00 cm3; T ¼ 25.0°C. Reprinted with permission from Kerezsi, I.; Lente, G.; Fabian, I.
Inorg. Chem. 2007, 46, 4230–4238. Copyright 2007, American Chemical Society.
c
f
0.06
g
h
A (460 nm)
0.03
0.00
0 100 200
t (s)
Fig. 15 Kinetic curves in the photoinitiated reaction of I2 with ClO3 . Solid lines show the
best fit on the basis of the proposed kinetic model (Scheme 19). [I2] ¼ 88 μM; ½ClO3 ¼
25:1 mM (c, h, i), 16.7 mM (f ), 8.3 mM (g); [H+] ¼ 0.948 M (c, f, g), 0.237 M (h), 0.356 M (i);
continuous illumination; T ¼ 25.0°C. Reprinted with permission from Galajda, M.; Lente, G.;
Fabian, I. J. Am. Chem. Soc. 2007, 129, 7738–7739. Copyright 2007, American Chemical
Society.
0.2
A (460 nm)
Dark (40–500 s)
0.1
Continuous
illumination
0.0
0 300 600
t (s)
Fig. 16 Kinetic curve measured in the photoinitiated reaction of I2 with ClO3 . A long
dark period was inserted into the measurement to prove the fact that no light is nec-
essary to maintain the reaction in the rapidly decreasing region. [I2] ¼ 0.39 mM;
½ClO3 ¼ 25 mM; [H+] ¼ 0.948 M; T ¼ 25.0°C. Reprinted with permission from
Galajda, M.; Lente, G.; Fabian, I. J. Am. Chem. Soc. 2007, 129, 7738–7739. Copyright
2007, American Chemical Society.
The Kinetics and Mechanism of Complex Redox Reactions 47
Scheme 20 The general scheme of the modular Avantes photoreactor. Reprinted with
permission from Ditroi, T.; Kalmar, J.; Pino-Chamorro, J. A.; Erdei, Z.; Lente, G.; Fabian, I. Pho-
tochem. Photobiol. Sci. 2016, 15, 589–594. Copyright 2016, The Royal Society of Chemistry
and Owner Societies.
Light to spectrometer
lamp light
Adjustable source
Fixed
Fixed
Sample
Adjustable
Cable to
Mirror plug Magnetic stirrer Mirror spectrometer
Flow in-and outlet (below) plug
Fig. 17 The scheme and the photo of the sample holder of the modular Avantes
photoreactor. Reprinted with permission from Ditroi, T.; Kalmar, J.; Pino-Chamorro, J. A.;
Erdei, Z.; Lente, G.; Fabian, I. Photochem. Photobiol. Sci. 2016, 15, 589–594. Copyright
2016, The Royal Society of Chemistry and Owner Societies.
of the excitation light and was not able to trigger photochemical reactions in
the photosensitive systems studied so far. This feature makes it possible to
monitor the thermal reactions during the dark periods. As an example,
the results obtained in the ClO3 I2 reaction are shown in Fig. 18.
One of the kinetic traces was obtained with continuous illumination. In
the other case, the excitation light was turned off after 60 s. Completion of
the reaction requires a longer time in the dark but the absorbance decays are
essentially parallel in the two experiments. This observation is consistent
with the kinetic model proposed for this reaction (Scheme 19). It is an inher-
ent feature of autocatalytic systems that the autocatalyst accumulates to a
The Kinetics and Mechanism of Complex Redox Reactions 49
B: dark
0.2
0.1
0.0
0 100 200
t (s)
Fig. 18 Kinetic traces detected in the chlorate–iodine reaction. [I2] ¼ 0.38 mM;
½ClO3 ¼ 25 mM; [HClO4] ¼ 1.0 M; path length: 1.00 cm; T ¼ 25.0°C; V ¼ 3.00 cm3; stir-
ring: 800 rpm. Curve A: continuous illumination. Curve B: illumination switched off after
60 s. Reprinted with permission from Ditroi, T.; Kalmar, J.; Pino-Chamorro, J. A.; Erdei, Z.;
Lente, G.; Fabian, I. Photochem. Photobiol. Sci. 2016, 15, 589–594. Copyright 2016, The
Royal Society of Chemistry and Owner Societies.
certain concentration level before the reaction significantly speeds up. Con-
tinuous illumination steadily generates the autocatalyst and its “critical” con-
centration is reached earlier than in experiments when illumination is turned
off. After this point, the thermal reaction steps become the main source of
the autocatalyst and the contribution of photolytic reactions to the kinetics
can be neglected.
Testing the applicability of the photoreactor in various reactive systems
revealed that it also makes possible monitoring kinetic processes in hetero-
geneous systems. Such results are discussed in the following section.
Scheme 21 Kinetic model for the photodegradation of salicylic acid (SA) in the pres-
ence of suspended silica–titania aerogel (A13). The symbol hν indicates that photons
take part in a reaction step. E is the molar absorption coefficient of SA and l is the optical
path length (145).
The Kinetics and Mechanism of Complex Redox Reactions 53
Adsorption
Adsorption
80
90 Control Control
60
A13
A13
80 40
Extrapolation Extrapolation
20
c/c 0 (%)
c/c 0 (%)
Salicylic acid (SA) Methylene blue (MB)
70
99
98 Adsorption 99 Adsorption
97
96 98
0 50 100 150 0 50 100 150
t (min) t (min)
Fig. 20 Experimental kinetic curves of the photodegradation of salicylic acid (SA, left
panel) and methylene blue (MB, right panel) in the absence (●) and in the presence
of suspended titania–silica aerogel A13 (■). The bottom figures were magnified from
the top ones. All kinetic curves were recorded in an immersion-type batch photoreactor
by offline UV–vis quantification. Continuous lines are the results of mathematical sim-
ulation based on the extended Langmuir–Hinshelwood kinetic model (Scheme 21).
Dashed lines represent extrapolated kinetic curves calculated without taking into
account the kinetic effect of the adsorption of the substrate on the surface. Reprinted
with permission from Lazar, I.; Kalmar, J.; Peter, A.; Szilagyi, A.; Gyori, E.; Ditroi, T.;
Fabian, I. Appl. Surf. Sci. 2015, 356, 521–531. Copyright 2015, Elsevier B.V.
Scheme 22 Kinetic model for the adsorption of methylene blue (MB) on silica aerogel
particles. A free adsorption site on the aerogel is symbolized by S, and an occupied site
by SMB. The first process (S1 and S2) is the reversible adsorption of the dye, and the
second process (S3 and F4) is the reversible aggregation of those aerogel particles
which are covered by MB. The time-dependent concentrations of dissolved MB, free
and covered aerogel particles, and aggregates are [MB], [S], [SMB] and [aggr], respec-
tively. The initial (total) concentrations of MB and the aerogel are cMB and cgel, respec-
tively. Time-dependent surface coverage is θ. The adsorptive capacity of the aerogel is
s ¼ 48 μmol/g. The rate constants (kS1 kS4) were determined by global kinetic data
fitting (152).
The Kinetics and Mechanism of Complex Redox Reactions 55
The known UV–vis spectrum of the dye and the apparent absorbance
spectrum of the initial aerogel suspension were incorporated into the model.
Eventually, a global kinetic data fitting proved that the two-step model
(Scheme 22) adequately describes the experimental traces.
To complete the mechanistic study, the morphological characterization
of the silica aerogel was performed by SEM and N2 porosimetry (152). The
suspension of silica aerogel was further characterized by NMR
cryoporometry (153) and NMR diffusiometry (154,155). These methods
gave excellent supporting information to elaborate further the mechanistic
aspects of the kinetics of adsorption. It was established that silica aerogel
retains its open mesoporous structure while dispersed in water. The self-
diffusion of water is somewhat hindered inside the pores, but the particles
are highly permeable for the solvent. Thus, it was further proved by the
structural study that the diffusion and subsequent adsorption of small mol-
ecules cannot be prolonged inside the pores of silica aerogel.
An additional interesting observation was made during the above
detailed adsorption experiments. The clean walls of the spectrophotometric
cuvette used in the study also adsorbed methylene blue. The kinetics of the
phenomenon were investigated in detail (156), and the results were found to
be in good agreement with previously published results (157).
The above examples demonstrate well the possible gains of adapting the
methodology of homogeneous reaction kinetics for studying non-
homogeneous physicochemical processes. The usefulness of this approach
lies in collecting indirect information on the mechanistic aspects of compli-
cated reactions which cannot be studied by any direct means. In this sense,
the approach described earlier can open new horizons in understanding the
mechanisms of interface processes, heterogeneous catalytic processes, elec-
trode reactions, and other elusive nonhomogeneous systems.
7. CONCLUDING REMARKS
Because of the diversity of complex redox processes, it is difficult to
suggest a bulletproof strategy for exploring their mechanisms. In general,
the stoichiometry as a function of reaction time, the final stoichiometry,
and the kinetic features need to be studied under as broad experimental con-
ditions as possible. In many cases, thorough characterization of the reactive
intermediates is the key to in-depth understanding of the mechanism. While
simplified methods may provide essential information on various details, the
56 Mária Szabó et al.
pitfalls of using such techniques are obvious. Thus, simultaneous and critical
evaluation of all available experimental results is essential to validate the con-
clusions. Whenever it is feasible, the experiments should be complemented
with theoretical calculations on potential reaction paths and structures of the
intermediates and transition states.
In the last few decades, enormous developments have been achieved in
computational methods. These techniques opened new dimensions in col-
lecting, evaluating, and fitting experimental data as well as predicting energy
profiles for even complex reactive systems. There is an increasing number of
examples when calculated geometries and energies for reactants, products,
intermediates, and transition states corroborate mechanistic conclusions
obtained on the basis of experimental observations. Nevertheless, there is
plenty of room for improvement in order to obtain more precise theoret-
ical predictions. In solution phase, particularly in water, solute–solvent
interactions may have tremendous effects on the kinetic behavior of a reac-
tive system. As of yet, the arsenal of computational chemistry is not strong
enough to handle such problems with sufficiently high precision. How-
ever, this area is intensively studied and these efforts coupled with the ever
growing computational capacities are expected to bring breakthrough
results in the future.
As far as experimental methodologies are concerned, we have witnessed
massive developments in this area, too. The new devices offer new oppor-
tunities to collect larger experimental datasets with higher precision, time
resolution, and sensitivities than before. Many of the recent studies have
explored the possibilities of the nonconventional use of experimental
methods for kinetic purposes. Thus, NMR, IR, and CD spectroscopies have
been used for monitoring the progress of chemical reactions. Mass spectrom-
etry has become an invaluable tool to identify and characterize reactive
intermediates in a number of reactions. Perhaps these techniques do not
match the performance of well-established kinetic methods, but, there is
a promising tendency to construct dedicated instruments or accessories
which satisfy better the requirements of kinetic studies. As an example, spe-
cial low-field NMR spectrometers have been introduced in the market
recently with the primary objective of studying reaction kinetics.
Recent studies on complex reaction mechanisms made clear that reliable,
fairly detailed kinetic models can be postulated for these systems. The results
have clarified fundamental aspects of solution phase reaction kinetics and
provided a solid chemical background for practical applications. These
achievements will certainly inspire further research in this field.
The Kinetics and Mechanism of Complex Redox Reactions 57
ACKNOWLEDGMENTS
This research was supported by the Hungarian Science Foundation (OTKA: NK-105156), as
well as by the EU and cofinanced by the European Regional Development Fund under the
project GINOP-2.3.2-15-2016-00008. J.K. is indebted to the University of Debrecen (RH/
751/2015) and also to the Ministry of Human Capacities of Hungary (New National
Excellence Program) for financial support.
REFERENCES
1. Hush, N. S. Trans. Faraday Soc. 1961, 57, 557–580.
2. Marcus, R. A. Annu. Rev. Phys. Chem. 1964, 15, 155–196.
3. Quite often the reactions show marked pH dependencies associated with the acid–base
equilibria of the reactive components, i.e., the reacting species exist in different pro-
tonated forms in aqueous solution. The protolytic equilibria are typically established
at diffusion controlled rate and the corresponding reactions can be treated as fast
preequilibria. Consequently, the concentration ratios of the various protonated com-
ponents are determined by the actual pH. In this paper, we follow the commonly
accepted practice in the literature, and use only one name or formulae for a component
which actually corresponds to all protonated forms of a reactant or intermediate being in
equilibrium. Distinction between the different forms is made only when it is required
by the clarity of presentation.
4. Forni, L.; Bahnemann, D.; Hart, E. J. J. Phys. Chem. 1982, 86, 255–259.
5. Staehelin, J.; Hoigne, J. Environ. Sci. Technol. 1982, 16, 676–681.
6. B€uhler, R. E.; Staehelin, J.; Hoigne, J. J. Phys. Chem. 1984, 88, 2560–2564.
uhler, R. E.; Hoigne, J. J. Phys. Chem. 1984, 88, 5999–6004.
7. Staehelin, J.; B€
8. Tomiyasu, H.; Fukutomi, H.; Gordon, G. Inorg. Chem. 1985, 24, 2962–2966.
9. Chelkowska, K.; Grasso, D.; Fabian, I.; Gordon, G. Ozone Sci. Eng. 1992, 14, 33–49.
10. Bard, A. J.; Parsons, R.; Jordan, K. Standard Potentials in Aqueous Solution; Marcek
Dekker, Inc.: New York, 1985; p 829.
11. Nemes, A.; Fabian, I.; Gordon, G. Inorg. React. Mech. 2000, 2, 327–341.
12. Nemes, A.; Fabian, I.; Gordon, G. Ozone Sci. Eng. 2000, 22, 287–304.
13. Nemes, A.; Fabian, I.; van Eldik, R. J. Phys. Chem. A 2000, 104, 7995–8000.
14. Thorell, H. D.; Stenklo, K.; Karlsson, J.; Nilsson, T. Appl. Environ. Microbiol. 2003, 69,
5585–5592.
15. Streit, B. R.; DuBois, J. L. Biochemistry 2008, 47, 5271–5280.
16. Gordon, G.; Kieffer, R. G.; Rosenblatt, D. H. Prog. Inorg. Chem. 1972, 15, 201–286.
17. Sant’Anna, R. T. P.; Santos, C. M. P.; Silva, G. P.; Ferreira, R. J. R.; Oliveira, A. P.;
Cortes, C. E. S.; Faria, R. B. J. Braz. Chem. Soc. 2012, 23, 1543–1550.
18. White, G. C. Handbook of Chlorination and Alternative Disinfectants; Van Nostrand
Reinhold: New York, 1992.
19. Vogt, H.; Balej, J.; Bennett, J. E.; Wintzer, P.; Sheikh, S. A.; Gallone, P.;
Vasudevan, S.; Pelin, K. In: Ullmann’s Encyclopedia of Industrial Chemistry; Wiley-
VCH Verlag GmbH & Co. KGaA: Weinheim, Germany, 2000.
20. Collman, J. P.; Boulatov, R.; Sunderland, C. J.; Shiryaeva, I. M.; Berg, K. E. J. Am.
Chem. Soc. 2002, 124, 10670–10671.
21. Odeh, I. N.; Francisco, J. S.; Margerum, D. W. Inorg. Chem. 2002, 41, 6500–6506.
21a. Csordas, V.; Bubnis, B.; Fabian, I.; Gordon, G. Inorg. Chem. 2001, 40, 1833–1836.
22. Wang, L.; Margerum, D. W. Inorg. Chem. 2002, 41, 6099–6105.
23. Noss, C. I.; Hauchman, F. S.; Olivieri, V. P. Water Res. 1986, 20, 351–356.
24. Tan, H. K.; Wheeler, W. B.; Wei, C. I. Mutat. Res. 1987, 188, 259–266.
58 Mária Szabó et al.
25. Napolitano, M. J.; Stewart, D. J.; Margerum, D. W. Chem. Res. Toxicol. 2006, 19,
1451–1458.
26. Darkwa, J.; Olojo, R.; Chikwana, E.; Simoyi, R. H. J. Phys. Chem. A 2004, 108,
5576–5587.
27. Ison, A.; Odeh, I. N.; Margerum, D. W. Inorg. Chem. 2006, 45, 8768–8775.
28. Stewart, D. J.; Napolitano, M. J.; Bakhmutova-Albert, E. V.; Margerum, D. W. Inorg.
Chem. 2008, 47, 1639–1647.
29. Fabian, I.; Gordon, G. Inorg. Chem. 1992, 31, 2144–2150.
30. Fabian, I.; Gordon, G. Inorg. Chem. 1991, 30, 3994–3999.
31. Orban, M.; Dateo, C.; De Kepper, P.; Epstein, I. R. J. Am. Chem. Soc. 1982, 104,
5911–5918.
32. Peintler, G.; Cseko, G.; Petz, A.; Horvath, A. K. Phys. Chem. Chem. Phys. 2010, 12,
2356–2364.
33. Horváth, A. K. J. Phys. Chem. A 2005, 109, 5124–5128.
34. Liu, Y.; Zhou, W.; Zheng, T.; Zhao, Y.; Gao, Q.; Pan, C.; Horváth, A. K. J. Phys.
Chem. A 2016, 120, 2514–2520.
35. Kormanyos, B.; Nagypal, I.; Peintler, G.; Horvath, A. K. Inorg. Chem. 2008, 47,
7914–7920.
36. Orban, M.; De Kepper, P.; Epstein, I. R. J. Phys. Chem. 1982, 86, 431–433.
37. Orban, M.; Epstein, I. R. J. Phys. Chem. 1982, 86, 3907–3910.
38. Maselko, J.; Epstein, I. R. J. Chem. Phys. 1984, 80, 3175–3178.
39. Nagypal, I.; Epstein, I. R. J. Phys. Chem. 1986, 90, 6285–6292.
40. Horváth, A. K.; Nagypál, I. J. Phys. Chem. A 1998, 102, 7267–7272.
41. Pan, C. W.; Stanbury, D. M. J. Phys. Chem. A 2014, 118, 6827–6831.
42. Gauffre, F.; Labrot, V.; Boissonade, J.; De Kepper, P.; Dulos, E. J. Phys. Chem. A 2003,
107, 4452–4456.
43. Horvath, D.; Toth, A. J. Chem. Phys. 1998, 108, 1447–1451.
44. Fuentes, M.; Kuperman, M. N.; De Kepper, P. J. Phys. Chem. A 2001, 105,
6769–6774.
45. Virányi, Z.; Horváth, D.; Tóth, Á. J. Phys. Chem. A 2006, 110, 3614–3618.
46. Huff Hartz, K. E.; Nicoson, J. S.; Wang, L.; Margerum, D. W. Inorg. Chem. 2003, 42,
78–87.
47. Rolia, E.; Chakrabarti, C. L. Environ. Sci. Technol. 1982, 16, 852–857.
48. Cseko, G.; Horvath, A. K. J. Phys. Chem. A 2012, 116, 2911–2919.
49. Horváth, A. K.; Nagypál, I.; Peintler, G.; Epstein, I. R. J. Am. Chem. Soc. 2004, 126,
6246–6247.
50. Horvath, A. K.; Nagypal, I. N. J. Phys. Chem. A 2006, 110, 4753–4758.
51. Nagypal, I.; Horvath, A. K. Chaos 2015, 25, 064604.
52. Slaughter, L. M.; Collman, J. P.; Eberspacher, T. A.; Brauman, J. I. Inorg. Chem. 2004,
43, 5198–5204.
53. Umile, T. P.; Wang, D.; Groves, J. T. Inorg. Chem. 2011, 50, 10353–10362.
54. Hu, Z.; Du, H.; Man, W.-L.; Leung, C.-F.; Liang, H.; Lau, T.-C. Chem. Commun.
2012, 48, 1102–1104.
55. Zdilla, M. J.; Lee, A. Q.; Abu-Omar, M. M. Angew. Chem. Int. Ed. 2008, 47,
7697–7700.
56. Zdilla, M. J.; Lee, A. Q.; Abu-Omar, M. M. Inorg. Chem. 2009, 48, 2260–2268.
57. Hicks, S. D.; Kim, D.; Xiong, S.; Medvedev, G. A.; Caruthers, J.; Hong, S.; Nam, W.;
Abu-Omar, M. M. J. Am. Chem. Soc. 2014, 136, 3680–3686.
58. Hicks, S. D.; Xiong, S.; Bougher, C. J.; Medvedev, G. A.; Caruthers, J.; Abu-Omar, M. M.
J.PorphyrinsPhthalocyanines2015,19,492–499.
59. Keith, J. M.; Abu-Omar, M. M.; Hall, M. B. Inorg. Chem. 2011, 50, 7928–7930.
60. Galajda, M.; Fodor, T.; Purgel, M.; Fabian, I. RSC Adv. 2015, 5, 10512–10520.
The Kinetics and Mechanism of Complex Redox Reactions 59
98. Pochtarenko, L.; Zilbermann, I.; Shamir, D.; Meyerstein, D. J. Coord. Chem. 2013, 66,
4355–4362.
99. Gilbert, B. C.; Stell, J. K. J. Chem. Soc., Perkin Trans. 2 1990, 1281–1288.
100. Gilbert, B. C.; Stell, J. K. J. Chem. Soc. Faraday Trans. 1990, 86, 3261–3266.
101. Lente, G.; Kalmár, J.; Baranyai, Z.; Kun, A.; Kek, I.; Bajusz, D.; Takács, M.; Veres, L.;
Fábián, I. Inorg. Chem. 2009, 48, 1763–1773.
102. Kalmár, J.; Lente, G.; Fábián, I. Inorg. Chem. 2013, 52, 2150–2156.
103. Betterton, E. A. Environ. Sci. Technol. 1992, 26, 527–532.
104. Beller, G.; Szabó, M.; Lente, G.; Fábián, I. J. Org. Chem. 2016, 81, 5345–5353.
105. Balogh, A.; Lente, G.; Kalmar, J.; Fabian, I. Int. J. Chem. Kinet. 2015, 47, 773–782.
106. Conrad, A. R.; Hassanin, H. A.; Tubergen, M. J.; Fabian, I.; Brasch, N. E. New J.
Chem. 2012, 36, 1408–1412.
107. Peintler, G. ZITA 5.0: A Comprehensive Program Package for Fitting Parameters of Chemical
Reaction Mechanisms; University of Szeged: Szeged, Hungary, 1999.
108. Thompson, R. C. Inorg. Chem. 1981, 20, 3745–3748.
109. Beller, G.; Bátki, G.; Lente, G.; Fábián, I. J. Coord. Chem. 2010, 63, 2586–2597.
110. Beller, G.; Lente, G.; Fábián, I. Inorg. Chem. 2010, 49, 3968–3970.
111. Beller, G.; Lente, G.; Fábián, I. Submitted to Inorg. Chem. 2017.
112. Kerezsi, I.; Lente, G.; Fabian, I. Dalton Trans. 2006, 955–960.
113. Melichercik, M.; Treindl, L. J. Phys. Chem. 1989, 93, 7652–7654.
114. Maerker, G.; Case, F. H. J. Am. Chem. Soc. 1958, 80, 2745–2748.
115. Gillard, R. D. Inorg. Chim. Acta 1981, 53, L173.
116. Rozen, S.; Dayan, S. Angew. Chem. Int. Ed. 1999, 38, 3471–3473.
117. Peintler, G.; Nagypál, I.; Jancsó, A.; Epstein, I. R.; Kustin, K. J. Phys. Chem. A 1997,
101, 8013–8020.
118. Kennedy, R. J.; Stock, A. M. J. Org. Chem. 1960, 25, 1901–1906.
119. Gallopo, A. R.; Edwards, J. O. J. Org. Chem. 1981, 46, 1684–1688.
120. McKay, S. E.; Sooter, J. A.; Bodige, S. G.; Blackstock, S. C. Heterocycl. Commun. 2001,
7, 307–312.
121. Mixan, C. E.; Pews, R. G. J. Org. Chem. 1977, 42, 1869–1871.
122. G€obel, M.; Karaghiosoff, K.; Klap€ otke, T. M.; Piercey, D. G.; Stierstorfer, J. J. Am.
Chem. Soc. 2010, 132, 17216–17226.
123. Agrawal, A.; Sailani, R.; Gupta, B.; Khandelwal, C. L.; Sharma, P. D. J. Korean Chem.
Soc. 2012, 56, 212–216.
124. Costas, M.; Chen, K.; Que, L., Jr. Coord. Chem. Rev. 2000, 200–202, 517–544.
125. Lente, G.; Fabian, I. Dalton Trans. 2007, 4268–4275.
126. Chow, T. W.-S.; Wong, E. L.-M.; Guo, Z.; Liu, Y.; Huang, J.-S.; Che, C.-M. J. Am.
Chem. Soc. 2010, 132, 13229–13239.
127. Tse, C.-W.; Chow, T. W.-S.; Guo, Z.; Lee, H. K.; Huang, J.-S.; Che, C.-M. Angew.
Chem. Int. Ed. 2014, 53, 798–803.
128. Liu, P.; Wong, E. L.-M.; Yuen, A. W.-H.; Che, C.-M. Org. Lett. 2008, 10,
3275–3278.
129. Lente, G.; Espenson, J. H. Int. J. Chem. Kinet. 2004, 36, 449–455.
130. Fabian, I.; Lente, G. Pure Appl. Chem. 2010, 82, 1957–1973.
131. Lente, G.; Espenson, J. H. Chem. Commun. 2003, 1162–1163.
132. Lente, G.; Espenson, J. H. J. Photochem. Photobiol. A 2004, 163, 249–258.
133. Brandt, C.; van Eldik, R. Chem. Rev. 1995, 95, 119–190.
134. Brandt, C.; Fabian, I.; van Eldik, R. Inorg. Chem. 1994, 33, 687–701.
135. Kerezsi, I.; Lente, G.; Fabian, I. J. Am. Chem. Soc. 2005, 127, 4785–4793.
136. Kerezsi, I.; Lente, G.; Fabian, I. Inorg. Chem. 2007, 46, 4230–4238.
137. Jortner, J.; Ottolenghi, M.; Stein, G. J. Phys. Chem. 1962, 66, 2042.
138. Jortner, J.; Ottolenghi, M.; Stein, G. J. Phys. Chem. 1964, 68, 247.
The Kinetics and Mechanism of Complex Redox Reactions 61
139. Huie, R. E.; Clifton, C. L. Chem. Phys. Lett. 1993, 205, 163–167.
140. Grossweiner, L. I.; Matheson, M. S. J. Phys. Chem. 1957, 61, 1089.
141. Shoute, L. C. T.; Alfassi, Z. B.; Neta, P.; Huie, R. E. J. Phys. Chem. 1991, 95,
3238–3242.
142. Galajda, M.; Lente, G.; Fabian, I. J. Am. Chem. Soc. 2007, 129, 7738–7739.
143. Gombar, M.; Jozsa, E.; Braun, M.; Osz, K. Photochem. Photobiol. Sci. 2012, 11,
1592–1595.
144. Ditroi, T.; Kalmar, J.; Pino-Chamorro, J. A.; Erdei, Z.; Lente, G.; Fabian, I. Photochem.
Photobiol. Sci. 2016, 15, 589–594.
145. Lazar, I.; Kalmar, J.; Peter, A.; Szilagyi, A.; Gyori, E.; Ditroi, T.; Fabian, I. Appl. Surf.
Sci. 2015, 356, 521–531.
146. Serpone, N.; Emeline, A. V. J. Phys. Chem. Lett. 2012, 3, 673–677.
147. Fujishima, A.; Rao, T. N.; Tryk, D. A. J. Photochem. Photobiol. C 2000, 1, 1–21.
148. Linsebigler, A. L.; Lu, G. Q.; Yates, J. T. Chem. Rev. 1995, 95, 735–758.
149. Brosillon, S.; Lhomme, L.; Vallet, C.; Bouzaza, A.; Wolbert, D. Appl. Catal. B. 2008,
78, 232–241.
150. Konstantinou, I. K.; Albanis, T. A. Appl. Catal. B 2004, 49, 1–14.
151. Veres, P.; Keri, M.; Bányai, I.; Lázár, I.; Fábián, I.; Domingoc, C.; Kalmár, J. Colloids
Surf. B Biointerfaces 2017, 152, 229–237.
152. Kalmar, J.; Keri, M.; Erdei, Z.; Banyai, I.; Lazar, I.; Lente, G.; Fabian, I. RSC Adv.
2015, 5, 107237–107246.
153. Petrov, O. V.; Furo, I. Prog. Nucl. Magn. Reson. Spectrosc. 2009, 54, 97–122.
154. Keri, M.; Peng, C.; Shi, X.; Banyai, I. J. Phys. Chem. B 2015, 119, 3312–3319.
155. Banyai, I.; Keri, M.; Nagy, Z.; Berka, M.; Balogh, L. P. Soft Matter 2013, 9, 1645–1655.
156. Kalmar, J.; Lente, G.; Fabian, I. Dyes Pigm. 2016, 127, 170–178.
157. Tsunoda, K. I.; Umemura, T.; Ueno, H.; Okuno, E.; Akaiwa, H. Appl. Spectrosc. 2003,
57, 1273–1277.
ARTICLE IN PRESS
Contents
1. Introduction 64
1.1 O2 Activation: A Greener Alternative 64
1.2 Bioinspired Model Systems as a Common Strategy to Study Enzymes 65
2. Modeling Tyrosinase: O–O Cleavage in Dinuclear Copper Systems 67
2.1 Dicopper Model Complexes for O2 Activation 68
2.2 Model Complexes Exhibiting Tyrosinase-Like Activity. The Dilemma
of the Real Hydroxylation Agent 69
2.3 Upgrading the Challenge: Hydroxylation of Stronger C–F Bonds 72
3. O–O Cleavage in Iron-Oxygen Species 79
3.1 O–O Cleavage in Iron-Containing Enzymes 79
3.2 Mechanism of Action of Nonheme Iron Catalysts in Hydrocarbon Oxidation 83
3.3 Trapping Mononuclear Nonheme Iron-Oxygen Species Relevant to Iron
Oxygenases. O–O Cleavage in FeOOR Species: Accessing High-Valent
Compounds 84
3.4 Spectroscopically Characterized Oxoiron(V) Species 97
4. Summary 99
References 100
Abstract
Oxygenase enzymes catalyze the oxidation of hydrocarbons in a regio- and stereo-
selective manner using O2 as a sacrificial oxidant. These enzymes, which often contain
iron and/or copper in their active site, are the source of inspiration for the development
of novel methodologies to perform oxidative transformations in a more environ-
mentally friendly way, using benign oxidants such as O2 and H2O2. The ability of such
metals to attain different oxidation states is the key to facilitate the redox processes
associated with the formation and cleavage of the O–O bond. With the aim of gaining
insight into both the structure and reactivity of enzymes, bioinorganic chemists have
devoted efforts to learn the intimate details of the processes associated with these reac-
tions. This is mostly carried out through the use of low molecular weight coordination
compounds. One of the key issues to develop further more effective bioinspired catalysts
is to understand the basis of their performance. In this vein, herein, we aim to depict
several examples for which the formation and cleavage of the oxygen–oxygen bond,
as well as the reactivity of the resulting species, have been studied through model
systems.
1. INTRODUCTION
1.1 O2 Activation: A Greener Alternative
Selective oxidations of organic molecules, especially hydrocarbons, are of
huge importance in industry (1–3). Millions of tons of alcohols, carbonyl
compounds, and epoxides are produced every year and used as reaction pre-
cursors in all areas of chemical industries. As a consequence of environmental
concerns, attention has been focused on the development of catalytic meth-
odologies (rather than stoichiometric) in order to minimize the cost of waste
disposal and avoid the use of harmful oxidants such as dichromate, perman-
ganate, and osmium tetroxide. Thus, the development of new procedures
that allows the performance of oxidation reactions under mild conditions
using green oxidants such as O2 and H2O2 is one of the biggest challenges
for modern synthetic organic chemistry (4).
The reaction of O2 with closed shell organic molecules is favorable from
the thermodynamic point of view (5). However, under ambient conditions
such oxidation reactions are very slow. This lack of reactivity results from
unfavorable kinetics: O2 has two unpaired electrons in its π antibonding
orbitals (S ¼ 1, triplet ground state), and this makes the reaction toward
organic substrates (generally S ¼ 0) spin forbidden. However, O2 can inter-
act with molecules containing unpaired electrons such as radicals (S ¼ 1/2)
and transition metal centers. Indeed, aerobic organisms have evolved to take
advantage of metal–oxygen interactions with the final aim of using their oxi-
dizing power. Interestingly, such reactions take place in a controlled fashion
in the active site of various enzymes (mainly oxidases and oxygenases).
Copper- and iron-based (heme and nonheme) proteins are commonly
found in processes where O2 activation takes place. Especially relevant
for the purpose of this review is their activity as mono- or dioxygenases; thus
the incorporation of one or two oxygen atoms from O2 into an organic sub-
strate. Upon O2 binding to the metallic center, reduced species that are more
ARTICLE IN PRESS
O2 O2 O2
III • n+ (n+1)+ •
Superoxo (Porph)Fe –OO M M
¯¯¯¯¯ –OO M(n+1)+–OO•
H+, e– H+, e–
a b 2 e−
(From cofactor)
Peroxo (Porph)FeIII–OOH M(n+1)+–OO–M(n+1)+ M(n+1)+–OO(H)
G
O–O bond H+
cleavage −H2O
O
Oxo (Porph•+)FeIV = O M(n+2)+ M(n+2)+ FeV = O CuII–O• FeIV = O
O OH
Cytochrome P450 Mn+ = FeII particulate a Mn+ = FeII Rieske oxygenases
heme peroxidases methane monooxygenase Mn+ = CuI monocopper
catalases Mn+ = CuI tyrosinase hydroxylases and amine oxidases
focuses on the study and development of synthetic systems that imitate the
formation, function, or structure of biologically produced substances and
materials and biological mechanisms and processes. In a long-term perspec-
tive, the preparation of compounds that reproduce enzyme functions could
provide new reagents or catalysts for practical applications. In this context,
O2 binding and activation in model systems containing transition metals
have been extensively explored, not only for the biological relevance of
this reaction but also for the potential industrial interest in performing selec-
tive oxidation catalysis in a cheaper and more environmentally friendly
manner.
Thus, the purpose of synthetic model chemistry through the synthesis of
bioinspired synthetic models is twofold: on one hand, mimicking the function
of an enzyme involved in a relevant chemical transformation and, on the
other hand, providing mechanistic and structural insight into the nature
of the biological system. The improvement and development of several
spectroscopic techniques such as electron paramagnetic resonance (EPR),
M€ ossbauer, Raman, X-ray absorption spectroscopy, and mass spectrometry
have greatly aided the trapping and characterization of several metal-oxygen
species. In some cases, these are too short lived or do not accumulate suffi-
ciently to be trapped and characterized. If this is the case, clues about the
nature of these species need to be acquired through indirect methods, such
as the study of their reactivity using specific substrates (6) and/or computa-
tional methods.
ARTICLE IN PRESS
A B O
O
H2O NHis NHis
CuI CuI
R NHis NHis
NHis NHis
O2
H+
R
NHis O NHis
CuII CuII
O NHis NHis
N O N NHis O NHis
CuII CuII s
P
N O N
N H N
R H+ OH
O R
N O N
CuII CuII
N O N N
N
Scheme 2 (A) X-ray structure of the substrate-bound tyrosinase (1WX2 PDB) (8,17).
(B) Mechanism of action of tyrosinase toward the hydroxylation of a monophenolic
substrate.
the Cu2O2 core. This interaction promotes the rotation of the Cu2O2
moiety and orientates one of the oxygen atoms toward the arene ring.
Then the O–O bond is cleaved and the close proximity of the substrate
facilitates an electrophilic attack of the peroxo moiety on the aromatic
ring, so that ortho-hydroxylation occurs. In the last step, the deoxy form
is regenerated after release of the ortho-quinone product and a water mol-
ecule (Scheme 2B).
A B O O
O
LCu II II
Cu L LCuII CuIIL LCuIII CuIIIL
O O O
trans-μ-1,2-peroxo μ-η2:η2 -peroxo bis(μ-oxo)
(TP) (SP) (O)
Scheme 3 Schematic representation of some Cu2O2 compounds. (A) trans-μ-1,2-peroxo
species (TP) and (B) equilibrium between SP and O species.
of the O–O bond constitutes one of the key reactions taking place during
photosynthesis, and this study constituted the first example where the forma-
tion and cleavage of the O–O bond were experimentally linked. Interestingly,
the SP/O equilibrium is highly dependent on steric factors induced by the
ligand (23), but it is also influenced by other factors such as solvent (24), elec-
tronic effects on the ligand, and counterions. As a general trend, nonbulky
ligands favor the formation of O species (shorter Cu–Cu distance) (23,24).
Furthermore, this finding opened the debate about whether the real
active species in tyrosinase, truly responsible for the biological ortho-
hydroxylation of phenols, was SP or O. Through the use of model systems,
it has been demonstrated that O is also capable of performing this reaction
(10,17,25).
N N
N N N N N N N N
N O N O O
CuII CuII D N CuII CuII N D N N CuII CuII N N
O O D O
N N N N D N N N N
N N
N
N N N N N
H H N N
N N O N O
O N CuII
II II N O N CuIII CuIII CuII N
Cu Cu
O CuIII CuIII N O N N O
N N N N N
H H O N
N N N
Fig. 2 Reported Cu2O2 systems that act as functional tyrosinase models toward external
substrates.
thus the compound could carry out the ortho-hydroxylation of various phe-
nolates yielding the catechol as the major product.
More evidence about the capability of O species to hydroxylate pheno-
lates was reported by Company et al. (25). A dicopper complex was synthe-
sized using a dinucleating ligand scaffold (m-XYLMeAN; Fig. 2) that consisted
of a meta-xylyl moiety connecting two tridentate sites. Upon reaction with
O2 at 90°C the O species [CuIII2(O)2(m-XYLMeAN)]2+ was formed and
fully characterized by several spectroscopic techniques. Interestingly, upon
addition of the phenolate a new purple intermediate species was formed.
Trapping and further characterization revealed that it corresponded to the
phenolate bound to the Cu2O2 core prior to oxidation. In the same context,
based upon a closely related study, Stack, Herres-Pawlis, and coworkers
reported in 2009 the full characterization of another O species containing
an aminoguanidine type of ligand [CuIII2(O)2(LAG)2]2+ (Fig. 2) that was able
to ortho-hydroxylate 2,6-di-tert-butylphenolate in good yields (32).
Finally, the ortho-hydroxylation of phenols to catechols was also per-
formed by an unsymmetric [CuII2(O2)(m-XYLN3N4)]2+ TP species, in
which the two copper ions have different coordination environments
(Fig. 2). One of the copper ions is bound to a triamine site, while the other
contains a tetraamine ligand site. Strikingly, [CuII2(O2)(m-XYLN3N4)]2+
exhibited different reactivity patterns compared to the symmetric TP ana-
logue [CuII2(O2)(m-XYLN4N4)]2+, both generated from the corresponding
dinuclear copper(I) complex and O2 at cryogenic temperatures. Surpris-
ingly, only the unsymmetric TP compound was able to perform ortho-
hydroxylation of external phenolates to form the catechol product, a
reaction not observed before for any TP species (33). Mechanistic studies
revealed that the unsymmetric TP was acting as an electrophilic oxidant,
contrary to the typical nucleophilicity shown by TP species (1,18). This
difference in reactivity was attributed to the unsymmetric nature of the
Cu2O2 moiety forced by the unsymmetric ligand. Coordination of the phe-
nolate substrate to the tridentate site results from the unprecedented electro-
philic reactivity of the unsymmetric end-on trans-peroxido core. Instead, the
most common TP species contain copper ions bound to tetradentate ligands,
and the copper ion is coordinatively saturated, unsuitable for phenolate bind-
ing (33). Recently, Solomon, Karlin, and coworkers performed new density
functional theory (DFT) calculations and proposed that in this system, TP is
not the actual hydroxylating species of the reaction, but instead, it is in equi-
librium with an O species that performs the hydroxylation (34). The same
authors provided experimental evidence of an equilibrium between TP
ARTICLE IN PRESS
and O species in a related system (34). However, the Solomon and Karlin
proposal of a rapid TP and O equilibrium cannot account for the lack of elec-
trophilic reactivity observed against typical substrates for O type of species
such as phosphines and sulfides, suggesting that isomerization, if it is taking
place, occurs only after phenolate binding.
Finally, it is worth mentioning that inspired by the mechanistic studies
mentioned earlier, some investigations have demonstrated and proven the
potential viability of these copper-oxygen reactions in catalytic processes
with relevance in organic synthesis (35–37).
N Cl N N O N
O2
N CuI CuI N N CuII CuII N
reductant N O N
N N
r.t., 24 h H
[CuI2(XYLCl)]2+
N Br N O2 N O N
I
Cu I I
Cu r.t., 16 h CuI Cu
N N N N
O
H
[CuI2(2,6-bpb-1-Br)]2+
Scheme 4 Intramolecular oxidative dehalogenation mediated by copper(I) complexes
and O2.
A B
21 21
18 18 N N
N N
III O
15 III O 15 N Cu CuIII N
N Cu CuIII N O
O
e (mM−1/cm)
e (mM−1/cm)
O F
N N N N
12 12 F
2(μ-O)2(m-XYL
III MeAN 2+
[Cu )] 9
9 [CuIII2(μ-O)2(OC6H3F2)(m-XYLMeAN)]+
6 6
3 3
0 0
350 550 750 950 350 550 750 950
Wavelength (nm) Wavelength (nm)
Fig. 3 Visual color changes observed during the reaction of [CuI2(m-XYLMeAN)]2+ with O2
and sodium 2,6-difluorophenolate in acetone at 90ºC along with the UV–vis spectra
recorded at 90ºC and the schematic representation of the compounds. (A) Fully
formed [CuIII2(O)2(m-XYLMeAN)]2+. (B) Sudden color change to intense purple upon addi-
tion of sodium 2,6-difluorophenolate to [CuIII2(O)2(m-XYLMeAN)]2+ caused by the coordi-
nation of the phenolate moiety to one copper center.
via O species
2+
N N
NaDFP (3 equiv.)
N CuIII O
CuIIIN
O
N N OH
CuII O CuII F OH
O
2+ O F
NH HN F
CuII O CuII
O NaDFP (3 equiv.)
N N
H H O–O bond cleavage
via P species
2+
N N CuII O CuII
II O II O
N Cu Cu N NaDFP (3 equiv.) OH
D O D O F F OH
D N N D
F
Scheme 5 Reaction of the different Cu2O2 compounds discussed herein toward NaDFP.
ARTICLE IN PRESS
Heme Nonheme
O Glu O
Glu O
N N O Asp FeIV O
Fe +IV Glu FeIV FeIV COO–
N N O His His
His O O His
S
Cys
Cytochrome P450 Soluble methane monooxygenase Taurine dioxygenase
(Compound I) (sMMO-Q) (TauD-J)
Fig. 4 Representative examples of spectroscopically characterized heme and nonheme
iron-oxygen species in enzymes.
ARTICLE IN PRESS
A B
R-OH OH2 H C
O
R-H
FeIII
FeIV∑
H2O
N N
Fe H2O Hydrogen atom
O R-H
N N abstraction
Fe ∑ IV
Peroxide shunt R-H
S FeIII OH ∑C
Cys Cpd I NaOCl, ROOH,
H2O RCO3H, PhIO
e – FeIV
H+
HO R-H
Fe O Oxygen rebound
R-H FeII
FeIII
FeIII HO C
O2
– +
e ,H
Scheme 7 (A) Proposed catalytic cycle for cyt-P450s. (B) Postulated oxygen rebound
mechanism for C–H hydroxylation in cyt-P450s.
ARTICLE IN PRESS
ARTICLE IN PRESS
O Asp H 2O
N O His O O
O His OH
Asp FeIII
B Asp
His O
HO via FeIII (OOH) O
HO
Asp
H+, e–, 2 H2O
O
His O
FeIII O–O cleavage
His O
O His OH via FeV (O)(OH)
O FeV
Asp His O
O
Asp
Scheme 8 (A) Schematic representation of the active site of naphthalene 1,2-dioxygenase (NDO). (B) X-ray structure of O2-bound oxygenase
component of NDO. (C) Proposed catalytic cycle of naphthalene 1,2-dioxygenase (NDO). Panel (B): Adapted from Karlsson, A.; Parales, J. V.;
Parales, R. E.; Gibson, D. T.; Eklund, H.; Ramaswamy, S. Science 2003, 299, 1039.
ARTICLE IN PRESS
A B
HO O
O N O N
N N
Fe III Base FeIII
N N N Acid N N N
A
2+
O
N
O O
FeIII O
O O
N
O
[FeIII(O2COCH3)(qn)2]2+
B R′ 2+
R R
2+
N
N N O O
N O FeIII
Fe III N O
O
O O N
O N
R R
R′
[FeIII(O2COCH3)(6Me2-BPP)]2+ R = R′ = H [FeIII(O2COCH3)(BPMEN)]2+
R = Me, R′ = OMe [FeIII(O2COCH3)(BPMEN*)]2+
R′ 2+
R R
2+
tBu
N N
N O O N O O
R FeIII FeIII
N O N O
R′ N R′′ N
R tBu
R R
R′
R′ 2+
2+
R R O
R
N
N O O
O O
Fe III N FeIII N
N O N
N N
R R
R′
R = R′ = H [FeIII(O2COCH3)(PDP)]2+ [FeIII(O2COR)(13-TMC)]2+
R = Me, R′ = OMe [FeIII(O2COCH3)(PDP*)]2+
Fig. 5 See legend on opposite page.
ARTICLE IN PRESS
H
H
O H
O O O O
H •O O
N4
L Fe III N4
L Fe IV LN4FeIII
O O O O
CH3 CH3
CH3
Scheme 11 Diagram of the mechanism proposed by Shaik, Que, and coworkers for the
formation of a peracetate intermediate
2+ 2+
N Heterolytic N
N O O–O cleavage N O
FeIII O FeV O
N O N O
N N
Scheme 12 Generation of high-valent oxoiron compounds after heterolytic O–O cleav-
age in acylperoxoiron(III) complexes. Please note that the formulation of the high-valent
species as an oxoiron(V) or an oxoiron(IV) coupled to an alkyl radical is still under
discussion.
O 2+ O 2+
2+
N O N
N N
N V O N O
N Fe O O FeV O
N O FeV O
N N O
N O N
O O
g-values 2.07, 2.01, 1.96 g-values 2.071, 2.008, 1.960 g-values 2.070, 2.005, 1.956
(40%) (<1%) (3%)
Fig. 6 Compounds displaying the S ¼ 1/2 EPR-active species with gmax ¼ 2.07 after
reaction of the corresponding iron(II) precursor and peracetic acid or H2O2/AcOH at
low temperature along with their proposed formulation as oxoiron(V) compounds
and its accumulated yield. The high-valent compound is generated upon O–O bond
cleavage of the corresponding previously formed acylperoxoiron(III) species. Please
note that its formulation as an oxoiron(IV) radical carboxyl is still a matter of debate.
were made (127). EPR analysis of a sample, frozen following mixing the
iron complex with hydrogen peroxide (20 equiv.) in the presence of acetic
acid, afforded the acylperoxoiron(III) compound and also a minor species
(<1% of Fe) with g-values at 2.071, 2.008, and 1.960. These rhombic
species with gmax ¼ 2.07 were assigned to formally oxoiron(V) species, highly
probably generated after the heterolytic O–O bond cleavage of the
acylperoxoiron(III) compound (Fig. 6). Unfortunately, the low yield of such
species precluded further spectroscopic studies.
Recently, Talsi and coworkers published reports where the nature of the
metastable species formed upon reaction of an iron(II) precursor, H2O2, and
different carboxylic acids was analyzed by EPR (128). From their work, it is
concluded that the nature of the S ¼ 1/2 species depends on the structure of
the carboxylic acid employed. Intermediates displaying large g-factor anisot-
ropy are generated when carboxylic acids with primary and secondary
α-carbons are employed. In contrast, the use of tertiary α-carbon favors
lower g-factor anisotropy. The authors proposed an oxoiron(IV) carboxyl
radical for the latter species, while an oxoiron(V) was the chosen formulation
for the larger g-factor anisotropy (nonbranched carboxylic acids). Com-
pounds with small g-factor anisotropy exhibited higher levels of
enantioselectivity in the epoxidation of chalcone substrates. This was
explained in terms of the additional stabilization via delocalization of the
unpaired electron over the carboxylic moiety.
In very recent work, the same authors also proposed that the iron-
catalyzed oxidation of olefins might follow different pathways depending
ARTICLE IN PRESS
[FeII(PyNMe3)]2+ (1 equiv.) O O
1 2 + 3 4 +
R R R R
R1 R2 R3 R4
AlkeneA AlkeneB AcOOH (10 equiv.)
MeCN:acetone 1:3 EpoxideA EpoxideB
(100 equiv.) –60°C
EpoxideA
vs = 9.5 ± 0.5 k2A / k2B = 8.18 ± 0.03
C5H11 C5H11 EpoxideB
Scheme 14 Schematic representation of the intermolecular competitive epoxidation of
pairs of olefins (alkeneA and alkeneB) by the [FeII(PyNMe3)(CH3CN)2]2+/AcOOH catalytic
system. EpoxideA/epoxideB: ratio of epoxideA and epoxideB products determined by GC.
(kA2 /kB2): ratio of second-order rate constants for the reaction of α with alkeneA (kA2 ) and
alkeneB (kB2) in acetonitrile/acetone 1:3 at 60°C determined by stopped-flow (131).
A – – –
O O O
O O O
N O N N O N N O N
FeV FeV N FeV
N N N N N N
O O O
O O O
B + C 2+
N O
N O N O
FeV FeIV
N N N Cl
O
N
N
O
[FeV(O)(NC(O)CH3)(TMC)]+ [FeV(O)(Cl-acac•+)(Me3tacn)]2+
Fig. 7 Spectroscopically detected oxoiron(V) compounds (A) with the TAML platforms
(B) generated from the one-electron oxidation of an oxoiron(IV) complex by Que and
coworkers and (C) generated by Che and coworkers after reaction of an iron(III) precur-
sor and Oxone®. Cl-acac ¼ 3-chloro-acetylacetonate.
4. SUMMARY
The generation of (su)peroxo species upon the reduction of O2 by
copper- and iron-based enzymes (or model systems) is a prior step toward
opening the door to an extensive scenery of opportunities. One of the most
interesting transformations is the reaction involving the cleavage of the O–O
bond. Indeed, the resulting species, namely high-valent compounds, can
present reactivity patterns not observed for the peroxo species. Herein,
we have presented examples where the O–O bond cleavage in copper
and iron-based model complexes has led to a dramatic change in the
reactivity.
O–O bond cleavage in peroxodicopper(II) species leads to the gener-
ation of high-valent bis(μ-oxo)dicopper(III) species. Both species can per-
form the ortho-hydroxylation of phenolates, mimicking the model enzyme
ARTICLE IN PRESS
REFERENCES
1. Que, L.; Tolman, W. B. Nature 2008, 455, 333.
2. Punniyamurthy, T.; Velusamy, S.; Iqbal, J. Chem. Rev. 2005, 105, 2329.
3. Crabtree, R. H. Chem. Rev. 2010, 110, 575.
4. Oloo, W. N.; Que, L., Jr. Comprehensive Inorganic Chemistry II, 2nd ed.; Elsevier:
Amsterdam, 2013; p763.
5. Kovacs, J. A. Science 2003, 299, 1024.
6. Costas, M.; Chen, K.; Que, L., Jr. Coord. Chem. Rev. 2000, 200–202, 517.
ARTICLE IN PRESS
7. Solomon, E. I.; Sundaram, U. M.; Machonkin, T. E. Chem. Rev. 1996, 96, 2563.
8. Matoba, Y.; Kumagai, T.; Yamamoto, A.; Yoshitsu, H.; Sugiyama, M. J. Biol. Chem.
2006, 281, 8981.
9. Decker, H.; Schweikardt, T.; Tuczek, F. Angew. Chem. Int. Ed. 2006, 45, 4546.
10. Rolff, M.; Schottenheim, J.; Decker, H.; Tuczek, F. Chem. Soc. Rev. 2011, 40, 4077.
11. Company, A. Ideas in Chemistry and Molecular Sciences. Wiley-VCH Verlag GmbH &
Co. KGaA: Weinheim, 2010; p265.
12. Decker, H.; Dillinger, R.; Tuczek, F. Angew. Chem. Int. Ed. 2000, 39, 1591.
13. Solomon, E. I.; Heppner, D. E.; Johnston, E. M.; Ginsbach, J. W.; Cirera, J.;
Qayyum, M.; Kieber-Emmons, M. T.; Kjaergaard, C. H.; Hadt, R. G.; Tian, L. Chem.
Rev. 2014, 114, 3659.
14. Elwell, C. E.; Gagnon, N. L.; Neisen, B. D.; Dhar, D.; Spaeth, A. D.; Yee, G. M.;
Tolman, W. B. Chem. Rev. 2017, 117, 2059–2107.
15. Citek, C.; Herres-Pawlis, S.; Stack, T. D. P. Acc. Chem. Res. 2015, 48, 2424.
16. Keown, W.; Gary, J. B.; Stack, T. D. P. J. Biol. Inorg. Chem. 2016, 1.
17. Serrano-Plana, J.; Garcia-Bosch, I.; Company, A.; Costas, M. Acc. Chem. Res. 2015,
48, 2397.
18. Mirica, L. M.; Ottenwaelder, X.; Stack, T. D. P. Chem. Rev. 2004, 104, 1013.
19. Lewis, E. A.; Tolman, W. B. Chem. Rev. 2004, 104, 1047.
20. Jacobson, R. R.; Tyeklar, Z.; Farooq, A.; Karlin, K. D.; Liu, S.; Zubieta, J. J. Am.
Chem. Soc. 1988, 110, 3690.
21. Kitajima, N.; Fujisawa, K.; Fujimoto, C.; Morooka, Y.; Hashimoto, S.; Kitagawa, T.;
Toriumi, K.; Tatsumi, K.; Nakamura, A. J. Am. Chem. Soc. 1992, 114, 1277.
22. Halfen, J. A.; Mahapatra, S.; Wilkinson, E. C.; Kaderli, S.; Young, V. G.; Que, L.;
Zuberb€ uhler, A. D.; Tolman, W. B. Science 1996, 271, 1397.
23. Mahadevan, V.; Henson, M. J.; Solomon, E. I.; Stack, T. D. P. J. Am. Chem. Soc. 2000,
122, 10249.
24. Lam, B. M. T.; Halfen, J. A.; Young, V. G.; Hagadorn, J. R.; Holland, P. L.; Lledós, A.;
Cucurull-Sánchez, L.; Novoa, J. J.; Alvarez, S.; Tolman, W. B. Inorg. Chem. 2000, 39,
4059.
25. Company, A.; Palavicini, S.; Garcia-Bosch, I.; Mas-Balleste, R.; Que, L.; Rybak-
Akimova, E. V.; Casella, L.; Ribas, X.; Costas, M. Chem. Eur. J. 2008, 14, 3535.
26. Karlin, K. D.; Hayes, J. C.; Gultneh, Y.; Cruse, R. W.; McKown, J. W.;
Hutchinson, J. P.; Zubieta, J. J. Am. Chem. Soc. 1984, 106, 2121.
27. Casella, L.; Monzani, E.; Gullotti, M.; Cavagnino, D.; Cerina, G.; Santagostini, L.;
Ugo, R. Inorg. Chem. 1996, 35, 7516.
28. Santagostini, L.; Gullotti, M.; Monzani, E.; Casella, L.; Dillinger, R.; Tuczek, F. Chem.
Eur. J. 2000, 6, 519.
29. Itoh, S.; Kumei, H.; Taki, M.; Nagatomo, S.; Kitagawa, T.; Fukuzumi, S. J. Am. Chem.
Soc. 2001, 123, 6708.
30. Mirica, L. M.; Vance, M.; Rudd, D. J.; Hedman, B.; Hodgson, K. O.; Solomon, E. I.;
Stack, T. D. P. Science 2005, 308, 1890.
31. Citek, C.; Lyons, C. T.; Wasinger, E. C.; Stack, T. D. P. Nat. Chem. 2012, 4, 317.
32. Herres-Pawlis, S.; Verma, P.; Haase, R.; Kang, P.; Lyons, C. T.; Wasinger, E. C.;
orke, U.; Henkel, G.; Stack, T. D. P. J. Am. Chem. Soc. 2009, 131, 1154.
Fl€
33. Garcia-Bosch, I.; Company, A.; Frisch, J. R.; Torrent-Sucarrat, M.; Cardellach, M.;
Gamba, I.; G€ uell, M.; Casella, L.; Que, L.; Ribas, X.; Luis, J. M.; Costas, M. Angew.
Chem. Int. Ed. 2010, 49, 2406.
34. Kieber-Emmons, M. T.; Ginsbach, J. W.; Wick, P. K.; Lucas, H. R.; Helton, M. E.;
Lucchese, B.; Suzuki, M.; Zuberb€ uhler, A. D.; Karlin, K. D.; Solomon, E. I. Angew.
Chem. Int. Ed. 2014, 53, 4935.
35. Huang, Z.; Lumb, J.-P. Angew. Chem. Int. Ed. 2016, 55, 11543.
ARTICLE IN PRESS
36. Esguerra, K. V. N.; Fall, Y.; Petitjean, L.; Lumb, J.-P. J. Am. Chem. Soc. 2014, 136,
7662.
37. Hoffmann, A.; Citek, C.; Binder, S.; Goos, A.; R€ ubhausen, M.; Troeppner, O.;
Ivanovic-Burmazovic, I.; Wasinger, E. C.; Stack, T. D. P.; Herres-Pawlis, S. Angew.
Chem. Int. Ed. 2013, 52, 5398.
38. M€uller, K.; Faeh, C.; Diederich, F. Science 2007, 317, 1881.
39. Smart, B. E. J. Fluor. Chem. 2001, 109, 3.
40. Amii, H.; Uneyama, K. Chem. Rev. 2009, 109, 2119.
41. Natarajan, R.; Azerad, R.; Badet, B.; Copin, E. J. Fluor. Chem. 2005, 126, 424.
42. Peelen, S.; Rietjens, I. M. C. M.; Boersma, M. G.; Vervoort, J. Eur. J. Biochem. 1995,
227, 284.
43. Bondar, V. S.; Boersma, M. G.; van Berkel, W. J. H.; Finkelstein, Z. I.; Golovlev, E. L.;
Baskunov, B. P.; Vervoort, J.; Golovleva, L. A.; Rietjens, I. M. C. M. FEMS Microbiol.
Lett. 1999, 181, 73.
44. Osborne, R. L.; Raner, G. M.; Hager, L. P.; Dawson, J. H. J. Am. Chem. Soc. 2006,
128, 1036.
45. Fox, B. G.; Borneman, J. G.; Wackett, L. P.; Lipscomb, J. D. Biochemistry 1990, 29,
6419.
46. Battaini, G.; Monzani, E.; Casella, L.; Lonardi, E.; Tepper, A. W. J. W.;
Canters, G. W.; Bubacco, L. J. Biol. Chem. 2002, 277, 44606.
47. Nasir, M. S.; Cohen, B. I.; Karlin, K. D. Inorg. Chim. Acta 1990, 176, 185.
48. Gelling, O. J.; Feringa, B. L. Recl. Trav. Chim. Pays-Bas 1991, 110, 89.
49. Serrano-Plana, J.; Garcia-Bosch, I.; Miyake, R.; Costas, M.; Company, A. Angew.
Chem. Int. Ed. 2014, 53, 9608.
50. Tolman, W. B. Acc. Chem. Res. 1997, 30, 227.
51. Mirica, L. M.; Vance, M.; Rudd, D. J.; Hedman, B.; Hodgson, K. O.; Solomon, E. I.;
Stack, T. D. P. J. Am. Chem. Soc. 2002, 124, 9332.
52. Colomban, C.; Kudrik, E. V.; Afanasiev, P.; Sorokin, A. B. J. Am. Chem. Soc. 2014,
136, 11321.
53. Sahu, S.; Quesne, M. G.; Davies, C. G.; D€ urr, M.; Ivanovic-Burmazovic, I.;
Siegler, M. A.; Jameson, G. N. L.; de Visser, S. P.; Goldberg, D. P. J. Am. Chem.
Soc. 2014, 136, 13542.
54. de Ruiter, G.; Thompson, N. B.; Takase, M. K.; Agapie, T. J. Am. Chem. Soc. 2016,
138, 1486.
55. Groves, J. T. J. Inorg. Biochem. 2006, 100, 434.
56. Kovaleva, E. G.; Neibergall, M. B.; Chakrabarty, S.; Lipscomb, J. D. Acc. Chem. Res.
2007, 40, 475.
57. Gamba, I.; Codolà, Z.; Lloret-Fillol, J.; Costas, M. Coord. Chem. Rev. 2017, 334, 2.
58. Banerjee, R.; Proshlyakov, Y.; Lipscomb, J. D.; Proshlyakov, D. A. Nature 2015, 518,
431.
59. Costas, M.; Que, J. L. Angew. Chem. Int. Ed. 2002, 41, 2179.
60. Bryliakov, K. P.; Talsi, E. P. Coord. Chem. Rev. 2014, 276, 73.
61. Kryatov, S. V.; Rybak-Akimova, E. V.; Schindler, S. Chem. Rev. 2005, 105, 2175.
62. Poulos, T. L. Chem. Rev. 2014, 114, 3919.
63. Denisov, I. G.; Makris, T. M.; Sligar, S. G.; Schlichting, I. Chem. Rev. 2005, 105, 2253.
64. Loew, G. H.; Harris, D. L. Chem. Rev. 2000, 100, 407.
65. Meunier, B.; de Visser, S. P.; Shaik, S. Chem. Rev. 2004, 104, 3947.
66. Groves, J. T.; McClusky, G. A.; White, R. E.; Coon, M. J. Biochem. Biophys. Res.
Commun. 1978, 81, 154.
67. Groves, J. T.; McClusky, G. A. J. Am. Chem. Soc. 1976, 98, 859.
68. Rittle, J.; Green, M. T. Science 2010, 330, 933.
ARTICLE IN PRESS
69. Sydor, P. K.; Barry, S. M.; Odulate, O. M.; Barona-Gomez, F.; Haynes, S. W.;
Corre, C.; Song, L.; Challis, G. L. Nat. Chem. 2011, 3, 388.
70. Gibson, D. T.; Resnick, S. M.; Lee, K.; Brand, J. M.; Torok, D. S.; Wackett, L. P.;
Schocken, M. J.; Haigler, B. E. J. Bacteriol. 1995, 177, 2615.
71. Mohammadi, M.; Viger, J.-F.; Kumar, P.; Barriault, D.; Bolin, J. T.; Sylvestre, M.
J. Biol. Chem. 2011, 286, 27612.
72. D’Ordine, R. L.; Rydel, T. J.; Storek, M. J.; Sturman, E. J.; Moshiri, F.; Bartlett, R. K.;
Brown, G. R.; Eilers, R. J.; Dart, C.; Qi, Y.; Flasinski, S.; Franklin, S. J. J. Mol. Biol.
2009, 392, 481.
73. Neibergall, M. B.; Stubna, A.; Mekmouche, Y.; M€ unck, E.; Lipscomb, J. D.
Biochemistry 2007, 46, 8004.
74. Ferraro, D. J.; Gakhar, L.; Ramaswamy, S. Biochem. Biophys. Res. Commun. 2005,
338, 175.
75. Barry, S. M.; Challis, G. L. ACS Catal. 2013, 3, 2362.
76. Yoshiyama-Yanagawa, T.; Enya, S.; Shimada-Niwa, Y.; Yaguchi, S.; Haramoto, Y.;
Matsuya, T.; Shiomi, K.; Sasakura, Y.; Takahashi, S.; Asashima, M.; Kataoka, H.;
Niwa, R. J. Biol. Chem. 2011, 286, 25756.
77. Kauppi, B.; Lee, K.; Carredano, E.; Parales, R. E.; Gibson, D. T.; Eklund, H.;
Ramaswamy, S. Structure 1998, 6, 571.
78. Koehntop, K. D.; Emerson, J. P.; Que, L. J. Biol. Inorg. Chem. 2005, 10, 87.
79. Bruijnincx, P. C. A.; van Koten, G.; Klein Gebbink, R. J. M. Chem. Soc. Rev. 2008, 37,
2716.
80. Karlsson, A.; Parales, J. V.; Parales, R. E.; Gibson, D. T.; Eklund, H.; Ramaswamy, S.
Science 2003, 299, 1039.
81. Ashikawa, Y.; Fujimoto, Z.; Usami, Y.; Inoue, K.; Noguchi, H.; Yamane, H.;
Nojiri, H. BMC Struct. Biol. 2012, 12, 1.
82. Thibon, A.; Jollet, V.; Ribal, C.; Senechal-David, K.; Billon, L.; Sorokin, A. B.;
Banse, F. Chem. Eur. J. 2012, 18, 2715.
83. Chakrabarty, S.; Austin, R. N.; Deng, D.; Groves, J. T.; Lipscomb, J. D. J. Am. Chem.
Soc. 2007, 129, 3514.
84. Decker, A.; Chow, M. S.; Kemsley, J. N.; Lehnert, N.; Solomon, E. I. J. Am. Chem.
Soc. 2006, 128, 4719.
85. Neese, F.; Zaleski, J. M.; Loeb Zaleski, K.; Solomon, E. I. J. Am. Chem. Soc. 2000, 122,
11703.
86. Kumar, D.; Hirao, H.; Shaik, S.; Kozlowski, P. M. J. Am. Chem. Soc. 2006, 128, 16148.
87. Oloo, W. N.; Que, L. Acc. Chem. Res. 2015, 48, 2612.
88. Olivo, G.; Cussó, O.; Costas, M. Chem. Asian J. 2016, 11, 3148.
89. Olivo, G.; Cussó, O.; Borrell, M.; Costas, M. J. Biol. Inorg. Chem. 2017, 1.
90. Lindhorst, A. C.; Haslinger, S.; Kuhn, F. E. Chem. Commun. 2015, 51, 17193.
91. Cussó, O.; Garcia-Bosch, I.; Ribas, X.; Lloret-Fillol, J.; Costas, M. J. Am. Chem. Soc.
2013, 135, 14871.
92. Costas, M.; Mehn, M. P.; Jensen, M. P.; Que, L. Chem. Rev. 2004, 104, 939.
93. Engelmann, X.; Monte-Perez, I.; Ray, K. Angew. Chem. Int. Ed. 2016, 55, 7632.
94. Ray, K.; Pfaff, F. F.; Wang, B.; Nam, W. J. Am. Chem. Soc. 2014, 136, 13942.
95. Xing, G.; Diao, Y.; Hoffart, L. M.; Barr, E. W.; Prabhu, K. S.; Arner, R. J.;
Reddy, C. C.; Krebs, C.; Bollinger, J. M. Proc. Natl. Acad. Sci. U.S.A. 2006, 103, 6130.
96. Jeoung, J.-H.; Bommer, M.; Lin, T.-Y.; Dobbek, H. Proc. Natl. Acad. Sci. U.S.A.
2013, 110, 12625.
97. Shan, X.; Que, L. Proc. Natl. Acad. Sci. U.S.A. 2005, 102, 5340.
98. Zhao, M.; Helms, B.; Slonkina, E.; Friedle, S.; Lee, D.; DuBois, J.; Hedman, B.;
Hodgson, K. O.; Frechet, J. M. J.; Lippard, S. J. J. Am. Chem. Soc. 2008, 130, 4352.
ARTICLE IN PRESS
99. Chiang, C.-W.; Kleespies, S. T.; Stout, H. D.; Meier, K. K.; Li, P.-Y.; Bominaar, E. L.;
Que, L.; M€ unck, E.; Lee, W.-Z. J. Am. Chem. Soc. 2014, 136, 10846.
100. Cho, J.; Jeon, S.; Wilson, S. A.; Liu, L. V.; Kang, E. A.; Braymer, J. J.; Lim, M. H.;
Hedman, B.; Hodgson, K. O.; Valentine, J. S.; Solomon, E. I.; Nam, W. Nature
2011, 478, 502.
101. Park, M. J.; Lee, J.; Suh, Y.; Kim, J.; Nam, W. J. Am. Chem. Soc. 2006, 128, 2630.
102. Seo, M. S.; Kamachi, T.; Kouno, T.; Murata, K.; Park, M. J.; Yoshizawa, K.; Nam, W.
Angew. Chem. Int. Ed. 2007, 46, 2291.
103. Oloo, W. N.; Fielding, A. J.; Que, L. J. Am. Chem. Soc. 2013, 135, 6438.
104. Roelfes, G.; Vrajmasu, V.; Chen, K.; Ho, R. Y. N.; Rohde, J.-U.; Zondervan, C.; la
Crois, R. M.; Schudde, E. P.; Lutz, M.; Spek, A. L.; Hage, R.; Feringa, B. L.;
M€ unck, E.; Que, L. Inorg. Chem. 2003, 42, 2639.
105. Mikhalyova, E. A.; Makhlynets, O. V.; Palluccio, T. D.; Filatov, A. S.; Rybak-
Akimova, E. V. Chem. Commun. 2012, 48, 687.
106. Thibon, A.; England, J.; Martinho, M.; Young, V. G.; Frisch, J. R.; Guillot, R.;
unck, E.; Que, L.; Banse, F. Angew. Chem. Int. Ed. 2008, 47, 7064.
Girerd, J.-J.; M€
107. Hong, S.; Lee, Y.-M.; Shin, W.; Fukuzumi, S.; Nam, W. J. Am. Chem. Soc. 2009, 131,
13910.
108. Bukowski, M. R.; Comba, P.; Limberg, C.; Merz, M.; Que, L.; Wistuba, T. Angew.
Chem. Int. Ed. 2004, 43, 1283.
109. Mekmouche, Y.; Hummel, H.; Ho, R. Y. N.; Que, J. L.; Sch€ unemann, V.;
Thomas, F.; Trautwein, A. X.; Lebrun, C.; Gorgy, K.; Lepr^etre, J.-C.;
Collomb, M.-N.; Deronzier, A.; Fontecave, M.; Menage, S. Chem. Eur. J. 2002, 8,
1196.
110. He, Y.; Goldsmith, C. R. Chem. Commun. 2012, 48, 10532.
111. Li, F.; Meier, K. K.; Cranswick, M. A.; Chakrabarti, M.; Van Heuvelen, K. M.;
M€ unck, E.; Que, L. J. Am. Chem. Soc. 2011, 133, 7256.
112. Ho, Y. N.; Que, L., Jr.; Roelfes, G.; Feringa, B. L.; Hermant, R.; Hage, R. Chem.
Commun. 1999, 2161
113. Kim, Y. M.; Cho, K.-B.; Cho, J.; Wang, B.; Li, C.; Shaik, S.; Nam, W. J. Am. Chem.
Soc. 2013, 135, 8838.
114. Liu, L. V.; Hong, S.; Cho, J.; Nam, W.; Solomon, E. I. J. Am. Chem. Soc. 2013, 135,
3286.
115. Makhlynets, O. V.; Rybak-Akimova, E. V. Chem. Eur. J. 2010, 16, 13995.
116. Wang, B.; Lee, Y.-M.; Clemancey, M.; Seo, M. S.; Sarangi, R.; Latour, J.-M.;
Nam, W. J. Am. Chem. Soc. 2016, 138, 2426.
117. Furutachi, H.; Hashimoto, K.; Nagatomo, S.; Endo, T.; Fujinami, S.; Watanabe, Y.;
Kitagawa, T.; Suzuki, M. J. Am. Chem. Soc. 2005, 127, 4550.
118. Zhang, X.; Furutachi, H.; Tojo, T.; Tsugawa, T.; Fujinami, S.; Sakurai, T.; Suzuki, M.
Chem. Lett. 2011, 40, 515.
119. Guisado-Barrios, G.; Zhang, Y.; Harkins, A. M.; Richens, D. T. Inorg. Chem. Commun.
2012, 20, 81.
120. Duban, E. A.; Bryliakov, K. P.; Talsi, E. P. Eur. J. Inorg. Chem. 2007, 2007, 852.
121. Lyakin, O. Y.; Bryliakov, K. P.; Britovsek, G. J. P.; Talsi, E. P. J. Am. Chem. Soc. 2009,
131, 10798.
122. Lyakin, O. Y.; Bryliakov, K. P.; Talsi, E. P. Inorg. Chem. 2011, 50, 5526.
123. Oloo, W. N.; Meier, K. K.; Wang, Y.; Shaik, S.; M€ unck, E.; Que, L. Nat. Commun.
2014, 5, 3046.
124. Makhlynets, O. V.; Oloo, W. N.; Moroz, Y. S.; Belaya, I. G.; Palluccio, T. D.;
Filatov, A. S.; Muller, P.; Cranswick, M. A.; Que, L.; Rybak-Akimova, E. V. Chem.
Commun. 2014, 50, 645.
ARTICLE IN PRESS
125. Wang, Y.; Janardanan, D.; Usharani, D.; Han, K.; Que, L.; Shaik, S. ACS Catal. 2013,
3, 1334.
126. Khusnutdinova, J. R.; Luo, J.; Rath, N. P.; Mirica, L. M. Inorg. Chem. 2013, 52, 3920.
127. Lyakin, O. Y.; Zima, A. M.; Samsonenko, D. G.; Bryliakov, K. P.; Talsi, E. P. ACS
Catal. 2015, 5, 2702.
128. Zima, A. M.; Lyakin, O. Y.; Ottenbacher, R. V.; Bryliakov, K. P.; Talsi, E. P. ACS
Catal. 2016, 6, 5399.
129. Zima, A. M.; Lyakin, O. Y.; Ottenbacher, R. V.; Bryliakov, K. P.; Talsi, E. P. ACS
Catal. 2017, 7, 60.
130. Serrano-Plana, J.; Oloo, W. N.; Acosta-Rueda, L.; Meier, K. K.; Verdejo, B.; Garcı́a-
España, E.; Basallote, M. G.; M€ unck, E.; Que, L.; Company, A.; Costas, M. J. Am.
Chem. Soc. 2015, 137, 15833.
131. Serrano-Plana, J.; Aguinaco, A.; Belda, R.; Garcı́a-España, E.; Basallote, M. G.;
Company, A.; Costas, M. Angew. Chem. Int. Ed. 2016, 55, 6310.
132. Chanda, A.; Popescu, D.-L.; de Oliveira, F. T.; Bominaar, E. L.; Ryabov, A. D.;
M€unck, E.; Collins, T. J. J. Inorg. Biochem. 2006, 100, 606.
133. de Oliveira, F. T.; Chanda, A.; Banerjee, D.; Shan, X.; Mondal, S.; Que, L.;
Bominaar, E. L.; M€ unck, E.; Collins, T. J. Science 2007, 315, 835.
134. Ghosh, M.; Singh, K. K.; Panda, C.; Weitz, A.; Hendrich, M. P.; Collins, T. J.;
Dhar, B. B.; Sen Gupta, S. J. Am. Chem. Soc. 2014, 136, 9524.
135. Kwon, E.; Cho, K.-B.; Hong, S.; Nam, W. Chem. Commun. 2014, 50, 5572.
136. Kundu, S.; Thompson, J. V. K.; Shen, L. Q.; Mills, M. R.; Bominaar, E. L.;
Ryabov, A. D.; Collins, T. J. Chem. Eur. J. 2015, 21, 1803.
137. Mills, M. R.; Weitz, A. C.; Hendrich, M. P.; Ryabov, A. D.; Collins, T. J. J. Am.
Chem. Soc. 2016, 138, 13866.
uell, M.; Ribas, X.; Luis, J. M.; Cronin, L.; Costas, M. Nat.
138. Prat, I.; Mathieson, J. S.; G€
Chem. 2011, 3, 788.
139. McDonald, A. R.; Que, L. Nat. Chem. 2011, 3, 761.
140. Hitomi, Y.; Arakawa, K.; Funabiki, T.; Kodera, M. Angew. Chem. Int. Ed. 2012, 51,
3448.
141. Chow, T. W.-S.; Wong, E. L.-M.; Guo, Z.; Liu, Y.; Huang, J.-S.; Che, C.-M. J. Am.
Chem. Soc. 2010, 132, 13229.
142. Van Heuvelen, K. M.; Fiedler, A. T.; Shan, X.; De Hont, R. F.; Meier, K. K.;
Bominaar, E. L.; M€ unck, E.; Que, L. Proc. Natl. Acad. Sci. U.S.A. 2012, 109, 11933.
143. Tse, C.-W.; Chow, T. W.-S.; Guo, Z.; Lee, H. K.; Huang, J.-S.; Che, C.-M. Angew.
Chem. Int. Ed. 2014, 53, 798.
ARTICLE IN PRESS
Contents
1. Introduction 108
2. Preparation and Spectroscopic Characterization of μ-Nitrido Diiron Macrocyclic
Complexes 111
2.1 Structural Determination by X-Ray Diffraction 112
2.2 Structural Determination by Extended X-Ray Absorption Fine Structure 115
2.3 Mass Spectrometry 116
2.4 Determination of the Iron Oxidation State by Mo €ssbauer, XANES, and
EPR Techniques 116
2.5 X-Ray Absorption and Emission Spectroscopies 119
2.6 Relationship Between Structure of μ-Nitrido Diiron Complexes and Their
Oxidation Properties 121
3. High-Valent Diiron-Oxo Species and Their Spectroscopic Characterization 122
3.1 Phthalocyanine Platform 122
3.2 Porphyrin Platform 124
3.3 Influence of the Macrocyclic Structure on the Formation of Diiron
Oxo Species 127
4. Catalytic Properties 128
4.1 Comparison of Oxidation Properties of Diiron and Iron Oxo Species 128
4.2 Oxidation of Methane 130
4.3 Oxidation of Ethane 134
4.4 Oxidation of Benzene 136
4.5 Reactivity of μ-Nitrido Diiron Complexes in Combination With tBuOOH 139
4.6 Oxidation of Alkylaromatic Compounds 147
4.7 Formation of C–C Bonds 149
4.8 Oxidative Dehalogenation 152
4.9 Transformation of Aromatic C–F Bonds Under Oxidative Conditions 153
4.10 Degradation of Recalcitrant Pollutants 158
Abstract
A novel bioinspired approach to the development of powerful catalysts for oxidation
is based on the N-bridged diiron phthalocyanine and porphyrin complexes. This scaf-
fold is particularly suited for the stabilization of FeIVFeIV entities and can therefore be
useful for the preparation of oxidizing active species. The possibility of the charge
delocalization on two iron sites, two macrocyclic ligands, and the nitrogen bridge
makes possible the activation of peroxides including H2O2. The ultra high-valent
diiron-oxo species (L)FeIV–N–FeIV(L+%)]O (L ¼ phthalocyanine, porphyrin) have been
detected at low temperatures and characterized by cryospray MS, UV–vis, EPR, X-ray
absorption spectroscopy, and Mo €ssbauer techniques. These highly electrophilic (L)
FeIV–N–FeIV(L+%)]O species show outstanding reactivity. The catalytic applications
of μ-nitrido diiron complexes include oxidation of methane and benzene, transforma-
tion of aromatic C–F bonds in oxidative conditions, oxidative dechlorination, and for-
mation of C–C bonds. Importantly, all these reactions can be carried out under clean
and mild conditions with high conversions and turnover numbers. μ-Nitrido diiron
species demonstrate similar mechanistic features (18O labeling, formation of benzene
epoxide, and NIH shift in the aromatic oxidation) (see Section 4.4 and Kudrik and
Sorokin, 2008 for the explanation) as enzymes operating via high-valent iron-oxo spe-
cies. μ-Nitrido diiron complexes transform perfluorinated aromatic compounds in oxi-
dative conditions, while the strongest oxidizing enzymes do not. Advanced
spectroscopic and reactivity studies confirm the participation of high-valent diiron-
oxo species in these catalytic reactions.
1. INTRODUCTION
The ability of cytochrome P450 (1) and methane monooxygenase
(MMO) (2,3) enzymes to perform challenging oxidations of hydrocarbons
has inspired an extensive research in bioinspired catalysis. The objective of
these studies is to understand how P450 and MMO enzymes catalyze dif-
ficult chemical reactions under very mild conditions, and, using this
knowledge, to develop efficient and practical chemical catalysts. These
enzymes activate dioxygen to form high-valent iron-oxo entities having
strong oxidizing properties. Diiron nonheme oxo species of soluble
MMO (sMMO) perform the oxidation of CH4 to CH3OH under ambient
conditions, a reaction that still remains a fundamental challenge in
ARTICLE IN PRESS
O
IV O
LFe IV O
Fe L FeIV + .
O
or FeIV + . N
IV IV
O Fe O Fe FeIV
L L
A
Poor oxidant OH
O O O
Principal O
.
pathway - HO-
FeIV +HO FeIII FeIV + . FeV
B OH
O O O
O
Strong oxidant
Fig. 3 Formation of the high-valent iron-oxo species from iron peroxocomplexes at
mononuclear and binuclear macrocyclic platforms.
R3
R3 R4
R1 R2
R2 R4 N
R2 N
N N
R2 N N R1 Fe
Fe N N
R1 N N R3
N R2 R4 N
R2 R4
R1 N R2 R3 N R5
R2 R2 R1 R2
R2 N
R2 N R5 N N
N R1 N
Fe Fe
R1 N N R2 N N N
R5
N
R2 R2
R2 R1
R5
N(1)
Fe(la)
N(5a)
N(3a)
N(2a) N(4a)
(FeTPP)2N (FePzPr8)2N
C(82)
C(81) C(72)
C(71)
C(b7)
C(b8)
C(
a7
C(m1) )
C(12) C(a8) C(m4) C(62)
C(11)
N(4)
C(a1
Fe(1) N(4)
1.665(4)
C(a6) C(61)
N(1)
)
N(3) C(b6)
C(b1) Fe(1)
175.2(2) N
N(1) C(b5)
1.649(4)
C(b2)
N(3)
Fe(2) C(a2) )
a5
N(2)
C(b3)
C(b4)
C(31) C(41)
C(32) C(42)
(FeOEP)2N
Fig. 5 Crystal structures of (FeTPP)2N, (FePzPr8)2N, and side-on and top-down view of
(FeOEP)2N. Hydrogen atoms are omitted for clarity.
ARTICLE IN PRESS
(FeTPP)2N (41) 177.0(4)° 1.6795(4) 2.003(3) — 28.7° 3.36 3.93
(FeOEP)2N (42) 175.2(2)° 1.657(11) 2.005(5) — 23.1° 3.31 3.83
[(FeTPP)2N](SbCl6) (30) 180° 1.6280(7) 1.979(5) 30.3° 3.26 4.00
[TPPFeNFePc] [(THF) 179.0(6)° 1.625(2) 2.00(5) Eclipsed 3.28 3.51
H2O]I5 (43)
[(FePc)2N]Br2 (44) 180° 1.639(2) 1.954(9) 2.495 39° 3.28 3.28
[(FePc)2N](N3)2I3 (45) 177.4(4)° 1.650(1) 1.947(5) 2.152(7) 38.5(5)° 3.30 3.46
(FePzPr8)2N (39) 168.5(2)° 1.656(4) 1.914(4)– — 26.2 3.32 3.89
1.662(4) 1.932(4)
ARTICLE IN PRESS
t
t Bu
Bu
t
t
Bu
Bu
+3.5
IV +.
t
t
Bu
Bu t
Bu
t
t
t
Bu Bu
Bu t
Bu
t
Bu
IV
+3.5
t
t
Bu
Bu
t
Bu
t
Bu X = F, Cl, Br
€ssbauer,
2.4 Determination of the Iron Oxidation State by Mo
XANES, and EPR Techniques
This important information can be obtained using a combination of several
spectroscopic methods. The number of distinct Fe sites in the sample and
their oxidation, spin states, and ratio can be determined by M€
ossbauer spec-
troscopy. Thus, equivalence or nonequivalence of the iron sites in μ-nitrido
diiron complexes can be probed. Diiron macrocyclic complexes can be
ARTICLE IN PRESS
often contain a macrocyclic cation radical and they are isoelectronic with
Fe(IV)(μ-N)Fe(V) species. In sharp contrast to bioinspired high-valent
iron-oxo species, some of these ultra high-valent diiron complexes are stable
at room temperature. Their high oxidation state can be identified by the
M€ ossbauer method on the basis of very low and even negative values of iso-
mer shift. The Fe(IV)(μ-N)Fe(IV) porphyrin and phthalocyanine complexes
exhibit δ values between 0.03 and 0.13 mm s1.
The EPR spectra of μ-nitrido diiron complexes allow distinguishing
three electronic states. The Fe(+3.5)(μ-N)Fe(+3.5) complexes are
S ¼ 1/2 species with axial symmetry formally resulting from antiferromag-
netic coupling between Fe(IV) (S ¼ 1) and Fe(III) (S ¼ 3/2) in the Fe(III)–μ
N–Fe(IV) core. One-electron oxidized Fe(IV)Fe(IV) complexes are EPR
silent. Two-electron oxidized Fe(IV)Fe(IV) cation-radical species features
a single strong narrow symmetric signal at g 2.00 due to an organic radical.
For example, frozen (FeOEP)2N solution in THF showed low-spin signals
in the g 2 region corresponding to the S ¼ 1/2 species (Fig. 7) (51).
The signal of (FeOEP)2N contained a major axial species with g║ ¼ 2.06
and g┴ ¼ 2.01. Minor species at g ¼ 2.15 exhibited a characteristic 14N
hyperfine splitting. The EPR spectrum of (FeTPP)2N recorded at the same
conditions showed signals at g║ ¼ 2.01 and g┴ ¼ 2.15 with a well-resolved
isotropic 14N hyperfine structure, which can only be observed at a low
dimer concentration in weakly interacting solvents (53). The major axial sig-
nal in the (FeOEP)2N EPR spectrum can be formed due to an increase of
axiality owing to the interactions between the (FeOEP)2N molecules,
which should be more favorable than in the case of more hindered
(FeTPP)2N. The similar axial signal was observed for structurally related
(FePctBu4)2N in CH2Cl2 solution (54). The minor signal of (FeOEP)2N
at g ¼ 2.15 is due to naked species resembling the (FeTPP)2N complex with
200
g = 2.06 (FeOEP)2N 500 21 G (FeTPP)2N
g = 2.15
0 300
I (a.u.)
I (a .u.)
g = 2.01
100
–200
–100
g = 2.15
g = 2.01
–400 –300
3000 3100 3200 3300 3400 3500 3000 3100 3200 3300 3400
H (G) H (mT)
Fig. 7 X-band EPR spectra of (FeOEP)2N and (FeTPP)2N recorded in THF at 110K.
ARTICLE IN PRESS
1.35
Absorbance
FeIIIFeIV
7114.1 eV
1.15
FeIIIPc:
7112.8 eV
0.95
7108 7112 7116
eV
Fig. 8 Preedge region of the XAS spectra of mononuclear FePctBu4 (d d d) in com-
parison with dimeric (FePctBu4)2N (dd), (Cl)(PctBu4)FeIV–N–FeIV(PctBu4)+%(Cl) (—), and
(Br)(PctBu4)FeIV–N–FeIV(PctBu4)+%(Br) (solid line) complexes.
of the preedge peak is consistent with the increase of the efficient positive
charge on the Fe sites, leading to a stronger electron bonding. Upon
formation of (Cl)(PctBu4)FeIV–N–FeIV(PctBu4)+%(Cl) and (Br)(PctBu4)
FeIV–N–FeIV(PctBu4)+%(Br), a further increase of preedge energy to
7115.2 eV was observed due to the higher Fe oxidation state. Notewor-
thy, the second lobe of the preedge peak appeared at 7113.4 eV. This
pre-peak feature with two lobes can probably be explained by a non-
equivalent character of the Fe sites owing to the presence of a cation rad-
ical on one phthalocyanine ligand. As a result, the removal of 3d orbitals
degeneration leads to multiple excited states, resulting in superposition of
two types of preedges. This two-lobe feature of the preedge peak is char-
acteristic of the high-valent FeIV–μN–FeIV complexes having a mac-
rocycle cation-radical.
The RIXS studies at Fe K-edge provide the unique possibility of observ-
ing 3d4 Fe(IV) spin systems (62). RIXS and EXAFS spectra can also be
simulated theoretically and compared with the experimental data (48).
Combined Fe K-edge XAS and the DFT simulations attribute preedge fea-
tures to the details of the electronic structure. In contrast to related μ-oxo-
dimers containing antiferromagnetically coupled high spin centers, μ-nitrido
Fe(III)Fe(IV), Fe(IV)Fe(IV), and Fe(IV)Fe(IV) cation-radical complexes are
in a low-spin (LS) state (62).
ARTICLE IN PRESS
OOH O
+
HOO–
2 redox equivalents
FeIV + .
III III
Fe Fe
above FeIII state
Cationic Neutra l Cationic
OH–
Intens.
(%)
1599.7268 +MS, 0.8–1.3 min #(45–77)
100
(FePctBu4)2N+
H2O2–0.00018
80
60
O1–0.00279
40
OK[(FePctBu4)2N]+ HOO–[(FePct(Bu4)2N]+
20 1633.7322
1615.7239
0
1595 1600 1605 1610 1615 1620 1625 1630 1635 m/z
Fig. 10 ESI-MS spectrum (positive mode) recorded in the course of reaction of 1 μM
(FePctBu4)2N in the presence of 1000 equiv. H2O2 and 2000 equiv. Et3N.
ARTICLE IN PRESS
18
16
O O
H218O2 oxidant 1617.9
H2O2 oxidant 1615.9 100
100 .
Fe IV + 1617.1 Fe IV + .
1615.0 1616.9 80
Relative abundance
80
Relative abundance
N N
1618.9
60 Fe IV 60 Fe IV
40 1617.9 40
1616.1 1619.8
1613.0 1614.0 1618.9 1622.9
20 1619.7 20
1614.1 1620.8
1612.0
0 0
1612 1614 1616 1618 1620 1615 1620
m/z m/z
1615.7 1617.7
100 1614.7 100
1616.7
Simulation
Simulation
Relative abundance
Relative abundance
80 80
60 1616.7 60 1618.7
40 40
1617.7 1619.7
20 20
1612.7 1613.7 1614.7 1615.7
1618.7 1620.7
1611.7 1619.7 1613.7 1621.7
0 0
1610 1612 1614 1616 1618 1620 1614 1616 1618 1620 1622
m/z m/z
Fig. 11 Positive ESI-MS spectra of the oxo species detected in the reaction of
(FePctBu4)2N with H216O2 and H218O2 (MeCN, 25°C).
ARTICLE IN PRESS
Absorbance
-
1.4 O COAr
O -
O
1.2 FeIII −80°C FeIII FeIV + .
+m-CPBA 10 min
N N N
1.0 −H+ −OCOAr−
FeIV FeIV FeIV
immediately
0.8
OCOAr
385, 410, 529 nm 406, 548 nm 399, ~630 nm
0.6 t1/2 ~ 20 min at −80°C
0.4
0.2
0.0
0.0
0.2
0.0
Absorption (%)
0.2 B
0.0
0.2
C
−2 0 2
Velocity (mm/s)
Fig. 13 Mo €ssbauer spectra of the labeled [(TPP)57Fe(μ-N)57Fe(O)(TPP%+)]. Spectra were
recorded at 4.2K with a magnetic field applied parallel (A: 60 mT, B: 7 T) or perpendicular
(C: 7 T) to the γ-beam (hatched marks). Simulation 1 was obtained assuming a unique
S ¼ 0 Fe site with the following parameters: δ ¼ 0.000 mm s1, ΔEQ ¼ + 0.746 mm s1,
η ¼ 0 (fixed), and Γ fwhm ¼ 0.284 mm s1. Simulation 2 was performed assuming two dis-
tinct S ¼ 0 Fe sites in the 1:1 ratio with the following parameters: δ1 ¼ 0.056 mm s1,
ΔEQ1 ¼ + 0.758 mm s1, δ2 ¼ 0.056 mm s1, ΔEQ2 ¼ + 0.740 mm s1, η1 ¼ η2 ¼ 0 (fixed),
and Γ fwhm,1 ¼ Γ fwhm,2 ¼ 0.246 mm s1. Contributions of sites 1 and 2 are shown above
the experimental spectra as solid and dashed lines, respectively.
ARTICLE IN PRESS
FeIV
2351.4 N
2352.5
FeIV +. 585.1 O
Fe H+
O 568.1 Fe OH
+H+
Fe
2350 2355 2360
MS2 NH
585.1 O O
568.1 +600.1
Fe Fe
472.1
500 1000 1500 2000 2500 560 570 580 590 600 610
m/z m/z
oxo ligands were situated at more electron-rich iron sites (route A, Fig. 14).
Only trace amounts of species containing an oxo entity on the electron-
deficient iron center were detected. Therefore, the nature of macrocyclic
ligands influences the formation of the active diiron-oxo species and ulti-
mately might also affect their catalytic properties.
4. CATALYTIC PROPERTIES
4.1 Comparison of Oxidation Properties of Diiron and Iron
Oxo Species
Successful preparation of high-valent iron and diiron-oxo species with the
same tetraphenylporphyrin ligands provided a rare possibility to evaluate the
influence of the dimeric structure on the catalytic activity without interfer-
ence from other factors. Both oxo species were prepared at 60°C and their
reactivity was evaluated using UV–vis decay kinetics in the presence of
ethylbenzene, adamantane, or cyclohexane (41). A direct comparison of
reactivity of (TPP)FeIV(μ-N)FeIV(O)(TPP%+) and (TPP+%)Fe]O under
single-turnover conditions revealed the diiron species to be a much stronger
oxidant (Table 2).
Remarkably, the diiron-oxo species was 26 and 130 times more active
compared to the monomeric oxo complex in the oxidation of ethylbenzene
and adamantane, respectively (Fig. 16).
ARTICLE IN PRESS
kobs (S−1)
0.00 0.01 0.02 0.03 0.04 0.05 0.000 0.005 0.010 0.015 0.020 0.025
[PhEt] (M) [Adamantane] (M)
The stronger the C–H bond, the larger is the difference in reactivity
between the two species. While the diiron-oxo complex was characterized
by a second-order rate constant k60°C ¼ 0.079 M1s1 in the oxidation of
cyclohexane (bond dissociation energy, BDEC–H ¼ 99 kcal mol1) at 60°
C, no reaction was observed with (TPP+%)Fe]O under the same condi-
tions. This rate constant is among the highest values for cyclohexane oxida-
tion by biomimetic complexes (41). The rate constant at 25°C estimated
from the temperature dependence was calculated to be k25°C 3.4 M1s1.
Such a high value suggests that (TPP)FeIV(μ-N)FeIV(O)(TPP%+) might be
able to oxidize stronger C–H bonds. The kH/kD value obtained from the
second-order rate constants for C6H12 and C6D12 oxidations was 3.6, indi-
cating the involvement of C–H bond cleavage in the rate-determining step
(Fig. 17).
ARTICLE IN PRESS
0.040 O
D OH D
0.035 FeIV +. H
0.030 N 25°C
+
OH
0.025 kH = 0.086
FeIV
kobs (s−1)
0.015 Fe + .
IV
O
0.010 N
D FeIV + .
0.005 kD = 0.024 FeIV
kH/kD = 2.96 ± 0.10
0.000 kH/kD = 3.16 ± 0.10
0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 0.45
Concentration (M)
H
HCOOH + CH3OH
(FePctBu4)2N
C 68%
H H + H2O2
32 bar, 60°C, 20 h DCOOH + CD3OH
H 32%
CD3CN
-
OH
O O
H+
.
Fe III FeIV+
N N
Fe IV H2O Fe IV
Fig. 19 Formation of the high-valent diiron-oxo active species in the presence of acids.
ARTICLE IN PRESS
120
60°C
0.075 M H2SO4
100
120
Concentration (mM)
80 100
[HCHO]
80
60 [HCO2H]
60
40
40
20
20
0 0
0 50 65 75 85 100 200 25°C 40°C 45°C 50°C 60°C 80°C
[H2SO4] (mM)
TON: 52 74 130 207 223 160
TON: 23 65 134 223 167 74 34
Fig. 20 Dependence of the efficiency of the methane oxidation on the H2SO4 concen-
tration and temperature.
N N
N N t
Bu
SO2R
N N N N Fe N N Fe N N
Fe N N N N N
N N N t
Bu
N SO2R N
N N
SO2R N SO2R < N < t
Bu N t
Bu
N N t N
SO2R Bu N
N
N N N Fe N N N Fe N
Fe N N N N N N
N N SO2R N t
Bu
N N N
t
Bu
SO2R
The efficiency of the CH4 oxidation depends also on the catalyst struc-
ture. Using heteroleptic μ-nitrido diiron phthalocyanine complexes, we
found that the formation of the oxo species occurred preferentially at an
electron-rich iron site of the dimer (Fig. 14) (49). In agreement with the
ESI-MS and DFT studies, the growth of the electron-donating
character of the phthalocyanine ligand along the series [FePc(SO2tBu)4]2
N < (FePc)2N < [FePc(tBu)4]2N led to an increase of the catalytic efficiency.
The values of TON in this row markedly increased: 32.1 ! 102.9 ! 223.4
(Fig. 21).
Importantly, the Fe(μN)Fe structural motif of (FePctBu4)2N was essen-
tial for the catalytic activity. Mononuclear FePctBu4 as well as the
corresponding diiron μ-oxo (Fe–O–Fe) and μ-carbido (Fe]C]Fe) com-
plexes were not active in the oxidation of methane.
ARTICLE IN PRESS
oxidation of C2H6 and CH4. However, the TON of the oxidation of CH4
and C2H6 in H2O was comparable: TONHCOOH ¼ 26 (16) for CH4 and
TONAcOH ¼ 33, TONHCOOH ¼ 27 for C2H6. Unexpectedly, the efficiency
of ethane oxidation in 75 mM H2SO4 was even lower than that of methane:
TONAcOH ¼ 41, TONHCOOH ¼ 44 for C2H6 vs TONHCOOH ¼ 223
for CH4.
Surprisingly, the oxidation of propane under the same reaction condi-
tions (except PPrH ¼ 20 bar at 60°C instead of 32 bar for CH4 and C2H6)
was even less efficient (69). Comparable amounts of formic
(TON ¼ 15.4), acetic (TON ¼ 5.9), and propionic acids as well as
propan-1-ol, propane-2-ol, propionaldehyde, and acetone were obtained
with an estimated total TON 60. Relative reactivity of C–H bonds in
the oxidation of CH4, C2H6, and C3H8 together with the values of their
C–H bond dissociation energy and solubility in water is given in Table 4.
The order of reactivity in the electrophilic reactions correlates with sta-
bilization of positive charges or follows the order of BDEC–H when radical
species are involved. For example, the normalized reactivity of the C–H
bonds of CH4, C2H6, and C3H8 in the oxidation by Tl(CF3COO)3–
CF3COOH system was 1:25:150 (70). The (FePctBu4)2N/SiO2–H2O2
system exhibits an unusual 1:1:1 reactivity in the oxidation of CH4,
C2H6, and C3H8 in water. The possible explanation is the formation of
an adduct between the diiron-oxo species and C2H6 or C3H8 molecules
before the oxidation event. A similar explanation for metal-oxo complexes
has recently been reported (71). Remarkably, the C–H bond in CH4 was
five times more reactive than the C–H bond in C2H6 when the oxidation
was performed in 75 mM H2SO4 (Table 4). This unusual reactivity of elec-
trophilic μ-nitrido diiron-oxo species is not yet understood. Further studies
are necessary to provide deeper insight into this reaction mechanism. The
Table 4 Comparison of the C–H Bond Dissociation Energies (BDE), Solubilities in Water
(1 bar, 20°C), and Reactivities of CH4, C2H6, and C3H8 in the Oxidation by (FePctBu4)2
N/SiO2–H2O2 System (68)
BDE Solubility in Reactivity on C–H Reactivity on C–H bond,a
Alkane (kcal mol21) H2O (mM) bond,a H2O 75 mM H2SO4
CH4 104.9 1.42 6.5 52.3
C2H6 101.4 1.87 7.7 10.5
C3H8 100.4 1.70 7.5 n.d.
a
Reactivity is defined as total turnover number normalized for the number of C–H bonds in alkane.
ARTICLE IN PRESS
nature of the support, strength, and loading of acidic groups should also be
studied to optimize activity and selectivity of these catalysts and to control
better C–C bond cleavage.
Abundance
95,000
OH
90,000
85,000
80,000
75,000 O
70,000
65,000
60,000
55,000 O
50,000 O
45,000 O
40,000
35,000 O
30,000
25,000
20,000
15,000
10,000
5000
0
4.00 4.50 5.00 5.50 6.00 6.50 7.00 7.50 8.00 8.50 9.00 9.50
Time (min)
Fig. 22 GC-MS analysis of the oxidation of 1:1 mixture of C6H6 and C6D6 by
(FePctBu4)2N–H2O2 system. Isotopomers show slightly different retention times on
GC, deuterated compounds being eluted first. This phenomenon is well seen in the case
of 1,4-benzoquinone and phenol.
ARTICLE IN PRESS
OH O
O
t
(FePc Bu4)2N–H2O2
MeCN (60°C)
TONPhOH = 66 O
O O O
H No NIH shift OH OH O
D D D D H H D D
+
H H H H D D H H
D D H O
PhOH-d3 PhOH-d2 BQ-d2
O H O H D
H
D D D O
D
D
H H H H H H
D D D
-D -H -D -H
K1 K2
OH OH H D
D H D D D OH D OH
H H H H H H H H
D NIH-shifted D D D NIH-shifted
PhOH-d2 PhOH-d3 PhOH-d2 PhOH-d3
O O O
D H D D D D
H H H H D H
O O O
NIH-shifted NIH-shifted
BQ-d2
BQ-d1 BQ-d3
6% 75% 19%
t
Fig. 24 Oxidation of 1,3,5-trideuterobenzene by (FePc Bu4)2N–H2O2 system involving
NIH shift. NIH-shifted products are indicated with yellow ovals.
ARTICLE IN PRESS
50
30
20
10
0
0 10 20
Reaction time (h)
Fig. 25 Accumulation of cyclohexanone (▲), cyclohexanol (●), and bicyclohexyl (■) in
the course of the oxidation of neat cyclohexane (9.26 M) at 25°C in the presence of
0.1 mM (FePctBu4)2N and 0.25 M tBuOOH.
products based on the tBuOOH amount were 68% (3 h), 81% (6 h), and
94% (9 h) achieving 114% after 23 h. This finding strongly suggests the
involvement of O2 in the cyclohexane oxidation.
OtBu
O OH O
0.2 mM (FePctBu4)2N
0.25 MtBuOOH
+ + +
60°C, 14 h
oxidation reaction. The yields of the products and their composition were
strongly affected by the presence or absence of dioxygen (Fig. 26).
The high total concentration of the oxidation products of 536 mM was
attained in the presence of air. In anaerobic conditions, the product concen-
tration decreased, down to 199 mM. In addition, quite different product
compositions were obtained depending on the presence of O2. Allylic alco-
hol (23.3%) and ketone (68.7%) were the dominant oxidation products in
the aerobic conditions, whereas 3-tert-butylperoxocyclohexene and 3,30 -
bicyclohexenyl accounted only for 6.8% and 1.2% of products, respectively.
In contrast, the allylic peroxide (53.9%) was the major product under an
inert atmosphere and the content of allylic alcohol and ketone decreased
to 11.1% and 19.2%, respectively. It is noteworthy that the concentration
of 2-cyclohexen-1-one dropped from 368 mM in the presence of air down
to 38.2 mM under Ar (a decrease by a factor of 9.6). The significant amount
of 3,30 -bicyclohexenyl (15.8%) arising from coupling of cyclohexenyl rad-
icals was formed (increase by a factor of 5.1 compared with aerobic condi-
tions). The total TON dropped from 2709 in air down to 1152 under Ar.
The yield of the oxidation products in the presence of air reached 361%
based on the tBuOOH amount. All these results are indicative of the signif-
icant involvement of O2 in the oxidation of cyclohexene.
H H H H
H H 47.7%
H H H H
+
H D H H D D
t
H H D D 0.5 mM (FePc Bu4)2N
0.35 M H2O2
+ H D 45.0%
60°C
H H D D
H D H H D D
+
D D D D
47.7 + 47.7 + 45.0
kH / kD = = 2.36 D D
45.0 + 7.3 + 7.3 7.3%
D D D D
Fig. 27 Oxidation of benzene to biphenyl by (FePctBu4)2N–tBuOOH system: determina-
tion of kinetic isotope effect.
ARTICLE IN PRESS
formation of benzene epoxide (75), biphenyl was obtained with a 91% selec-
tivity in the former case. Kinetic isotope effects in the oxidation of benzene
by tBuOOH and H2O2 catalyzed by (FePctBu4)2N were also different: 2.36
and 1.16, respectively. The tBuO% radical was claimed in a publication to be
incapable of the oxidation of benzene (86). Decomposition of tBuOOH in
benzene in the presence of the tBuOOtBu initiator resulted in the formation
of acetone, tBuOH, CO, CO2, and a small amount of O2 without products
of benzene oxidation. Consequently, the formation of the benzene oxida-
tion products in the (FePctBu4)2N–tBuOOH system suggests the involve-
ment of (Pc)FeIV(μ-N)FeIV]O(Pc) in the oxidation by abstracting of a
hydrogen atom from benzene. Phenyl radicals recombine to form the biphe-
nyl product since their recombination with alkoxyl radicals is slow.
t FeIVNFeIII–OH Cy–H
BuOOH
Recombination
FeIVNFeIVK O . in cage
Cy Cy–Cy
FeIVNFeIII–O–OtBu t . .
BuO Cy Cage
escape
t O2
BuOH Cy–H
IV III
Fe NFe
. .
CyOOH CyOO + OOCy
FeIVNFeIII–O–OCy .
Cy Cy–H Cy–OH + Cy K O + O2
.
Fe NFe K O
IV III CyO O2
Cy–H
CyOH
FeIVNFeIII–OH Cy–H
Fig. 29 Proposed mechanism of the oxidation of cyclohexane and other hydrocarbons
by (FePctBu4)2N–tBuOOH system. Phthalocyanine ligands are omitted for clarity. Species
reacting with C–H bonds are depicted in red and principal products are in blue color.
Reprinted with permission from Kudrik, E. V.; Sorokin, A. B. J. Mol. Catal. A: Chem. 2017,
426, 499–505. Copyright 2017 Elsevier.
expected under these conditions. In fact, the parallel formation of two adja-
cent radicals is disfavored by the lower cyclohexane concentration. Instead,
Cy–H molecule reacts with either (Pc)FeIV(μ-N)FeIV]O(Pc) or tBuO%
radical to form the Cy radical, which is then trapped by adjacent active spe-
cies to form an oxidation product.
The pronounced dependence of the yield and composition of
cyclohexene oxidation products in the presence of O2 (Fig. 26) confirms
the participation of O2 in the reaction. A sharp decrease of
2-cyclohexen-1-ol and 2-cyclohexen-1-one amounts observed in anaerobic
conditions, from 125.2 and 368 mM down to 22 and 38.2 mM, respectively,
indicates that these products should be formed through the reaction
pathways involving O2. In turn, a notable increase of 3-tert-buty-
lperoxocyclohexene and 3,30 -bicyclohexenyl contents under Ar points
out that the concurrent recombination of cyclohexenyl and tBuO% radicals
becomes a predominant pathway in the absence of O2. Thus, the
(FePctBu4)2N–tBuOOH system operates via one-electron oxidation path-
ways involving free radicals.
p-xylene at the scale of 44 million tons per year. The industrial process
involves aerobic radical oxidation in the presence of Co and Mn salts in
acetic acid at 200°C and 1.5 MPa pressure. Different catalytic approaches
have been developed in the search for more environmentally acceptable
and selective processes. Taking into account the high selectivity of μ-nitrido
diiron complexes in combination with tBuOOH to benzylic vs aromatic
oxidation, we have studied the complexes [FePc(SO2n–C6H13)4]2N and
[FePc(SO2tBu)4]2N bearing electron-withdrawing alkylsulfonyl substituents
in the oxidation of neat toluene and p-xylene at 20–60°C (40). Avoiding the
use of solvents is an important advantage from environmental and industrial
perspectives. Using 1 mM [FePc(SO2n–C6H13)4]2N solution, toluene was
oxidized to benzoic acid with 83% selectivity and a TON of 197 (Fig. 30).
PhCH2OH and PhCHO were minor products, whereas only traces of
p-cresol and 2-methyl-1,4-benzoquinone were detected. Due to the simul-
taneous generation of two active species according to the mechanism
described earlier (Fig. 29), the catalytic reaction was very efficient with only
a 0.01 mM catalyst loading affording TON ¼ 6570. It was noteworthy that
benzaldehyde was obtained as the principal product under these conditions.
The oxidation of p-xylene has afforded the products of benzylic oxida-
tion of only one methyl group with a TON of 587. When 1 mM [FePc
(SO2tBu)4]2N was used, p-toluic acid, p-tolualdehyde, and
4-methylbenzyl alcohol were obtained with 66%, 19%, and 15% selectivity,
respectively (Fig. 31) (40).
Again, the oxidation was very efficient with a low catalyst loading of
0.01 mM resulting in a TON of 13,300. Under these conditions, the selec-
tivity of the oxidation changed and p-tolualdehyde was obtained with 78%
selectivity.
+ +
+ +
O
t CH3
0.01 mol% (FePc Bu4)2N
O 0.15 equiv. tBuOOH
CH3C + X X
H 60°C, Ar
86 52
O
71 80
O
OH OH 71 51
O O 61 90
HO
O 62 76
HO
a
Reaction conditions: olefin (10 mmol), acetaldehyde (100 mmol), catalyst (1 μmol, 0.01 mol%),
60°C, 24 h.
b
0.1 mol% catalyst loading.
Fe+3.5NFe+3.5–O–OtBu
O
. X O
t
BuO O RC
RC FeIVNFeIV = O R H
H H
Inefficient
t O O
BuOH RC . FeIVNFeIII–O–H X O
RC.
R .
X A
Anti-Markovnikov addition
2.2
2.5
2.0
1.8
635
Abs at 635 nm
1.6
2.0 1.4
1.2
1.0
0.8
1.5
Absorbance
0.6
0.0 0.5 1.0 1.5 2.0 2.5 3.0
Molar ratio
1.0
690
0.5
531
0.0
400 500 600 700
l (nm)
Fig. 34 Spectral changes in the course of titration of 6.9 μM Cl–(Pc)FeIV(μ-N)FeIV
(Pc+%)–Cl with 2-mercaptoethanol. MeCN, 25°C. Inset: dependence of absorbance at
635 nm on the 2-mercaptoethanol/Cl–(Pc)FeIV(μ-N)FeIV(Pc+%)–Cl molar ratio.
F 0
FeIII FeIV +
C6F6/C6H6 (1:1)
30 equiv. tBuOOH
N N
60°C, 6 h
FeIV FeIV
Isolated yield–80% F
IV IV +%
Fig. 35 Stoichiometric formation of [(Pc)(F)Fe (μ-N)Fe (F)(Pc )]. Ovals represent tetra-
tert-butylphthalocyanine.
Conversion (TON)
(FePc)2N–H2O2 29% (226) 33% (152) 59% (341) 41% (336) 66% (351) 41% (169) 69% (240) 47% (120)
Fenton system 0% n.d. 0% 0% n.d. n.d. 0% 0%
Conversion (TON)
(FePc)2N–H2O2 82% (818) 30% (242) 45% (376) 20% (141) 31% (178) 40% (188)
Fenton system 7% (45) <2% (<15) <2% (<15) <4% (<9) <9% (70) <3% (<17)
O CH3
N
Conversion (TON) O
(FePc)2N–H2O2 99% (986) 45% (282) 15% (69) 29% (150)
Fenton system 98% (750) <7% (43) <2% (<17) 11% (78)
OH COOH SO3H F
F F F F F F F COOH
F F F F F F F COOH
Conversion (TON) F F F F
(FePc)2N – H2O2 98% (4825) 76% (2950) 53% (2140) 56% (1730)
Fig. 37 Catalytic heterogeneous defluorination by carbon-supported (FePctBu4)2N–
H2O2 system in D2O at 60°C for 15 h. The catalyst:substrate:oxidant ratio was
1:1000:26,000.
F OH F
Cl Cl Cl Cl Cl Cl
+
F F F F F F
Cl Cl
OH
97% 3%
F OH F
H H
+
F F F F F F
H OH
98% 2%
Fig. 38 Relative reactivities of C–F bond vs C–Cl and C–H bonds.
OH F OH F
F OH
F F F 6% F 94%
HF CO2 CO
F
Supported catalyst COOD
F F F COOD O
0.2 µmol COOD
+ H2O2 DF + CO2 + CO + + +
D2O, 60°C, 15 h COOD
F F 5200 862 602 41 F COOD H COOD
114 mmol F
OH mmol mmol mmol mmol 33 mmol 7.4 mmol
200 mmol
Fluorine balance: 97%
96% conversion
Carbon balance: 89%
Fig. 41 Heterogeneous catalytic mineralization of C6F5OH in water. Adapted with per-
mission from Colomban, C.; Kudrik, E. V.; Afanasiev, P.; Sorokin, A. B. J. Am. Chem. Soc.
2014, 136, 11321–11330. Copyright 2014 American Chemical Society.
OH
0.5 mol% catalyst HOOC
20 equiv. H2O2 CO2 CO
Water, 60°C, 3 h
A 54% organic carbon loss due to the formation of CO2/CO and an 89%
defluorination of C–F have been achieved (Fig. 41) (47).
μ-Nitrido diiron catalysts showed promising results in the degradation of
chlorinated phenols (95). The homogeneous oxidation of 2,6-
dichlorophenol (DCP) and 2,4,6-trichlorophenol (TCP) in water using
readily accessible water-soluble μ-nitrido diiron tetrasulfophthalocyanine
(FePcS)2N (96) and H2O2 was more efficient than with mononuclear FePcS
in terms of conversion, dechlorination degree, and total organic carbon
removal (Fig. 42).
While (FePcS)2N was quite stable under reaction conditions, the blue
color of FePcS almost disappeared after 15 min. The degradation of DCP
in the presence of FePcS started only when the complex was completely
bleached after 1 h. In contrast, the reaction with (FePcS)2N was rapid
and 70%–80% DCP conversion was achieved after 1 h. The (FePcS)2N–
H2O2 system performed mineralization of DCP, and notable amounts of
CO2 and CO were found in the gas phase after reaction. The (FePcS)2N
catalyst was also more efficient in oxidation of TCP. After 6 h reaction, a
46% conversion of TCP and a 11% TOC removal were obtained at pH 7
with 2 mol% (FePcS)2N loading, while no TCP conversion (less than 1.5%)
ARTICLE IN PRESS
+ H2O
–H2O (–HCl)
FeNFe
FeNFeOO–
(OH) (OH)
(OH)
(OH)
[O]
H2O
–COx –CO2
(OH)
ACKNOWLEDGMENTS
The author is grateful to all coworkers whose names are given in the references for their
valuable contributions to the development of this topic. Dr. P. Afanasiev and Dr. E. V.
Kudrik are particularly acknowledged for the fruitful collaboration and stimulating
discussions. Research support was provided by the Agence Nationale de Recherche
(ANR, France, Grants ANR-08-BLANC-0183-01 and ANR-16-CE29-0018-01), by
CNRS and RFBR (PICS project 6295, RFBR project 14-03-91054), and by Region
Rh^ one-Alpes.
REFERENCES
1. Ortiz de Montellano, P. R. Chem. Rev. 2010, 110, 932–948.
2. Tinberg, C. E.; Lippard, S. J. Acc. Chem. Res. 2011, 44, 280–288.
3. Banerjee, R.; Proshlyakov, Y.; Lipscomb, J. D.; Proshlyakov, D. A. Nature 2015, 518,
431–434.
4. Kawakami, N.; Shoji, O.; Watanabe, Y. Chem. Sci. 2013, 4, 2344–2348.
5. Meunier, B.; Robert, A.; Pratviel, G.; Bernadou, J. In: The Porphyrin Handbook;
Kadish, K. M., Smith, K. M., Guilard, R., Eds.; Vol. 4, Academic Press: New York,
2000; pp 119–187.
ARTICLE IN PRESS
6. McLain, J. L.; Lee, J.; Groves, J. T. In: Biomimetic Oxidations Catalyzed by Transition Metal
Complexes; Meunier, B. Ed.; Imperial College Press: London, 2000; pp 91–169.
7. Costas, M. Coord. Chem. Rev. 2011, 255, 2912–2932.
8. Costas, M.; Mehn, M. P.; Jensen, M. P.; Que, L., Jr. Chem. Rev. 2004, 104, 939–986.
9. Bryliakov, K. P.; Talsi, E. P. Coord. Chem. Rev. 2014, 276, 73–96.
10. Tshuva, E. Y.; Lippard, S. J. Chem. Rev. 2004, 104, 987–1012.
11. Olivo, G.; Cussό, O.; Costas, M. Chem. Asian J. 2016, 11, 3148–3158.
12. Talsi, E. P.; Bryliakov, K. P. Coord. Chem. Rev. 2012, 256, 1418–1434.
13. Lindhorst, A. C.; Haslinger, S.; K€ uhn, F. E. Chem. Commun. 2015, 51, 17193–17212.
14. Ryabov, A. D.; Collins, T. J. Adv. Inorg. Chem. 2009, 61, 471–521.
15. Friedle, S.; Reisner, E.; Lippard, S. J. Chem. Soc. Rev. 2010, 39, 2768–2779.
16. Sorokin, A. B.; Kudrik, E. V.; Bouchu, D. Chem. Commun. 2008, 2562–2564.
17. Nam, W.; Han, H. J.; Oh, S.-Y.; Lee, Y. J.; Choi, M. H.; Han, S.-Y.; Kim, C.;
Woo, S. K.; Shin, W. J. Am. Chem. Soc. 2000, 122, 8677–8684.
18. Floris, B.; Donzello, M. P.; Ercolani, C. In The Porphyrin Handbook; Kadish, K. M.,
Smith, K. M., Guilard, R., Eds.; Vol. 18, Elsevier Science: San Diego, 2003; pp 1–62.
19. Afanasiev, P.; Sorokin, A. B. Acc. Chem. Res. 2016, 49, 583–593.
€ Dumoulin, F.; Sorokin, A. B.; Ahsen, V. Turk. J. Chem. 2014, 38, 923–949.
20. İşci, U.;
21. Summerville, D. A.; Cohen, I. A. J. Am. Chem. Soc. 1976, 98, 1747–1752.
22. Scheidt, W. R.; Summerville, D. A.; Cohen, I. A. J. Am. Chem. Soc. 1976, 98,
6623–6628.
23. Kadish, K. M.; Bottomley, L. A.; Brace, J. G.; Winograd, N. J. Am. Chem. Soc. 1980,
102, 4341–4344.
24. Tatsumi, K.; Hoffmann, R. J. Am. Chem. Soc. 1981, 103, 3328–3341.
25. Schick, G. A.; Bocian, D. F. J. Am. Chem. Soc. 1983, 105, 1830–1838.
26. Bocian, D. F.; Findsen, E. W.; Hofmann, J. A.; Schick, G. A.; English, D. R.;
Hendrickson, D. N.; Suslick, K. S. Inorg. Chem. 1984, 23, 800–807.
27. Goedken, V. L.; Ercolani, C. J. Chem. Soc. Chem. Commun. 1984, 378–379.
28. Bottomley, L. A.; Gorce, J.-N.; Goedken, V. L.; Ercolani, C. Inorg. Chem. 1985, 24,
3733–3737.
29. Kennedy, B. J.; Murray, K. S.; Homborg, H.; Kalz, W. Inorg. Chim. Acta 1987, 134,
19–21.
30. Li, M.; Shang, M.; Ehlinger, N.; Schulz, C. E.; Scheidt, W. R. Inorg. Chem. 2000, 39,
580–583.
31. Stuzhin, P. A.; Latos-Grazynski, L.; Jezierski, A. Transit. Met. Chem. 1989, 14, 341–346.
32. Stuzhin, P. A.; Hamdush, M.; Homborg, H. Mendeleev Commun. 1997, 7, 196–198.
33. Ercolani, C.; Hewage, S.; Heucher, R.; Rossi, G. Inorg. Chem. 1993, 32, 2975–2977.
34. Ercolani, C.; Jubb, J.; Pennesi, G.; Russo, U.; Trigiante, G. Inorg. Chem. 1995, 34,
2535–2541.
35. Donzello, M. P.; Ercolani, C.; Kadish, K. M.; Ou, Z.; Russo, U. Inorg. Chem. 1998, 37,
3682–3688.
36. Zanotti, G.; Mattioli, G.; Notarantonio, S.; Paoletti, A. M.; Rossi, G.; Bonapasta, A. A.;
Pennesi, G. Macroheterocycles 2011, 4, 161–163.
37. J€ustel, T.; M€uller, M.; Weyherm€ uller, T.; Kressl, C.; Bill, E.; Hildebrandt, P.;
Lengen, M.; Grodzinski, M.; Trautwein, A. X.; Nuber, B.; Wieghardt, K. Chem.
Eur. J. 1999, 5, 793–810.
38. Meyer, K.; Bill, E.; Mienert, B.; Weyherm€ uller, T.; Wieghardt, K. J. Am. Chem. Soc.
1999, 5, 4859–4876.
39. Colomban, C.; Kudrik, E. V.; Tyurin, D. V.; Albrieux, F.; Nefedov, S. E.; Afanasiev, P.;
Sorokin, A. B. Dalton Trans. 2015, 44, 2240–2251.
€ Afanasiev, P.; Millet, J.-M. M.; Kudrik, E. V.; Ahsen, V.; Sorokin, A. B. Dalton
40. İşci, U.;
Trans. 2009, 7410–7420.
ARTICLE IN PRESS
41. Kudrik, E. V.; Afanasiev, P.; Alvarez, L. X.; Blondin, G.; Clemancey, M.; Latour, J.-M.;
Bouchu, D.; Albrieux, F.; Nefedov, S. E.; Sorokin, A. B. Nat. Chem. 2012, 4,
1024–1029.
42. Li, M.; Scheidt, W. R. J. Porphyr. Phthalocyanines 2014, 18, 380–384.
43. Donzello, M. P.; Ercolani, C.; Russo, U.; Chiesi-Villa, A.; Rizzoni, C. Inorg. Chem.
2001, 40, 2963–2967.
44. Moubaraki, M.; Benlian, D.; Baldy, A.; Pierrot, M. Acta Crystallogr. C. 1989, 45,
393–394.
45. Kienast, A.; Homborg, H. Z. Anorg. Allg. Chem. 1998, 624, 233–238.
46. Afanasiev, P.; Bouchu, D.; Kudrik, E. V.; Millet, J.-M. M.; Sorokin, A. B. Dalton Trans.
2009, 9828–9836.
47. Colomban, C.; Kudrik, E. V.; Afanasiev, P.; Sorokin, A. B. J. Am. Chem. Soc. 2014, 136,
11321–11330.
48. Colomban, C.; Kudrik, E. V.; Briois, V.; Shwarbrick, J. C.; Sorokin, A. B.; Afanasiev, P.
Inorg. Chem. 2014, 53, 11517–11530.
€ Faponle, A. S.; Afanasiev, P.; Albrieux, F.; Briois, V.; Ahsen, V.; Dumoulin, F.;
49. İşci, U.;
Sorokin, A. B.; de Visser, S. P. Chem. Sci. 2015, 6, 5063–5075.
50. English, D. R.; Hendrickson, D. N.; Suslick, K. S. Inorg. Chem. 1993, 32, 367–368.
51. Kudrik, E. V.; Afanasiev, P.; Bouchu, D.; Sorokin, A. B. J. Porphyr. Phthalocyanines 2011,
15, 583–591.
€ Dumoulin, F.; Ahsen, V.; Sorokin, A. B. J. Porphyr. Phthalocyanines 2010, 14,
52. İşci, U.;
324–334.
53. Schick, G. A.; Findsen, E. W.; Bocian, D. F. Inorg. Chem. 1982, 21, 2885–2887.
54. Afanasiev, P.; Kudrik, E. V.; Millet, J.-M. M.; Bouchu, D.; Sorokin, A. B. Dalton Trans.
2011, 40, 701–710.
55. Walker, F. A.; Reis, D.; Balke, V. L. J. Am. Chem. Soc. 1984, 106, 6888–6898.
56. De Groot, F. Chem. Rev. 2001, 101, 1779–1808.
57. Glatzel, P.; Bergmann, U. Coord. Chem. Rev. 2005, 249, 65–95.
58. Newcomb, M.; Halgrimson, J. A.; Horener, J. H.; Wasinger, E. C.; Chen, L. X.;
Sligar, S. G. Proc. Natl. Acad. Sci. U.S.A. 2008, 105, 8179–8184.
59. Yosca, T. H.; Rittle, J.; Krest, C. M.; Onderko, E. L.; Silakov, A.; Calixto, J. C.;
Behan, R. K.; Green, M. T. Science 2013, 342, 825–829.
60. Chandrasekaran, P.; Stieber, S. C. E.; Collins, T. J.; Que, L., Jr.; Neese, F.; DeBeer, S.
Dalton Trans. 2011, 40, 11070–11079.
61. de Oliveira, F. T.; Chanda, A.; Banerjee, D.; Shan, X.; Mondal, S.; Que, L., Jr.;
Bominaar, E. L.; M€ unck, E.; Collins, T. J. Science 2007, 315, 835–838.
62. Kudrik, E. V.; Safonova, O.; Glatzel, P.; Swarbrick, J. C.; Alvarez, L. X.; Sorokin, A. B.;
Afanasiev, P. Appl. Catal. B 2012, 113–114, 43–51.
63. Theodoridis, A.; Maigut, J.; Puchta, R.; Kudrik, E. V.; van Eldik, R. Inorg. Chem. 2008,
47, 2994–3013.
64. Nam, W. Acc. Chem. Res. 2007, 40, 522–531.
65. Afanasiev, P.; Kudrik, E. V.; Albrieux, F.; Briois, V.; Koifman, O. I.; Sorokin, A. B.
Chem. Commun. 2012, 48, 6088–6090.
66. Sorokin, A.; Robert, A.; Meunier, B. J. Am. Chem. Soc. 1993, 115, 7293–7299.
67. Sorokin, A. B.; Kudrik, E. V.; Alvarez, L. X.; Afanasiev, P.; Millet, J. M. M.; Bouchu, D.
Catal. Today 2010, 157, 149–154.
68. Alvarez, L. X.; Sorokin, A. B. J. Organomet. Chem. 2015, 793, 139–144.
69. Kudrik, E. V.; Afanasiev, P.; Bouchu, D.; Millet, J.-M. M.; Sorokin, A. B. J. Porphyr.
Phthalocyanines 2008, 12, 1078–1089.
70. Hashiguchi, B. G.; Konnick, M. M.; Bischof, S. M.; Gustafson, S. J.; Devarajan, D.;
Gunsalus, N.; Ess, D. H.; Periana, R. A. Science 2014, 343, 1232–1237.
ARTICLE IN PRESS
71. Garcia-Bosch, I.; Company, A.; Cady, C. W.; Styring, S.; Browne, W. R.; Ribas, X.;
Costas, M. Angew. Chem. Int. Ed. 2011, 50, 5648–5653.
72. Korzekwa, K. R.; Swinney, D. C.; Trager, W. F. Biochemistry 1989, 28, 9019–9027.
73. Mitchell, K. H.; Rogge, C. E.; Gierahn, T.; Fox, B. G. Proc. Natl. Acad. Sci. U.S.A.
2003, 100, 3784–3789.
74. de Visser, S. P.; Shaik, S. J. Am. Chem. Soc. 2003, 125, 7413–7424, and references
therein.
75. Kudrik, E. V.; Sorokin, A. B. Chem. Eur. J. 2008, 14, 7123–7126.
76. Boyd, D. R.; Sharma, N. D. Chem. Soc. Rev. 1996, 25, 289–296.
77. Bleasdale, C.; Cameron, R.; Edwards, C.; Golding, B. T. Chem. Res. Toxicol. 1997, 10,
1314–1318.
78. Jerina, D. M.; Daly, J. W. Science 1974, 185, 573–582.
79. Kudrik, E. V.; Sorokin, A. B. J. Mol. Catal. A Chem. 2017, 426, 499–505.
80. Shul’pin, G. B. J. Mol. Catal. A Chem. 2002, 189, 39–66.
81. Olivo, G.; Lanzalunga, O.; Di Stefano, S. Adv. Synth. Catal. 2016, 358, 843–863.
82. Barton, D. H. R.; Beck, A. H.; Taylor, D. K. Tetrahedron 1995, 51, 5245–5254.
83. Costas, M.; Chen, K.; Que, L., Jr. Coord. Chem. Rev. 2000, 200–202, 517–544.
84. Groves, J. T.; Nemo, T. E. J. Am. Chem. Soc. 1983, 105, 6243–6248.
85. Manchester, J. I.; Dinnocenzo, J. P.; Higgins, L. A.; Jones, J. P. J. Am. Chem. Soc. 1997,
119, 5069–5070.
86. Hiatt, R. R.; Mill, T.; Casteman, J. K. J. Org. Chem. 1968, 33, 1421–1428.
87. Zalomaeva, O. V.; Sorokin, A. B. New J. Chem. 2006, 30, 1768–1773.
88. Perollier, C.; Pergrale-Mejean, C.; Sorokin, A. B. New J. Chem. 2005, 29, 1400–1403.
89. Kudrik, E. V.; Alvarez, L. X.; Sorokin, A. B. Chem. Eur. J. 2011, 17, 9298–9301.
90. Hackett, J. C.; Sanan, T. T.; Hadad, C. M. Biochemistry 2007, 46, 5924–5940.
91. Rietjens, I. M.; den Besten, C.; Hanzlik, R. P.; van Bladeren, P. J. Chem. Res. Toxicol.
1997, 10, 629–635.
92. Bogaards, J. J. P.; Van Ommen, B.; Wolf, C. R.; Van Bladeren, P. J. Toxicol. Appl.
Pharmacol. 1995, 132, 44–52.
93. Rietjens, I. M. C. M.; Vervoort, J. Xenobiotica 1989, 19, 1297–1305.
94. Grushin, V. V. Acc. Chem. Res. 2010, 43, 160–171.
95. Colomban, C.; Kudrik, E. V.; Afanasiev, P.; Sorokin, A. B. Catal. Today 2014, 235,
14–19.
96. Stuzhin, P. A.; Ivanova, S. S.; Dereven’kov, I.; Makarov, S. V.; Silaghi-Dumitresku, R.;
Homborg, H. Macroheterocycles 2012, 5, 175–177.
97. Makarova, A. S.; Kudrik, E. V.; Makarov, S. V.; Koifman, O. I. J. Porphyr. Phthalocya-
nines 2014, 18, 604–613.
98. Quesne, M. G.; Senthilnathan, D.; Singh, D.; Kumar, D.; Maldivi, P.; Sorokin, A. B.;
de Visser, S. P. ACS Catal. 2016, 6, 2230–2243.
CHAPTER FOUR
Contents
1. Introduction 168
2. Metal-(Di)oxygen Intermediates 173
2.1 Short-Lived Iron-Dioxygen Complex in Cysteine Dioxygenase Enzymes 174
2.2 Iron(III)-Hydroperoxo in Heme and Nonheme Complexes 177
2.3 Spin-State Reactivity in Biomimetic Manganese(V)-Oxo Complexes 181
2.4 Aldehyde Deformylation by Manganese(III)-Peroxo Complexes 185
3. Conclusions 190
Acknowledgments 190
References 190
Abstract
Transition metals are common cofactors in enzymes and enable catalysis to take place
via reaction barriers that are accessible at room temperature. Oxygen-activating
metalloenzymes are versatile species in Nature involved in vital processes ranging from
biodegradation to biosynthesis. Since oxygen-activating intermediates are not readily
amenable to experimental study, research has started to focus on biomimetic model
systems that have the active site coordination sphere and structural features, but react
in solution. In our research group, we have been involved in computational modeling of
heme and nonheme iron dioxygenases as well as biomimetic models of these com-
plexes. In this contribution, an overview is given on recent results of the characterization
and reactivity patterns of metal-oxo, metal-peroxo, and metal-superoxo complexes. In
particular, in recent studies attempts were made to trap and characterize the short-lived
oxygen-bound intermediate in the catalytic cycle of cysteine dioxygenase. Many
suggested structures could be ruled out by theoretical considerations, yet these also
provided suggestions of possible candidates for the experimentally observed spectra.
In addition, we review recent studies on the nonheme iron(III)-hydroperoxo species
and how its reactivity patterns with arenes are dramatically different from those found
for heme iron(III)-hydroperoxo species. In the final two sections there is a description,
with illustrations, of a series of computational studies on manganese(V)-oxo and side-on
manganese(III)-peroxo moieties that identify a unique spin-state reactivity pattern with
a surprising product distribution.
1. INTRODUCTION
Oxygen activation by enzymes is one of the most common biochem-
ical reactions in Nature whereby one or both oxygen atoms of O2 are
donated into a substrate. Many of these monooxygenase and dioxygenase
enzymes employ transition metal centers to perform this catalytic reac-
tion (1–7). In monooxygenases, one oxygen atom of O2 is inserted into
the substrate, whereas the other oxygen atom is reduced to water (8–12),
while in dioxygenases both oxygen atoms are inserted into one or more sub-
strates (3,6,13,14). As molecular oxygen is in a triplet spin ground state and
organic substrates typically are in a singlet spin state, it has been hypothesized
that these enzymes enable an otherwise spin-forbidden reaction (4). These
oxidants enable this reaction due to the involvement of a transition metal
with virtual or partially occupied valence orbital subshells. However, in
recent years, several cofactor-independent dioxygenases have been trapped
and characterized that are able to transfer triplet dioxygen into a closed-shell
singlet substrate without the assistance of a transition metal center. For
instance, the enzyme 1-H-3-hydroxy-4-oxoquinaldine 2,4-dioxygenase
performs an intradiol-type dioxygenation of an aromatic substrate in the
absence of cofactor although the reaction is slow (15,16). Therefore, cofac-
tors, such as transition metals in metalloenzymes, are expected to speed up
biochemical reactions significantly by lowering the rate-determining energy
barrier in a reaction mechanism. Metalloenzymes can be mononuclear or
binuclear or contain more than two metal centers (17); however, in this
review we will focus on mononuclear iron complexes only.
A common structural motif in mononuclear nonheme iron dioxygenases is
an active site where the iron is bound to two histidine and one carboxylate
group of an amino acid side chain in a facial 2-His/1-Asp ligand feature
(7,18). In Fig. 1, the active site of the nonheme iron dioxygenase taurine/
α-ketoglutarate (α-KG)-dependent dioxygenase (TauD) is depicted and
shows its typical structural motif with the metal bound to the 2-His/1-Asp
Reactions of Bioinspired Complexes 169
Fig. 1 The active site structure of TauD with the typical 2-His/1-carboxylate ligand motif
and with α-ketoglutarate (α-KG) and taurine bound.
ligand environment, where the iron interacts with the side chains of His99,
Asp101, and His255. The structure shown in Fig. 1 is taken from the protein
data bank with identifier 1OS7 (19). In the active site, the metal iron center
is in a pentadentate coordination and thus is anchored to the two imidazolium
groups of the posttranslationally modified histidine residues and the carboxylic
group of aspartate. The fourth and fifth ligand positions of the metal are occu-
pied by the carboxylic acid and keto group of α-KG cosubstrate. TauD is
involved in the hydroxylation of taurine, which is a step in the biodegradation
of cysteine in the body.
TauD undergoes a catalytic cycle (Fig. 2) that starts off from an iron(II)
resting state (A), where the metal is bound to the 2-His/1-Asp ligand system
and three water molecules. Binding of α-KG displaces two water molecules
and subsequently dioxygen replaces the final one to form the elusive
iron(III)-superoxo complex (B). This intermediate reacts with α-KG by
decarboxylation and the formation of an iron(IV)-oxo (C), succinate, and
CO2. The iron(IV)-oxo species of TauD has been characterized with
UV–Vis, electron paramagnetic resonance (EPR), and M€ ossbauer spectro-
scopic measurements and shown to be in a quintet spin ground state (20).
Kinetic isotope effect (KIE) studies using deuterated taurine gave evidence
of a rate-determining hydrogen atom abstraction leading to an iron(III)-
hydroxo intermediate (D) that after OH rebound gives the alcohol product
complexes. Computational studies, initially with small active site models of
TauD, confirmed the catalytic cycle and showed the oxygen activation to be
170 Abayomi S. Faponle and Sam P. de Visser
a strong exothermic process with the most stable structure being the
iron(IV)-oxo intermediate (21,22). Subsequently, quantum mechanics/
molecular mechanics (QM/MM) studies on nonheme iron dioxygenases
TauD and AlkB (the latter are DNA repair enzymes) were performed that
took the complete protein environment into consideration (23,24).
Although the protein environment affects the barrier heights along the
reaction mechanism dramatically, the work on TauD with QM/MM
vs active site models gave the same overall conclusions. However, AlkB
was shown to proceed with a catalytic cycle that showed a major differ-
ence to that found for TauD; namely, the iron(IV)-oxo species was found
to undergo a 90-degree rotation during the catalytic cycle prior to
the hydrogen atom abstraction step. It was hypothesized that this unusual
rotation is essential to keep the dioxygen binding and substrate binding
separate (Fig. 2).
Further computational modeling of the high-valent iron(IV)-oxo inter-
mediate for nonheme iron dioxygenases including TauD and prolyl-4-
hydroxylase was performed in our group (25–30). The studies show that
the pentacoordinate nonheme iron(IV)-oxo complex is an extremely pow-
erful oxidant that reacts with substrates with significantly lower hydrogen
atom abstraction barriers than those for heme iron(IV)-oxo cation radical
(Compound I (CpdI)) species as found in cytochrome P450.
Reactions of Bioinspired Complexes 171
guides the reactivity patterns and gives the heme enzyme its unique chemical
properties. Indeed, computational modeling of propene activation by
models of P450 CpdI with peroxidase and catalase models of CpdI showed
higher reactivity of the P450 system by orders of magnitude (44–49). This is
due to the fact that the highest occupied molecular orbital (HOMO), the a2u
orbital, in P450 CpdI is a mixed porphyrin/axial ligand orbital and the
amount of mixing is dependent on the electron-donating properties of
the axial ligand. Therefore, a stronger electron-donating group, such as
OH or SH, yields an increase of the a2u-antibonding combination and
consequently lowers the electron affinity of the complex and makes these
complexes good oxidants. By contrast, strong electron-withdrawing groups,
such as histidine or neutral solvent molecules, lower the a2u orbitals and
increase the electron affinity of the complex and hence make it a much wea-
ker oxidant (50).
Cytochrome P450 CpdI and the iron(IV)-oxo species in nonheme iron
dioxygenases are versatile oxidants that react efficiently with substrates. Gen-
erally, these active catalytic intermediates of heme and nonheme enzymes
are able to activate strong aliphatic C–H bonds and convert them to alcohol
groups. Other common reactions catalyzed by iron(IV)-oxo complexes
include substrate epoxidation, aromatic hydroxylation, desaturation, N-
and O-dealkylation, and heteroatom transfers such as sulfoxidation reac-
tions (8–10). Although these catalytic intermediates are implicated in many
inorganic and bioinorganic reactions, spectroscopic evidence of their direct
involvement in reactions is sparse as they are short-lived due to their highly
reactive nature. However for the active species of the P450 catalytic cycle
known as CpdI, spectroscopic evidence was obtained through UV–Vis,
EPR, and M€ ossbauer spectroscopic techniques and was reported by Rittle
and Green (51). In heme and nonheme systems, the participation of a very
active metal-oxo center for chemical transformations is convincing; none-
theless, there is still a debate as to the catalytic efficiencies of alternative
oxygen-bound iron complexes, such as iron(II)-peroxo, iron(III)-superoxo,
and iron(III)-hydroperoxo species. For instance, the catalytic potency of
heme mononuclear iron(III)-hydroperoxo intermediate in P450 chemistry
has been disputed, as experimental and computational studies have shown
that it is a sluggish oxidant in substrate oxidation of P450 catalysis, and there-
fore would not be the principal oxidant in hydroxylation of organic sub-
strates (52–60). These studies contrast the findings that exist for
biomimetic nonheme iron systems whereby the nonheme iron(III)-
hydroperoxo species is catalytically efficient and can perform substrate
Reactions of Bioinspired Complexes 173
2. METAL-(DI)OXYGEN INTERMEDIATES
As described earlier, the catalytic cycles of heme and nonheme iron
monooxygenases and dioxygenases generally proceed through the forma-
tion of a high-valent metal(IV)-oxo intermediate. For instance, in TauD
(20–22) dioxygen binds the iron(II) center as an iron(III)-superoxo group
that attacks the keto-position of α-ketoglutarate to form succinate, CO2,
and iron(IV)-oxo species. The iron(IV)-oxo intermediate abstracts a hydro-
gen atom from the taurine substrate and after radical rebound gives hydrox-
ylated taurine, an intermediate in the cysteine metabolism pathway in the
body. In CDO, by contrast, both oxygen atoms are transferred to the sub-
strate (cysteine) in a consecutive process via cysteine sulfoxide to form the
cysteine sulfinic acid product (31,32,67). Interestingly, the nonheme iron
dioxygenase isopenicillin N synthase reacts with substrate through four con-
secutive hydrogen atom abstraction reactions (68,69). This proceeds by the
formation of an iron(III)-superoxo reactant from an iron(II) resting state and
molecular oxygen, which after hydrogen atom abstraction is converted into
an iron(II)-hydroperoxo intermediate. The latter abstracts a hydrogen atom
174 Abayomi S. Faponle and Sam P. de Visser
5 5
TD-DFT B TD-DFT C TD-DFT D TD-DFT
5 5
E
562 353
630
509 543
644
structures 5D and 5E can be ruled out as the intermediates responsible for the
absorption features in the experimental spectrum. Either no spectroscopic
signal in the correct place is seen, or no signal is seen at all for both inter-
mediates. Second, the CASSCF results implicate two clear absorption signals
in the 500–700 nm region for both 5B and 5C, whereby the intensity of the
peaks for 5C appears to match the experiment the best, although both peaks
are shifted with respect to the experimental assignment. Therefore, compu-
tational analysis implicated two possible candidates responsible for the
experimentally observed absorption maxima, namely 5B or 5C. The theory
slightly favors the 5C assignment, but the error of the calculations is too large
for a definitive conclusion. Unfortunately, theory fails to resolve the exper-
imental conundrum and assign the sole species responsible for the absorption
spectra, but the results mostly point to the bicyclic ring structure in the quin-
tet spin state as the species giving the experimental spectra. As such, further
analytical work will be necessary to distinguish between the two species,
especially using analytic tools that can detect them within a shorter time
for instance, at less than 10 ms, in order to assign the role and the nature
of the oxygen adduct intermediates in the catalytic cycle of CDO.
gave sluggish reactivity patterns for Cpd0 as compared to that of CpdI. Fur-
ther experimental studies of biomimetic model complexes confirmed the
conclusions of the theory (59).
Unlike the heme iron(III)-hydroperoxo that has been shown to be a slug-
gish oxidant of substrate hydroxylation reactions, a surprising result was
found with the hexacoordinated nonheme iron(III)-hydroperoxo counter-
part. In contrast to the heme Cpd0 structure, it was proven to be a potent
oxidant of, for example, halide transfer and aromatic hydroxylation reac-
tions (61–63). This prompted us to perform a detailed computational study
of the aromatic hydroxylation of arenes by heme and nonheme iron(III)-
hydroperoxo complexes (64,65).
A detailed computational analysis was performed on an experimentally and
spectroscopically characterized pentadentate nonheme iron(III)-hydroperoxo
complex, namely, ½ðL5 2 ÞFeIII OOH with L5 2 ¼ N methyl N ,N 0 , N 0
2+
2.381 H 1.950 H
O O
2.116 O1.696 1.851 O1.751
Fe Fe
2TS 2TS 2TS
CO,1
25.6 CO,1 CO,2
23.3
2TS
CO,2
2TS
PT,1
2Re
1
2I
A,1
4.4
2.9 2.9
0.0 −0.6
2Re
2 2I
A,2
2P
A
−53.7
1
Fig. 5 Free energy profiles (in kcal mol ) for arene activation by a nonheme iron(III)-
hydroperoxo complex. Free energies obtained at UB3LYP/BS2 + PCM//UB3LYP/BS1. From
Faponle, A.S.; Quesne, M.G.; Sastri, C.V.; Banse, F.; de Visser, S.P. Chem. Eur. J. 2015, 21,
1221–1236.
Fig. 6 Thermochemical analysis of heterolytic and homolytic cleavage of the O–O bond
in nonheme (left) and heme (right) iron(III)-hydroperoxo complexes. Free energies in sol-
vent given in kcal mol1.
and hence can stabilize metals in high oxidation states easily (94,95). In
particular, in collaboration with the Goldberg group, we investigated the
structure and reactivity of a manganese(V)-oxo corrolazine complex
[Mn(O)(H8Cz)X], H8Cz is corrolazine without side chains and X is the axial
ligand (X ¼ no ligand or CN/F). We initially investigated the axial ligand
effect on the dehydrogenation of 9,10-dihydroanthracene and showed that
the reaction rate was enhanced by a factor of 2100 upon the addition of F,
while it increased by a factor of 16,000 with the addition of CN (96,97).
Similar rate enhancements were seen for the use of 1,4-cyclohexadiene as a
substrate. It was established that the main cause of the rate enhancement was
increased acidity of the manganese(IV)-hydroxo product, which is formed as
a result of strong electron-donating properties of the axial ligand. These ini-
tial studies only considered the closed-shell singlet spin ground state as it is
known to be the ground state for the [Mn(O)(H8Cz)] complex. Shaik and
coworkers, however, contrasted these studies and proposed an alternative
hypothesis where the reactant has close-lying singlet and triplet spin states
and a spin-state crossing to a higher spin state and thereby would lower
the reaction rate (98).
Fig. 7 shows high-lying occupied and low-lying virtual orbitals of the
[Mn(O)(H8Cz)(CN)] complex. Thus, the molecular orbitals depend on
the manganese-oxo interactions and those on the corrolazine scaffold.
The lowest pair of orbitals shown in Fig. 7 is the bonding combination
of the 2px/2py atomic orbitals on oxygen with the 3dxz/3dyz atomic orbitals
on manganese: πxz/πyz. A little higher in energy is the nonbonding orbital
δxy that is located in the plane of the corrolazine ligand midway in between
the nitrogen atoms. Above the δxy orbital are the pair of antibonding orbitals
π * xz/π * yz and two virtual σ* orbitals for the interaction between the metal
and corrolazine nitrogen atoms (σ*x2 y2 ) and between the metal and oxo
group (σ*z2 ). A final orbital shown in Fig. 7 is the corrolazine π-orbital
labeled as a00 , which shows resemblance to the a1u orbital in porphyrins.
In the closed-shell singlet ground state of the [Mn(O)(H8Cz)] complex
the orbital occupation is [core] πxz 2 πyz 2 a00 2 δxy 2 . This orbital occupation cor-
responds to a short Mn–O distance and hence creates a triple bond between
manganese and oxygen. Higher in energy is a triplet spin state with [core]
πxz 2 πyz 2 a00 1 δxy 1 π*xz 1 π*yz 1 configuration, which becomes accessible upon
binding of, for instance, Zn2+ anions to the complex through a valence tau-
tomerism mechanism (99). In addition, there are two more possible triplet
spin states with occupation [core] πxz 2 πyz 2 a00 2 δxy 1 π*xz 1 π*yz 0 and [core]
πxz 2 πyz 1 a00 2 δxy 1 π*xz 1 π*yz 1 .
Reactions of Bioinspired Complexes 183
Fig. 7 Chemical structure and possible singlet and triplet spin orbital occupation of
[Mn(O)(H8Cz)(CN)]. Reprinted with permission from the American Chemical Society, Yang,
T.; Quesne, M. G.; Neu, H. M.; Cantú Reinhard, F. G.; Goldberg, D. P.; de Visser, S. P. J. Am.
Chem. Soc. 2016, 138, 12375–12386.
converted into a rate enhancement (log kx/kH) of the free energy of acti-
vation for para-X-thioanisole relative to para-H-thioanisole and the results
of the singlet and triplet spin barriers are given in Fig. 8. As can be seen, in
agreement with the experimental observation, the singlet spin plot gives a
V-shaped Hammett plot, whereas the plot is linear for the triplet spin state
of data. To confirm that no spin-state crossing from the singlet to the triplet
spin state is possible, we also calculated minimum energy crossing point
structures, but first they were high in energy (of the same level as the
sulfoxidation transition states) and second were not lying on the pathway
for sulfoxidation. Moreover, calculations of the spin–orbit coupling con-
stant gave very small values, which implicate little (if at all) spin-state cross-
ing from singlet to triplet. Consequently, the computational modeling
reveals a spin selective reactivity of [Mn(O)(H8Cz)(CN)] with thio-
anisoles and a dominant spin-state surface only. As such, a high spin state
is not essential for chemical reactivity, reactions can take place on a closed-
shell singlet spin-state surface.
It should be mentioned here that a recent benchmark study on the sub-
strate activation of para-X-substituted thioanisole sulfoxidation (X ¼ H, CH3,
OCH3, Cl) by [Fe(O)(N4Py)]2+, N4Py ¼ N,N-bis(2-pyridylmethyl)-N-bis
(2-pyridyl)methylamine, with a range of density functional theory methods
showed that computation reproduces the trends from Hammett type, linear
free energy relationship plots with almost all methods, but often gives a sys-
tematic error from the experimental enthalpy of activation (103). A parallel
outcome was found for regioselectivity patterns of bifurcation pathways
(104,105).
1.0 H
log(kX/kH)
2.0
0.0
1.5 N(CH3)2 CN OCH3 Br
1.0 NH2 –1.0
OCH3 NH2
0.5 Br –2.0 CH3
H
r = –1.21 –3.0
0.0 CH3 N(CH3)2
–0.5 –4.0
–1 –0.5 0 0.5 1 –1.0 –0.5 0.0 0.5 1.0
σP σP
C
2pC1
C
C
σCH2 2pC1
H σOH2
H 1sH1
H
O
πOO,xy2
σOO2
π*OO,xy2
O
O O πxz2 O O
πxz2 π*xz1
HAT π*xz1
Mn Mn Mn
1 1
3dxz1 3dxy1 σ*x2–y2 σ*z2 3dyz1 3dxy1 σ*x2–y2 σ*z2
1 1
3dyz1 3dxy1 σ*x2–y2 σ*z2
1 1
5[MnIII(O )(L)]2+
2 TSHA IHA
Fig. 11 Valence bond structures for the reaction mechanism of hydrogen atom abstrac-
tion by a side-on manganese-peroxo complex.
σCO2
σCO2 C O 2pO2
σCO2
C O C O
πCO2 2pC 1
2pO1 σO2-C2
πOO,xy2 O
π*OO,xy2 O
O O πxz2 O O
Nucleophilic π* 1 πxz2 π*xz1
xz
into 2pO
attack
Mn Mn Mn
1 1 1 1
3dxz1 3dxy1 σ*x2–y2 σ*z2 1
3dxy1 σ*x2–y2 σ*z2
1
3dxy σ*x2–y2 σ*z2
1
5[MnIII(O 2+
2)(L)] TSNA INA
Fig. 12 Valence bond structures for the reaction mechanism for nucleophilic addition of
aldehydes by a side-on manganese-peroxo complex.
188 Abayomi S. Faponle and Sam P. de Visser
3dxz 1 3dxy 1 σ*x2 y2 1 σ*z2 1 . In addition, there are two relevant orbitals on the
peroxo moiety, namely πOO,xy and π * OO,xy both occupied with two elec-
trons. In the hydrogen atom abstraction step, the σCH orbital for the inter-
action of the C and H atoms breaks into atomic orbitals: 2pC and 1sH. Next,
the πOO,xy and π * OO,xy convert back to atomic orbitals and one electron
pairs up with the 1sH atomic orbital to form the new σOH bond. Two elec-
trons originating from the πOO,xy/π * OO,xy orbitals pair up with the manga-
nese 3dxz electron to form a new manganese-oxo three-electron bond:
πxz 2 π*xz 1 . The last electron from the peroxo bond is promoted to the
3dyz orbital of manganese. Therefore, the hydrogen atom abstraction barrier
will be determined by the energy to break the C–H bond of the substrate
(σCH), the energy to form the O–H bond in the product (σOH), the energy
to break the π-bond of the peroxo group (πOO,xy/π * OO,xy), and finally the
energy to excite an electron from the peroxo to the 3dyz orbital on
manganese.
The contrasting nucleophilic addition pathway is shown at the bottom of
Fig. 10. Similar to the hydrogen atom abstraction step, the πOO,xy and
π * OO,xy revert to atomic orbitals and an end-on peroxo is formed with a
new set of πxz/π * xz orbitals along the manganese-oxo group. However,
no electron transfer into the manganese takes place, but instead the electron
is donated into the carbonyl group of the substrate. In particular, the π-bond
of the carbonyl (πCO) breaks into atomic orbitals (2pC and 2pO), whereby
the 2pO orbital receives a second electron from the peroxo group and the
2pC forms a covalent bond (σO2–C) with the peroxo moiety. Therefore,
the relative electron affinity of the substrate carbonyl vs the manganese atom
will determine whether the dominant pathway is hydrogen atom abstraction
or nucleophilic addition.
To further explain and rationalize the bifurcation pathways and make
predictive measurements on how the regioselectivity can be changed, we
designed a valence bond/molecular orbital scheme to understand the details
of the reaction mechanisms. These valence bond curve-crossing diagrams
were initially developed by Shaik (110) and, for instance, show predicted
hydrogen atom abstraction barriers for cytochrome P450 CpdI (111).
Recently, we designed a different model based on the crossing of two parab-
olas (112). Thus, in the two-parabola curve-crossing description the poten-
tial energy curve (y) is described as a parabola with the minimum energy
point for the reactants located at reaction coordinate xR ¼ 0, i.e., yR ¼ ax2
where a is a constant. The product geometry is located at the minimum
Reactions of Bioinspired Complexes 189
3. CONCLUSIONS
As highlighted by several examples in this work, metal-oxo,
metal-peroxo, and metal-hydroperoxo moieties show unique reactivity pat-
terns with substrates. Often these metal complexes have close-lying spin and
electronic states and the crossing-over from one surface to the other affects
the reactivity patterns with substrates. Computational modeling has given
insight into the nature of metal-oxo, metal-peroxo, and metal-hydroperoxo
complexes. Some of these complexes are intermediates in the catalytic cycles
of heme and nonheme iron enzymes, but not all of these are reactive with
substrates. Our on-going work elucidates structure and reactivity and pre-
dicts trends.
ACKNOWLEDGMENTS
A.S.F. thanks the Tertiary Education Trust Fund Nigeria for a studentship. The Inorganic
Reaction Mechanisms Discussion group of the Dalton Division of the Royal Society of
Chemistry is thanked for support.
REFERENCES
1. Solomon, E. I.; Brunold, T. C.; Davis, M. I.; Kemsley, J. N.; Lee, S.-K.; Lehnert, N.;
Neese, F.; Skulan, A. J.; Yang, Y.-S.; Zhou, J. Chem. Rev. 2000, 100, 235–349.
2. Bugg, T. D. H. Curr. Opin. Chem. Biol. 2001, 5, 550–555.
3. Ryle, M. J.; Hausinger, R. P. Curr. Opin. Chem. Biol. 2002, 6, 193–201.
4. Costas, M.; Mehn, M. P.; Jensen, M. P.; Que, L., Jr. Chem. Rev. 2004, 104, 939–986.
5. Abu-Omar, M. M.; Loaiza, A.; Hontzeas, N. Chem. Rev. 2005, 105, 2227–2252.
6. de Visser, S. P., Kumar, D., Eds. Iron-Containing Enzymes: Versatile Catalysts of Hydrox-
ylation Reaction in Nature; RSC Publishing: Cambridge, UK, 2011.
7. Bruijnincx, P. C.; van Koten, G.; Klein Gebbink, R. J. Chem. Soc. Rev. 2008, 37,
2716–2744.
8. Sono, M.; Roach, M. P.; Coulter, E. D.; Dawson, J. H. Chem. Rev. 1996, 96,
2841–2888.
9. Ortiz de Montellano, P. R. Ed. Cytochrome P450: Structure, Mechanism and Biochemistry,
3rd ed.; Kluwer Academic/Plenum Publishers: New York, 2005.
10. Meunier, B.; de Visser, S. P.; Shaik, S. Chem. Rev. 2004, 104, 3947–3980.
Reactions of Bioinspired Complexes 191
11. Denisov, I. G.; Makris, T. M.; Sligar, S. G.; Schlichting, I. Chem. Rev. 2005, 105,
2253–2277.
12. Watanabe, Y.; Nakajima, H.; Ueno, T. Acc. Chem. Res. 2007, 40, 554–562.
13. Krebs, C.; Galonic Fujimori, D.; Walsh, C. T.; Bollinger, J. M., Jr. Acc. Chem. Res.
2007, 40, 484–492.
14. Hausinger, R. P. Crit. Rev. Biochem. Mol. Biol. 2004, 39, 21–68.
15. Hernández-Ortega, A.; Quesne, M. G.; Bui, S.; Heuts, D. P. H. M.; Steiner, R. A.;
Heyes, D. J.; de Visser, S. P.; Scrutton, N. S. J. Biol. Chem. 2014, 289, 8620–8632.
16. Hernández-Ortega, A.; Quesne, M. G.; Bui, S.; Heyes, D. J.; Steiner, R. A.;
Scrutton, N. S.; de Visser, S. P. J. Am. Chem. Soc. 2015, 137, 7474–7487.
17. Solomon, E. I.; Decker, A.; Lehnert, N. Proc. Natl. Acad. Sci. U. S. A. 2003, 100,
3589–3594.
18. de Visser, S. P. Coord. Chem. Rev. 2009, 253, 754–768.
19. O’Brien, J. R.; Schuller, D. J.; Yang, V. S.; Dillard, B. D.; Lanzilotta, W. N.
Biochemistry 2003, 42, 5547–5554.
20. Bollinger, J. M., Jr.; Price, J. C.; Hoffart, L. M.; Barr, E. W.; Krebs, C. Eur. J. Inorg.
Chem. 2005, 4245–4254.
21. Borowski, T.; Bassan, A.; Siegbahn, P. E. M. Chem. Eur. J. 2004, 10, 1031–1041.
22. de Visser, S. P. Chem. Commun. 2007, 171–173.
23. Godfrey, E.; Porro, C. S.; de Visser, S. P. J. Phys. Chem. A 2008, 112, 2464–2468.
24. Quesne, M. G.; Latifi, R.; Gonzalez-Ovalle, L. E.; Kumar, D.; de Visser, S. P. Chem.
Eur. J. 2014, 20, 435–446.
25. de Visser, S. P. Angew. Chem. Int. Ed. 2006, 45, 1790–1793.
26. de Visser, S. P. J. Am. Chem. Soc. 2006, 128, 9813–9824.
27. Latifi, R.; Bagherzadeh, M.; de Visser, S. P. Chem. Eur. J. 2009, 15, 6651–6662.
28. de Visser, S. P. J. Am. Chem. Soc. 2010, 132, 1087–1097.
29. Karamzadeh, B.; Kumar, D.; Sastry, G. N.; de Visser, S. P. J. Phys. Chem. A 2010, 114,
13234–13243.
30. Pratter, S. M.; Konstantinovics, C.; DiGiuro, C. L. M.; Leitner, E.; Kumar, D.; de
Visser, S. P.; Grogan, G.; Straganz, G. D. Angew. Chem. Int. Ed. 2013, 52, 9677–9681.
31. Straganz, G. D.; Nidetzky, B. ChemBioChem 2006, 7, 1536–1548.
32. Joseph, C. A.; Maroney, M. J. Chem. Commun. 2007, 32, 3338–3349.
33. Goncharenko, K. V.; Vit, A.; Blankenfeldt, W.; Seebeck, F. P. Angew. Chem. Int. Ed.
2015, 54, 2821–2824.
34. Goncharenko, K. V.; Seebeck, F. P. Chem. Commun. 2016, 52, 1945–1948.
35. Aluri, S.; de Visser, S. P. J. Am. Chem. Soc. 2007, 129, 14846–14847.
36. de Visser, S. P.; Straganz, G. D. J. Phys. Chem. A 2009, 113, 1835–1846.
37. Kumar, D.; Thiel, W.; de Visser, S. P. J. Am. Chem. Soc. 2011, 133, 3869–3882.
38. Kumar, D.; Sastry, G. N.; Goldberg, D. P.; de Visser, S. P. J. Phys. Chem. A 2012, 116,
582–591.
39. Sallmann, M.; Kumar, S.; Chernev, P.; Nehrkorn, J.; Schnegg, A.; Kumar, D.;
Dau, H.; Limberg, C.; de Visser, S. P. Chem. Eur. J. 2015, 21, 7470–7479.
40. Ortiz de Montellano, P. R. Chem. Rev. 2010, 110, 932–967.
41. Costas, M. Coord. Chem. Rev. 2011, 255, 2912–2932.
42. de Visser, S. P. Adv. Inorg. Chem. 2012, 64, 1–31.
43. de Visser, S. P.; Nam, W. In Handbook of Porphyrin Science; Kadish, K. M., Smith, K. M.,
Guilard, R., Eds.; World Scientific Publishing Co: New Jersey, 2010; pp 85–140.
Chapter 44.
44. de Visser, S. P.; Ogliaro, F.; Sharma, P. K.; Shaik, S. Angew. Chem. Int. Ed. 2002, 41,
1947–1951.
45. de Visser, S. P.; Ogliaro, F.; Sharma, P. K.; Shaik, S. J. Am. Chem. Soc. 2002, 124,
11809–11826.
192 Abayomi S. Faponle and Sam P. de Visser
46. de Visser, S. P.; Kumar, D.; Neumann, R.; Shaik, S. Angew. Chem. Int. Ed. 2004, 43,
5661–5665.
47. Kumar, D.; de Visser, S. P.; Sharma, P. K.; Derat, D.; Shaik, S. J. Biol. Inorg. Chem.
2005, 10, 181–189.
48. de Visser, S. P. J. Biol. Inorg. Chem. 2006, 11, 168–178.
49. Wang, R.; de Visser, S. P. J. Inorg. Biochem. 2007, 101, 1464–1472.
50. de Visser, S. P.; Shaik, S.; Sharma, P. K.; Kumar, D.; Thiel, W. J. Am. Chem. Soc. 2003,
125, 15779–15788.
51. Rittle, J.; Green, M. T. Science 2010, 330, 933–937.
52. Cryle, M. J.; De Voss, J. J. Angew. Chem. Int. Ed. Engl. 2006, 45, 8221–8223.
53. Fertinger, C.; Hessenauer-Ilicheva, N.; Franke, A.; van Eldik, R. Chem. Eur. J. 2009,
15, 13435–13440.
54. Franke, A.; Wolak, M.; van Eldik, R. Chem. Eur. J. 2009, 15, 10182–10198.
55. Ogliaro, F.; de Visser, S. P.; Cohen, S.; Sharma, P. K.; Shaik, S. J. Am. Chem. Soc.
2002, 124, 2806–2817.
56. Kamachi, T.; Shiota, Y.; Ohta, T.; Yoshizawa, K. Bull. Chem. Soc. Jpn. 2003, 76,
721–732.
57. Kitagishi, H.; Tamaki, M.; Ueda, T.; Hirota, S.; Ohta, T.; Naruta, Y.; Kano, K. J. Am.
Chem. Soc. 2010, 132, 16730–16732.
58. Ohta, T.; Liu, J.-G.; Naruta, Y. Coord. Chem. Rev. 2013, 257, 407–413.
59. Park, M. J.; Lee, J.; Suh, Y.; Kim, J.; Nam, W. J. Am. Chem. Soc. 2006, 128,
2630–2634.
60. Vaz, A. D.; McGinnity, D. F.; Coon, M. J. Proc. Natl. Acad. Sci. U. S. A. 1998, 95,
3555–3560.
61. Vardhaman, A. K.; Sastri, C. V.; Kumar, D.; de Visser, S. P. Chem. Commun. 2011, 47,
11044–11046.
62. Thibon, A.; Jollet, V.; Ribal, C.; Senechal-David, K.; Billon, L.; Sorokin, A. B.;
Banse, F. Chem. Eur. J. 2012, 18, 2715–2724.
63. Vardhaman, A. K.; Barman, P.; Kumar, S.; Sastri, C. V.; Kumar, D.; de Visser, S. P.
Chem. Commun. 2013, 49, 10926–10928.
64. Faponle, A. S.; Quesne, M. G.; Sastri, C. V.; Banse, F.; de Visser, S. P. Chem. Eur. J.
2015, 21, 1221–1236.
65. Faponle, A. S.; Banse, F.; de Visser, S. P. J. Biol. Inorg. Chem. 2016, 21, 453–462.
66. Kryatov, S. V.; Rybak-Akimova, E. V.; Schindler, S. Chem. Rev. 2005, 105,
2175–2226.
67. Stipanuk, M. H. Annu. Rev. Nutr. 2004, 24, 539–577.
68. Baldwin, J. E.; Bradley, M. Chem. Rev. 1990, 90, 1079–1088.
69. Lundberg, M.; Siegbahn, P. E. M.; Morokuma, K. Biochemistry 2008, 47, 1031–1042.
70. Kumar, D.; Hirao, H.; Shaik, S.; Kozlowski, P. M. J. Am. Chem. Soc. 2006, 128,
16148–16158.
71. Liu, L. V.; Bell, C. B., III; Wong, S. D.; Wilson, S. A.; Kwak, Y.; Chow, M. S.;
Zhao, J.; Hodgson, K. O.; Hedman, B.; Solomon, E. I. Proc. Natl. Acad. Sci. U. S.
A. 2010, 107, 22419–22424.
72. Stubbe, J.; Kozarich, J. W.; Wu, W.; Vanderwall, D. E. Acc. Chem. Res. 1996, 29,
322–330.
73. Burger, R. M. Chem. Rev. 1998, 98, 1153–1170.
74. Heafield, M. T.; Fearn, S.; Steventon, G. B.; Waring, R. H.; Williams, A. C.;
Sturman, S. G. Neurosci. Lett. 1990, 110, 216–224.
75. Perry, T. L.; Norman, M. G.; Yong, V. W.; Whiting, S.; Crichton, J. U.; Hansen, S.;
Kish, S. J. Ann. Neurol. 1985, 18, 482–495.
76. Brait, M.; Ling, S.; Nagpal, J. K.; Chang, X.; Park, H. L.; Lee, J.; Okamura, J.;
Yamashita, K.; Sidransky, D.; Kim, M. S. PLoS One 2012, 7, e44951.
Reactions of Bioinspired Complexes 193
77. Stipanuk, M. H.; Simmons, C. R.; Karplus, P. A.; Dominy, J. E., Jr. Amino Acids 2010,
41, 91–112.
78. Stipanuk, M. H.; Ueki, I. J. Inherited Metab. Dis. 2010, 34, 17–34.
79. Gonzalez-Ovalle, L. E.; Quesne, M. G.; Kumar, D.; Goldberg, D. P.; de Visser, S. P.
Org. Biomol. Chem. 2012, 10, 5401–5409.
80. McQuilken, A. C.; Goldberg, D. P. Dalton Trans. 2012, 41, 10883–10899.
81. Widger, L. R.; Davies, C. G.; Yang, T.; Siegler, M. A.; Troeppner, O.;
Jameson, G. N. L.; Ivanovic-Burmazovic, I.; Goldberg, D. P. J. Am. Chem. Soc.
2014, 136, 2699–2701.
82. Tchesnokov, E. P.; Faponle, A. S.; Davies, C. G.; Quesne, M. G.; Turner, R.;
Fellner, M.; Souness, R. J.; Wilbanks, S. M.; de Visser, S. P.; Jameson, G. N. L. Chem.
Commun. 2016, 52, 8814–8817.
83. Porro, C. S.; Sutcliffe, M. J.; de Visser, S. P. J. Phys. Chem. A 2009, 113, 11635–11642.
84. Thibon, A.; Bartoli, J.-F.; Guillot, R.; Sainton, J.; Martinho, M.; Mansuy, D.; Banse, F.
J. Mol. Catal. A 2008, 287, 115–120.
85. de Visser, S. P.; Oh, K.; Han, A.-R.; Nam, W. Inorg. Chem. 2007, 46, 4632–4641.
86. de Visser, S. P.; Tan, L. S. J. Am. Chem. Soc. 2008, 130, 12961–12974.
87. Sainna, M. A.; Kumar, S.; Kumar, D.; Fornarini, S.; Crestoni, M. E.; de Visser, S. P.
Chem. Sci. 2015, 6, 1516–1529.
88. Ji, L.; Faponle, A. S.; Quesne, M. G.; Sainna, M. A.; Zhang, J.; Franke, A.; Kumar, D.;
van Eldik, R.; Liu, W.; de Visser, S. P. Chem. Eur. J. 2015, 21, 9083–9092.
89. Faponle, A. S.; Quesne, M. G.; de Visser, S. P. Chem. Eur. J. 2016, 22, 5478–5483.
90. Quesne, M. G.; Senthilnathan, D.; Singh, D.; Kumar, D.; Maldivi, P.; Sorokin, A. B.;
de Visser, S. P. ACS Catal. 2016, 6, 2230–2243.
91. Jackson, T. A.; Brunold, T. C. Acc. Chem. Res. 2004, 37, 461–470.
92. Streit, B. R.; Blanc, B.; Lukat-Rodgers, G. S.; Lukat-Rodgers, K. R.; Dubois, J. L.
J. Am. Chem. Soc. 2010, 132, 5711–5724.
93. Siegbahn, P. E. M. Chem. Eur. J. 2008, 14, 8290–8302.
94. Neu, H.; Baglia, R. A.; Goldberg, D. P. Acc. Chem. Res. 2015, 48, 2754–2764.
95. Chen, Z.; Yin, G. Chem. Soc. Rev. 2015, 44, 1083–1100.
96. Prokop, K. A.; de Visser, S. P.; Goldberg, D. P. Angew. Chem. Int. Ed. 2010, 49,
5091–5095.
97. Prokop, K. A.; Neu, H. M.; de Visser, S. P.; Goldberg, D. P. J. Am. Chem. Soc. 2011,
133, 15874–15877.
98. Janardanan, D.; Usharani, D.; Shaik, S. Angew. Chem. Int. Ed. 2012, 51, 4421–4425.
99. Leeladee, P.; Baglia, R. A.; Prokop, K. A.; Latifi, R.; de Visser, S. P.; Goldberg, D. P.
J. Am. Chem. Soc. 2012, 134, 10397–10400.
100. Neu, H. M.; Yang, T.; Baglia, R. A.; Yosca, T. H.; Green, M. T.; Quesne, M. G.; de
Visser, S. P.; Goldberg, D. P. J. Am. Chem. Soc. 2014, 136, 13845–13852.
101. Neu, H. M.; Quesne, M. G.; Yang, T.; Prokop-Prigge, K. A.; Lancaster, K. M.;
Donohoe, J.; DeBeer, S.; de Visser, S. P.; Goldberg, D. P. Chem. Eur. J. 2014, 20,
14584–14588.
102. Yang, T.; Quesne, M. G.; Neu, H. M.; Cantú Reinhard, F. G.; Goldberg, D. P.; de
Visser, S. P. J. Am. Chem. Soc. 2016, 138, 12375–12386.
103. Cantú Reinhard, F. G.; Faponle, A. S.; de Visser, S. P. J. Phys. Chem. A 2016, 120,
9805–9814.
104. Vardhaman, A. K.; Barman, P.; Kumar, S.; Sastri, C. V.; Kumar, D.; de Visser, S. P.
Angew. Chem. Int. Ed. 2013, 52, 12288–12292.
105. Kumar, S.; Faponle, A. S.; Barman, P.; Vardhaman, A. K.; Sastri, C. V.; Kumar, D.; de
Visser, S. P. J. Am. Chem. Soc. 2014, 136, 17102–17115.
106. Barman, P.; Upadhyay, P.; Faponle, A. S.; Kumar, J.; Nag, S. S.; Kumar, D.;
Sastri, C. V.; de Visser, S. P. Angew. Chem. Int. Ed. 2016, 55, 11091–11095.
194 Abayomi S. Faponle and Sam P. de Visser
Contents
1. Introduction 196
2. Compounds 198
3. Kinetic Studies 206
3.1 Spontaneous Processes With Monodentate N(imine) Ligands 209
3.2 Spontaneous Processes With Chelate N(amino)–N(imine) Ligands 215
4. Synergy With DFT Calculations 221
4.1 Five- vs Seven-Membered Platinacycle Stability 225
4.2 cis vs trans Stability for B-Type Intermediates 225
4.3 Formation of Five- or Seven-Membered Platinacycles From Bcis-Type
Intermediates 228
5. Concluding Remarks 239
Acknowledgments 240
References 240
Abstract
Oxidative addition and reductive elimination reactions are fundamental steps in pro-
cesses related to synthetic chemistry involving organometallic compounds. In these
reactions a metal in two available oxidation states (generally differing in two units) is
needed, platinum centers being a very good example. The relative inertness of diamag-
netic PtII and PtIV organometallic species (having, respectively, d8 square-planar or d6
octahedral arrangements), enables an easy monitoring of time-resolved reactivity,
including its posterior kinetic analysis. Specifically, imine ligands containing C–X bonds
have been observed to oxidatively add to {PtII(Aryl)2} moieties, which sequentially
undergo C–C reductive elimination and C–H bond activation on the new ligand formed.
These new species have been found to contain mostly seven-membered metallacycles,
despite the obvious thermodynamic preference for five-membered cycles, which are
found only in some rather specific instances. The kinetic preference of the complexes
obtained has been studied from a kinetico-mechanistic perspective, that included
obtaining thermal- and pressure-derived activation parameters, and a dramatic influ-
ence on the spectator halido ligands, and the substituents on the aryl groups has been
established. To complete this kinetic and mechanism (kinetico-mechanistic) study, the-
oretical calculations have also been conducted to model the data collected and pro-
pose both the elementary steps and the factors determining the specificity of the
full process.
1. INTRODUCTION
Kinetics experiments in solution lead to the collection of kinetic data
that can be analyzed in terms of rate laws, which together with activation
parameters acquired from temperature and pressure variable experiments,
may lead to mechanistic proposals. The value of such analyses and proposals
is compromised unless due diligence regarding reactant and solvent purity is
followed, and furthermore reproducibility of measurements is assured, and
primary data and derived secondary data and parameters are subject to
appropriate error analysis.
In the last several decades the throughput of kinetics experiments has
changed dramatically by instrument improvement, automation, and vali-
dated data analysis software. Developments in chemical synthesis have
yielded a wider range of subtle reactant variations leading to wider data sets.
Consequently, provided the caveats within the experimental approach are
followed, reliable new reaction mechanisms frequently ensue.
In order to understand further the detail of reaction mechanism path-
ways, the experimentalists have, over the last two to three decades, at their
disposal, the ability to take advantage of the application of density functional
theory (DFT) computation methodology. This methodology represents a
significant and appealing addition to the overall repertoire of approaches
by investigators for a detailed explanation of the time course, energetics,
and structural aspects of their chemical reaction systems. Successes in using
this computational approach are widely reported. Indeed, it will be shown in
this contribution that a combination of kinetics and mechanism studies and
modeling by DFT computations has led to a comprehensive understanding
of the formation of platinacycles through various stages starting from
diarylplatinum(II) scaffolds.
Diarylplatinum(II) Scaffolds for Kinetic and Mechanistic Studies 197
2. COMPOUNDS
Although the complexes [PtMe2(NN)], where NN is a diimine ligand,
such as 2,20 -bipyridine or 1,10-phenanthroline, are among the most reactive
transition-metal complexes in intermolecular oxidative addition of alkyl
halides, aryl halides fail to react with these PtII complexes. In this respect,
the first reported oxidative additions of directed aryl halides to PtII have been
achieved using ligands of formula RCH]NCH2CH2NMe2 (1–3). In these,
R is an ortho-halogenoaryl group, and the ligand coordinates via both nitro-
gen atoms to a dimethylplatinum(II) center producing a [PtMe2(RCH]
NCH2CH2NMe2)] species that ultimately leads to intramolecular oxidative
addition of the aryl-halogen bond. This strategy was successful in producing
C–X (X ¼ Br, Cl, F) bond activation leading to PtIV compounds of type
[PtMe2X(C5CH4CH]NCH2CH2NMe2)]. In the same studies C–H bond
activation was also achieved; in this case a final Me–H reductive elimination
producing methane and PtII compounds of type [PtMe(C5CH4CH]
NCH2CH2NMe2)] takes place (Scheme 1, top).
Further work in this area involved the use of ligands with the same type
of organometallic moieties, but with a single N-donor directing group, with
a general formula 2-XC6H4CH]NCH2-20 -X0 C6H4 (4–6). In this case, the
reaction of these ligands with [Pt2Me4(μ-SMe2)2] may produce different
Scheme 1 Oxidative addition reaction mechanism for ligands of general formulae RCH]NCH2CH2NMe2, 2-XC6H4CH]NCH2Ar, and ArCH]
NCH2(2-XC6H4) on [Pt2Me4(μ-SMe2)2].
200 Gabriel Aullón et al.
observed follow the general sequence indicated earlier, but with the final
cyclometallation step being more favored for Caromatic–H than for
Caliphatic–H bonds and for endo- than for exo-metallacycles, so that the latter
are formed only when the ortho positions of the benzylidene rings are
blocked with fluorine atoms.
Summarizing, all the reactions shown in Schemes 2–4 for the formation
of [C,N]-PtII metallacycles containing a biaryl linkage, included or not in
the final platinacycle, involve intramolecular C–X (X ¼ Br or Cl) bond acti-
vation followed by Caryl–Caryl reductive elimination to produce non-
cyclometallated intermediates that could be detected when the reactions
were monitored by 1H or 19F NMR spectroscopy (13,15). However, none
of these intermediates could be isolated and characterized crystallographi-
cally. Nevertheless, ligands containing two nitrogen donor atoms such as
Ar0 CHNCH2CH2NMe2 would be expected to produce more stable inter-
mediates containing a [N,N0 ]-chelate.
In contrast to the results indicated so far for [C,N] systems (Scheme 2, com-
pounds of type A), early studies carried out with [C,N,N0 ]-PtIV cyclometallated
compounds of the general formula [PtXAr2(Ar0 CHNCH2CH2NMe2],
revealed a distinct behavior for X ¼ Br or X ¼ Cl with respect to the reactivity
indicated in Schemes 2 and 3 (18). For X ¼ Cl, seven-membered [C,N,N0 ]-PtII
cyclometallated compounds of general formula [PtCl(Ar-Ar0 CH]
NCH2CH2NMe2)] are easily obtained (10–12,14,18,19) (Scheme 2), and
crystal structure determinations have been reported for representative examples
(see Fig. 2). Moreover antitumor properties have been studied for some of them
(14,19).
In contrast, a five-membered [C,N,N0 ]-PtII cyclometallated compound
containing an external biaryl linkage (Scheme 3) is formed from [PtBr(4-
MeC6H4)2(CC5H4CHNCH2CH2NMe2] under analogous conditions. In
an attempt to understand the different chemical behavior observed for
bromo or chloro-[C,N,N0 ] systems, these reactions have been thoroughly
studied (18). Careful selection of the reaction conditions extracted from
the kinetic studies indicated in Section 3 allowed the detection and charac-
terization, including by X-ray crystallography, of two isomers of the non-
cyclometallated PtII compound arising from Caryl–Caryl reductive
elimination, thus supporting the existence of the reaction intermediates
assumed for the reactivity with [C,N] systems.
In this respect and in an attempt to obtain a seven-membered [C,N,N0 ]-
PtII cyclometallated compound for X ¼ Br, the reaction of [Pt2(4-
MeC6H4)4(μ-SEt2)2] with imine 2-Br,6-FC6H3CH]NCH2CH2NMe2
Diarylplatinum(II) Scaffolds for Kinetic and Mechanistic Studies 205
has also been studied (11), and, effectively, the presence of an inert C–F
bond at the ortho position of the aryl ring of the imine ligand prevents the
C–H activation at the imine, and thus, the reaction is driven toward the
formation of a seven-membered platinacycle containing an internal biaryl
linkage (Scheme 5). Again, for this system two isomers of the non-
cyclometallated compound containing a biaryl ligand were isolated and crys-
tallographically characterized.
206 Gabriel Aullón et al.
3. KINETIC STUDIES
Reactions involving platinum organometallic complexes with simple
cis-{PtIIR2} units (R ¼ Me, Ph) have been proved to be extremely well
behaved for the directed oxidative addition reaction of C–X or C–H bonds
indicated in Section 2 (Scheme 1) (4–6,9,20,21). This has allowed us to
study from a kinetico-mechanistic perspective the reaction with the ligands
indicated in Scheme 6 having monofunctional (imine) or bifunctional
(amino-imine) directing units (22).
Independently of the directing groups used, the process has been found
to be occurring via the initial formation of an unsaturated tricoordinated
species that reacts in a concerted oxidative addition fashion to produce a
pentacoordinated intermediate (23,24). The rapid coordination of the sixth
(dangling or available in the medium) ligand produces the final compound
(Scheme 1). Fig. 3A collects the isokinetic plot generated with all the data
available, indicating that the process occurs indeed via the same concerted
tricentered mechanism (22). Even the available data for systems lacking
hydrogen bonding characteristics show a very good and extended enough
ΔV{/ΔS{ correlation (25) (Fig. 3B).
A 100
50
ΔS⫽ ⲐJ K–1mol–1
–50
–100
–150
–200
–250
15 30 45 60 75 90 105 120 135
ΔH⫽ ⲐkJ mol–1
B 20
ΔV⫽ Ⲑcm3mol–1
–20
–40
–250 –200 –150 –100 –50 0 50 100
ΔS⫽ ⲐJ K–1mol–1
Fig. 3 Isokinetic (A) and ΔV{/ΔS{ (B) correlation plots for the series of concerted oxida-
tive addition C–X and C–H activation reactions of compounds indicated in Scheme 6 on
{PtIIR2} (R ¼ Me, Ph) moieties.
Ph Ph
SMe2
Ph Pt N 3.6 103
93 3 29 10 12.8 0.6
(CHCl3, 298 K)
Br
Ph
SMe2
Ph Pt N 7.3 104
94 3 12 9 9.5 1.1
(CHCl3, 298 K)
Br
C6F5 4-ClC6H4
SEt2
C6F5 Pt N Fast
Br
4-MeC6H4 Ph
SEt2
4-MeC6H4 Pt N
Fast
F Br
4-MeC6H4 Ph
SMe2
4-MeC6H4 Pt N Fast
F Br
4-MeC6H4 Ph
SMe2
4-MeC6H4 Pt N Fast
Br
Ph
Ph
SMe2
Ph Pt N 10 103
98 4 22 27 2
(toluene, 340 K)
F Br
4-FC6H4 Ph
SEt2
4-FC6H4 Pt N Fast
F Br
a
Corresponds to the isomerization process indicated in Scheme 10.
Diarylplatinum(II) Scaffolds for Kinetic and Mechanistic Studies 213
3.0 104
91 7 9 24 0 — — — —
(CHCl3, 298 K)
7.8 105
100 4 10 1 0 — — — —
(CHCl3, 298 K)
8.5 105
— — — — 86 8 85 22 34 4
(xylene, 361 K)
9.5 104
65 1 115 5 0 — — — —
(toluene, 340 K)
6.7 104
83 7 –65 21 0 — — — —
(toluene, 340 K)
13 104
75 3 –83 9 0 — — — —
(toluene, 340 K)
Fast — — — —
2.3 103
84 5 –71 16 –21 3 — — — —
(toluene, 340 K)a
Scheme 9 Modification of the reactivity shown in Scheme 8 for the L ¼ SEt2, Aryl ¼ C6F5, X ¼ Br system producing a five-membered final
platinacycle.
Diarylplatinum(II) Scaffolds for Kinetic and Mechanistic Studies 215
P/ atm
0 300 600 900 1200 1500 1800 2100
–7.0
–7.7
Ink
–8.4
–9.1
–9.8
–9
In(k/T )
–12
–15
–18
Fig. 4 Eyring and lnk vs P plots for the rate-determining step observed in the reaction
indicated in Scheme 8 with Aryl ¼ Ph, L ¼ SMe2, X ¼ Br, ligand 4 from Scheme 6 with
Aryl ¼ Ph (circles), and ligand 4 from Scheme 6 with Aryl ¼ 4-FC6H4, Ph (squares).
Scheme 11 Models of the species occurring during the set of reactions indicated in
Scheme 2 for ligands of type 1, 2, or 3 from Scheme 6.
moiety (Scheme 9), possibly due to the difficulty of the activation of a C–F
bond in the species B formed as an intermediate. For the rest of the systems
studied the final compounds isolated have always the structure of complexes
of type 7C (Scheme 8). Nevertheless for the systems with the N(amino)–
N(imine) chelating ligands the outcome of the full process from the
{PtII(Aryl)2} units is more diverse, the reactivity indicated in Scheme 5 from
Section 3.1 being a clear summary. As a general rule substituting the ligands
of type 2 and 3 in Scheme 6 at the remaining ortho position leads to a com-
plex of type A that reductively couples with one of the Aryl ¼ 4-MeC6H4
ligands to produce compounds of type B that only produce final
cyclometallated complexes of type 7C as found for the systems indicated ear-
lier. Nevertheless, for the ortho unsubstituted complexes of type A the for-
mation of the more thermodynamically stable complexes of type 5C is also
observed in some cases. This fact indicates that for these chelate complexes
the formation of seven-membered metallacycles of type 7C can be associ-
ated, at least in part, with the presence of a C–Y bond that is too strong
to produce such a cyclometalation reaction.
218 Gabriel Aullón et al.
–12
Ink/T
–14
–16
–18
0.0028 0.0029 0.0030 0.0031 0.0032 0.0033
T –1 / k –1
B
–8 First step observed
Second step observed
–10
–12
Ink/T
–14
–16
–18
0.0028 0.0029 0.0030 0.0031 0.0032 0.0033
T –1 / k –1
Fig. 5 Eyring plots for reactions observed by UV–vis monitoring of the sequential spon-
taneous process occurring in toluene/xylene solutions of bromo complex with no chloro
or fluoro substituents on the initial metallated ligand (Scheme 12) of type A (A) and
Btrans (B). Fitted lines are common to both graphs.
Fig. 6 Reductively coupled species of type Btrans and Bcis appearing during
the spontaneous type A to type 5C (top, no chloro or fluoro substituents on the initial
metallated ligand) or 7C (bottom, with fluoro substituent on the initial metallated
ligand) reactions.
dashed line plot to the A ! Btrans reductive elimination reaction. Even the
isomerization between the E and Z forms of the –CH]N– bond has been
determined as for other simpler systems (18,21). As a whole the full reaction
sequence can be described by the previous Scheme 10, where most of the
different steps have been resolved as a result of careful tuning of the reaction
conditions of time and temperature. Parallel time-resolved NMR measure-
ments have confirmed these assignments, and Table 2 collects the relevant
associated data. Nevertheless for some of the systems studied the isomeriza-
tion reaction has not been observed, thus indicating that the process is fast
under the conditions studied, as already observed for some of the systems
indicated in Table 1. As a whole, when the processes on the chelate
N(amino)–N(imine) and monodentate N(imine)–L systems are compared, both
appear to be extremely complex and depending on the large number of vari-
ables involved. This is not surprising given the number of reaction steps
Diarylplatinum(II) Scaffolds for Kinetic and Mechanistic Studies 221
involved in the full reactivity, which makes any claim such as faster than or
slower than meaningless. Furthermore, the characterization of the intermedi-
ate species during the full process also brings in some news facts that have to
be considered with respect to the isolation of only the less-reactive species of
the full set.
Nevertheless, the most striking feature of the reactivity indicated in the
previous pages relates to the five- or seven-membered platinacyclic nature of
the final complex obtained. As seen in Table 2 only for one of the reactions
studied, no doubt, the most thermodynamically stable five-membered plat-
inacyclic compound is obtained, and the tuning of such specificity cannot be
related to the different reaction sequences observed, all being rather equiv-
alent. Only the detailed single-step sequence occurring in the Bcis ! 7C or
Bcis ! 5C process (Scheme 13) can explain such tuning. Further DFT cal-
culations have been conducted (see Section 4) in order to establish the pref-
erences once the empirical results are fully ascertained. A similar approach
has been conducted in other organometallic systems with rather impressive
synergic outcome (31,32).
Table 2 Relevant Kinetic (Xylene Solution, 340 K) and Activation Parameters of the Spontaneous
Measured on Compound of Type A (Scheme 10)
Compound A A ! Btrans Btrans ! Bcis
4-MeC6H4
Me2N
Not Not
4-MeC6H4 Pt N 240 97 4 –13 11 150 42 5 –179 15
determined determined
Br
4-MeC6H4
Me2N
4-MeC6H4 Not
Pt N 9.1 122 5 33 13 Fast
determined
Cl
4-MeC6H4
Me2N
4-MeC6H4 N Not
Pt 3.4 118 5 13 13 Fast
determined
Cl Cl
4-MeC6H4
Me2N
4-MeC6H4 Pt N 7.1 121 2 28 7 –9 2 7.1 54 4 –169 12 –24 4
F Br
4-MeC6H4
Me2N
4-MeC6H4 Not Not
Pt N 55,000 69 15 –50 45 1.8 63 5 –154 13
determined determined
F Cl
Diarylplatinum(II) Scaffolds for Kinetic and Mechanistic Studies 223
Bcis ! 7C Bcis ! 5C
Not
— — — — 30 86 7 –63 20
determined
Not
0.29 141 15 60 44 — — — —
determined
29 102 5 –16 15 29 — — — —
Fast — — — —
Not
2200 106 15 32 40 — — — —
determined
Scheme 13 Detailed sequential reaction steps needed for the transformation of compounds of type Bcis to cycloplatinated compounds of
type 7C or 5C (Scheme 10).
Diarylplatinum(II) Scaffolds for Kinetic and Mechanistic Studies 225
4-MeC6H4 Ph 4-MeC6H4 Ph
SMe2 SMe2
4-MeC6H4 Pt N 5C: 54.3 4-MeC6H4 Pt N 5C: 58.5
3 4
7C: 34.8 7C: 38.2
Br Cl
4-FC6H4 Ph 4-FC6H4 Ph
SMe2 SMe2
4-FC6H4 Pt N 5C: 52.7 4-FC6H4 Pt N 5C: 52.7
5 6
7C: 40.8 7C: 34.5
Br Cl
4-MeC6H4 4-MeC6H4
Me2N Me2N
5C: 70.3 5C: 64.5
7a 4-MeC6H4 Pt N 8a 4-MeC6H4 Pt N
7C: 38.5 7C: 31.1
Br Cl
4-MeC6H4 4-MeC6H4
Me2N Me2N
5C: — 5C: —
9b 4-MeC6H4 Pt N 10b 4-MeC6H4 Pt N
7C: 44.4 7C: 44.9
F Br F Cl
a
Xylene solution, 139°C.
b
Toluene solution, 110°C.
Diarylplatinum(II) Scaffolds for Kinetic and Mechanistic Studies 227
150
Free energy (kJ mol–1)
100
50
Reaction coordinate
Fig. 7 Computed free energy profile for the Btrans > Bcis isomerization of complexes
on entries 7 (solid) and 8 (dashed) in Table 3.
4-MeC6H4 Ph 4-MeC6H4 Ph
SMe2 SMe2
4-MeC6H4 Pt N Btrans: 0.0 4-MeC6H4 Pt N Btrans: 0.0
3 4
Bcis: 3.1 Bcis: 5.7
Br Cl
4-FC6H4 Ph 4-FC6H4 Ph
SMe2 SMe2
4-FC6H4 Pt N Btrans: 0.0 4-FC6H4 Pt N Btrans: 0.0
5 6
Bcis: 1.3 Bcis: 6.1
Br Cl
4-MeC6H4 4-MeC6H4
Me2N Me2N
Btrans: 0.0 Btrans: 0.0
7a 4-MeC6H4 Pt N 8a 4-MeC6H4 Pt N
Bcis: 15.8 Bcis: 32.3
Br Cl
4-MeC6H4 4-MeC6H4
Me2N Me2N
Btrans: 0.0 Btrans: 0.0
9b 4-MeC6H4 Pt N 10b 4-MeC6H4 Pt N
Bcis: 15.3 Bcis: 17.7
F Br F Cl
a
Xylene solution, 139°C.
b
Toluene solution, 110°C.
230 Gabriel Aullón et al.
Scheme 15 Reaction pathways leading to 5C (I, top) and 7C (II, bottom) type of com-
pounds from PtII species of type Bcis with monodentate N(imine) ligands.
Table 5 Computed Relative Free Energies (in kJ mol1 and in Toluene Solution at 70°C)
for the Reaction Leading to PtII Compounds of Type 5C and 7C From Complexes of
Type A With Monodentate N(imine) Ligands (Entries 1, 3, and 5 of Table 3)
Fig. 8 Computed structures for the transition states leading to products 5C (left, path-
way I) and 7C (right, pathway II) from compounds of type Bcis originated form com-
pound of type A in entry 1 of Table 3 (distances in Å, nonrelevant H atoms have
been omitted for clarity).
Table 6 Smallest H–Pt–(Aryl) Torsion Angles (in Degrees) and Computed Free Energies
(in kJ mol1) for the Transition States Indicated in Table 5 for the C–H Activation and
Reductive Elimination Reactions Studied
Entry in Table 3
1 3 5
Fig. 9 Qualitative time-resolved (arbitrary time scale) concentration profile for the com-
plexes with monodentate N(imine) and SMe2 ligands involved in entries 1, 3, and 5 of
Table 3 (solid line, compounds of type A; dashed line, compounds of type 7C; dotted line,
compounds of type 5C).
The computed relative free energy values collected in Table 5 have also
been used to build a qualitative kinetic profile simulation model to evaluate
the alternative formation of the final five- and seven-membered
platinacycles, 5C and 7C, starting from the corresponding Bcis parent inter-
mediates of entries 1, 3, and 5 in Table 3 (Fig. 9). The computed results
totally agree with the experimental observations and confirm that only prod-
ucts of type 7C are expected in the reaction from bromido complexes of
type A containing a set of monodentate N(imine) and a SMe2 ligands. The
possible amount of the analogous five-membered ring product 5C remains,
in all cases lower than 7%, and the 5C:7C ratios are 1:14, 1:30, and 1:73 for
complexes involved in entries 1, 3, and 5 of Table 3, respectively.
Scheme 16 Reaction pathways leading to 5C (I, top) and 7C (II, bottom) type of com-
pounds from PtII species of type Bcis with chelate N(amino)–N(imine) ligands.
Diarylplatinum(II) Scaffolds for Kinetic and Mechanistic Studies 235
Table 7 Computed Relative Free Energies (in kJ mol1 and in Xylene Solution at 139°C)
for the Reaction Leading to PtII Compounds of Type 5C and 7C From Complexes of
Type A With Chelate N(amino)–N(imine) Ligands (Entries 7 and 8 of Table 3)
Entry in Table 3
Reaction pathway Intermediate
7 8
Bcis 0.0 0.0
—
iBcis 90.1 97.9
OATS-CH5 119.6 128.4
B-CH5 115.9 127.9
I
RETS-CH5 141.5 155.6
5C 70.3 64.5
OATS-CH7 146.4 149.8
B-CH7 126.4 136.0
II
RETS-CH7 145.1 149.1
7C 38.5 31.1
Table 8 Smallest H–Pt–(Aryl) Torsion Angles (in Degrees) and Computed Free Energies
(in kJ mol1) for the Transition States Indicated in Table 7 for the C–H Activation and
Reductive Elimination Reactions Studied
Entry in Table 3
7 8
H–Pt–Aryl ΔG H–Pt–Aryl ΔG
OATS-CH5 89.4 119.6 89.4 128.4
RETS-CH5 58.5 141.5 53.2 155.6
OATS-CH7 66.1 146.4 66.7 149.8
RETS-CH7 70.8 145.1 71.1 149.1
Diarylplatinum(II) Scaffolds for Kinetic and Mechanistic Studies 237
Even so, a careful analysis reveals that the relatively small torsion angle is in
fact larger than those found for the analogous transition states of the reac-
tivity of the systems of entries 1, 3, 5, and 8 from Table 3 (RETS-CH5
H–Pt–(Aryl) torsion angles being 52.5, 52.3, 53.8, and 53.2 degree,
respectively). This, somehow, low energetic requirement could be directly
related to the preferential formation of compound of type 5C in this case,
thus explaining the switching in reactivity from the obtention of type 7C
complexes.
The experimental observation that the spontaneous reaction of type A
complex in entry 7 on Table 3 is much faster than that of the system of entry
8 can be immediately associated with the calculated energy demands above
(Table 8) (11). The computed free energies for the reactions, despite differ-
ences in reaction conditions and calculations, indicate that for the bromido
complex (entry 7) the energy requirement is 8 kJ mol1 less than for the chlo-
ride analogue (entry 8). Furthermore, for the systems from entries 7 and 8 of
Table 3, the reactivity shown in Scheme 16 has been found to take place after a
kinetically and spectroscopically detected Btrans > Bcis rearrangement (see
Section 3). Consequently, the highest barrier found in the preferred reaction
pathway for each compound in Scheme 16 has to be lower than that for the
isomerization reaction. Indeed, this is observed for the computed data for both
systems; even for some other systems the isomerization reaction has been
found to be rate-determining (13). For the bromido compound (entry 7 of
Table 3) the isomerization (Isom_TS) and reductive elimination (RETS-
CH5) barriers are 138.4 and 141.5 kJ mol1, respectively; for the chlorido
compound of entry 8 the isomerization transition state (Isom_TS) and the
C–H oxidative addition transition state (OATS-CH7) have values of 140.1
and 149.8 kJ mol1, respectively.
As a whole, the data collected in Table 7 allow the building of a quali-
tative kinetic simulation model for evaluating the formation, over time of
the final five- and seven-membered platinacycle compounds of types 5C
and 7C from the starting Bcis complexes of entries 7 and 8 in Table 3
(Fig. 10). A very satisfactory qualitative agreement is found, even though
the minor product is present in significant amounts in both complexes:
for the bromido compound in entry 7 the 5C:7C ratio is 87:13, while for
the chlorido complex in entry 8 the ratio diminishes to 73:24. These results
indicate that, unfortunately, the computed free energy differences between
pathways I and II are not as important as they should be from the experi-
mentally collected results. Nevertheless, the overall trend and selectivity
are successfully explained.
238 Gabriel Aullón et al.
Fig. 10 Qualitative product concentration evolution over time for PtII complexes with
chelate N(amino)–N(imine) ligands (entries 7 and 8 in Table 3) in arbitrary time scale (solid
line, compounds of type A; dashed line, compounds of type 7C; dotted line, compounds
of type 5C).
Table 9 Computed Relative Free Energies (in kJ mol1 and in Toluene Solution at
110°C) for the Reaction Leading to PtII Compounds of Type 7C From Complexes of
Type A With Chelate N(amino)–N(imine) Ligands (Entries 9 and 10 of Table 3)
Entry in Table 3
Intermediate
9 10
Bcis 0.0 0.0
iBcis 89.3 90.8
OATS-CH7 138.1 137.1
B-CH7 121.5 119.5
RETS-CH7 137.5 136.4
7C 44.4 44.9
Fig. 11 Qualitative product concentration evolution over time for PtII complexes with
chelate N(amino)–N(imine) ligands (entries 9 and 10 in Table 3) in arbitrary time scale.
5. CONCLUDING REMARKS
In this contribution, we have illustrated how a series of oxidative addi-
tion and reductive elimination reactions, occurring on platinum(II) organ-
ometallic complexes, can be resolved experimentally by the use of an
appropriate interlock between preparative and kinetic methodologies.
Namely, the reaction of bis(aryl)platinum(II) precursors with imine or
amino-imine ligands leads to the formation of platinacyclic compounds with
five- or seven-membered metallacycles via a sequence that involves C–X
bond oxidative addition plus reductive C–C coupling followed by C–H oxi-
dative addition with a final C–H reductive elimination. Given the fact that
the process includes a series of non-simple and fairly slow processes, several
intermediates have been proposed and fully characterized in the reaction
media. Nevertheless, with the precision of the approach some of these char-
acterized species are found to be completely irrelevant in the sequential
240 Gabriel Aullón et al.
reaction pathway; that is, they are de facto false intermediates or dead-end
compounds.
The kinetico-mechanistic studies carried out on this time-resolved
reactivity has provided series of thermal- and pressure-derived activation
parameters that has allowed a fairly comprehensive description of the reac-
tion sequence involved in the full process. Nevertheless, a careful and com-
prehensive analysis has had to be applied, since the rate sequence is not
uniformly applicable for the full series of complexes. That is, the combina-
tion of two reactions having only slightly different activation energies pro-
duces dramatic changes when taken jointly, and the rate-determining step of
the full process could differ within a series of very similar reactions.
In this respect, the synergy between experiments and DFT calculations
has been found to be very important in order to improve the understanding
of both the mechanisms involved and the observed reactivity. DFT calcu-
lations have not only ascertained the elementary reaction steps of the process,
they have also explained the kinetic preference for the less thermodynam-
ically stable products found in the majority of cases. Furthermore, the pres-
ence and incidence in the overall process of dead-end false intermediate
compounds can be also assessed through calculations.
It is thus clear that computational studies, when fully supported by the
empirical results, are able to fill in the areas of the puzzle that cannot be
experimentally explored and resolved. In this respect, the set of studies pres-
ented in this contribution constitute a perfect example of how a close col-
laboration between experimentalists and theoreticians, with their specific
perspectives when observing and interpreting data, provides remarkable
value-added results to the work carried out.
ACKNOWLEDGMENTS
We thank the Spanish national research agency for its economic support. In particular project
Grant numbers CTQ2009-11501, CTQ2012-37821-C2-01, CTQ2015-65707-C2-1-P,
CTQ2015-65040-P, and CTQ2015-64579-C3-1-P from the Ministerio de Economı́a y
Competitividad/FEDER are acknowledged. Allocation of computer resources at IQTCUB
is also acknowledged.
REFERENCES
1. Anderson, C. M.; Puddephatt, R. J.; Ferguson, G.; Lough, A. J. J. Chem. Soc. Chem.
Commun. 1989, 1297–1298.
2. Anderson, C. M.; Crespo, M.; Jennings, M. C.; Lough, A. J.; Ferguson, G.;
Puddephatt, R. J. Organometallics 1991, 10, 2672–2679.
Diarylplatinum(II) Scaffolds for Kinetic and Mechanistic Studies 241
35. Santoro, S.; Kalek, M.; Huang, G.; Himo, F. Acc. Chem. Res. 2016, 49, 1006–1018.
36. Sperger, T.; Sanhueza, I. A.; Schoenebeck, F. Acc. Chem. Res. 2016, 49, 1311–1319.
37. Zhang, X.; Chung, L. W.; Wu, Y.-D. Acc. Chem. Res. 2016, 49, 1302–1310.
38. Jover, J.; Miloserdov, F. M.; Benet-Buchholz, J.; Grushin, V. V.; Maseras, F.
Organometallics 2014, 33, 6531–6543.
39. Durr, A. B.; Yin, G.; Kalvet, I.; Napoly, F.; Schoenebeck, F. Chem. Sci. 2016, 7,
1076–1081.
40. Sperger, T.; Fisher, H. C.; Schoenebeck, F. WIREs Comput. Mol. Sci. 2016, 6, 226–242.
41. Hoops, S.; Sahle, S.; Gauges, R.; Lee, C.; Pahle, J.; Simus, N.; Singhal, M.; Xu, L.;
Mendes, P.; Kummer, U. Bioinformatics 2006, 22, 3067–3074.
CHAPTER SIX
Contents
1. Introduction 244
1.1 π-Acceptor vs σ-Donor Effect of Nitrogen/Carbon N^C/N^N/C Tridentate
Ligands 246
2. Pull-and-Push Effects of Pt(II) Complexes With Coordinated N^C/N^N/C
π-Acceptor Nonleaving Ligands 252
2.1 Controlling the π-Acceptor Properties of N^C/N^N/C Chelates via a Donor
Atom Effect 252
2.2 Controlling the π-Acceptor Properties of Terpy via Extended Ring
Conjugation 259
2.3 Controlling the π-Acceptor Properties of Terpy and Related Chelates
Through a Substituent Effect 261
2.4 Controlling the π-Acceptor Properties of Terpy Through an Ancillary
Substituent Effect 262
2.5 Incorporating Bis(Pyrazolyl)Pyridine/Benzene; Bis(70 -Azaindolyl)Pyridine/
Benzene; 1,3-Bis(80 -Quinolyl)Pyridine/Benzene; or Bis(Iminopyridyl/
Isoquinolyl)Isoindoline as Nonleaving Ligands of Square-Planar Pt(II)
Complexes 264
2.6 Controlling the π-Acceptor Properties of Other N-donor Chelates 269
3. Conclusions 272
Acknowledgments 274
References 274
Abstract
In this chapter, we report on some of the highlights of the research work which has
been carried out in our laboratories on the role and influence of nitrogen-/carbon-
donor tridentate ligands (N^C/N^N/C) on the rate of substitution of labile ligands from
model square-planar Pt(II) complexes. This work was founded on the hypothesis that
tailored kinetic control of substitution reactions through changing the electronic prop-
erties of the spectator ligand backbone of Pt(II) complexes can be an insightful avenue
toward the optimization of the efficacy of future antitumor Pt(II) drugs. Focusing on the
nitrogen-/carbon-donor tridentates (N^C/N^N/C), several Pt(II) complexes were synthe-
sized and used to study systematically the mechanisms and rates of substituting the
labile coligand from the complexes using biorelevant nucleophiles. The trends in reac-
tivity as the nonleaving ligands in the complexes were systematically changed were
used to understand the electronic and steric roles of the coordinated tridentate/
bidentates on the lability of their complexes. Our kinetic data source can be used for
the tailor-designing of future metal-based drugs with rigid nonleaving ligands, given
that the lability of such complexes in biological systems plays a role on their ultimate
in vivo pharmacokinetics (i.e., toxicity, deactivation and development of resistance, and
cytotoxicity).
ABBREVIATIONS
A associative mechanism
aaa, app… ppp coordinated nonleaving nitrogen tridentate ligands with variable number
of amine groups and pyridyl rings
aaa0 coordinated bidentate and monodentate amine ligands (aa ¼ en ¼ ethylenediamine;
a0 ¼ amine)
bpma bis(2-pyridylmethyl)amine
D dissociative mechanism
DFT density functional theory
dien diethylenetriamine
HOMO highest occupied molecular orbital
LUMO lowest unoccupied molecular orbital
(N^C/N^N/C) nonleaving tridentate ligands with nitrogen- and/or carbon-donor atoms
NBO natural nonbonding orbitals
py pyridine
terpy 20 200 :60 200 -terpyridine
tmtu 1,1,3,3-tetramethyl-2-thiourea
tu thiourea
1. INTRODUCTION
The kinetic control of the lability of low-spin d8 square-planar com-
plexes in biological systems and their ability to intercalate the planar spec-
tator backbone between the base pairs of DNA are some of the key
aspects determining the efficacy (cytotoxicity) of antitumor Pt(II)-based
drugs (1–3). An extremely inert complex will have slow rates of complex
formation with DNA nucleobases, while a very reactive complex will be
Lability of Square-Planar Pt(II) Complexes 245
the activation barrier to the formation of the activated state of the d-orbitals
of the Pt(II), leading to facile substitution of the leaving group from the
complex.
H2N NH
H3N Pt NH2 NH2 NH2
Pt
OH2 OH2
Pt(aaa⬘) Pt(aaa)
NH N
N N
NH2 Pt N
N N N
NH2 Pt NH2 H3N Pt Pt
OH2
Pt(pap) OH2 OH2 OH2
Pt(apa) Pt(app) Pt(ppp)
NH
NH
N Pt N
N Pd N
OH2
OH2
Pt(pap) Pd(pap)
Fig. 1 Structures of cationic square-planar Pt(II) complexes used to study the effects of
chelation as well as replacing amine donors with π-accepting pyridines in tridentate
nitrogen-donor chelates (15).
Lability of Square-Planar Pt(II) Complexes 247
The explicit role of π-acceptor groups on the reactivity of Pt(II) complexes was
reported for the first time in a quantitative manner.
The kinetic data obtained for the aqua substitution by thiourea and
iodide nucleophiles have been collated into Table 1.
As shown in Table 1, the value of k2 for the nucleophilic substitution of
the aqua leaving group from the metal complexes by tu, tmtu, and I
increased by factors of about 5.6 103, 4.8 104, and 3.3 104, respec-
tively, for changing the coordination structure of the complexes from
Pt(aaa) to the Pt(ppp) (Table 1, rate constants, entry 8 vs 2–5;7). The lability
factors calculated for Pt(ppp) were much larger than could be predicted
empirically from the combined π-effects on the rate of substitution due
to systematic structural changes introduced onto the nonleaving ligands of
its analogues having either 1 or 2 isolated pyridyl rings in their chelate ligands
(14,15). The high intrinsic reactivity of Pt(ppp) relative to Pt(aaa) arose
from the strong π-acceptor effect of the terpy ligand due to its conjugated
structure (12). The delocalized and energetically low-lying π*-molecular
orbitals of the three pyridyl rings of terpy integrate electronic communica-
tion within the entire ligand (14,15). As a consequence, the electrophilicity
of Pt(ppp) was the highest compared with its analogues. During the sub-
stitution process, the strong π-acceptor effect of terpy enhances π*-
acceptance of electron density from the metal d-orbitals. This stabilizes
the formation of a bond between the metal and the incoming nucleophile
in the transition state, leading to facile substitution of the leaving group. By
ranking the reactivity of the ternary Pt(II) complexes between analogues
with either 1 or 2 pyridyl rings at different positions, it was established that
the π-effect due to the tridentate ligand was strongest when the π*-acceptor
pyridyl ligand is coordinated trans to the leaving group (19).
Interestingly, the strength of the π-effect of chelate N-donors also
depends on the softness and hence the diffusivity of the orbitals of the donor
metal ion involved in the back donation of electron density into the chelate
ligand (5). A comparison of the aqua lability of Pt(pap), [Pt(bpma)H2O]2 +,
and Pd(pap) (23), [Pd(bpma)H2O]2 +, revealed that the latter pair is only
103 times more reactive than the former (Table 1, entry 6 vs 5). This is signif-
icantly lower than the average reactivity factor of 104–105 reported (12) for the
lability of Pd(II)/Pt(II) couples bearing amine chelate ligands on the basis of
the hard acid–base theory (7). Owing to the large diffusivity of the 5d orbitals
of Pt compared to the smaller 4d orbitals of Pd, the back donation of electron
density is stronger for Pt(pap) than it is for Pd(pap). This increases the
Table 1 Second-Order Rate Constants, k2 (Std. Error), M1 s1 at 25°C and Activation Data (Within Temperature Range: 288–308 K) for Aqua
Substitution From Cationic Amine/Pyridyl Pt(II) Complexes
Kinetic Data
2
tu tmtu I
k2 ΔH≠ ΔS≠ k2 ΔH≠ ΔS≠ k2 ΔH≠ ΔS≠
Complex pKa (M21 s21) (kJ mol ) (J mol21 K21) (M21 s21)
21
(kJ mol ) (J mol21 K21) (M21 s21)
21
(kJ mol ) (J mol21 K21) Ref.
21
reactivity significantly for Pt(pap) more than it does for Pd(pap), thereby
reducing the reactivity advantage of the Pt complex over its Pd analogue
by only three orders of magnitude.
The reactivity of the aqua Pt(II) complexes (14,15) also showed a pos-
itive trend with respect to the acidity of the coordinated aqua ligands (24). As
shown in Fig. 2, the Brønsted acidity of the aqua coligand of the Pt(II) com-
plexes increases with increasing number of π-acceptor rings in the
nonleaving ligand and is mirrored by an increase in reactivity of the Pt(II)
complexes. The acidity of the coordinated aqua ligand increases linearly
with increasing number of π-acceptor nonleaving ligands (24) as reflected
by a decrease in the spectrophotometrically determined pKa values of the
aqua complexes (14,15). Apart from influencing intrinsic reactivity, the
π-acceptor strength of the ligand has a profound effect upon the hydrolysis
equilibria of the complexes. This becomes an important pharmacokinetic
aspect of the Pt(II) complexes especially in the intracellular environment
of the cell where the aquation of the complex is triggered by a low concen-
tration of chloride ions (25,26).
Whether the strength of the π-effect of N-donor ligands of Pt(II)
complexes is related to the denticity or chelating property of the spectator
ligand has been explored. To determine whether denticity of a nonleaving
ligand has an intrinsic capacity to enhance the rate of substitution, two Pt(II)
amine complexes, viz., [Pt(en)(NH3)(OH2)](ClO4)2, Pt(aaa0 ) {aa ¼ en ¼
ethylenediamine; a0 ¼ amine}, and [Pt(dien)(OH2)](ClO4)2, Pt(aaa)
{aaa ¼ dien ¼ diethylenetriamine}, were synthesized and the lability of
3.0
1.5
N
aap
N or N Pt2+ N or N 1.0
apa
π-Acceptor ability
OH2 0.5
aaa pKa value
+ Nu, –H2O k1 0.0
Increase in k1
–0.5
0.0 0.5 1.0 1.5 2.0
s = log(ka/ka0)
the aqua ligand measured (22). Substitution of the aqua ligand from the
complexes by a series of neutral and anionic nucleophiles was carried
out under pseudo-first-order conditions as a function of concentration
and temperature. An increase in the extent of chelation from the bidentate
complex, Pt(aaa0 ), to the tridentate complex, Pt(aaa), increased the rate
of aqua substitution from the complexes by an average factor of 3 (Table 1,
rate constants, entry 2 vs 1). In addition, computational analysis of the com-
plexes indicated a lengthened Pt-OH2 bond for Pt(aaa) compared to the
Pt(aaa0 ). It was concluded that the thermodynamic stability associated
with chelation promoted ground-state destabilization of the Pt-OH2 bond
of the Pt(aaa) relative to that of Pt(aaa0 ), leading to increased labilization
of the leaving group.
The activation parameters which are presented in Table 1 support an
associative mode of activation for the substitution of the leaving group from
the Pt(II) complexes. The activation entropies are all negative, while the
activation enthalpies are relatively low. Characteristically negative activation
entropy and activation volume (27) for the forward reactions suggested that
in all cases nucleophilic substitution proceeded via a bimolecular activation
transition state in which bond formation was the rate-limiting step (5,28).
According to the results obtained for the substitution reactions presented
herein, the sensitivity of the rate constants to the nature (donor properties)
as well as the concentration of the entering ligands confirms the associative
character of the activated complex forming the substituted products. This is
expected since the complexes studied are all four square-planar and can
accommodate the synchronous breaking of the bond to the leaving group
and the formation of the new bond with the substituting nucleophile via
an 18-electron triangular bipyramidal transition state (7).
The important results, just described, stimulated us to carry out more
related studies on this subject aimed at enacting a systematic control of
the kinetics of the substitution reactions of the Pt(II) complexes through
changing their electronic and steric properties of the spectator ligand back-
bone. Kinetic control of the substitution behavior of the complexes is
important for optimizing their pharmacokinetic properties as well as their
efficacy as potential antitumor Pt(II) drugs. Herein, we report on some of
the highlights of the work which has been carried out in our laboratory
on the role of nitrogen-donor multidentate ligands on the rate of substitu-
tion of square-planar Pt(II) complexes in acidic aqueous or dry methanol
media.
252 Allen Mambanda and Deogratius Jaganyi
C(CH3)3
(CH3)3C C(CH3)3
N N N
N N N N N N
Pt Pt
Pt
Cl Cl Cl
Pt1 Pt3 Pt4
me F
N N
Pt N N N N
Pt Pt
Cl
Cl Cl
Pt2 Pt2 Pt2
N N N N N
N N N N N N N N
Pt Pt Pt Pt
Cl Cl Cl Cl
Pt5 Pt6 P8
Pt7
F3C F3C
N N
N N N
Pt Pt
Cl Cl
Pt9 Pt10
A B
TU
0,75 3,75
0,60 3,00
Rel. abs.
kobs (s–1)
0,45 2,25
0,15 0,75 I
–
TMTU
–
SCN
0,00 0,00
0 300 600 900 1200 1500 1800 2100 0,000 0,002 0,004 0,006 0,008 0,010
Time(s) [Nucleophile] (mol dm–3)
Fig. 4 (A) Kinetic traces from the stopped-flow analyzer for the chloride substitution
from Pt4 by thiocyanate (SCN) (31). (B) Dependence of kobs on the concentration of
incoming nucleophiles. Reproduced from Reddy, D.; Jaganyi, D. Dalton Trans. 2008,
(47), 6724–6731 with permission from the RSC.
254 Allen Mambanda and Deogratius Jaganyi
where k2 and k2 are the first-order rate constant for the solvolytic pathway
and the second-order rate constant for the direct substitution of the labile
2 2
R R
X
D1 D1
k2
1
R D2 Pt Cl + Nu 1
R D2 Pt Nu
N N
2
2 R
R
2
R
k–2 + S
Fast + Nu
D1
1 S
R D2 Pt
2
R
R1 = R2 = H; D1 = D2 = N : Pt1. R1 = R2 = H; D1 = C; D2 = N : Pt2.
R1 = CH3 ; R2 = H; D1 = C; D2 = N : Pt2me. R1 = F; R2 = H; D1 = C; D2 = N : Pt2F.
R1 = R2 = tBu-; D1 = D2 = N : Pt4.
phne
R1 = R2 = H; D1 = D2 = N : Pt3.
ligand from the complexes, respectively. The latter was deduced from the
slope of the kobs vs concentration of nucleophiles, an example of which is
shown in Fig. 4.
In all case studies, the mechanism of substitution was limiting associative
(A) in nature, characterized by low enthalpies of activation and significantly
negative entropy of activation. For this mechanism, the final product forms
rapidly from a pentavalent-activated complex, involving a direct attack by
the nucleophile on the complex. The formation of a new bond to the nucle-
ophile is the rate-limiting step. Thus, the activated complex is characterized
by a decrease in the entropy and a collapse in the partial volumes (27) when
compared to the initial states of the reactants.
As a follow-up to our earlier studies, we studied the effect of changing
the structure of a typical strong π-acceptor ligand such as terpy on the reac-
tivity of the Pt(II) derivative complexes. Studies have shown that Pt(II) com-
plexes of terpy are bioactive and can efficiently inhibit human thioredoxin
reductase (32,33) and display antiprotozoal activity (34) as well as anticancer
potency (35). The potential applications of derivatives of terpy Pt(II) com-
plexes in oncology are rooted in their ability to link covalently to and at the
same time intercalate between the nucleobases of DNA. Although the
monofunctional DNA conjugates of these complexes are noncytotoxic, a
combination of intercalative association of the planar aromatic heterocyclic
ligands between adjacent base pairs of DNA and covalent binding is a good
recipe for effecting impairments that induce instability within the helical
structure of DNA. The instability is fundamentally related to the combined
structural effects of the monofunctional covalent binding and disruption of
the interstrand dipolar and intrastrand π/π*interactions between the com-
plementary bases and planar rings, respectively. The extent of helical insta-
bility depends also on the π-surface size of the planar backbone of the
nonleaving ligand as well as the charge on the metal complex. The des-
tabilized complex conjugate between DNA and the Pt(II) intercalator acti-
vates cellular pathways, some of which have a chemotherapeutic effect in
cancer cells. Several in vitro studies have shown that Pt(II) complexes with
planar aromatic ligands including terpy, its derivatives, and other related
ligands destabilize the helical structure of DNA via favorable intercalative
and/or stacking interactions, some of which have relevance to their
in vitro anticancer activity (35–37). For example, the monocationic Pt(II)
terpy derivative, [Pt(terpy)(2-hydroxyethanethiolate)]+, has been known
to intercalate into calf thymus DNA with a remarkably high binding con-
stant of 1.2(0.2) 106 M1 at pH 6.8 (38). A terpy derivative complex,
256 Allen Mambanda and Deogratius Jaganyi
ground-state properties of the bond between the Pt atom and leaving group
as it occurs in the measurable trans-influence of a σ-strong donor in the trans
position (44). This decreases the natural nonbonding orbital (NBO) charges
and hence the Lewis acidity of the Pt atom, leading to lower rates of sub-
stitution of the leaving group from the complex. As can be noticed from
the data in Table 2 (rate constants, entry 2 vs 3), the cis-influence (39,40) is
somehow weaker than the trans-influence for square-Pt(II) complexes with
mixed σ/π groups within the coordinated chelate.
terpy ligand to receive electron density from the d orbitals of the metal into
its π*-acceptor molecular orbitals. The tert-butyl groups donate electrons
inductively into the terpy rings, thereby reducing the π*-effect of the ligand.
This destabilized the formation of the activated complex, expected to
accommodate extra electrons from the incoming nucleophile by raising
the energies of the ligand-centered LUMOs. This resulted in retarded rates
of substitution. A similar result was reported in a comparative case study in
which these two complexes were reacted with azole nucleophiles (47). DFT
calculations of Pt1 and Pt4, and a series of other analogues containing either
electron-donating or electron-withdrawing groups in the periphery posi-
tions affirmed that the introduction of electron-donating substituents on
the π-acceptor terpy ligand decreased its propensity to receive electron den-
sity from the metal center. The positive charge on the metal center of Pt4 is
lower than on Pt1, while the energy separation of the frontier molecular
orbitals (EHOMO ELUMO) of the ground states of the complexes increased
from Pt1 to Pt4. This reflects a less reactive metal center, while the opposite
is true for electron-withdrawing groups (31).
The study of the substituent effect on the rate of substitution of chloride
was extended to two analogues of Pt2 with either a 40 -methyl (Pt2me) or a
40 -fluoro (Pt2F) group on the 1,3-bis(pyridyl)benzene (N^C^N)
nonleaving ligand (41,51). Both complexes were more reactive than Pt2
(39,41) (Table 2, rate constants, entries 4–5 vs 3) toward thiourea ligands
and azoles (51), while the 40 -fluoro derivative was slightly more reactive
than the 40 -methyl-substituted complex. In general, the 40 -substituents on
the phenyl ring of the NCN ligand increased the rate of substitution of
the complexes relative to the rate for Pt2. The electron-donating methyl
group destabilized the ground-state properties of the complex compared
to those of Pt2. The electron-withdrawing 40 -fluoro-substituent enhanced
the π-acceptor property of the ligand relative to that of the unsubstituted
ligand of Pt2. As a result, both the Pt2me and the 40 -fluoro (Pt2F) were
more reactive than Pt2, with the latter slightly edging the former.
Fig. 6 Crystal structures of Pt6 (53) and its pyrazole-substituted product, Pt6pz(47).
Reproduced from Field, J. S.; Haines, R. J.; McMillin, D. R.; Summerton, G. C. J. Chem.
Soc. Dalton Trans. 2002, 1369–1376 and Reddy, D.; Akerman, K. J.; Akerman, M. P.;
Jaganyi, D. Transition Met. Chem. 2011, 36 (6), 593–602 with permission from the IUC
and RSC, respectively.
264 Allen Mambanda and Deogratius Jaganyi
N N
N
N N N N N N N
N N N N N N N Pt N
Pt Pt Pt
Cl
Cl Cl Cl
Pt12 Pt13
Pt1 Pt11
N N N N
N N N N
Pt Pt N Pt N
N Pt N
Cl Cl Cl
Cl
Pt2 Pt14 Pt15 Pt16
N N N
N N N N N N N N N
N Pt N
N Pt N N Pt N N Pt N
Cl
Cl Cl Cl
Pt17 Pt18 Pt19
Pt20
Fig. 7 Schematic structures of Pt(II) complexes with 2,6-bis(pyrazolyl)pyridine (54)/
benzene (56) or 2,6-bis(7-azaindolyl/80 -quinolyl)pyridine (54)/benzene (55) or
isoindoline (56) nonleaving ligands.
those of Pt2 (59). The bite angles for these complexes are near 180 degrees.
Such an ideal bite angle ensures inertness toward substitution due to a
stronger crystal field of the strain-free nonleaving ligand. To attain the
free-strain chelates, the ligand coordinates with a torsional twist about the
central phenyl/pyridyl-Pt plane with interplane angles in the range
19—31 degrees (55). The twisting is more pronounced for the 1,3-bis(80 -
quinolyl)benzene than for bis(70 -azaindolyl)benzene due to the difference
in the steric demands of the lateral rings in the ligands. Similar conforma-
tional distortions guaranteed a pure octahedral geometry for the Ru(II)
complex bearing the analogous ligand, 2,6-bis(80 -quinolyl)pyridine (60).
Additionally, the twisting of the coordinated ligands lowers the rate of sub-
stitution of the coligand compared to Pt2 because of the steric hindrance of
the off-plane moieties of the tridentates toward the incoming substituting
nucleophile. The out-of-plane distortions also put a bonding strain on
the linear combination of atomic orbitals forming the extended π-surface
of the frontier molecular orbitals of the planar tridentate. This weakens its
capacity to receive electron density from the d-orbitals of the metal by
raising the energies of the LUMO. This causes the substitution process to
be slower than in Pt2. Similar decelerations of the rate of substitution were
reported for Pt(II) complexes (61–63) with an isochelate (six-atom) struc-
tures. The lower reactivity of Pt16 (which has a bis(70 -azaindolyl)benzene
ligand) compared to Pt15 (with a 1,3-bis(80 -quinolyl)benzene ligand) is
attributed to the electron-rich nature of the lateral 70 -azaindolyl moieties
(57), which destabilizes the LUMO leading to a large HOMO–LUMO
energy gap (55).
The HOMOs of the complexes (55) are similar in their isodensity map-
ping. They are concentrated along the PtdCl bond, the Pt atom, and along
the Pt–C(deprotonated) of the central phenyl ring. The central phenyl ring lab-
ilizes the coligand through its strong trans-influence of the deprotonated
carbon. Additionally, some pockets of electron density are located on the
flanking aromatic rings (8-quinolyl and the 70 -azaindolyl), and this also con-
firms their weaker capacity to receive electron density through back bond-
ing. Thus, replacing the lateral pyridines of terpy with a pyrazolyl ring or
fusing 70 -azaindolyl/80 -quinolyl moieties between the pyridine rings of
terpy reduces the reactivity of their complexes towards substitutions due
to a weaker π-acceptor capacity of the coordinated ligand. The calculated
NBO charges on the Pt atoms of Pt11–Pt13 or Pt14/Pt16 were found
to be lower than those of Pt1 or Pt2, respectively. Based on the experimen-
tal data, the π-acceptor capacities of the N-donor moieties of the tridentate
Lability of Square-Planar Pt(II) Complexes 267
nitrogen chelates (and hence the Lewis π-acidities impact at the metal cen-
ters) can be ranked as: pyridyl ≫ quinolyl > pyrazolyl > azaindolyl.
The effect of the size of chelate ring at the Pt(II) center on the rate of
substitution was broadened to include square-planar Pt(II) complexes of
the bis(iminopyridyl/isoquinolyl)isoindolines (Pt17–Pt19) (56). In general,
the neutral [bis(iminopyridyl/isoquinolyl)isoindolate)Pt(II)Cl] complexes
are significantly inert toward substitution when compared with Pt1. The
order of reactivity with tu as the substituting nucleophile is (second-order
rate constants at 25°C) Pt1 (1490 M1 s1) (40) ≫ Pt17 (155 M1 s1) >
Pt18 (30 M1 s1) > Pt19 (0.98 M1 s1).
The genesis of the inertness toward substitution of the bis(iminopyridyl/
isoquinolyl)isoindolines Pt(II) complexes arises mainly from their coordina-
tion geometry around the Pt(II) center. As shown in their optimized struc-
tures in Fig. 8 and also from literature reports on the crystal structures of
related complexes (64–66), the optimized structures are planar and their
geometry around the metal center is close to an ideal square-planar geom-
etry. The analogous ligand, 1,3-bis(2-thiazolylimino)isoindoline, also forms
near-perfect 1:1 or 1:2 octahedral complexes with Fe(II) ions (67). In
-
-
-
- -
-
these ligands to terpy-type ligands is the bis(imino) groups which are the
gateways of the delocalization of excess electron density from the hind side
of the naphthyl/phenyl rings into the flanking π*-acceptor pyridines. The
imino bridges weaken the π-acidity of the pyridyl rings when compared
to those in terpy. This leads to slower rates of substitution of the coligand
in their complexes. Thus, the π-acceptor capacity of the N-donor moieties
of the tridentate nitrogen chelates (and hence the Lewis π-acidities impact at
the metal centers) can be ranked as: pyridyl ≫ isoindolyl > phenyl[f]
isoindolyl.
When the rate of chloride substitution from Pt19 was compared to its
isostructural analogue, Pt17, the former was found to be about two orders
of magnitude less reactive. This is possibly because the lateral isoquinoline
rings of Pt19 are intrinsically poorer π-acceptors (48,49) than the pyridines
in terpy. A weaker π-acceptor ligand at a position cis to the leaving ligand
decreases the effective charge at the Pt atom and reduces the electrophilicity
of the complex (48,49). This slows the substitution process further relative
to that of Pt17. This anomaly is supported by the trends in the DFT-
computed data. Pt19 has the largest HOMO–LUMO energy gap and the
lowest electrophilicity index among the bis(iminoaryl)isoindolate com-
plexes studied.
N N N
N Pt N N N
Pt N Pt N
Cl Cl Cl
Pt21 Pt22 Pt23
S
N Pt N
Cl
Pt24
N
N
Cl
Cl 1 N Pt
1 N Pt R
R N
N Cl
Cl
2
2 R
R
Pt25 Pt26
Fig. 9 Structures of Pt(pap)Cl, its analogues, and two Pt complexes with
2-(pyrazolylmethyl)pyridine or 8-quinolylamine ligands.
Table 4 Second-Order Rate Constants, k2 (Std. Error), M1 s1 at 25°C for Chloride
Substitution From the Complexes
Kinetic Data Labilization
Factor for
tu tmtu Im
tu/Im {k2(j)/
k2(ref.) (%)},
Complex *(%)Increase/or
(Modification) k2 (M21 s21) k2 (M21 s21) k2 (M21 s21) Ref. Decrease
1 2
(Pt20) or 5.0(0.7) 10 3.4(0.04) 10 (71) 1
Pt(bpma)Cl
(derivative of 0.45 (72) 1
Pt(pap)) (0.01)
(reference
complex)
Pt21 2.9(0.3) 101 4.9(0.1) 102 (71) 0.57Pt20
(47.2%)
Pt22 0.9(0.7) 101 2.8(0.1) 102 (71) 0.178Pt20
(82.2%)
Pt23 9.50 (72) 2108Pt20
(0.1) 102 (210.8%)
Im ¼ imidazole; *(%)increase/decrease ¼ {k2( j ) k2(Pt1 or Pt2/Pt1)}/k2(Pt1 or Pt2/Pt1).
density at the metal center, which retarded the substitution of the chloride
by the incoming nucleophile. A similar reactivity trend had been reported
before when an isoquinolyl group was incorporated in one of the lateral pyr-
idyl rings of a terpy chelate, vide supra (48,49). It is clear that despite its
extended π-surface, the tridentate ligand, bis(8-quinolinyl)amine, is a
weaker π-acceptor of electron density from the metal center compared to
terpy. This qualifies 8-quinolyl moieties as better σ-/π-donors toward the
metal center compared to pyridyl rings. The energy level (2.28 eV) of
the LUMO for Pt22 is higher than that of Pt20 Pt (3.40 eV), which sup-
ports a weaker back donation of excess electron density from metal orbitals
into the ligand-centered LUMOS.
In a more recent study (74,75), a set of Pt(II) complexes bearing either a
2-(pyrazolylmethyl)pyridine or a 2-(pyrazolylmethyl)quinoline bidentate
ligand was synthesized and the aqua substitution studied in acidic aqueous
medium under pseudo-first-order conditions using UV–visible spectro-
photometry. The structures of two of the complexes namely: [Pt(II){2-
[3,5-bis(trifluoromethyl)pyrazol-1-ylmethyl]quinoline}]2+ (Pt24) and [Pt(II)
272 Allen Mambanda and Deogratius Jaganyi
{2-[3,5-bis(trifluoromethyl)pyrazol-1-ylmethyl]pyridine}(H2O)2]2+ (Pt25)
are shown in Fig. 9. The reactivity trend confirmed that the quinoline sub-
structure in the (pyrazolylmethyl)quinoline ligands acts as an apparent donor
of electron density toward the metal center rather than being a strong
π-acceptor of electron density from the orbitals of the metal. The phenyl ring
of the benzopyridine weakens the overall π-acceptor property of the quinoline
moiety of the bidentate ligand, leading to slower rates of substitution from the
complex compared to its pyridyl analogue. By comparing the reactivity of the
other complexes in the two case studies, electron-withdrawing substituents on
the 3,5-positions of the pyrazolyl ring of the [3,5-bis(trifluoromethyl)pyrazol-
1-ylmethyl]pyridine nonleaving ligand enhanced the π-acceptor of the
pyrazolyl ring, leading to faster rates of substitution. The opposite was true
for electron-donating groups.
3. CONCLUSIONS
From a comparative analysis of the reactivity of Pt(II) complexes
with rigid N^C/N^N/C tridentate nonleaving ligands, it can be concluded
that the substitutional lability of the leaving ligand depends to a greater
extent on the strength of the π-back bonding of the π-acceptor properties
or the π /σ-trans-effect of the N^C/N^N/C nonleaving ligand as well
as the coordination strain on the leaving group due to acute bite angles.
To a smaller extent, it depends also on the denticity of the ligand on the
platinum atom.
When the central pyridyl ring of a coordinated terpy is replaced by a
deprotonated benzene, the stronger σ-donor influence of the PtdC desta-
bilizes the ground-state properties of the bond trans to it. This facilitates the
substitution of the leaving group by an incoming nucleophile. The same
effect, for example, is observed when other strong σ-donor groups such
as the thioether (SR2) replace a secondary amine (NR2) donor in bpma,
a N^N^N tridentate bearing isolated pyridyl rings.
However, when one of the lateral pyridyl rings of the terpy ligand was
replaced by a deprotonated phenyl ring, accumulation of electron density at
the Pt atom decelerated the rate of substitution of the leaving group. A cis-
coordinated σ-donor (e.g., a phenyl ring) or a poor π-acceptor moiety
(e.g., an isoquinoline moiety) within the ligand framework of a typical
π-acceptor accumulated electron density at the metal center, leading to
lower rates of substitution.
Lability of Square-Planar Pt(II) Complexes 273
which can be used to tune and optimize the reactivity of metal-based square-
planar complexes for possible maximization of the pharmacokinetics that
may be relevant to antitumor activity.
ACKNOWLEDGMENTS
The authors thank the National Research Foundation of South Africa (NRF) for funding.
D.J. thanks Prof. R. van Eldik for international collaboration. He further thanks his
former and current students, Dr. D. Reddy, Dr. P. Ongoma, Dr. A. Mambanda, Dr. I.
Wekesa, Dr. G. Kinunda, Dr. I. Shaira, Mrs. K-.L. Barry, Ms. P. Papo, Ms. S. Nkabinde,
and B. Khusi, for their contributions toward this work.
REFERENCES
1. Wong, E.; Giandomenico, C. M. Chem. Rev. 1999, 99, 2451–2466.
2. Reedijk, J. Proc. Natl. Acad. Sci. U.S.A. 2003, 100, 3611–3616.
3. Reedijk, J. Platin. Met. Rev. 2008, 52, 2–11.
4. Jansen, B. A. J.; Brouwer, J.; Reedijk, J. J. Inorg. Biochem. 2002, 89, 197–202.
5. Basolo, F.; Pearson, R. G. Mechanisms of Inorganic Reactions: A Study of Metal Complexes in
Solution, 2nd ed.; John Wiley & Sons Inc.: New York, 1967
6. Hubbard, C. D.; van Eldik, R. J. Coord. Chem. 2007, 60, 1–51.
7. Tobe, M. L.; Burgess, J. Inorganic Reaction Mechanisms. Longman: Harlow, Essex,
England; New York, 1999.
8. Bogojeski, J.; Petrovic, B.; Bugarčic, Ž. D.; Pablo, O., Eds.; Chronic Lymphocytic Leuke-
mia; InTechOpen: Europe, 2012, pp 339–366.
9. Brabec, V.; Kasparkova, J. Drug Resist. Updat. 2002, 5, 147–161.
10. Jung, Y.; Lippard, S. J. Chem. Rev. 2007, 107, 1387–1407.
11. Kukushkin, Y. N.; Ukraintsev, V. B. Zh. Neorg. Khim. 1972, 17, 2687–2689.
12. Mureinik, R. J.; Bidani, M. Inorg. Chim. Acta 1978, 29, 37–41.
13. Pitteri, B.; Marangoni, G.; Cattalini, L.; Bobbo, T. J. Chem. Soc. Dalton Trans. 1995,
3853–3859.
14. Jaganyi, D.; Hofmann, A.; van Eldik, R. Angew. Chem. Int. Ed. 2001, 40, 1680–1683.
15. Hofmann, A.; Jaganyi, D.; Munro, O. Q.; Liehr, G.; van Eldik, R. Inorg. Chem. 2003,
42, 1688–1700.
16. Czap, A.; Heinemann, F. W.; van Eldik, R. Inorg. Chem. 2004, 43, 7832–7843.
17. Pitteri, B.; Bortoluzzi, M. Polyhedron 2006, 25, 2698–2704.
18. Petrovic, B.; Bugarcic, Z. D.; Dees, A.; Ivanovic-Burmazovic, I.; Heinemann, F. W.;
Puchta, R.; Steinmann, S. N.; Corminboeuf, C.; van Eldik, R. Inorg. Chem. 2012, 51,
1516–1529.
19. Bugarcic, Z. D.; Bogojeski, J.; van Eldik, R. Coord. Chem. Rev. 2015, 292, 91–106.
20. Wilkins, R. G. Kinetics and Mechanism of Reactions of Transition Metal Complexes, 2nd ed.;
VCH: Weinheim; New York, 1991, p. 356.
21. Bugarčic, Ž. D.; Liehr, G.; van Eldik, R. J. Chem. Soc. Dalton Trans. 2002, 951.
22. Reddy, D.; Jaganyi, D. Transition Met. Chem. 2006, 31, 792–800.
23. Jaganyi, D.; Tiba, F.; Munro, O. Q.; Petrovic, B.; Bugarcic, Z. D. Dalton Trans. 2006,
2943–2949.
24. Grinberg, A. A.; Stetsenko, A. I.; Mitkinova, N. D.; Tikhonova, L. S. Zh. Neorg. Khim.
1971, 16, 264–266.
25. Reedijk, J. Chem. Commun. 1996, 801–806.
26. van Zutphen, S.; Reedijk, J. Coord. Chem. Rev. 2005, 249, 2845–2853.
27. Hubbard, C. D.; van Eldik, R. Inorg. Chim. Acta 2010, 363, 2357–2374.
Lability of Square-Planar Pt(II) Complexes 275
28. Wilkins, R. G. Kinetics and Mechanism of Reactions of Transition Metal Complexes; VCH:
Weinheim; New York, 1991, p. 105.
29. Eryazici, I.; Moorefield, C. N.; Newkome, G. R. Chem. Rev. 2008, 108, 1834–1895.
30. Cummings, S. D. Coord. Chem. Rev. 2009, 253, 449–478.
31. Reddy, D.; Jaganyi, D. Dalton Trans. 2008, 6724–6731.
32. Becker, K.; Herold-Mende, C.; Park, J. J.; Lowe, G.; Schirmer, R. H. J. Med. Chem.
2001, 44, 2784–2792.
33. Ross, S. A.; Carr, C. A.; Briet, J. W.; Lowe, G. Anticancer Drug Des. 2000, 15, 431–439.
34. Lowe, G.; Droz, A. S.; Vilaivan, T.; Weaver, G. W.; Tweedale, L.; Pratt, J. M.;
Rock, P.; Yardley, V.; Croft, S. L. J. Med. Chem. 1999, 42, 999–1006.
35. McFadyen, W. D.; Wakelin, L. P. G.; Roos, I. A. G.; Leopold, V. A. J. Med. Chem.
1985, 28, 1113–1116.
36. Bligh, S. W. A.; Bashall, A.; Garrud, C.; McPartlin, M.; Wardle, N.; White, K.;
Padhye, S.; Barve, V.; Kundu, G. Dalton Trans. 2003, 184.
37. Bertrand, H.; Bombard, S.; Monchaud, D.; Talbot, E.; Guedin, A.; Mergny, J.-L.;
Grunert, R.; Bednarski, P. J.; Teulade-Fichou, M.-P. Org. Biomol. Chem. 2009, 7,
2864–2871.
38. Jennette, K. W.; Gill, J. T.; Sadownick, J. A.; Lippard, S. J. J. Am. Chem. Soc. 1976, 98,
6159–6168.
39. Hofmann, A.; Dahlenburg, L.; van Eldik, R. Inorg. Chem. 2003, 42, 6528–6538.
40. Jaganyi, D.; Reddy, D.; Gertenbach, J. A.; Hofmann, A.; van Eldik, R. Dalton Trans.
2004, 299–304.
41. Papo, T. R.; Jaganyi, D. J. Coord. Chem. 2015, 68, 794–807.
42. Jaganyi, D.; Boer, K.-L. D.; Gertenbach, J.; Perils, J. Int. J. Chem. Kinet. 2008, 40,
808–818.
43. Schm€ ulling, M.; Ryabov, A. D.; van Eldik, R. J. Chem. Soc. Dalton Trans. 1994,
1257–1263.
44. Schm€ ulling, M.; Grove, D. M.; van Koten, G.; van Eldik, R.; Veldman, N.; Spek, A. L.
Organometallics 1996, 15, 1384–1391.
45. Romeo, R.; Plutino, M. R.; Monsu Scolaro, L.; Stoccoro, S.; Minghetti, G. Inorg.
Chem. 2000, 39, 4749–4755.
46. Bailey, J. A.; Hill, M. G.; Marsh, R. E.; Miskowski, V. M.; Schaefer, W. P.; Gray, H. B.
Inorg. Chem. 1995, 34, 4591–4599.
47. Reddy, D.; Akerman, K. J.; Akerman, M. P.; Jaganyi, D. Transition Met. Chem. 2011, 36,
593–602.
48. Ongoma, P.; Jaganyi, D. Dalton Trans. 2012, 41, 10724–10730.
49. Shaira, A.; Reddy, D.; Jaganyi, D. Dalton Trans. 2013, 42, 8426–8436.
50. Lai, S.-W.; Chan, M. C. W.; Cheung, K.-K.; Che, C.-M. Inorg. Chem. 1999, 38,
4262–4267.
51. Papo, T. R.; Jaganyi, D. Transition Met. Chem. 2015, 40, 53–60.
52. McMillin, D. R.; Moore, J. J. Coord. Chem. Rev. 2002, 229, 113–121.
53. Field, J. S.; Haines, R. J.; McMillin, D. R.; Summerton, G. C. J. Chem. Soc. Dalton
Trans. 2002, 1369–1376.
54. Wekesa, I. M. Dissertation, University of KwaZulu-Natal, South Africa, 2014.
55. Wekesa, I. M.; Jaganyi, D. J. Coord. Chem. 2016, 69, 389–403.
56. Wekesa, I. M.; Jaganyi, D. Dalton Trans. 2014, 43, 2549–2558.
57. Garner, K. L.; Parkes, L. F.; Piper, J. D.; Williams, J. A. Inorg. Chem. 2010, 49, 476–487.
58. Hu, Y.-Z.; Wilson, M. H.; Zong, R.; Bonnefous, C.; McMillin, D. R.;
Thummel, R. P. Dalton Trans. 2005, 354–358.
59. Basolo, F.; Gray, H. B.; Pearson, R. G. J. Am. Chem. Soc. 1960, 82, 4200–4203.
€
60. Abrahamsson, M.; J€ager, M.; Osterman, T.; Eriksson, L.; Persson, P.; Becker, H.-C.;
Johansson, O.; Hammarstr€ om, L. J. Am. Chem. Soc. 2006, 128, 12616–12617.
276 Allen Mambanda and Deogratius Jaganyi
61. Đurovic, M.; Bogojeski, J.; Petrovic, B.; Petrovic, D.; Heinemann, F. W.;
Bugarčic, Ž. D. Polyhedron 2012, 41, 70–76.
62. Mijatovic, A.; Bogojeski, J.; Petrovic, B.; Bugarcic, Z. D. Inorg. Chim. Acta 2012, 383,
300–304.
63. Selimovic, E.; Petrovic, B.; Canovic, D.; Bugarcic, Z. D.; Bogojeski, J. Aust. J. Chem.
2013, 66, 534–538.
64. Hanson, K.; Roskop, L.; Djurovich, P. I.; Zahariev, F.; Gordon, M. S.;
Thompson, M. E. J. Am. Chem. Soc. 2010, 132, 16247–16255.
65. Wen, H. M.; Wu, Y. H.; Fan, Y.; Zhang, L. Y.; Chen, C. N.; Chen, Z. N. Inorg. Chem.
2010, 49, 2210–2221.
66. Br€oring, M.; Kleeberg, C. Inorg. Chim. Acta 2007, 360, 3281–3286.
67. Martic, G.; Engle, J. T.; Ziegler, C. J. Inorg. Chem. Commun. 2011, 14, 1749–1752.
68. Yam, V. W.-W.; Tang, R. P.-L.; Wong, K. M.-C.; Cheung, K.-K. Organometallics
2001, 20, 4476–4482.
69. Zhang, H.; Zhang, B.; Li, Y.; Sun, W. Inorg. Chem. 2009, 48, 3617–3627.
70. Ongoma, P. O.; Jaganyi, D. Dalton Trans. 2013, 42, 2724–2734.
71. Kinunda, G.; Jaganyi, D. Transition Met. Chem. 2014, 39, 451–459.
72. Nkabinde, S. N. Dissertation, University of KwaZulu-Natal, South Africa, 2014.
73. Pitteri, B.; Bortoluzzi, M.; Marangoni, G. Transition Met. Chem. 2005, 30, 1008–1013.
74. Khusi, B. B.; Mambanda, A.; Jaganyi, D. Transition Met. Chem. 2016, 41, 191–203.
75. Khusi, B. B.; Mambanda, A.; Jaganyi, D. J. Coord. Chem. 2016, 69, 2121–2135.
CHAPTER SEVEN
Contents
1. Introduction 278
2. S-Nitrosothiols, RSNOs, a Brief Overview on Structure and Reactivity 280
3. Thionitrous Acid HSNO and Thionitrite SNO, Elusive Aqueous Intermediates 282
4. Polysulfides and Sulfur Sols 287
5. Perthionitrite, S2NO. Identification of Iyellow 288
5.1 Available Results 288
5.2 Absorption Spectra Calculations 289
5.3 Consistency With X-ray Structural Data 291
5.4 Chemical Routes Following Transnitrosation of RSNO With H2S 292
6. Coordination Chemistry of Nitrosothiols, Thionitrous Acid, Thionitrite, and
Perthionitrite 295
6.1 Nitrosothiols 295
6.2 Thionitrous Acid/Thionitrite 298
6.3 Perthionitrite 298
6.4 The Gmelin Reaction, [Fe(CN)5(NO)]2 + HS 299
7. Conclusions 306
Acknowledgments 306
References 306
Abstract
The chemistry of aqueous NO and H2S as redox regulators of cellular and physiological
responses in cardiovascular, immune or neurological tissues has raised the question of
the overlapping pathophysiological functions often involving similar molecular targets.
The interactions of NO with H2S may functionally influence each other and focus has
been directed to new N/S hybrid species eventually determining signaling capabilities.
Besides the well-studied nitrosothiols, RSNOs, the eruption of H2S in the mechanistic
scene has stimulated increased interest in thionitrous acid, HSNO, and thionitrite, NOS,
as well as in perthionitrite (nitrosopersulfide), S2NO. We discuss the elusive chemistry of
the latter molecules as intermediates in selected reactions in aqueous solution, either as
free species or as bound to iron metal centers. The coordination chemistry involves
mainly an updating on the “Gmelin” reaction proceeding upon mixing nitroprusside
[Fe(CN)5(NO)]2 and H2S, with controversial and still unsolved mechanistic issues related
to the onset of NO, HNO/N2O, polysulfides HSn (n ¼ 2–7), together with bound thio-
nitrous acid/thionitrite/perthionitrite and other intermediates and products.
1. INTRODUCTION
NO and H2S, two molecules frequently named “gasotransmitters”
(1,2), accomplish diverse biological functions associated with animal (3)
and plant (4,5) physiology: regulation of blood pressure, neurotransmission,
immune response, as well as plant defense responses, stomata closure, abiotic
stress, seed germination, etc. Both compounds are involved in aqueous
1-electron or multielectron redox chemistry with generation of species
whose structure-reactivity behavior needs to be elucidated for discerning
how the chemistry translates into a biological response. On the one hand,
NO is a radical molecule able to react either as an oxidant or reductant
(2,6); it is ubiquitously placed in the redox system comprising the eight-
electron interconversion between nitrates and ammonia, and affords a
versatile mechanistic chemistry covered by the activity of several enzymes:
NO—synthases, NO and NO2 —reductases, NH3—oxidases, NH2OH—
oxidoreductases, etc. (7) On the other hand H2S can only behave as a reduc-
tant; it may also produce up to 8-electron changes, with species in oxidation
states in the range 2 to +6, i.e., from sulfides to sulfates (8,9). The eventual
availability and redox reactivity of O2 may control the chemistry of each of the
intermediates, which can also be influenced by the disposal of metal-binding
coordination sites (2,10).
The NO signaling cascade has been increasingly well characterized
through the identification and chemical properties of distinct nitrosyl redox
states NO+, NO%, NO/HNO as intermediates in the oxidative or reduc-
tive cycles (2,6). Less understood are the biological–pharmacological effects
of sulfides; species other than H2S might be responsible for signaling, like
sulfane sulfur So, an uncharged species with six valence electrons having a
unique ability to attach reversibly to other sulfur atoms as in elemental sulfur
(S8), persulfides (RSSH), polysulfides (HSn , n ¼ 2–7) thiosulfate S2 O3 2 ,
and others (11–13).
There is a growing appreciation that both H2S and NO behave as mes-
sengers with connecting biochemistries (14–20). In this NO/H2S
N/S Intermediates in the “Crosstalk” of NO and H2S 279
shorter than in NO (126 pm) and longer than in NO+ (106 pm) and NO%
(115 pm), supporting a bond order of 2 (28,29,35). Typical values for the
N-S distances are at 175 pm. The trends on the different properties of
RSNOs can be discussed under the structural framework described in
Figs. 1 and 2.
RSNOs undergo a variety of chemical reactions. A distinctive one is the
spontaneous thermal decomposition giving NO and RSSR. It has been
established that the half-life of different aqueous RSNOs varies from seconds
to hours, or even days. Most importantly, decomposition rates are currently
catalyzed by traces of metal ions, particularly by copper, a property that can
be best controlled by using chelating agents such as dipicolinic acid (dipic)
(28,29,36). For these reasons, structural correlations are difficult to establish,
a drawback that is reinforced by the influence of oxygen and light on the
decompositions (irradiation of RSNOs at 340 and 550–600 nm produces
NO% and RS% radicals) (29). The uncatalyzed aqueous decomposition reac-
tion has been proposed to be reversible, described by reaction (1):
The RS% radicals may combine forming RSSR (Eq. 2), and can also react
with thiolate RS to produce the very reactive RSSR% radical (Eq. 3), a
source of RSOO% in the presence of O2. These radicals can be detected by
spin-trapping techniques (37).
A high value of ΔG1 o ¼ + 110 kJ mol1 has been estimated for reac-
tion (1), for nitrosocysteine (38). Therefore, we would hardly expect the
uncatalyzed reaction (1) to proceed significantly to the right, unless a very
fast removal of products were onset.
Reactions of RSNOs with RS are biochemically important. They
comprise the 1,2-addition of RS at the N–O bond, followed by processes
resulting in oxidation of sulfur and NO reduction. The nature of interme-
diates and products depends on the reagent ratios; thus, N2O, NH2OH, and
NH3 are produced under moderate excess of thiolate, whereas NH3 is the
only N-containing product at a higher excess. Different mechanisms have
been proposed (39–41). RSNOs can also be reduced by alcohols, amines,
phosphines, etc. (29).
282 Juan P. Marcolongo et al.
proton shuttle decrease these barriers to 37 kJ mol1, making the latter
two isomers kinetically accessible under physiological conditions (43).
Very recently, cis- and trans-conformers of HSNO have been prepared
by mixing diluted H2S and NO that react over metallic surfaces at room
temperature (44). Identification has been achieved by Fourier-transform
microwave spectroscopy and quantum chemistry structural calculations,
yielding significantly long S–N distances for the cis- and trans-species,
183.4 and 185.2 pm, respectively (cf. with 175 pm for RSNOs). Although
changes might be expected upon hydration, the results are quite significant
for suggesting accessible homolytic/heterolytic paths for HSNO reactivity
upon biorelevant conditions, as discussed below.
There are no reports on the pKa of HSNO. A comparison with nitrous
acid HONO (3.25) allows predicting that HSNO should be more acidic,
thus converting to the anionic thionitrite form SNO in the biorelevant
aqueous solutions at pHs 7. A value of 2 has been very recently suggested
(45). By performing pulse radiolysis of anaerobic NO2 =H2 S mixtures, the
difference spectra allowed proposing a value of 340 nm for the maximum in
the UV–vis spectrum of HSNO, supported by a mass spectrometric (MS)
identification of a protonated species (24). This could be considered a ten-
tative value, casting some doubt on the putative coexistence of SNO, given
that the pH used was as high as 11. Recent modern computational work led
to calculated weak absorptions at 315 and 360 nm for HSNO in water
(Table 1) (49). A value at 315 nm was calculated for SNO in acetonitrile,
fairly close to the experimental value in the same solvent, 323 nm (23).
Care should be exercised when discussing the meaning of macroscopic
acidity constants of systems which can be protonated in nonequivalent sites.
Although each one of the conjugated weak acids has a microscopic acidity
constant (Kai), the system behaves macroscopically as if only one weak acid
in equilibrium with its conjugated weak base existed in solution. This is so
simply because the different Kai constants freeze the ratio between any pair
of protonated species (and eventually also for any two unprotonated ones)
making these values pH-independent. In such a system the apparent equi-
Xn
librium constant Kap is given by Kap 1
¼ Kai1 . In the specific situation
i¼1
where the dispersion of the individual Kai is high, the value of Kap is dom-
inated by the acid/base with the weakest microscopic Kai (50). In the present
case this would be NSOH, for which an estimation of pKa 10–11 appears
as reasonable.
284 Juan P. Marcolongo et al.
Table 1 TD-DFT Electronic Spectral Calculations of N/S Hybrid and Related Species in
Water, Methanol, and Aprotic Solvents
λmax Calcd (nm)
Compound Solvent λmax Exp (nm) (Osc. Str., a.u.)
[S2NO] H2O 409 (46)–412 (26,27) 411 (0.03)a
Methanol 425 (23) 431 (0.025)a
Acetone 448b (24,25) 458 (0.03)a
Acetonitrile 450 (25) 458 (0.02)a
[O2NO] H2O 302 (47) 307 (0.03)
CH2Cl2 340 (47) 339 (0.04)
EtSNO H2O 330c (48) 280, 310, 330d
ON(SH)S Acetonitrile 358e (25) 368 (0.05)
e
HON(S)S Acetonitrile 358 (25) 351 (0.4)
HSNO Water 340f (24) 315, 360d
SNO Acetonitrile 323 (23) 315 (0.02)
a
Reported in Ref. (49), with the exception of the value for methanol.
b
Also measured at 448 nm in DMSO or DMF in Ref. (46).
c
Observed as a shoulder in the spectra of aqueous [FeII(CN)5(NOSR)]3 ions. Also measured at
330–350 nm with free thiols in organic solvents (29).
d
Low intensity absorption bands.
e
Assigned as a mixture of isomers ON(SH)S and HON(S)S.
f
Generated by pulse radiolysis of deoxygenated solutions, pH 11.
For the oscillator strengths, a damping factor γ ¼ 0.2 fs1 was used.
The uncharged character of HSNO favors its ability for crossing mem-
branes and provides a new scenario for the modulation of the RSNO profile
in cells through the transnitrosation with cysteine residues in proteins,
reaction (7).
For reaction (6), the mixture of reactants at pH 7.4 induced the decay of
the UV–vis main band of GSNO (λmax, 334 nm) with onset of a moderately
stable intermediate, Iyellow, with λmax at 412 nm (24). Fig. 3 shows a similar
picture evolving at pH 10 (51). Related reactions were also studied with
S-nitrosocysteine (CysNO), S-nitrosopenicillamine (SPEN), and S-nitroso-
N-acetylpenicillamine (SNAP) (26,51).
For GSNO, the UV–vis display (pH 7.4 or 10) did not match with the
stoichiometry of reaction (6), given that HSNO has been reported to absorb
at 330–340 nm, not at 412 nm (24,49). The band of HSNO might be hid-
den below the absorption of GSNO or it could rapidly decay in terms of the
reactivity of HSNO at room temperature. The MS positive evidence for
HSNO obtained with cryogenic experiments (24) has been complemented
by some UV–vis evidence appearing in the reaction of HS with SNAP
through the onset of a transient species with λmax at 320 nm, assigned
to SNO (26). Transnitrosation reactions such as in Eqs. (4) and (6) are
reversible processes, though under pH 7.4 conditions, the poor nucleophi-
licity of GSH could hardly ascribe a significant rate to the reverse reaction.
By measuring the decrease of [HS], a value of k6 ¼ 84 M1 s1 has been
reported (24).
The aqueous reactivity of HSNO has been under close scrutiny given its
potential ability to form a second generation of intermediates with putative
specific signaling roles (24–27). Closely related to reaction (1), reaction (8a)
implies the homolytic cleavage of the S–N bond with the production of NO
Fig. 3 Transnitrosation reaction of 103 M GSNO and HS, pH 10. Decay of GSNO at
334 nm and build-up of Iyellow at 412 nm. Adapted from Munro, A. P.; Williams, D. L. H.
J. Chem. Soc. Perkin 2000, 21, 1794–1797, with permission of The Royal Society of
Chemistry.
286 Juan P. Marcolongo et al.
and reactive S% radicals (8b). Under the availability of HS, the formation
and reactivity of HS2 %2 radicals (8c) may produce NO and disulfides irre-
versibly under catalytic conditions (8d), given the strong reducing power of
HS2 %2 : (52)
Fig. 4 Calculated electronic spectra for S2NO in water (black), methanol (blue), acetone
(red), and acetonitrile (green), using TD-DFT and QM-MM molecular dynamics
simulations.
Table 2 Selected Distances and Angles With Standard Deviation for Solid [PNP][S2NO]
(PNP+ ¼ Bis(Triphenyl)Phosphaniminium) (25), and for the Anionic Species in Water,
Methanol, Acetone, and Acetonitrile, Calculated Through Molecular Dynamics (MD)a
MD MD MD MD
Parameter DRX (25) (H2O) (MeOH) (Me2CO) (MeCN)
d(N1-O1) (Å) 1.25 1.24 1.24 1.24 1.24
(0.01) (0.03) (0.02) (0.02) (0.04)
d(N1-S1) (Å) 1.70 1.79 1.78 1.80 1.80
(0.01) (0.01) (0.06) (0.07) (0.08)
d(S1-S2) (Å) 1.97 2.07 2.04 2.03 2.04
(0.01) (0.06) (0.04) (0.04) (0.04)
θ(O1-N1-S1) (degree) 117.8 119 119 120 120
(0.2) (5) (4) (4) (4)
θ(N1-S1-S2) (degree) 115.1 111 113 117 117
(0.2) (5) (5) (6) (5)
−
N1 S1
O1 S2
a
Reported in Ref. (49), with the exception of the value for methanol.
292 Juan P. Marcolongo et al.
On the other hand, although reaction (14) has not been reported, it could
proceed faster than (8c), given the expected favorable nucleophilicity of
HS2 over HS toward the S% radical. In fact, a thermochemical estima-
tion allows obtaining ΔGo 14 ¼ 62 kJ mol1 (45). Perthiyl radicals S2 %
have been characterized and described as more stable species than S%
(62). They have been proposed to participate both in the generation and
in the homolytic decomposition of S2NO during the H2S-transnitrosation
processes, through reaction (15) (27).
The above presented complex picture has been tested through simula-
tion procedures, and the details on the assumed reactions and constants
are analyzed as follows. Fig. 5 shows the traces for the decay of the initial
reactants and the build-up of different intermediates in a restricted time win-
dow, for 0.5 mM GSNO and H2S, mimicking the conditions used in Ref.
(24). We considered reaction (6) as irreversible, given the negligible nucle-
ophilic reactivity of GSH, with k6 ¼ 84 M1 s1 (24). For the equilibrium
reaction (8a), we used k8a ¼ 0.12 s1 (as measured by the [NO] build-up)
(24), and k8a 107 M1 s1 (an estimated value for a rapid radical recom-
bination). The required data for reactions (8b) and (8c) were taken from Ref.
(52). The value of K9 0.05 was estimated by assuming values for
k9 ¼ 500 M1 s1 and k9 ¼ 104 M1 s1. K9 was considered lower than
K12 (K12 100–1000, with k12 ¼ 105 M1 s1 and k12 ¼ 103 M1 s1 at
pH 7) (49), consistently with the smaller reactivity of thiolates in comparison
with persulfides (60). The consumption of HNO was traced either to reac-
tion (16) yielding N2O (63) or to reaction (17) giving HSNHOH (64) with
further timely production of NH2OH. Rate constants for the reactions of
0.5
GSH
0.4
Concentration (mM)
0.3
0.2
SSNO–
NO•
0.1 HSNHOH
HSNO
GSNO
HS–
0.0
0 20 40 60 80 100 120
Time (s)
Fig. 5 Simulated traces for selected species when mixing 0.5 mM GSNO and H2S, as
described in the text.
294 Juan P. Marcolongo et al.
HS + HNO ! HS NHOH k17 ¼ 1:2 106 M1 s1 ðRef : 64Þ: (17)
The onset of reaction (12) makes the GSNO consumption through reac-
tion (6) autocatalytic with respect to HS2 . It also provides an explanation
for the net GSNO ! S2NO conversion (334 nm ! 412 nm) and the
absence of specific UV–vis spectral features for HSNO (24). Autocatalysis
is frequently associated with the build-up of induction periods for the gen-
eration of product, showing S-shaped traces (66). In the underlying condi-
tions, a requirement of sulfur radicals (reactions 8a–8d) seems crucial for the
generation of the more reactive HS2 . The induction times have been
reported to increase with [O2] and to decrease with [HS] (29), and this fact
relates to the observed early consumption of O2 (26), a trapping agent for
S% and HS2 %2 (37). Overall, these autocatalytic features constitute favor-
able and specific evidence supporting the proposed mechanism highlighting
the role of disulfides in biochemistry.
As a conclusion on the validity of the simulation procedures, we should
remark that only a limited set of experimental conditions has been consid-
ered, namely the equimolar GSNO/HS situation (24,51). Indeed, a wider
experimental approach is needed for testing the influence of increased
[HS]/[RSNO], changing the type of used RSNOs, as well as better dis-
closing the stoichiometric results under exhaustive conditions (viz., the
yields of N2O, NH2OH, or eventually NH3 and the conditions for the onset
of polysulfides) (24).
6.3 Perthionitrite
Direct reaction between freshly generated aqueous S2NO and hemoglobin
(Hb) centers, also extended to myoglobin (Mb), has been very recently
established (58). By using deoxyHbII and/or deoxygenated methemoglobin,
HbIII, the addition of free S2NO rapidly produced nitrosyl hemoglobin,
HbIINO, with additional formation of polysulfides HSx , or HS2, respec-
tively. The studies were carried out using time resolved EPR and UV–vis
methods, and also showed that heme-species without a vacant site, like
HbIICO or HbIIO2, did not produce bound NO, suggesting the necessary
previous coordination of S2NO to the metal center. The latter event has
not been demonstrated however, and further mechanistic studies are in
order. It is worth pointing out that the authors used the GSNO/H2S reac-
tion to generate free S2NO with a subsequent degassing, thus assuring the
elimination of the previously produced NO, formed through the reactivity
of HSNO (see Section 5.4). On the other hand, remarkable evidence can be
anticipated on the coordination of S2NO to [FeII(CN)5]3, as shown in
Section 6.4.
N/S Intermediates in the “Crosstalk” of NO and H2S 299
Fig. 6 Absorbance at 535 nm against time for the reaction of 0.05 mM [Fe(CN)5(NO)]2
and HS, R ¼ 30. pH increases upward: 8.7, 9.5, 10.5, and 12.3. Adapted from
Quiroga, S. L.; Almaraz, A. E.; Amorebieta, V. T.; Perissinotti, L. L.; Olabe, J. A. Chem. Eur.
J. 2011, 17, 4145–4156. with permission of Wiley.
addition step and the fast isomerization and deprotonation equilibria of the
isomers:
2 3
FeðCNÞ5 ðNOÞ + HS . FeðCNÞ5 ðNOSHÞ (22)
3 3
FeðCNÞ5 ðNOSHÞ . FeðCNÞ5 ðNSOHÞ (23)
3 3 4
FeðCNÞ5 ðNOSHÞ = FeðCNÞ5 ðNSOHÞ . FeðCNÞ5 ðNOSÞ + H+
(24)
Fig. 7 (A) Successive UV–vis spectra after mixing 0.1 mM [Fe(CN)5(NO)]2 and HS, pH
8.9, R ¼ 30. (B) Successive UV–vis spectra, same conditions as in (A), 20 s after mixing.
302 Juan P. Marcolongo et al.
Fig. 8 (A) Successive UV–vis spectra after mixing 0.1 mM [Fe(CN)5(NO)]2 and HS, pH
8.9, R ¼ 100. (B) Successive UV–vis spectra, same conditions as in (A), 1.5 s after mixing.
Fig. 9 (A) Successive UV–vis spectra after mixing 0.05 mM [Fe(CN)5(NO)]2 and HS, pH
12, R ¼ 100. (B) Successive UV–vis spectra, same conditions as in (A), 6 s after mixing.
Fig. 10 Successive spectra for the reaction of 0.05 mM [Fe(CN)5(NO)]2 with aqueous
Na2S2, pH 12, R 1 (34). The first spectrum in black was measured 0.5 s after mixing
and corresponds to buffered HS2 . The next five spectra (red to violet) correspond to
reaction times: 1.4, 2.7, 4.0, 5.3, and 6.5 s.
shows a spectrum that converged after several months yielding a broad band
centered at 552 nm. Overall, a preliminary consideration of our results and
those of Wu and coworkers (33) suggests that the perthionitrite complex
[Fe(CN)5(NOS2)]4 absorbs at 550 nm, and that I550 could transform
in a slower way into a polysulfide-bound species [Fe(CN)5(NOSx)]4,
I575. The conversion would require the availability of sulfane sulfur (So)
in the medium, a feasible situation in the pH range 7–9 due to the decom-
position of HS2 and ensuing formation of polysulfides, as discussed in
Section 4.
A summary of the overall mechanistic features involves identifying
[Fe(CN)5(NOSH)]3 and [Fe(CN)5(NOS)]4 as the initial intermediates
formed in a pH-dependent way. Both anions have similar band maxima
at 535–540 nm, a similar situation reported earlier for free HSNO
and NOS. The novel picture deals with the pH-dependent reactivity of
both species toward the N–S bond homolysis. On the one hand,
[Fe(CN)5(NOS)]4 is moderately stable at pH values 11, affording a decay
of the 535-nm absorption with a t½ 60 s, yielding [Fe(CN)5(NO%)]3
(detected by UV–vis and EPR), probably [Fe(CN)5(HNO)]3, and HS%
radicals that are a source of HS2 , as well as NH3 and N2O (30). The decay
at 535 nm shows a subsequent very slow step comprising the decomposition
of the [Fe(CN)5(NO)]3 intermediate (k 105 s1), also producing addi-
tional N2O (30). On the other hand, and in sharp contrast, working in the
pH range 7–10 allows I575 emerging in a few seconds after mixing, associated
with the reactivity of [Fe(CN)5(NOSH)]3 (t½ 6 s). In addition to reac-
tions (22–24), we define reaction (25) by considering similar arguments as
exposed above for the generation of free S2NO.
3 3
FeðCNÞ5 ðNOSHÞ = FeðCNÞ5 ðNSOHÞ
4 (25)
+HS2 . FeðCNÞ5 ðNOS2 Þ + HS + H +
Although the main question related to the identification of the “red” and
“blue” intermediates seems to be correctly focused by highlighting the dif-
ferent chemistries of HS and HS2 as nucleophilic reagents, solving the
ambiguities on the clear identification of I550 and I570 must be pursued.
A relevant question deals with I550 being either a true intermediate species
or an artifact appearing because of band-overlap during the
535 nm ! 575 nm transformation. Our current work (34) is focused on a
deeper mechanistic probe, also searching for the influence of O2 on the
early onset of new colored intermediates, the chemistry of HNO generation
and N2O-release, as well as on the role of the 1-electron reduced
306 Juan P. Marcolongo et al.
7. CONCLUSIONS
The thionitrous acid HSNO intermediate (in fact, a mixture of ther-
mally accessible tautomers in the aqueous solutions) has been reasonably well
identified by MS and UV–vis spectroscopies, aided by theoretical calcula-
tions. HSNO survives sufficiently after its generation as an initial product
of the transnitrosation reaction of GSNO with H2S. HSNO affords a rich
chemistry toward different substrates, either leading to NO, probably
HNO or eventually other transnitrosation products. It can also generate
S2NO through the reaction with early generated HS2 in the medium.
Although the biologically significant signaling ability of S2NO has not
been demonstrated yet (25,45), the identity and survival of S2NO in water
for minutes/hours are well established facts (49,58). However, the latter
assertion is still strongly questioned in the very recent reports by Filipovic
and Ivanovic-Burmazovic (60,79,80). Indeed, a better knowledge of the
O2-dependent decay routes of S2NO is needed in the time scale of
minutes/hours, giving either NO, HNO/N2O or other hybrid species,
and N-reduced products. The recently reported reactivity of S2NO in apro-
tic solvents toward CN, GSH, and H2S (60) ought to be contrasted with
measurements in aqueous media in search for a pH dependence. The coor-
dinated “Gmelin” species [FeII(CN)5(NOSH)]3 and [FeII(CN)5(NOS)]4
appear to be well-characterized reactive anions (“red” intermediates absorbing
at 535–540 nm), though the true absorption maximum of the “blue” inter-
mediate [FeII(CN)5(NOS2)]4 formed in the pH range 7–10 is still uncertain.
Unraveling the chemistry of the latter species and of other intermediates is still
a main challenge for a thorough, complete description of the Gmelin process.
ACKNOWLEDGMENTS
We thank the University of Buenos Aires and CONICET for financial support. We are
grateful to Dr. Valentı́n T. Amorebieta for his experimental contribution on the Gmelin
reaction, and to Dr. Sara E. Bari for fruitful discussions.
REFERENCES
1. Wang, R. Physiol. Rev. 2012, 92, 791–896.
2. Fukuto, J. M.; Carrington, S. J.; Tantillo, D. J.; Harrison, J. G.; Ignarro, L. J.;
Freeman, B. A.; Chen, A.; Wink, D. A. Chem. Res. Toxicol. 2012, 25, 769–793.
N/S Intermediates in the “Crosstalk” of NO and H2S 307
3. Ignarro, J. L. Nitric Oxide: Biology and Pathobiology. Academic Press: San Diego, 2000.
4. Calderwood, A.; Kopriva, S. Nitric Oxide 2014, 41, 72–78.
5. Bari, S. E.; Olabe, J. A. In Gasotransmitters in Plants. The Rise of a New Paradigm in Cell
Signalling; Lamattina, L., Garcı́a-Mata, C., Eds.; Springer International Publishing:
Switzerland, 2016; pp 289–327. ch. 14.
6. Bari, S. E.; Olabe, J. A.; Slep, L. D. Adv. Inorg. Chem. 2014, 67, 87–144.
7. Lehnert, N.; Berto, T. C.; Galinato, M. G. I.; Goodrich, L. E. In The Handbook of Por-
phyrin Science; Kadish, K. M., Smith, K. M., Guilard, R., Eds.; Vol. 14 ;World Scientific:
New Jersey, 2011; pp 1–247. 63.
8. Li, Q.; Lancaster, J. R., Jr. Nitric Oxide 2013, 35, 21–34.
9. Mishanina, T. V.; Libiad, M.; Banerjee, R. Free Rad. Biol. Med. 2015, 11, 457–464.
10. Olabe, J. A. Adv. Inorg. Chem. 2004, 55, 61–126.
11. Toohey, J. L. Anal. Biochem. 2011, 413, 1–7.
12. Ono, K.; Akaike, T.; Sawa, T.; Kumagai, Y.; Wink, D. A.; Tantillo, D. J.; Hobbs, A. J.;
Nagy, P.; Xian, M.; Lin, J.; Fukuto, J. M. Free Rad. Biol. Med. 2014, 77, 82–94.
13. Cuevasanta, E.; Moller, M. N.; Alvarez, B. Arch. Biochem. Biophys. 2017, 617, 9–25.
14. Whiteman, M.; Li, L.; Kostetski, I.; Chu, S. H.; Siau, J. L.; Bhatia, M.; Moore, P. K.
Biochem. Biophys. Res. Commun. 2006, 343, 303–310.
15. Yong, Q. C.; Cheong, J. L.; Hua, F.; Deng, L. W.; Khoo, Y. M.; Lee, H. S.; Perry, A.;
Wood, M.; Whiteman, M.; Bian, J. S. Antioxid. Redox Signal 2011, 14, 2081–2091.
16. Coletta, C.; Papapetropoulos, A.; Erdelyi, K.; Olah, G.; Modis, K.; Panopoulos, P.;
Asimakopoulou, A.; Gero, D.; Sharina, I.; Martin, E.; Szabo, C. Proc. Natl. Acad. Sci.
U.S.A 2012, 109(23), 9161–9166.
17. Fago, A.; Jensen, F. B.; Tota, B.; Feelisch, M.; Olson, K. R.; Helbo, S.; Lefevre, S.;
Mancardi, D.; Palumbo, A.; Sandvik, G. K.; Skovgaard, N. Comp. Biochem. Physiol.
A 2012, 162, 1–6.
18. Lo Faro, M. L.; Fox, B.; Whatmore, J. L.; Winyard, P. G.; Whiteman, M. Nitric Oxide
2014, 41, 38–47.
19. Berenyiova, A.; Grman, M.; Mijuskovic, A.; Stasko, A.; Misak, A.; Nagy, P.;
Ondriasova, E.; Cacanyiova, S.; Brezova, V.; Feelisch, M.; Ondrias, K. Nitric Oxide
2015, 46, 123–130.
20. Grman, M.; Jawad Nassim, M.; Leontiev, R.; Misak, A.; Jakusova, V.; Ondrias, K.;
Jacob, C. Antioxidants 2017, 6, 14.
21. King, S. B. Free Rad. Biol. Med. 2013, 55, 1–7.
22. Nonella, M.; Huber, J. R.; Ha, T. K. J. Phys. Chem. 1987, 91, 5203–5209.
23. Seel, F.; Kuhn, R.; Simon, G.; Wagner, M.; Krebs, B.; Dartmann, M. Z. Naturforsch.
1985, 40b, 1607–1617.
24. Filipovic, M. R.; Miljkovic, J. L.; Nauser, T.; Royzen, M.; Klos, K.; Shubina, T.;
Koppenol, W. H.; Lippard, S. J.; Ivanovic-Burmazovic, I. J. Am. Chem. Soc. 2012,
134, 12016–12027.
25. Wedmann, R.; Zahl, A.; Shubina, T. E.; Durr, M.; Heinemann, F. W.; Eberhard, B.;
Bugenhagen, C.; Burger, P.; Ivanovic-Burmazovic, I.; Filipovic, M. R. Inorg. Chem.
2015, 54, 9367–9380.
26. Cortese-Krott, M. M.; Fernandez, B. O.; Santos, J. L. T.; Mergia, E.; Grman, M.;
Nagy, P.; Kelm, M.; Butler, A.; Feelisch, M. Redox Biol. 2014, 2, 234–244.
27. Cortese-Krott, M. M.; Kuhnle, G. G.; Dyson, A.; Fernandez, B. O.; Grman, M.;
DuMond, J. F.; Barrow, M. P.; McLeod, G.; Nakagawa, H.; Ondrias, K.; Nagy, P.;
King, S. B.; Saavedra, J. E.; Keefer, L. K.; Singer, M.; Kelm, M.; Butler, A. R.;
Feelisch, M. Proc. Natl. Acad. Sci. U.S.A. 2015, 112, 4651–4660.
28. Broniowska, K. A.; Hogg, A. Antioxid. Redox Signal. 2012, 17, 969–980.
29. Szacilowski, K.; Stasicka, Z. Progr. React. Kin. Mech. 2001, 26, 1–58.
308 Juan P. Marcolongo et al.
30. Quiroga, S. L.; Almaraz, A. E.; Amorebieta, V. T.; Perissinotti, L. L.; Olabe, J. A. Chem.
Eur. J. 2011, 17, 4145–4156.
31. Filipovic, M. R.; Ivanovic-Burmazovic, I. Chem. Eur. J. 2012, 18, 13538–13540.
32. Filipovic, M. R.; Eberhardt, M.; Prokopovic, V.; Mijuskovic, A.; Orescanin Dusic, O.;
Reeh, P. H.; Ivanovic-Burmazovic, I. J. Med. Chem. 2013, 56, 1499–1508.
33. Gao, Y.; Toubaei, A.; Kong, X.; Wu, G. Chem. Eur. J. 2015, 21, 17172–17177.
34. Olabe, J.A., 3rd European Colloquium on Inorganic Reaction Mechanisms, ECIRM
2016, June 2125, Kraków. Oral presentation, unpublished work.
35. Arulsamy, N.; Bohle, D. S.; Butt, J. A.; Irvine, G. J.; Jordan, P. A.; Sagan, E. J. Am.
Chem. Soc. 1999, 121, 7115–7123.
36. Hu, Y.; Stanbury, D. M. Inorg. Chem. 2016, 55, 7797–7803.
37. Das, T. N.; Huie, R. E.; Neta, P.; Padmaja, S. J. Phys. Chem. A 1999, 103, 5221–5226.
38. Koppenol, W. H. Inorg. Chem. 2012, 51, 5637–5641.
39. Arnelle, D. R.; Stamler, J. S. Arch. Biochem. Biophys. 1999, 318(2), 279–285.
40. Singh, S. P.; Wishnok, J. S.; Keshive, M.; Deen, W. M.; Tannenbaum, S. R. Proc. Natl.
Acad. Sci. U.S.A. 1996, 93, 14428–14433.
41. Wong, P. S. Y.; Hyun, J.; Fukuto, J. M.; Shirota, F. N.; DeMaster, E. G.;
Shoeman, D. W.; Nagasawa, H. T. Biochemistry 1998, 37, 5362–5371.
42. Cortese-Krott, M. M.; Butler, A.; Woollins, J. D.; Feelisch, M. Dalton Trans. 2016, 45,
5908–5919.
43. Ivanova, L. V.; Anton, B. J.; Timerghazin, Q. K. Phys. Chem. Chem. Phys. 2014, 16,
8476–8486.
44. Nava, M.; Martin-Drummel, M. A.; Lopez, C. A.; Crabtree, K. N.; Womack, C. C.;
Nguyen, T. L.; Thorwirth, S.; Cummins, C. C.; Stanton, J. F.; McCarthy, M. C. J. Am.
Chem. Soc. 2016, 138, 11441–11444.
45. Koppenol, W. H.; Bounds, P. L. Arch. Biochem. Biophys. 2017, 617, 3–8.
46. Seel, F.; Wagner, M. Z. Anorg. Allg. Chem. 1988, 558, 189–192.
47. Bohle, D. S.; Hansert, B.; Paulson, S. C.; Smith, B. D. J. Am. Chem. Soc. 1994, 116,
7423–7424.
48. Szacilowski, K.; Chmura, A.; Stasicka, Z. Coord. Chem. Rev. 2005, 249, 2408–2436.
49. Marcolongo, J. P.; Morzan, U. N.; Zeida, A.; Scherlis, D. A.; Olabe, J. A. Phys. Chem.
Chem. Phys. 2016, 18, 30047–30052.
50. Slep, L. D.; Pollak, S.; Olabe, J. A. Inorg. Chem. 1999, 38, 4369–4371.
51. Munro, A. P.; Williams, D. L. H. J. Chem. Soc. Perkin 2000, 21, 1794–1797.
52. Armstrong, D. A.; Huie, R. E.; Koppenol, W. H.; Lymar, S. V.; Merenyi, G.; Neta, P.;
Ruscic, B.; Stanbury, D. M.; Steenken, S.; Wardman, P. Pure Appl. Chem. 2015, 87,
1139–1150.
53. Eberhard, M.; Dux, M.; Namer, B.; Miljkovic, J.; Cordasic, N.; Will, C.; Kichko, T. L.;
de la Roche, J.; Fischer, M.; Suarez, S. A.; Bikiel, D.; Dorsch, K.; Leffler, A.; Babes, A.;
Lampert, A.; Lennerz, J. K.; Jacobbi, J.; Marti, M. A.; Doctorovich, F.; Hoggestat, E. D.;
Zygmunt, P. M.; Ivanovic-Burmazovic, I.; Messlinger, K.; Reeh, P.; Filipovic, M. R.
Nat. Commun. 2014, 5, 4381.
54. Nagy, P. Methods Enzymol. 2015, 554, 3–29.
55. Cuevasanta, E.; Zeida, A.; Carballal, S.; Wedmann, R.; Morzan, U. N.; Trujillo, M.;
Radi, R.; Estrin, D. A.; Filipovic, M. R.; Alvarez, B. Free Radic. Biol. Med. 2015,
80, 93–100.
56. Giggenbach, W. Inorg. Chem. 1971, 11, 1333–1338.
57. Bailey, T. S.; Henthorn, H. A.; Pluth, M. D. Inorg. Chem. 2016, 55, 12618–12625.
58. Bolden, C.; King, S. B.; Kim-Shapiro, D. B. Free Rad. Biol. Med. 2016, 99, 418–425.
59. Estrı́n, D. A.; Baraldo, L. M.; Slep, L. D.; Barja, B. C.; Olabe, J. A. Inorg. Chem. 1996,
35, 3897–3903.
N/S Intermediates in the “Crosstalk” of NO and H2S 309
Contents
1. Introduction: The Reactivity of M3S4 (M ¼ Mo, W) Clusters 312
1.1 Metal-Centered Reactivity 313
1.2 Chalcogenide-Centered Reactivity 316
2. Experimental and Computational Methods 320
3. Kinetics and Mechanistic Studies on the [3 + 2] Cycloaddition Reaction Between
M3S4 Clusters and Alkynes 322
3.1 The Kinetics of Reaction 322
3.2 The Effect of the Alkyne 324
3.3 The Effect of the Metal 332
3.4 The Effect of the Ancillary Ligands at the Metal Centers 335
3.5 The Effect of the Solvent 336
4. Conclusions and Outlook 339
Acknowledgments 340
References 340
Abstract
Whereas the mechanistic aspects of the reactions at the metal sites of M3S4 (M ¼ Mo, W)
clusters are relatively well understood, much less is known about those occurring at
the sulfur atoms. In this chapter, we describe our recent results on the mechanism
of the [3 + 2] cycloaddition reaction between these clusters and alkynes. In all cases,
the process involves the concerted formation of two C–S bonds in a single kinetic step,
as a result of the interaction between an M(μ-S)2 moiety of the cluster and the sp
C atoms of the alkyne. The effects associated with the nature of the alkyne, the metal
centers, the ligands bound to them, and the solvent have been analyzed by using a
methodology consisting of two main steps: (a) the study of the kinetics of the reactions
by using global analysis of the UV–Vis spectral changes, and the characterization of the
resulting products by means of X-ray, ESI-MS, UV–Vis, or NMR spectroscopy; (b) the com-
putational analysis of the processes by using density functional theory methods, in
some cases complemented with the use of the activation strain model and energy
decomposition analysis approaches.
ABBREVIATIONS
adc acetylene dicarboxylic acid
ASM activation strain model
btd 2-butyn-1,4-diol
CF3
PhA 1-ethynyl-3,5-bis(trifluoromethyl)benzene
dbbpy 4,40 -di-tert-butyl-2,20 -bipyridine
DFT density functional theory
diphos diphosphine ligand
dmad dimethyl acetylenedicarboxylate
EDA energy decomposition analysis
ESI-MS electrospray ionization mass spectrometry
FMO Frontier molecular orbital
F
PhA 1-ethynyl-4-fluorobenzene
HDS hydrodesulfurization
HOMO highest occupied molecular orbital
LUMO lowest unoccupied molecular orbital
NMR nuclear magnetic resonance
osa outer-sphere adduct
PES potential energy surface
PrA propargyl alcohol
pyr pyramidal
TD-DFT time-dependent density functional theory
tet tetrahedral
UV–Vis ultraviolet–visible
Fig. 1 Two different representations of the core of M3Q4 clusters illustrating the C3v
symmetry (left) and the two types (c, d) of inequivalent ancillary monodentate ligands
(right).
the [M3] fragment featuring six electrons for the formation of three M–M
bonds (1). Often, three monodentate ligands complete the coordination
environment of the M centers, which feature a roughly octahedral config-
uration (Fig. 1, right), if the M–M interactions are disregarded. The reac-
tivity of [M3Q4]4+ clusters has been studied during the last decades because
they provide an excellent opportunity to detect the possible changes asso-
ciated with the proximity of close equivalent reaction sites. For the purpose
of summarizing the results of previous studies, the results have been
divided into two main categories, i.e., metal-centered and sulfur-centered
reactivity.
ligands at the d sites are various orders of magnitude more labile than those at
the c sites (3). Moreover, they also concluded that the substitution of each
type of H2O ligand takes place with statistically controlled kinetics, i.e.,
the experimental kinetic traces can be fitted to a model with a single kinetic
step with the rate constant corresponding to the reaction at the third metal
center instead of the expected three successive steps. This phenomenon, also
observed for instance during the formation/decomposition of binuclear
metal complexes with symmetrical polyaza macrocycles (4), requires the
simultaneous fulfillment of two conditions: (a) the metal centers must
behave as independent chromophores; (b) the rate constants for the reaction
at each metal center must be in a statistical ratio (i.e., k1 ¼ 3 k3, k2 ¼ 2 k3).
From a chemical viewpoint, this occurrence is very informative as it requires
the metal centers to behave independently despite their proximity and inter-
actions through bridging ligands and metal–metal bonds. Notably, we have
revised recently the statistical behavior on various [M3Q4(H2O)9]4+ clusters
using state-of-the-art experimental and computational methods. These
studies concluded that the appearance of the phenomenon should not
be taken for granted, as for instance, while the reexamination of the substi-
tution of H2O by NCS at [W3S4(H2O)9]4+ confirmed the existence of sta-
tistical kinetics (5), a subsequent study on the reaction of [Mo3S4(H2O)9]4+
with Cl resulted in a nonstatistical behavior (6). In the latter case, density
functional theory (DFT) and time-dependent density functional theory
(TD-DFT) calculations were also employed to demonstrate the effects
associated with the presence of M–M interactions on the kinetics of the
substitutions. By computing the energy barrier for the substitution of each
of the three equivalent c and d H2O ligands, as well as the ultraviolet–visible
(UV–Vis) spectrum of reactant, intermediates, and products resulting
from these substitutions, it was concluded that none of the conditions
required to observe statistical kinetics are fulfilled during the reaction of
[Mo3S4(H2O)9]4+ with Cl.
DFT calculations for the reaction with HCl supported this hypothesis,
indicating that the interaction of the cluster with one acid molecule can
indeed result in the formation of the reaction product with a moderate
energy barrier of 13.4 kcal mol1 in CH2Cl2 (TS1 in Fig. 3). Nevertheless,
the presence of the second acid molecule slightly decreases the barrier of the
process up to 12.2 kcal mol1 via the formation of a H-bond interaction
between the two acid molecules (TS2 in Fig. 3), this pathway being there-
fore preferred under acid excess (8b). Additionally, factors such as the nature
of the metal center (9), the formation of ion pairs (8c), and the nature of the
diphosphine ligands (10) have also been analyzed recently.
316 Andres G. Algarra and Manuel G. Basallote
2.18
2.25
1.98
2.10
1.
35
2.19
1.94 2.06
0.81 0.78
TS1 TS2
Fig. 3 Transition state structures (Å, B3LYP) for the reaction of [W3S4H3(PH3)6]+,
employed as a model for [W3S4H3(dmpe)3]+, with one (TS1) and two (TS2) HCl molecules
to generate [W3S4H2Cl(PH3)6]+ and H2 (8b).
Fig. 4 Reaction of [Mo3M0 S4(H2O)10]4+ (M0 ¼ Ni, Pd) with tet-H3PO2 to generate
[Mo3M0 (pyr-H3PO2)S4(H2O)9]4+. For simplicity, the H2O ligands coordinated to Mo cen-
ters are not shown.
Fig. 7 Products observed in the reaction of alkynes with M3S4 clusters. Adapted with
permission from Pino-Chamorro, J. Á.; Algarra, A. G.; Fernández-Trujillo, M. J.;
Hernández-Molina, R.; Basallote, M. G. Inorg. Chem. 2013, 52 (24), 14334–14342. Copyright
2013 American Chemical Society.
mechanism has long been debated (23). Two alternative mechanisms were
postulated for such a process (Fig. 8), one involving the concerted [3 + 2]
addition of an O]Os]O moiety across the C]C bond, and the other
suggesting a stepwise process whereby the initial [2 + 2] addition of an
Os]O moiety across the C]C bond results in a four-membered
metallacyclic intermediate, which rearranges into the final osma-2,5-
dioxolane in a second step. Interestingly, by combining computational
and experimental results (23), it has been demonstrated that the [3 + 2] mech-
anism is preferred.
320 Andres G. Algarra and Manuel G. Basallote
Fig. 9 Cuboidal clusters and alkynes employed throughout this chapter. For simplicity,
only the coordination environment of one metal center has been drawn.
322 Andres G. Algarra and Manuel G. Basallote
In some cases, the interaction energy (ΔEint) has a major role in whether
a process takes place or not, and then it is useful to further decompose it by
means of an energy decomposition analysis (EDA) method (25). Herein, we
employed the localized molecular orbital EDA, developed by Su and Li (26),
which allows to partition the previously obtained interaction energies along
the PES into electrostatic (ΔEes), exchange (ΔEex), repulsion (ΔErep), polar-
ization (ΔEpol), and dispersion (ΔEdisp) components (Eq. 4):
ΔEint ¼ ΔEes + ΔEex + ΔErep + ΔEpol + ΔEdisp (4)
Importantly, within this scheme the polarization term (ΔEpol) corre-
sponds to the stabilizing effect caused by relaxation of the fragment orbitals
upon binding and includes empty-occupied orbital mixing within one frag-
ment due to the presence of the other (polarization), and between the two
fragments (charge transfer). Qualitatively, it can therefore be related to the
highest occupied molecular orbital (HOMO)–lowest unoccupied molecular
orbital (LUMO) interactions employed within the framework of Frontier
molecular orbital (FMO) theory to explain the reactivity and regioselectivity
of pericyclic reactions.
Table 2 Summary of the Kinetic Rate Constants (k1, M1 s1) for the Formation of Type I
Products
Cluster Solvent Alkyne k1 (M21 s21) References
[1]4+ H2O adc 45 2a 20
adc 169 7 b
20
btd 1.92 0.02 a
20
btd 3.0 0.1 b
20
[2] +
CH3CN adc 7.8 0.2 27
btd (8.1 0.1) 103 27
dmad 35 1 28
3
PrA (3.74 0.07) 10 28
PhA (3.3 0.1) 103 28
3
F
PhA (8.7 0.2) 10 28
3
CF3
PhA (13.6 0.7) 10 28
CH2Cl2 dmad (8.0 0.2) 28
3
PhA (4 1) 10 28
[3] +
CH3CN adc 6.3 0.1 29
dmad 9.0 0.1 29
2
btd (1.5 0.2) 10 29
2
PrA (4.4 0.2) 10 29
2
PhA (3.64 0.07) 10 29
a +
Mean values in Hpts/Lipts 2 M with different H concentrations ranging from 0.5 to 2.0 M.
b
Mean values in HCl/LiCl 2 M with different H+ concentrations ranging from 0.5 to 2.0 M.
Fig. 10 Spectral changes observed for the reaction of [1]+ with adc in 1 M HCl water
solution (T ¼ 25°C; [1]+ ¼ 8 104 M: [adc] ¼ 0.04 M; time base ¼ 5 s).
I products takes place in a single step via concerted transition states (TSs) in
which both C–S bonds are formed simultaneously. Importantly, alternative
mechanisms involving the formation of intermediate structures with one C–
S bond were only located in the triplet PES and showed much higher rel-
ative energies (typically over 40 kcal mol1).
As an example, the structures computed for the TS and type I product for
the reaction of [2]+ with the symmetric alkyne btd are included in Fig. 11.
Their analysis indicates that both structures are close to the Cs symmetry
point group, with d(S1–C1) d(S2–C2) and d(Mo1–S1) (Mo1–S2), and
the C^C moiety of the alkyne approaching the cluster through the plane
formed by the S1–Mo1–S2 moiety. The structures also show the preferential
interaction between these two moieties, characterized by the shortening of
Mo1–S1 and Mo1–S2 distances in the TS (2.31 Å, cf. 2.33 Å in [2]+) and the
lengthening of Mo3–S1 and Mo2–S2 distances by ca. 0.05 Å. Mo–Mo
C1 C1
S1 S1
Mo1 C2 Mo1 C2
S2 S2
Mo3 S3 Mo3 S3
Mo2 Mo2
distances also show similar trends, with Mo1–Mo2 and Mo1–Mo3 distances
being ca. 0.05 Å longer than Mo2–Mo3.
To illustrate the similarity of the structural changes in the reaction of the
clusters [1]4+, [2]+, and [3]+ with alkynes, Table 3 includes a summary of the
changes in the most relevant distances and angles during the course of var-
ious reactions modeled computationally. The values in the table indicate that
Mo–S distances (d1 and d2) and S–Mo–S angle (α1) are similar for the three
clusters, and the same is true for the C–C bond length (d3) and R–C–C
angles (α2 and α3) at the different alkynes. The computed structures of
the reaction products also show great similarity, especially those with sym-
metrical alkynes. The structural changes in the cluster when proceeding
from reactant to type I products are small, with the values of d1 and d2
increasing only by ca. 0.05 Å and α1 decreasing by ca. 11 degrees, while
the values for the different reactions show, in general, only small deviations.
In contrast, the alkynes undergo larger structural changes, as expected from
the change in the hybridization of the carbon atoms from sp to sp2 through-
out the process. Thus, the d3 values increase by ca. 0.12 Å and the angles
change from values close to 180 degrees to ca. 125 degrees. Surprisingly,
the structures of the TSs are also quite similar for all the systems despite
the very different nature of the alkynes and the variation of the rate constants
derived from experimental kinetics results. Thus, the Mo–S distances remain
essentially constant (deviations smaller than 0.02 Å), whereas the S–Mo–S
angle decreases to ca. 92 degrees. Again, the distances and angles involving
the alkyne show larger changes; d3 increases by ca. 0.05 Å, and α2 and α3
increase to ca. 146 degrees, thus showing that the structures of the TSs
are located in all cases almost midway between those of the corresponding
reactants and products.
Despite the similarity of the structural changes, the computed activation
(ΔG#) and reaction (ΔGr) free energies show significant differences
depending on the alkyne employed, as illustrated in Table 4 for the reactions
of cluster [2]+. Thus, in agreement with the experimental observations, the
barriers for the reactions of this cluster with adc and dmad are significantly
lower than the barriers for others, and these two reactions also appear to be
thermodynamicallya more favored. The reaction with unsymmetrical alky-
nes leads to structures with higher degrees of asymmetry, although it is
important to highlight that the concerted nature of the process remains.
a
Note that the small positive ΔGr values are probably only the result of a systematic error associated with
the employed level of theory as in practice all reactions take place experimentally.
Mechanism of [3 + 2] Cycloaddition With Alkynes 327
Parameter
α1 α2 α3
Reaction d1 (Å) d2 (Å) d3 (Å) (degrees) (degrees) (degrees)
Reactants [1]4+ + btd 2.297 2.297 1.210 98.3 179.3 179.4
+
[2] + btd 2.325 2.325 1.211 97.2 179.0 178.3
+
[2] + adc 2.325 2.325 1.211 97.2 176.1 176.1
[2]+ + PhA 2.325 2.325 1.211 97.2 180.0 180.0
+
[3] + btd 2.352 2.375 1.224 97.0 179.5 179.5
+
[3] + adc 2.352 2.375 1.227 97.0 176.2 176.2
[3]+ + PhA 2.352 2.375 1.228 97.0 176.2 176.2
4+
TSs [1] + btd 2.290 2.295 1.254 90.7 147.2 146.7
+
[2] + btd 2.311 2.307 1.254 90.9 145.9 145.0
[2]+ + adc 2.308 2.305 1.256 92.3 143.9 145.2
+
[2] + PhA 2.326 2.303 1.261 90.4 138.2 152.8
+
[3] + btd 2.344 2.369 1.267 91.3 142.9 145.1
+
[3] + adc 2.356 2.349 1.270 94.0 139.2 154.1
+
[3] + PhA 2.368 2.366 1.279 90.7 138.1 148.7
4+
Products [1] + btd 2.355 2.367 1.332 84.6 128.5 128.1
+
[2] + btd 2.385 2.380 1.336 85.0 126.0 126.5
+
[2] + adc 2.374 2.381 1.338 85.9 125.8 125.4
[2]+ + PhA 2.391 2.387 1.337 85.1 122.4 124.4
+
[3] + btd 2.412 2.422 1.338 86.2 125.6 127.1
+
[3] + adc 2.403 2.408 1.339 87.2 128.0 127.8
[3]+ + PhA 2.426 2.438 1.340 85.8 123.6 125.9
328 Andres G. Algarra and Manuel G. Basallote
Table 4 Summary of Activation (ΔG#) and Reaction (ΔGr) Free Energies (kcal mol1,
B3LYP(PCM)), Computed for the Reaction of [2]+ With Alkynes, Together With the
Δr(C–S) and Δr(Mo–S) Parameters (Å) Calculated Both at the TS and at the Type
I Product Geometries
At the TS At the Type I Product
Alkyne ΔG# ΔGr Δr(C–S) Δr(Mo–S) Δr(C–S) Δr(Mo–S)
adc 13.3 0.7 0.041 0.003 0.008 0.007
dmad 11.9 2.1 0.040 0.002 0.001 0.009
btd 21.9 6.0 0.011 0.004 0.004 0.005
PrA 23.1 5.3 0.070 0.003 0.019 0.000
PhA 21.6 4.9 0.404 0.022 0.037 0.004
F
PhA 21.3 5.3 0.407 0.022 0.035 0.007
CF3
PhA 18.3 3.4 0.388 0.029 0.034 0.007
Table 5 ASM Analysis (kcal mol1, B3LYP(PCM)) of the Reactions Between [2]+ and the
Alkynes adc and btd
Reaction ΔE# ΔEr ΔE#strain ([2]+) ΔE#strain (Alkyne) ΔE#strain (Total) ΔEint
[2]+ + adc 17.2 3.6 20.9 2.8 23.8 6.6
[2] + btd +
25.0 9.6 23.0 3.1 26.1 1.1
A B
60 20
40
30 −20
20
−40
10
0 −60
4.0 3.5 3.0 2.5 2.0 4.0 3.5 3.0 2.5 2.0
x (Å) x (Å)
C D
60 60
ΔEstrain (alkyne in [2]+.alkyne)
ΔEstrain ([2]+ in [2]+.alkyne)
50 50
40 40
(kcal mol−1)
(kcal mol−1)
30 30
20 20
10 10
0 0
4.0 3.5 3.0 2.5 2.0 4.0 3.5 3.0 2.5 2.0
x (Å) x (Å)
Fig. 12 Activation strain diagrams (kcal mol1, B3LYP(PCM)) for the reaction of [2]+ with
btd (open symbols) and adc (gray symbols) along the reaction coordinate x (Å) projected
onto the two forming C–S bonds. Note that ΔE ¼ ΔEint ([2]+alkyne) + ΔEstrain([2]+) +
ΔEstrain(alkyne). Adapted from Pino-Chamorro, J. Á.; Gushchin, A. L.; Fernández-Trujillo,
M. J.; Hernández-Molina, R.; Vicent, C.; Algarra, A. G.; Basallote, M. G. Chem. Eur. J.
2015, 21 (7), 2835–2844. Copyright Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.
by taking into account that the Mo(μ-S)2 moiety of [2]+ is already nonlinear,
and therefore, it does not require major structural changes to react with the
alkyne. In contrast, the formal change in the hybridization of the reacting
C atoms of the alkyne, from sp to sp2, produces changes in the R–C^C
angles that result in most of the total strain energy (ΔEstrain).
As shown in Table 5, the ΔE#strain values for the reactions with adc and
btd are 23.8 and 26.1 kcal mol1 at the TS geometries, respectively.
Although these values are already in line with the experiments, the same
table indicates that the differences in ΔE#int also contribute to lower the bar-
rier for the reaction with adc by 5.5 kcal mol1. Inspection of the ΔEint cur-
ves in Fig. 12B shows that in both cases, this parameter reaches its maximum
near the TS geometries (ca. 2.8–2.4 Å). Interestingly, the roughly
5 kcal mol1 difference between the two ΔE#int values is not only evident
within this region of the diagram but also seems to remain practically con-
stant up to the reaction products (ca. 1.9 Å).
Alternatively, FMO arguments can be used to explain the differences in
ΔE#int for the two reactions from a qualitative viewpoint. To do so, the ener-
gies of the HOMO and LUMO of [2]+ and alkynes are plotted in Fig. 13
both at their ground-state geometries (laterals of each plot) and at their
geometries at the TSs (central area of each plot). Similar to other
Fig. 13 Energies (eV, B3LYP(PCM)) of the HOMO and LUMO orbitals of [2]+ and alkyne
(adc (left) and btd (right)) fragments in their ground-state geometries and TSs for the
formation of type I products. The arrows represent the smallest HOMO–LUMO gap for
each TS. Adapted from Pino-Chamorro, J. Á.; Gushchin, A. L.; Fernández-Trujillo, M. J.;
Hernández-Molina, R.; Vicent, C.; Algarra, A. G.; Basallote, M. G. Chem. Eur. J. 2015,
21 (7), 2835–2844. Copyright Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.
Mechanism of [3 + 2] Cycloaddition With Alkynes 331
cycloaddition processes (30), the deformation of the two fragments ([2]+ + adc
or [2]+ + btd) into their TS structures results in an increase in the energy of
the HOMOs and a decrease in those of the LUMOs. This leads to smaller
HOMO–LUMO gaps between the fragments, and therefore to more stabili-
zing interactions between them. Note that, in line with the symmetry-allowed
nature of the process according to the Woodward–Hoffmann rules (31),
the HOMO and LUMO orbitals of the cluster and of the alkyne have the
right symmetry to result in stabilizing HOMO([2]+)–LUMO(alkyne) and
HOMO(alkyne)–LUMO([2]+) interactions, the strength of these being
therefore mainly dependent on the HOMO–LUMO gaps. Fig. 14 shows a
simplified representation of these orbitals and their interactions.
In agreement with the relative small values of ΔE#strain ([2]+) for both
reactions and the negligible differences between them, [2]+ only undergoes
small changes in the energy and composition of its Frontier orbitals when
proceeding from its ground-state structure to the TS geometries (see
Fig. 13). On the contrary, clear differences are observed in the Frontier
orbitals of the alkynes, with those of adc being ca. 1–2 eV more stable than
those of btd at their both ground-state and TS geometries. Interestingly, fur-
ther analysis of these showed that the extra stabilization for adc is due to a
larger extent of charge delocalization over the carboxylic acid groups vs the
hydroxymethyl groups (27), an effect associated with the greater electron-
withdrawing character of the former. Thus, FMO theory allows an expla-
nation of the trends in ΔE#int based on the more favorable orbital interactions
between [2]+ and adc.
Fig. 14 Main orbital interactions in the reaction of [2]+ with alkynes. For simplicity, only
an Mo(μ-S)2 unit of the cluster has been represented. Adapted from Bustelo, E.;
Gushchin, A. L.; Fernández-Trujillo, M. J.; Basallote, M. G.; Algarra, A. G. Chem. Eur. J.
2015, 21, 14823–14833. Copyright Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.
332 Andres G. Algarra and Manuel G. Basallote
Taken together the results in this section highlight the importance of the
alkyne in [3 + 2] cycloaddition reactions. The trend has similarities with
other concerted cycloadditions such as 1,3-dipolar cycloadditions or
Diels–Alder reactions, in which the FMO interactions are largely influenced
by the electron-donating or electron-withdrawing substituents on the
alkyne/alkene.
Table 6 Computed Activation (ΔG#) and Reaction (ΔGr) Free Energies (kcal mol1,
B3LYP(PCM)) for the Reaction of [W3S4(Acac)3(py)3]+ ([2W]+) With Alkynes in
Acetonitrile, Together With the Differences (ΔΔG) in These Parameters Respect to
the Reactions of [2]+ (i.e., [2W]+–[2]+)
Alkyne ΔG# ΔGr ΔΔG# ΔΔGr
adc 13.8 7.9 0.5 8.6
dmad 14.3 8.4 2.5 10.5
btd 24.3 16.5 2.4 10.5
PrA 27.1 15.7 4.0 10.4
PhA 24.8 16.3 3.2 11.4
F
PhA 25.4 14.9 4.1 9.6
CF3
PhA 21.7 12.3 3.4 8.9
Adapted from Bustelo, E.; Gushchin, A. L.; Fernández-Trujillo, M. J.; Basallote, M. G.; Algarra, A. G.
Chem. Eur. J. 2015, 21, 14823–14833. Copyright Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.
Mechanism of [3 + 2] Cycloaddition With Alkynes 333
reaction free energies for the reactions of [2W]+, together with their differ-
ences with respect to those of [2]+. This shows that the ΔGr values for the
reactions of [2W]+ are ca. 10 kcal mol1 larger than those of [2]+,
thus leading to clearly endergonic processes, in agreement with the
experiments. Interestingly, the computed free energy barriers only rise by
0.5–4.1 kcal mol1, resulting in values still typical of reactions at room tem-
perature. This indicates that the lack of reaction between [2W]+ and the
alkynes is only a consequence of the unfavorable thermodynamics of the
processes.
The reaction of the clusters [2W]+ and [2]+ with btd was selected for
further analysis using the ASM methodology. Fig. 15 shows the two activa-
tion strain diagrams, computed at the same level of theory and reaction coor-
dinate as in Fig. 12. In general, the plots corresponding to ΔE, ΔEstrain, and
A B
60 20
ΔEint (cluster.btd) (kcal mol–1)
50
0
ΔE (kcal mol–1)
40
30 –20
20
–40
10
0 –60
4.0 3.5 3.0 2.5 2.0 4.0 3.5 3.0 2.5 2.0
x (Å) x (Å)
C D
ΔEstrain (btd in cluster.btd) (kcal mol–1)
60 60
ΔEstrain (cluster in cluster.btd)
50 50
40 40
(kcal mol–1)
30 30
20 20
10 10
0 0
4.0 3.5 3.0 2.5 2.0 4.0 3.5 3.0 2.5 2.0
x (Å) x (Å)
Fig. 15 Activation strain diagrams (kcal mol1, B3LYP(PCM)) for the reaction of btd with
[2]+ (gray symbols) and [2W]+ (open symbols) along the reaction coordinate x (Å) pro-
jected onto the two forming C–S bonds. Note that ΔE ¼ ΔEint (cluster btd) +
ΔEstrain(cluster) + ΔEstrain(btd). Adapted from Bustelo, E.; Gushchin, A. L.; Fernández-Trujillo,
M. J.; Basallote, M. G.; Algarra, A. G. Chem. Eur. J. 2015, 21, 14823–14833. Copyright Wiley-
VCH Verlag GmbH & Co. KGaA, Weinheim.
334 Andres G. Algarra and Manuel G. Basallote
ΔEint are relatively similar for both processes, featuring also the expected
trends previously observed. Nevertheless, the ΔE plots show that when pro-
ceeding from reactants (x ¼ 4.0) to products (x ¼ 1.9), the values for ΔE([2-
W]+btd) become gradually larger than those for ΔE([2]+btd), thus resulting
in larger differences in ΔEr than ΔE#. As expected, analysis of the strain
energies for cluster and alkyne indicates that deforming the former is less
energy-demanding. More importantly, the plots for ΔEstrain(cluster) and
ΔEstrain(btd) match almost perfectly for both reactions. This is somehow
unexpected as it implies that the nature of the metal center (Mo or W) does
not modify the energy required to deform the clusters themselves neither
that of btd. Consequently, the energetic differences for both reactions orig-
inate almost exclusively from those in interaction energy (ΔEint), i.e., the
relative differences in the plots for ΔE([2]+btd) and ΔE([2W]+btd) are
equivalent to those between ΔEint([2]+btd) and ΔEint([2W]+btd).
FMO arguments can be used again to explain the differences in ΔEint
from a qualitative viewpoint. Indeed, the computation of the HOMO
and LUMO energies of each fragment along the reaction coordinate
x shows that, while no significant differences are found for those of btd
in both reactions, the HOMO and LUMO energies of [2W]+ are system-
atically higher than those of [2]+ by 0.25 and 0.45 eV. This results in a larger
HOMO–LUMO gap for the interaction of [2W]+ with btd, thus explaining
the decrease in interaction energy. Analogous conclusions are reached when
an EDA is employed. Dissection of the ΔEint values for both reactions along
the reaction coordinate x into electrostatic, exchange, repulsion, polariza-
tion, and dispersion terms shows that most of these terms feature similar
values throughout the two PESs, with significant differences only appearing
for the stabilizing ΔEpol term, i.e., that accounting for the empty-occupied
orbital mixing between (charge transfer) and within (polarization) of each
fragment. This is shown graphically in Fig. 16, where the difference in each
term for the reactions of [2W]+ and [2]+ with btd has been represented.
Whereas most terms only show small and random changes with the distance,
significant differences in polarization energy (ΔΔEpol) start to be evident at
x 2.8 Å and continue to increase up to the reaction products. Thus, as the
ΔΔEpol increases when the two species become closer, the difference in
ΔEint (and in turn ΔE) becomes less pronounced at the TS geometries
(5 kcal mol1) than at the reaction products (12 kcal mol1).
As a summary, the results in this section demonstrate that substitution of
Mo by W in [2]+ reduces the reactivity vs alkynes of the resulting cluster.
Indeed, while the cluster [2]+ reacts with a variety of alkynes leading to
cycloaddition products, its tungsten analogue [2W]+ remains inert under
Mechanism of [3 + 2] Cycloaddition With Alkynes 335
Fig. 16 Plot of the differences in interaction energy (ΔΔEint) and their LMO-EDA-derived
contributions for the reactions of [2W]+ and [2]+ with btd along the reaction coordinate
x (Å) projected onto the two forming C–S bonds. Adapted from Bustelo, E.; Gushchin, A. L.;
Fernández-Trujillo, M. J.; Basallote, M. G.; Algarra, A. G. Chem. Eur. J. 2015, 21,
14823–14833. Copyright Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.
Table 7 Computed Activation (ΔG#) and Reaction (ΔGr) Free Energies (kcal mol1,
BP86) for the Reaction of [3]+ and [3W]+ With Alkynes in Acetonitrile, Together With the
Differences ([3W]+[3]+) in These Parameters Between Them
[3]+ [3W]+ Difference
Alkyne ΔG# ΔGr ΔG# ΔGr ΔΔG# ΔΔGr
adc 6.0 8.7 5.3 3.3 0.7 5.4
dmad 6.0 9.1 5.8 3.4 0.2 5.7
btd 12.1 4.0 13.4 2.9 1.3 6.9
PrA 10.3 5.5 12.5 2.1 2.2 7.6
PhA 8.4 6.4 10.8 0.5 2.4 6.9
Adapted from Pino-Chamorro, J. Á.; Laricheva, Y. A.; Guillamon, E.; Fernández-Trujillo, M. J.;
Bustelo, E.; Gushchin, A. L.; Shmelev, N. Y.; Abramov, P. A.; Sokolov, M. N.; Llusar, R.; Basallote,-
M. G.; Algarra, A. G. New J. Chem. 2016, 40, 7872–7880 with permission from the Centre National
de la Recherche Scientifique (CNRS) and The Royal Society of Chemistry.
The second-order rate constants obtained for the reaction of [3]+ with
alkynes in acetonitrile solutions can be compared with those of [2]+ in order
to test the importance of the ligands bound to the molybdenum centers in
the [3 + 2] cycloaddition reactions. The data, included in Table 1, show that
both [2]+ and [3]+ react with alkynes at relatively similar rates, and the reac-
tions with adc and dmad are still significantly faster than with the remaining
alkynes. Overall, this indicates that the change in the coordination environ-
ment of the Mo centers only leads to minor differences in reactivity.
An interesting point that deserves to be highlighted pertains to the ori-
entation of the dbbpy and Cl ligands at [3]+ and [3W]+. As shown in Fig. 17
for [3]+, the three possible Mo(μ-S)2 units are equivalent based on the C3
symmetry of the cluster. Nevertheless, the ligands trans to each (μ-S) center
within these units are different, and their different trans effects result in a
Δr(Mo–S) value of 0.02 Å. Although the effect is relatively small and in all
cases the processes are concerted in nature, the computations show that
the asymmetry on the coordination environment of Mo centers has an impact
on the TSs even for the reactions with symmetrical alkynes such as acetylene
(Fig. 17), which features a Δr(C–S) value of 0.03 Å for both C–S bonds.
2.24
2.26
25 2. 25
2.
51 2. 2.38 52 2. 2.41
2.35 2.35
2.44
2.37 2.3
7
has even been claimed in some cases as an evidence of the concerted nature
of the reaction under investigation (34).
In order to ascertain whether the formation of type I cycloaddition prod-
ucts between [M3(μ3-Q)(μ-Q)3]4+ clusters and alkynes is subjected to sol-
vent effects, we studied the kinetics of reaction of [2]+ with the alkynes
dmad and PhA not only in acetonitrile solutions but also in dichloromethane
(28). As expected, the resulting second-order rate constants, also included
in Table 1, compare very well with those for the same reactions in acetoni-
trile, thus pointing toward negligible solvent kinetic effects associated with
this [3 + 2] cycloaddition process.
A relatively different scenario arises in aqueous solutions, where the clus-
ter [1]4+ also reacts with alkynes such as adc and btd to generate the
corresponding type I cycloaddition products in a single kinetic step (see
Table 2) (20). In water, the –COOH and –CH2OH groups of the alkynes
can form H-bonding interactions with free H2O molecules (solvent) or with
those acting as ligands in the cluster. As a result, the [3 + 2] cycloaddition is
expected to begin with the formation of outer-sphere cluster–alkyne
adducts. Note that the process continues to be concerted, i.e., the two
C–S bonds are formed in a single kinetic step and, as noted earlier, the reac-
tion with adc is one order of magnitude faster than with btd. The computed
free energy profile for the reaction with btd is included in Fig. 18, which
shows that various outer-sphere adducts (osas) with relatively similar stabi-
lities can be formed depending on the relative position of btd with respect
to the cluster. Among them, osa1 features the correct geometry for the
338 Andres G. Algarra and Manuel G. Basallote
1.21
1.25
2.4
0
2.4
1
osa1 TS
TS (+2.8)
4+
[1] + btd
(0.0)
(–12.6)
osa3 osa2
Fig. 18 Computed free energy profile (kcal mol1, B3LYP(PCM)), for the reaction
between [1]4+ and btd, together with the geometries of three possible outer-sphere
cluster-alkyne adducts. Adapted with permission from Pino-Chamorro, J. Á.;
Algarra, A. G.; Fernández-Trujillo, M. J.; Hernández-Molina, R.; Basallote, M. G. Inorg. Chem.
2013, 52 (24), 14334–14342. Copyright 2013 American Chemical Society.
Mechanism of [3 + 2] Cycloaddition With Alkynes 339
ACKNOWLEDGMENTS
We express our gratitude to our coworkers Jose A. Pino-Chamorro, Marı́a Jesús Fernández-
Trujillo, Emilio Bustelo, Rita Hernández-Molina, Artem L. Gushchin, Cristian Vicent, Rosa
Llusar, and Maxim N. Sokolov. Financial support from the Spanish Ministerio de Economı́a y
Competitividad and FEDER funds from the European Union (Grants CTQ2015-
65707-C2-2-P and CTQ2015-71470-REDT) are also acknowledged.
REFERENCES
1. Feliz, M.; Llusar, R.; Andres, J.; Berski, S.; Silvi, B. New J. Chem. 2002, 26(7), 844–850.
2. (a) Hernandez-Molina, R.; Geoffrey Sykes, A. J. Chem. Soc. Dalton Trans. 1999, 18,
3137–3148; (b) Hernandez-Molina, R.; Sokolov, M. N.; Sykes, A. G. Acc. Chem.
Res. 2001, 34(3), 223–230.
3. (a) Kathirgamanathan, P.; Soares, A. B.; Richens, D. T.; Sykes, A. G. Inorg. Chem. 1985,
24(19), 2950–2954; (b) Ooi, B. L.; Sykes, A. G. Inorg. Chem. 1988, 27(2), 310–315;
(c) Ooi, B. L.; Sykes, A. G. Inorg. Chem. 1989, 28(20), 3799–3804; (d) Richens, D. T.;
Helm, L.; Pittet, P. A.; Merbach, A. E.; Nicolo, F.; Chapuis, G. Inorg. Chem. 1989,
28(7), 1394–1402; Richens, D. T.; Pittet, P.-A.; Merbach, A. E.; Humanes, M.;
Lamprecht, G. J.; Ooi, B.-L.; Sykes, A. G. J. Chem. Soc. Dalton Trans. 1993, (15),
2305–2311.
4. Basallote, M. G.; Durán, J.; Fernandez-Trujillo, M. J.; Máñez, M. A. J. Chem. Soc. Dalton
Trans. 1999, (21), 3817–3823; (b) Basallote, M. G.; Durán, J. n.; Fernández-Trujillo, M. J.;
Máñez, M. A. Polyhedron 2001, 20(1–2), 75–82; (c) Basallote, M. G.; Fernandez-Trujillo,-
M. J.; Manez, M. A. J. Chem. Soc. Dalton Trans. 2002, (19), 3691–3695.
5. Algarra, A. G.; Sokolov, M.; González-Platas, J.; Fernández-Trujillo, M. J.;
Basallote, M. G.; Hernández-Molina, R. Inorg. Chem. 2009, 48(8), 3639–3649.
6. Algarra, A. G.; Fernández-Trujillo, M. J.; Basallote, M. G. Chem. Eur. J. 2012, 18(16),
5036–5046.
7. Sorribes, I.; Wienh€ofer, G.; Vicent, C.; Junge, K.; Llusar, R.; Beller, M. Angew. Chem.
Int. Ed. 2012, 51(31), 7794–7798.
8. (a) Basallote, M. G.; Feliz, M.; Fernández-Trujillo, M. J.; Llusar, R.; Safont, V. S.;
Uriel, S. Chem. Eur. J. 2004, 10(6), 1463–1471; (b) Algarra, A. G.; Basallote, M. G.;
Feliz, M.; Fernandez-Trujillo, M. J.; Llusar, R.; Safont, V. S. Chem. Eur. J. 2006,
12(5), 1413–1426; (c) Algarra, A. G.; Basallote, M. G.; Fernández-Trujillo, M. J.;
Llusar, R.; Safont, V. S.; Vicent, C. Inorg. Chem. 2006, 45(15), 5774–5784.
9. Algarra, A. G.; Basallote, M. G.; Fernández-Trujillo, M. J.; Feliz, M.; Guillamón, E.;
Llusar, R.; Sorribes, I.; Vicent, C. Inorg. Chem. 2010, 49(13), 5935–5942.
Mechanism of [3 + 2] Cycloaddition With Alkynes 341
10. Algarra, A. G.; Basallote, M. G.; Fernández-Trujillo, M. J.; Guillamón, E.; Llusar, R.;
Segarra, M. D.; Vicent, C. Inorg. Chem. 2007, 46, 7668–7677.
11. (a) Hidai, M.; Kuwata, S.; Mizobe, Y. Acc. Chem. Res. 2000, 33(1), 46–52; (b) Llusar, R.;
Uriel, S. Eur. J. Inorg. Chem. 2003, 7, 1271–1290.
12. (a) Nagaraja, C. M.; Nethaji, M.; Jagirdar, B. R. Inorg. Chem. 2005, 44(12), 4145–4147;
(b) Akbayeva, D. N.; Di Vaira, M.; Seniori Costantini, S.; Peruzzini, M.; Stoppioni, P.
Dalton Trans. 2006, (2), 389–395.
13. (a) Algarra, A. G.; Basallote, M. G.; Fernandez-Trujillo, M. J.; Hernandez-Molina, R.;
Safont, V. S. Chem. Commun. 2007, 29, 3071–3073; (b) Algarra, A. G.; Fernandez-
Trujillo, M. J.; Hernandez-Molina, R.; Basallote, M. G. Dalton Trans. 2011, 40(34),
8589–8597; (c) Algarra, A. G.; Fernandez-Trujillo, M. J.; Hernandez-Molina, R.;
Basallote, M. G. Dalton Trans. 2011, 40(34), 8589–8597.
14. (a) Mueller, A.; Fedin, V. P.; Diemann, E.; Boegge, H.; Krickemeyer, E.;
Soelter, D.; Giuliani, A. M.; Barbieri, R.; Adler, P. Inorg. Chem. 1994, 33(10),
2243–2247; (b) Hernández-Molina, R.; Kalinina, I. V.; Abramov, P. A.;
Sokolov, M. N.; Virovets, A. V.; Platas, J. G.; Llusar, R.; Polo, V.; Vicent, C.;
Fedin, V. P. Inorg. Chem. 2008, 47(1), 306–314.
15. (a) Kuwata, S.; Hidai, M. Coord. Chem. Rev. 2001, 213(1), 211–305; (b) Angelici, R. J.
In: Encyclopedia of Inorganic Chemistry; Scott, R. A. Ed.; John Wiley & Sons, Ltd.:
Hoboken, NJ, 2006; pp 1–17; (c) Infantes-Molina, A.; Romero-Perez, A.; Eliche-
Quesada, D.; Merida-Robles, J.; Jimenez-López, A.; Rodrı́guez-Castellón, E. Transition
Metal Sulfide Catalysts for Petroleum Upgrading—Hydrodesulfurization Reactions; InTech:
Rijeka, Croatia, 2012.
16. (a) Jaramillo, T. F.; Bonde, J.; Zhang, J.; Ooi, B.-L.; Andersson, K.; Ulstrup, J.;
Chorkendorff, I. J. Phys. Chem. C 2008, 112(45), 17492–17498; (b) Kibsgaard, J.;
Jaramillo, T. F.; Besenbacher, F. Nat. Chem. 2014, 6(3), 248–253.
17. Pino-Chamorro, J. Á.; Laricheva, Y. A.; Guillamón, E.; Fernández-Trujillo, M. J.;
Algarra, A. G.; Gushchin, A. L.; Abramov, P. A.; Bustelo, E.; Llusar, R.;
Sokolov, M. N.; Basallote, M. G. Inorg. Chem. 2016, 55(19), 9912–9922.
18. (a) Shibahara, T.; Akashi, H. Inorg. Synth. 1992, 29, 260–269; (b) Shibahara, T.;
Sakane, G.; Mochida, S. J. Am. Chem. Soc. 1993, 115(22), 10408–10409.
19. (a) Maeyama, M.; Sakane, G.; Pierattelli, R.; Bertini, I.; Shibahara, T. Inorg. Chem. 2001,
40(9), 2111–2119; (b) Ide, Y.; Sasaki, M.; Maeyama, M.; Shibahara, T. Inorg. Chem.
2004, 43(2), 602–612; (c) Takagi, H.; Ide, Y.; Shibahara, T. C. R. Chim. 2005,
8(6–7), 985–992; (d) Ide, Y.; Shibahara, T. Inorg. Chem. 2007, 46(2), 357–359.
20. Pino-Chamorro, J. Á.; Algarra, A. G.; Fernández-Trujillo, M. J.; Hernández-Molina, R.;
Basallote, M. G. Inorg. Chem. 2013, 52(24), 14334–14342.
21. Rauchfuss, T. B. In Dithiolene Chemistry, Synthesis, Properties and Applications; Stiefel, E. I.
Ed.; Vol. 52; John Wiley & Sons, Inc.: Hoboken, NJ, 2004; pp 1–54.
22. (a) McKenna, M.; Wright, L. L.; Miller, D. J.; Tanner, L.; Haltiwanger, R. C.;
DuBois, M. R. J. Am. Chem. Soc. 1983, 105(16), 5329–5337; (b) Coucouvanis, D.;
Hadjikyriacou, A.; Toupadakis, A.; Koo, S. M.; Ileperuma, O.; Draganjac, M.;
Salifoglou, A. Inorg. Chem. 1991, 30(4), 754–767; (c) Kawaguchi, H.; Tatsumi, K.
J. Am. Chem. Soc. 1995, 117(13), 3885–3886; (d) Mallard, A.; Simonnet-Jegat, C.;
Lavanant, H.; Marrot, J.; Secheresse, F. Transit. Met. Chem. 2008, 33(2), 143–152;
(e) Chiu, W.-H.; Zhang, Q.-F.; Williams, I. D.; Leung, W.-H. Organometallics 2010,
29(11), 2631–2633.
23. Deubel, D. V.; Frenking, G. Acc. Chem. Res. 2003, 36(9), 645–651.
24. (a) Bickelhaupt, F. M.; Baerends, E. J.; Nibbering, N. M. M.; Ziegler, T. J. Am. Chem.
Soc. 1993, 115(20), 9160–9173; (b) Bickelhaupt, F. M. J. Comput. Chem. 1999, 20(1),
114–128; (c) van Zeist, W.-J.; Bickelhaupt, F. M. Org. Biomol. Chem. 2010, 8(14),
3118–3127; (d) Wolters, L. P.; Bickelhaupt, F. M. Wiley Interdiscip. Rev. Comput.
Mol. Sci. 2015, 5(4), 324–343.
342 Andres G. Algarra and Manuel G. Basallote
25. Hopffgarten, M. v.; Frenking, G. Wiley Interdiscip. Rev. Comput. Mol. Sci. 2012, 2(1),
43–62.
26. Su, P.; Li, H. J. Chem. Phys. 2009, 131(1), 014102.
27. Pino-Chamorro, J. Á.; Gushchin, A. L.; Fernández-Trujillo, M. J.; Hernández-Molina,-
R.; Vicent, C.; Algarra, A. G.; Basallote, M. G. Chem. Eur. J. 2015, 21(7), 2835–2844.
28. Bustelo, E.; Gushchin, A. L.; Fernández-Trujillo, M. J.; Basallote, M. G.; Algarra, A. G.
Chem. Eur. J. 2015, 21, 14823–14833.
29. Pino-Chamorro, J. Á.; Laricheva, Y. A.; Guillamon, E.; Fernández-Trujillo, M. J.;
Bustelo, E.; Gushchin, A. L.; Shmelev, N. Y.; Abramov, P. A.; Sokolov, M. N.;
Llusar, R.; Basallote, M. G.; Algarra, A. G. New J. Chem. 2016, 40, 7872–7880.
30. Ess, D. H.; Jones, G. O.; Houk, K. N. Adv. Synth. Catal. 2006, 348(16–17), 2337–2361.
31. Woodward, R. B.; Hoffmann, R. Angew. Chem. Int. Ed. Engl. 1969, 8(11), 781–853.
32. Atkins, P.; Overton, T.; Rourke, J.; Weller, M.; Armstrong, F. Shriver and Atkins’ Inor-
ganic Chemistry. 5th ed.; Oxford University Press: New York, 2009; pp 783–784.
33. Kumar, S.; Kumar, V.; Singh, S. P. Pericyclic Reactions: A Mechanistic and Problem-Solving
Approach; Elsevier Science: London, UK, 2015.
34. Sauer, J.; Sustmann, R. Angew. Chem. Int. Ed. Engl. 1980, 19(10), 779–807.
CHAPTER NINE
Contents
1. Introduction 344
2. Redox Homeostasis in Cells 346
3. Photodynamic Therapy 348
4. Penetration Depth 349
5. ROS-Generating Systems for PDT 351
6. ROS Generation Mechanisms 355
6.1 Possible Deactivation Pathways (Jablonski Diagram) 355
6.2 Type II Mechanism 357
6.3 Type I Mechanism 358
6.4 Role of Ascorbate in ROS Generation 361
7. Subcellular Localization of Photosensitizers in Cells 362
8. ROS-Mediated Biological Mechanisms 366
8.1 Apoptosis 366
8.2 Necrosis 367
8.3 Autophagy 369
8.4 ROS-Mediated Vascular Occlusion 369
8.5 Antitumor Immune Response 371
9. Methods of ROS Detection in PDT 372
9.1 1270 nm Phosphorescence 372
9.2 Detection of Radical Species by Electron Spin Resonance 374
9.3 ROS Detection by Fluorescent Probes 374
10. Strategies to Enhance ROS Generation in PDT 378
10.1 Inhibition of Antioxidant Enzymes 378
10.2 Nanoformulation of Photosensitizers 379
10.3 Photosensitization of TiO2 With Tetrapyrroles 382
10.4 Addition of Inorganic Salts 383
11. Summary 384
Acknowledgments 386
References 386
Abstract
Reactive oxygen species (ROS) play key roles in cell signaling systems and homeostasis,
and they are also fundamental to photodynamic therapy (PDT). PDT efficacy can be
affected by the nature and persistence of ROS. A comprehensive understanding of
ROS generation pathways greatly facilitates the analysis of photodynamic mechanisms
and enables potentiation of PDT efficacy. Diverse methods exist to distinguish between
Type I and Type II mechanisms of ROS generation. The direct monitoring of 1O2 forma-
tion involves the detection of its phosphorescence at 1270 nm. Electron spin resonance
is also used in conjunction with appropriate spin traps for detection of oxygen-centered
radical species. Moreover, a variety of more or less specific fluorescent probes are fre-
quently used to detect both singlet oxygen and free radicals. This chapter summarizes
our recent efforts in the design and characterization of new ROS-generating systems for
PDT. Special attention is given to bacteriochlorins because they absorb in the NIR, gen-
erate ROS via both Type I and Type II mechanisms, and are very efficient in the PDT
treatment of several types of tumors including pigmented melanoma. The current sta-
tus and possible opportunities of ROS generation and potentiation in PDT are
highlighted. Particular emphasis is placed on the elucidation of the ROS-mediated pho-
tochemical and molecular mechanisms that give rise to the establishment of PDT as a
first-line systemic treatment of highly resistant diseases, especially invasive and meta-
static tumors.
1. INTRODUCTION
Reactive oxygen species (ROS) are products of partial reduction of
molecular oxygen (O2). Two unpaired electrons with parallel spins located
in two separate orbitals of molecular oxygen make it highly susceptible to
formation of radical forms (1,2). As illustrated in Fig. 1, the one-electron
reduction product of molecular oxygen is called superoxide ion, while
reduction by two electrons leads to hydrogen peroxide. H2O2 is a rather
neutral ROS, but the subsequent product, the hydroxyl radical (HO%), is
one of the strongest oxidants ever described. Its standard reduction potential
of 2.31 V ensures reactions at a very low activation energy barrier and rates
close to diffusion-controlled (3). In addition to these chemically reactive
species delivered from oxygen presented in Fig. 1, a product from an energy
transfer reaction (singlet oxygen, 1O2) (4) will also be discussed in this review
due to its importance in PDT mechanisms.
The stereotypical view of ROS is that their production is unregulated,
and their intracellular targets are rather random. ROS-dependent oxidation
of intracellular lipids, proteins, and DNA leads to the damage of biomole-
cules and implicates several pathologies, including cancer, neurodegenera-
tive diseases, and atherosclerosis (5–7). Various chemical agents such as
drugs, pesticides, some metals, and metal oxides present in smog, some phys-
ical factors such as gamma or UV radiation, high pO2, and temperature, as
well as physiological stresses (injury, aging) lead to an enhanced production
of ROS. They are also created by neutrophils, eosinophils, and macrophages
during inflammation and by-products of mitochondrial-catalyzed electron
transport reactions. As illustrated in Fig. 2, ROS generated within such pro-
cesses result in oxidative damage to proteins, lipids, and nucleic acids and
disrupt functions of organs and cells consequently leading to cell death (8,9).
Although this damaging aspect of ROS is correct, there are no doubts that
they are responsible for many beneficial effects as well. Their formation
ensures proper functioning of metabolism and several signaling pathways
in cells. Both superoxide and hydrogen peroxide have been indicated as
signaling messengers (10). However, due to a higher stability of H2O2, it seems
to play a more important role as a signaling agent. Biochemical pathways
Fig. 2 Schematic view of the influence of ROS induced by various extrinsic factors on
cell metabolism.
346 Janusz M. Dąbrowski
and regulated enzymatic systems for generating H2O2 have been described
(11). Although ROS and their targets are spatially confined within the cell,
their role in redox signaling, metabolic regulation, innate immunity, stem cell
biology, and photodynamic therapy of cancer is absolutely undeniable (12).
This chapter starts with a brief description of the redox homeostasis and
oxidative stress in cells and indicates how this overproduction of ROS can
be used in anticancer therapies. Particular attention is given to photody-
namic therapy, a treatment that employs photogenerated ROS which
destroy unwanted cells/tissue. PDT has been widely exploited as a promis-
ing, minimally invasive anticancer and antimicrobial strategy over the recent
years. Nevertheless, PDT still faces several problems namely light penetra-
tion depth, Ps delivery and localization, Ps photophysics and photochemis-
try which all together contribute to the accurate engineering of ROS
formation. Starting at the molecular level and progressing to biological out-
comes, these and other factors are discussed to create a mechanistic point of
view on the current approaches that may overcome most of the PDT chal-
lenges. Consequently, the discussion is focused on the mechanisms of cel-
lular death and vascular occlusion as well as the ability of ROS to
stimulate immune response after PDT. Finally, several examples of combi-
nations with antioxidants, inorganic salts, and nanoparticles are given to
demonstrate the opportunities of ROS potentiation and eventual enhance-
ment of the therapeutic efficacy.
Fig. 3 Schematic illustration of the redox homeostasis and oxidative stress in the cell.
Fe2+), H2O2 can be converted to hydroxyl radicals (HO%), which are highly
reactive and can cause damage to lipids, proteins, and DNA. Fig. 3 illustrates
the basic reactions in cells ensuring control of homeostasis and the situation
when this control is affected by an excess of ROS and/or by depletion of
antioxidant activity in a condition known as oxidative stress.
As illustrated in Fig. 3, mitochondria reduce molecular oxygen to water
in the process known as oxidative phosphorylation. Cytochrome c oxidase
catalyzes the transfer of four electrons to an oxygen with progressive ROS
generation. The leakage of electrons from the mitochondrial electron trans-
port chains is the source of O2 • , which then is transformed to H2O2, HO%,
and peroxynitrite (ONOO), respectively (14,15). A moderate increase of
ROS promotes cell proliferation and survival. However, when the increase
of ROS reaches a certain level, it may overcome the antioxidant capacity of
the cell and trigger cell death. Normal cells can tolerate some amount of
exogenous ROS, while cancer cells, due to an abnormal metabolic activity,
change the redox dynamics to maintain the ROS level below the toxic
threshold (16). A further increase of ROS stress in cancer cells using exog-
enous ROS-modulating agents is likely to cause elevation of ROS above the
threshold level, leading to cell death. Since cancer cells are more susceptible
to exogenous ROS, their survival is more dependent on antioxidant activity
(13). Thus, ROS-mediated therapeutic strategies may cause more damage to
malignant cells than normal cells (17). One of the medical approaches, in
which the ROS-inducing agent is activated in the unwanted lesion, is
known as photodynamic therapy (PDT) (16,18).
348 Janusz M. Dąbrowski
3. PHOTODYNAMIC THERAPY
PDT is a treatment modality for cancer (19–24), age-related mac-
ular degeneration (25–27), and localized infections (28–39) that involves
the use of three separately nontoxic components: a photosensitizing drug
or photosensitizer (Ps), a light source that emits visible and/or near-
infrared (NIR) photons, and molecular oxygen dissolved in the target
tissue (18–20,22,40–45). The proper interaction of these elements leads
to the generation of ROS that are responsible for the photodynamic
effect. Fig. 4 illustrates the basic concept and biological consequences
of PDT.
Photogenerated ROS contribute to the tumor destruction which occurs
in accordance to several direct and indirect mechanisms. ROS usually lead to
the direct cell death by apoptosis and/or necrosis. Autophagy may also cause
the cell death, but on the other hand, its cytoprotective and prosurvival
functions are well documented (46–49). If the irradiation of the tumor takes
place after relatively short DLI, ROS damage tumor-associated vessels. This
strategy is known as vascular-targeted photodynamic therapy (V-PDT)
(26,40,50–58). PDT action ends with the activation of immune response
and induction of long-term antitumor memory (20,23,59–61). Among
many factors participating in the eradication of the treated tumor and
responsible for innate and adaptive immunity, the most important ones
are listed in Fig. 4.
4. PENETRATION DEPTH
The wavelength of light for effective photosensitizer activation in
order to generate ROS corresponds to an electronic absorption band of
the applicable compound. The penetration depth and efficient delivery of
light are two major barriers in anticancer PDT for deep tissue treatment.
As illustrated in Fig. 5, the consequences of light interaction with tissues
are not only the absorption but also the scattering, transmission, and reflec-
tion (70). Penetration depth of light through tissues depends on many
parameters such as photon energy, molar absorption coefficient, polariza-
tion, coherence, power density, time of illumination, and the tissue physi-
ology (e.g., pigmentation and hydration) (2,71). Endogenous fluorophores,
including hemoglobin and melanin, have a strong absorption in the visible
part of the spectrum below 630 nm. Therefore, an ideal Ps should have an
absorption peak above 630–700 nm to maximize tissue penetration (72).
Taking into account that water absorbs in the NIR and that the energy
decreases with increasing wavelength, the light in the range between 700
and 1000 nm is the most suitable for deep tissue penetration (73).
On the other hand, light of low energy (λ > 850 nm) is less effective in
ROS generation due to thermal effects caused by fast nonradiative transi-
tions and the narrow energy gap (45,74). Shorter wavelengths of light are
the most scattered by tissues, and their penetration is limited; therefore,
the photosensitizing agents absorbing the red or near-infrared photons
(between 650 and 850 nm) have the greatest potential because these wave-
lengths penetrate tissues the most effectively (18,45,73).
It is worth noting that the scattering and reflection of light also implicate
other challenges in PDT. These processes may lead to the situation where
the photons do not reach all parts of the irradiated area. In order to generate
ROS in whole tumor tissue, an accurate irradiation margin has to be applied.
For the tumors with thicknesses of 3–4 mm used in our studies (23,66,67),
the 3–4 mm margin should be associated with an irradiance at a depth
z ¼ 7 mm capable of producing ROS above the therapeutic threshold.
The threshold concentration for tissue necrosis by singlet oxygen was esti-
mated as [1O2] ¼ 0.9 mM for liver necrosis and [1O2] ¼ 93 mM for skin
necrosis (75,76). However, a typical threshold dose for tissue necrosis is
17 mM, and the amount of ROS produced per unit volume of tissue is given
by Eq. (1):
where R ¼ tirrE is the radiant exposure in J/cm2, and the numeric value
results from the use of the parameters of redaporfin (23). In vascular-targeted
PDT of colon carcinoma, we have used a drug dose of 0.75 mg kg1 which
gives a Ps concentration in plasma, [Ps]plasma ¼ 13 μM and [ROS] ¼ 0.3 M at
the tumor surface when R0 ¼ 50 J cm2. At a depth of z ¼ 7 mm, where
R ¼ R0exp(z/δ), for the optimized regimen with illumination at
Reactive Oxygen Species in Photodynamic Therapy 351
750 nm, we obtained [ROS] ¼ 14 mM, which should cause tissue necrosis.
Altogether, the success of the optimized treatment regimen is related to the
three-dimensional tumor margin of 3–4 mm (23).
To overcome the limited penetration depth of tissue, several strategies
have been applied including use of materials absorbing light in the NIR
and emitting in the visible. Upconverting nanoparticles and two-photon
excited nanoparticles are examples of such a methodology (77–79). More-
over, quantum dots and bioluminescence resonance energy transfer sys-
tems are also quite popular recently (2). Our approach in the PDT field is
much more simple and even more effective. We use NIR absorbing
(750 nm) photostable photosensitizers (e.g., bacteriochlorins) with ade-
quately designed treatment regimens (23). It has been estimated that light
at 750 nm can penetrate to a depth even higher than 10 mm and it is still effi-
cient in ROS generation (70,80).
Porphyrins are the most widely studied photosensitizers for both PDT
and photodynamic inactivation of microorganisms (PDI) due to their strong
absorption in the visible region, great ability to generate ROS, particularly
singlet oxygen (94,95), and biocompatibility (96,97). They are involved in a
number of biologically important functions, namely, oxygen transport and
storage (hemoglobin and myoglobin), electron transfer reactions (cyto-
chrome c, cytochrome oxidase), and energy conversion (photosynthesis)
(97). Their versatile synthesis provides applications also for a variety of mate-
rials, particularly for photocatalysis (98–100) and optoelectronics (101,102).
Porphyrins are tetrapyrrolic macrocycles built from four pyrroles connected
with a methine bridge (97). The addition of four phenolic groups to the
macrocycle provides an amphiphilic character and gives rise to the design
of therapeutic, diagnostic, and theranostic agents (103). The reduction of
a porphyrin macrocycle to chlorin and bacteriochlorin results in profound
changes of symmetry and leads to a significant increase of absorption in
the red and near-IR regions, respectively (104–111). The reduction of
one pyrrole leads to chlorins and reduction of two pyrroles gives bacteri-
ochlorins and destabilizes the π system, increases the energy of highest occu-
pied molecular orbital (HOMO), and makes these molecules more prone to
oxidation. While energy of the lowest unoccupied molecular orbital
(LUMO) does not change significantly, a reduction of the HOMO–LUMO
energy gap and a red shift of the Q band are observed.
In collaboration with Arnaut and Pereira from the University of Coimbra
we have studied a wide range of halogenated porphyrins, chlorins, and bacte-
riochlorins as promising photosensitizers for PDT and photocatalysis. More
recently, a partnership has been started with Dumoulin and Ahsen from Gebze
Technical University in order to explore the potential biomedical application
of phthalocyanines (Fig. 6).
The structures of both porphyrin derivatives and phthalocyanines are
modified by the presence of various substituents in order to modulate their
hydrophobic/hydrophilic character and desired spectroscopic and photo-
chemical properties (45,105,108,112–114). The introduction of halogen
atoms (X ] Cl or F) in the ortho positions of the phenyl ring of the Ps
accelerates the intersystem crossing (ISC) to the triplet excited state and
maximizes the triplet quantum yield ΦT. Additionally, the steric interac-
tion between the halogen atoms and hydrogen atoms in β positions dimin-
ishes the tendency of porphyrin derivatives to aggregation and increases
their photostability (108,112,115). The presence of sulfonic, sulfoester,
Fig. 6 Scheme of possible structures of phthalocyanine- and bacteriochlorin-based compounds together with their electronic absorption
spectra.
354 Janusz M. Dąbrowski
or sulfonamide groups in the meta positions of the phenyl rings enables tai-
loring the hydrophilicity/lipophilicity of the photosensitizers and provides
an additional steric protection against oxidation. An investigation of the
effect of the polyethylene glycol substituent and its fluorinated analogue
(Fig. 6, right) on the Zn(II) phthalocyanine photodynamic properties was
also the aim of an ongoing research project (113). Fig. 6 shows the absorp-
tion spectra of the representative halogenated porphyrin, chlorin, and
bacteriochlorin as well as phthalocyanines studied in our laboratories.
Halogenated porphyrins possess a typical absorption spectrum with
an intense band around 400 nm and four other less intense bands of
lower energies (45,108,112,116,117). Various peripheral substituents
present in the phenyl ring cause only relatively small changes in the inten-
sity and energy of electronic transitions (116,118). A more pronounced
effect was observed by introducing metal ions (Zn2+, Pd2+, Co3+) into
the porphyrin ring because the symmetry of the free-base porphyrin
has changed from D2h to D4h, and the absorption spectra show only
two Q bands (119). In the series: porphyrin > chlorin > bacteriochlorin,
the HOMO–LUMO gaps are becoming progressively smaller, and the
Qy bands are shifted to longer wavelengths. This explains the red absorp-
tion of chlorins at 650 nm and the infrared absorption of the bacteri-
ochlorins at 750 nm. A less intense band around 519–529 nm,
normally labeled as Qx, is observed along the series and the Soret band
is situated at 400–420 nm for porphyrins and chlorins. For bacteri-
ochlorins, the Soret band splits into two bands with maximum absorption
wavelengths lower than 380 nm. Phthalocyanines possess characteristic
absorption with an intense π ! π* transition, referred to the Q band
(λmax 670 nm), and less intense transition in the UV (λmax 350 nm)
(120–124). Some efforts have been made to move the absorption further
into the NIR (117). Substitution of Zn(II) phthalocyanine with eight
hydroxylated sulfanyl moieties in nonperipheral positions led to an absorp-
tion at nearly 800 nm but also resulted in a decreased singlet oxygen gen-
eration. The strongest absorption of bacteriochlorins lies in the middle of
the “phototherapeutic window” (λ 750 nm), where the tissues are the
most transparent and the nontoxic photons are characterized by an energy
still sufficient to generate ROS efficiently. Thus, above listed advantages
situate this group of tetrapyrroles among the most promising photosensi-
tizers for PDT (73,125) and makes them well suited for other possible
applications (23,41,58,67,104,105,107,115,126–133).
Reactive Oxygen Species in Photodynamic Therapy 355
6.1.1 Fluorescence
Fluorescence is not a desired pathway for the PDT application but can serve
as a tool for tumor detection and imaging. Moreover, it is very convenient to
study Ps cellular uptake and intracellular localization by fluorescence and/or
confocal microscopy. Furthermore, a variety of currently available fluores-
cent probes enable exploring mechanisms of cell death in PDT and moni-
toring singlet oxygen, superoxide ion, and hydroxyl radical formation
followed by Ps illumination inside the cell (134–137).
The presence of halogen atoms (Cl or F) in the structure of photosen-
sitizers studied in our laboratories reduces the fluorescence quantum yield
(ΦF) (41,104,108,112,115,138). This significant change is explained by
the internal heavy atom effect. ΦF values determined for halogenated por-
phyrins and bacteriochlorins are remarkably lower (especially those bearing
Cl atoms) than for nonhalogenated molecules. On the other hand, fluori-
nated chlorins exhibit the most intense fluorescence (ΦF approaching
40%). Considering their relatively high values of singlet oxygen generation
(ΦF¼ 60%), these chlorin-based compounds were proposed as potent
theranostic agents that can serve in both diagnostic and therapeutic
approaches at the same time (111).
Hydrogen peroxide and the sensitizer radical anion can react to form
hydroxyl radicals and hydroxide anion (Eq. 17). This is equivalent to the
one-electron reduction of hydrogen peroxide mediated by Fe2+, discussed
earlier, but in this process, Ps• acts as a reducing agent (41).
The results of our completed and ongoing projects show that the pho-
todynamic effect does not correlate with singlet oxygen quantum yields, but
rather with the ability of Ps to take part in the Type I mechanism
(45,104,109,110,119). It is clear that the most desirable situation is wherein
photodynamic action is mediated by both electron transfer and the energy
transfer mechanisms. However, PDT is more effective if Mechanism I is
operative and completed with generation of highly reactive hydroxyl radi-
cals (41,58,67).
Reactive Oxygen Species in Photodynamic Therapy 361
Vis–NIR
O2
Antioxidant
R F
F ROS
R
F
N F
M N
1
F F
N
N O2 HO H
O O
R F HO
Living cells
F R O2 •– –
O OH
Ascorbate
SOD
Prooxidant
X H2O2 HO•
GP Dead cells
CAT
H2O
H2O + O2
Fig. 8 The role of ascorbate in PDT mediated by bacteriochlorins and NIR light.
and its antioxidant effect should be more pronounced when singlet oxygen is
responsible for the photodynamic effect (Fig. 8) (149).
In biological in vitro experiments, ascorbate as a reducing agent can
regenerate photosensitizers following the Type I mechanism and act as a
prooxidant. On the other hand, AH– is also a facile singlet oxygen quencher
and may serve as an antioxidant. The predominant role played by ascorbate
in oxidative stress depends strongly on the origin of cells and types of the
processes involved at the cellular level. For example, we have demonstrated
that the addition of ascorbate and the inhibition of SOD markedly increases
the photodynamic effect toward A549 cells, but not toward CT26 cells.
Moreover, the inhibition of catalase and the depletion of the glutathione
pool also led to a potentiation of PDT in A549 cells (16). However, in order
to develop enhanced PDT sensitizers and design efficient PDT treatment
regimens, the approach should be one of first considering tissue and intra-
cellular localization, instead of trying to maximize singlet oxygen quantum
yields in in vitro tests (150).
7. SUBCELLULAR LOCALIZATION OF
PHOTOSENSITIZERS IN CELLS
Both Type I and Type II reactions may occur simultaneously,
depending on the type of photosensitizer, its oxidation potentials, and
amount of oxygen present in the cell/tissue (42,58,104,151). Due to the
Reactive Oxygen Species in Photodynamic Therapy 363
Intensity Intensity
250 250 Intensity
200 250
200
150 200
150
100 150
100
500 100
500
0 500
0
0 5 10 15 20 25 30 0 5 10 15 20 25 30 0
Distance (µm) Distance (µm) 0 5 10 15 20 25 30
Distance (µm)
Intensity (F2PMet) Intensity (ER-Tracker) Intensity (F2PMet) Intensity (Mito-Tracker) Intensity (F2PMet) Intensity (Lyso-Tracker)
Fig. 9 Intracellular localization of F2PMet in A549 cells. Cells were marked with dyes for endoplasmic reticulum (ER-Tracker), lysosomes (Lyso-
Tracker), and mitochondria (Mito-Tracker). The green topographic profile corresponds to the emission of the tracker and the red to the por-
phyrin emission.
Reactive Oxygen Species in Photodynamic Therapy 365
TNFR
Cytoplasm
TNF
Lysosome
Caspases
Apoptosis
Cell membrane
ROS, cytochrome C, AIF, Bcl-2
Nucleus Bid
Ribosomes
Bcl-2
Necrosis
Mitochondria
Ca2+
Bax/Bak ROS↑, ATP↓, Ca2+↑
Golgi apparatus
Fig. 10 Cellular targets for a Ps localization and ROS generation and consequent cell
death mechanisms in PDT. The mode of cell death observed after PDT depends on
the intracellular localization of the Ps- and PDT-related damage to these organelles.
8.1 Apoptosis
Photogenerated ROS trigger a cascade of molecular events that contribute
to an apoptotic cell death. Apoptosis is an irreversible direct cell death mech-
anism, considered by some authors to play a predominant role in killing cells
after PDT (173). It is termed as “programmed cell death” because it enables
a balance between survival and death mechanisms. Apoptosis might be
either suppressed or defective, eventually leading to an uncontrolled cell
Reactive Oxygen Species in Photodynamic Therapy 367
8.2 Necrosis
Necrosis occurs above the threshold of resistance of cells treated with ROS
or with other nonphysiological conditions that are responsible for the
368 Janusz M. Dąbrowski
8.3 Autophagy
Autophagy is a cellular process that involves the formation of a type of vac-
uoles called autophagosomes that devour cellular organelles and intracellular
proteins. The process ends with the fusion of the outer membranes of
autophagosomes and lysosomes. Hydrolases and lipases in the lysosomal
lumen degrade the autophagic contents, with the releasing amino acids, fatty
acids, and nucleosides proceeding into the cytosol (186). While autophagy is
usually considered as a prosurvival mechanism, if it is more excessive it may
be associated with the cell death (48). It is not, however, another cell death
mechanism because death is induced by other mechanisms that evoke an
autophagic response; therefore, it is often reported as “death with
autophagy” (187). The role of ROS as signaling molecules in starvation-
induced autophagy was recently described. It was shown that starvation
stimulates formation of ROS, specifically H2O2. These oxidative conditions
are essential for autophagy, as treatment with antioxidative agents abolished
the formation of autophagosomes and the consequent degradation of pro-
teins (188). As reported earlier, Bcl-2 damage and activation of Bid triggers
apoptosis, but Bcl-2 acts as an antiautophagic protein as well. It forms a com-
plex with the proautophagic protein Beclin-1; therefore, the loss of Bcl-2
may result in the initiation of autophagy (189). Autophagy offers protection
from PDT and inhibition of autophagy promotes PDT efficacy (190). A role
of autophagy in promoting a survival pathway was especially observed at low
light doses, inducing a moderate level of ROS (191). In contrast, a high dose
of light and a greater quantity of ROS activates prodeath mechanism (48).
The aim of our ongoing studies on LLC cells and tumors is to investigate the
infuence of the Ps localization, Ps drug dose and light dose on the prosurvival
and prodeath functions of authophagy and to correlate them with the PDT
efficacy.
in 83% of the treated mice (23,66,192). We assigned this efficacy to the fact
that redaporfin is relatively photostable and generates a high quantity of sin-
glet oxygen and oxygen-centered radicals.
5 μs Phenalenone
Phosphorescence int.
0.03 0.025 10 μs
0.01 Cl2PEt
15 μs
0.020 20 μs Cl2BEt
25 μs
O2 phosphorescence (a.u)
0.02
0.015 30 μs F2BMEt
0.008
k1CT / kn = 0.1
0.01 0.010
0.005 0.006
1
0.00
−5 −5 −5 −5 −5
0.000
0 1⫻10 2⫻10 3⫻10 4⫻10 5⫻10 1250 1260 1270 1280 1290 1300
Time (s) l (nm) 0.004
k1CT / kn = 1
1
k1 kCT
3
S* + O2 (3Σg–) {3S* O2 (3Σg–)} 1
{Sδ+ O2δ –} ksep S•+ + O2•−
0.002
k−1 k−CT
k2 k−et 0
0 10 20 30 40 50 60 70
S + 1O2 (1Δg) S + O2 (3Σg–) Laser pulse energy (mJ)
Fig. 11 Singlet oxygen 1270 nm phosphorescence spectra and traces recorded in the presence of halogenated porphyrins and bacteri-
ochlorins and phenalenone as the reference. In the frame at the bottom, the mechanisms of singlet oxygen and superoxide ion are illustrated.
374 Janusz M. Dąbrowski
H 3C N H
O⋅
H3C
H3C N+
O–
DMPO
H C O2H
Superoxide radical 3
H3C N H
O⋅
Fig. 12 Chemical structure of DMPO and EPR spectra recorded (left) and simulated (right) of bacteriochlorins in phosphate buffer saline (PBS)
or DMSO and in the presence of DMPO after illumination with a 750-nm laser.
X
◊OH O O O–
O O O
COO– COO–
HO O O HO O O
X = OH HPF 1
Dg
X = NH2 APF Cl Cl
O O
HOOC HOOC
OH
DHE
Fig. 13 Structures of commonly used fluorescent probes: APF, HPF, DHE, and SOSG and their reactions with various ROS.
Reactive Oxygen Species in Photodynamic Therapy 377
It was initially reported that these probes were relatively insensitive to 1O2.
However, recent studies indicate that fluorogenic interactions of APF with
1
O2 can be quite significant (136). On the other hand, HPF seems to be
more selective to hydroxyl radicals than APF (134).
Dihydroethidium (DHE) was suggested to be selective for O2 • detec-
tion if fluorescence is monitored at 570 nm, but this probe might be oxi-
dized by other ROS; therefore, it should rather be used for detection of
superoxide ion accompanied with HPLC analysis of generated products.
The structure of DHE together with its reaction with superoxide anion is
shown in Fig. 13.
Singlet oxygen sensor green (SOSG) is a very selective probe for 1O2
detection, but it hardly penetrates cell membranes (201). Its chemical struc-
ture and reaction with singlet oxygen are presented in Fig. 13. A procedure
for promoting cellular uptake of SOSG (202) published by Ogilby was suc-
cessfully adapted in our studies (see Fig. 14).
It is reported that APF can detect hydroxyl radicals and it is suggested that
it can also detect amounts of 1O2 (136). However, we have demonstrated
that the fluorescence signal from APF in comparison to SOSG was negligible
when Ps with a singlet oxygen quantum yield close to unity (ZnPMet) was
used. In view of the very high yield of 1O2 from ZnPMet (119), together with
the 200-fold greater sensitivity of APF to HO% than to 1O2 (137), it appears
that APF, HPF, and SOSG can be successfully used to distinguish between
these species generated either via Mechanism I or Mechanism II (134).
The irradiation of chlorinated bacteriochlorin (ClBOH) leads to
hydroxyl radical generation in solution as well as in cells (203). In order
to assess the generation of hydroxyl radicals by other bacteriochlorins
(F2BMet, FBMet, ClBEt, and Cl2BEt), we incubated each of them with
APF in A549 cell cultures. APF reacts with various ROS, but reaction of
APF with hydroxyl radicals is favored over that with singlet oxygen
(136). Excitation of cells at 488 nm with the laser of confocal microscopy
after the illumination of the cells with NIR light gave rise to fluorescence
at 530 nm, as illustrated in Fig. 14. The same figure demonstrates the use
of other fluorescent probes for detection of various ROS. It is clear that
our lead compound (redaporfin) generates singlet oxygen, superoxide
ion, and hydroxyl radicals at least in A549 cancer cells.
Experiments carried out with APF and HPF have demonstrated that the
highest fluorescence intensity was observed for F2BMEt, lower fluorescence
for both FBMet and Cl2BEt was noted, and only a very weak fluorescence
was observed in the case of ClBEt. Hence, the quantity of hydroxyl radical
generation follows the order ClBEt < FBMet Cl2BEt < F2BMet. It is
interesting to note that exactly the same dependence can be drawn for
the photodynamic effect results for these bacteriochlorins. F2BMet is the
most phototoxic and ClBEt possesses the lowest photodynamic activity
in vitro. Considering that among bacteriochlorins that have been studied,
F2BMet possesses the lowest yield of 1O2 production and other molecules
have similar singlet oxygen quantum yields leading to comparable amounts
of singlet oxygen, we can conclude that photodynamic efficacy is correlated
more with hydroxyl radical formation rather than with singlet oxygen gen-
eration (41,104).
conjugate than for chlorin alone. This increased ability to generate singlet
oxygen resulted in favorable biological activity of nanoencapsulated chlorin
e6 in colon carcinoma cells (CT26). Vilsinski and coworkers described pho-
tochemical properties and biological evaluation of aluminum chloride
phthalocyanine (AlPcCl) incorporated into Pluronic P123 and F127 dem-
onstrating also improved ROS generation and an enhanced photodynamic
effect (159). Recently, we have designed a pluronic-based nanoformulation
for redaporfin and showed that it enhances ROS generation by redaporfin.
Fig. 15 illustrates the method of preparation of pluronic-based materials,
their particle size distribution at physiological pH, and their controlled
release at slightly acidic pH, as well as the influence of the formed micelles
on the ROS generation (184).
Our results also indicate that modification of redaporfin via incorpora-
tion into Pluronic P-123 micelles led not only to an improved stability
and ROS generation but also to the increased selectivity toward tumor tis-
sue, enhanced local inflammation and significant antitumor response after its
excitation with NIR. We have also reported similar effects for a set of Zn2+-
coordinated phthalocyanines of different polarity encapsulated in F127,
P123, and L121 (113). The conclusion from our recent publications is that
our application of nanosized polymeric micelles not only increases the quan-
tity of ROS during PDT but also overcome challenges associated with the
delivery of hydrophobic photosensitizing, such as poor solubility, cellular
internalization, and tumor targeting. Pluronic micelles significantly increase
Ps stability, reduced and delayed its photobleaching, and thus enhanced
ROS generation, most notably hydroxyl radicals, leading to potentiation
of therapeutic efficacy and overcoming the resistance of highly pigmented
(B16F10) melanoma. Other authors also described the role of nanomaterials
in PDT for the same melanoma tumor model. Pheophorbide A was
conjugated via the redox-sensitive disulfide linkage to alginate. DOX/
PheoA-ALG nanoparticles which were preferentially accumulated in B16
melanoma tumors, resulting in substantial inhibition of tumor growth by
both classical chemotherapy and PDT (215). The impact of micellar formu-
lation of Ps on the PDT mechanism was also studied by Nonel and Hamblin.
They describe the modulation of Type I and II mechanisms by the micelle
core environment. Electron-rich poly(2-(diisopropylamino)ethyl methac-
rylate) micelles increased photoactivations from Type II to Type I
mechanisms, which significantly increased the generation of O2 • through
the electron transfer pathway over 1O2 production through the energy
transfer process. Again, these results demonstrate that micelles not only
Fig. 15 Influence of the nanoencapsulation of bacteriochlorin in pluronic micelles on the ROS generation, distribution, and controlled release.
382 Janusz M. Dąbrowski
hv
X
R X
R
R: SO3H, SO2NHCH3 X
N X
X: Cl, F M N
N
M: Zn2+ Co3+ X X N
R X
X R
O2 CB e– A
e– e–
Reduction
O⋅2– –⋅
e – A
H2O2
e– D+⋅
⋅OH Oxidation
VB h+ D
11. SUMMARY
For many years singlet oxygen was considered as a predominant ROS
involved in PDT. The role of the oxygen-centered radicals and hydrogen
peroxide in the photodynamic efficacy has been much less explored. How-
ever, in recent years Type I ROS have become discussed more often in PDT
protocols. Direct detection of singlet oxygen phosphorescence and use of an
EPR spin trap for detection of free radicals are probably the most appropriate
methods to study ROS generation mechanisms in solution. However, it is
much more difficult to adopt these techniques in biological in vitro studies.
Fluorescent ROS probes are simpler and less expensive to use, but their
selectivity toward various ROS still remains the challenge. The most useful
probes in our studies were HPF (HO% ⋙ 1O2), APF (HO% > 1O2), and
SOSG which is highly specific for 1O2. The intracellular diffusion of
ROS depends on their lifetimes. In the case of porphyrins, mostly singlet
oxygen is generated with a lifetime of a few microseconds. Thus, diffusion
between different sites within the cell is possible, and the damage can occur
not only at the generation site but also in other organelles (153,223). On the
other hand, bacteriochlorins generate ROS according to both mechanisms
(Type I and Type II). Singlet oxygen and hydrogen peroxide have longer
lifetimes and a higher diffusion range, whereas superoxide ion or hydroxyl
radicals are short-lived species and cause damage at the narrow generation
site. Thus, the localization of the photosensitizer in the cell can have a major
Reactive Oxygen Species in Photodynamic Therapy 385
ACKNOWLEDGMENTS
The work was supported by Grants no 2013/11/D/ST5/02995 and 2016/22/E/
NZ7/00420 (National Science Center, NCN) and no 0085/IP3/2015/73 (Ministry of
Science and Higher Education, MNiSW) awarded to J.M.D.
REFERENCES
1. Evans, J. L.; Maddux, B. A.; Goldfine, I. D. Antioxid. Redox Signal 2005, 7, 1040–1052.
2. Zhou, Z.; Song, J.; Nie, L.; Chen, X. Chem. Soc. Rev. 2016, 45, 6597–6626.
3. Oszajca, M.; Brindell, M.; Orzeł, Ł.; Da˛browski, J. M.; Śpiewak, K.; Łabuz, P.; Pacia, M.;
Stochel-Gaudyn, A.; Macyk, W.; van Eldik, R.; Stochel, G. Coord. Chem. Rev. 2016,
327–328, 143–165.
4. Ogilby, P. R. Chem. Soc. Rev. 2010, 39, 3181–3209.
5. Simonian, N.; Coyle, J. Ann. Rev. Pharm. Toxicol. 1996, 36, 83–106.
6. Niedzielska, E.; Smaga, I.; Gawlik, M.; Moniczewski, A.; Stankowicz, P.; Pera, J.;
Filip, M. Mol. Neurobiol. 2016, 53, 4094–4125.
7. Lin, M. T.; Beal, M. F. Nature 2006, 443, 787–795.
8. Parke, D.; Sapota, A. Int. J. Occup. Med. Environ. Health 1995, 9, 331–340.
9. Fuchs, J. Environmental Stressors in Health and Disease. CRC Press, New York, 2001;
Vol. 7.
10. Sundaresan, M.; Yu, Z.-X.; Ferrans, V. J.; Irani, K.; Finkel, T. Science 1995, 270, 296.
11. Stone, J. R.; Yang, S. Antioxidants Redox Signal 2006, 8, 243–270.
12. Woo, H. A.; Yim, S. H.; Shin, D. H.; Kang, D.; Yu, D.-Y.; Rhee, S. G. Cell 2010,
140, 517–528.
13. Trachootham, D.; Alexandre, J.; Huang, P. Nat. Rev. Drug Discov. 2009, 8, 579–591.
14. Vatansever, F.; de Melo, W. C.; Avci, P.; Vecchio, D.; Sadasivam, M.; Gupta, A.;
Chandran, R.; Karimi, M.; Parizotto, N. A.; Yin, R.; Tegos, G. P.;
Hamblin, M. R. FEMS Microbiol. Rev. 2013, 37, 955–989.
15. Fridovich, I. Aging Cell 2004, 3, 13–16.
16. Soares, H. T.; Campos, J. R. S.; Gomes-da-Silva, L. C.; Schaberle, F. A.;
Dabrowski, J. M.; Arnaut, L. G. Chembiochem 2016, 17, 836–842.
17. Pelicano, H.; Carney, D.; Huang, P. Drug Resist. Updat. 2004, 7, 97–110.
18. Dabrowski, J. M.; Arnaut, L. G. Photochem. Photobiol. Sci. 2015, 14, 1765–1780.
Reactive Oxygen Species in Photodynamic Therapy 387
19. Agostinis, P.; Berg, K.; Cengel, K. A.; Foster, T. H.; Girotti, A. W.; Gollnick, S. O.;
Hahn, S. M.; Hamblin, M. R.; Juzeniene, A.; Kessel, D.; Korbelik, M.; Moan, J.;
Mroz, P.; Nowis, D.; Piette, J.; Wilson, B. C.; Golab, J. CA Cancer J. Clin. 2011,
61, 250–281.
20. Castano, A. P.; Mroz, P.; Hamblin, M. R. Nat. Rev. Cancer 2006, 6, 535–545.
21. Gonçalves, N. P. F.; Simões, A. V. C.; Abreu, A. R.; Abrunhosa, A. J.;
Da˛browski, J. M.; Pereira, M. M. J. Porphyr. Phthalocya. 2015, 19, 946–955.
22. Dolmans, D. E. J. G. J.; Fukumura, D.; Jain, R. K. Nat. Rev. Cancer 2003, 3, 380–387.
23. Rocha, L. B.; Gomes-da-Silva, L. C.; Da˛browski, J. M.; Arnaut, L. G. Eur. J. Cancer
2015, 51, 1822–1830.
24. Spring, B. Q.; Rizvi, I.; Xu, N.; Hasan, T. Photochem. Photobiol. 2015, 14, 1476–1491.
25. Crabb, J. W.; Miyagi, M.; Gu, X.; Shadrach, K.; West, K. A.; Sakaguchi, H.;
Kamei, M.; Hasan, A.; Yan, L.; Rayborn, M. E. Proc. Natl. Acad. Sci. U.S.A. 2002,
99, 14682–14687.
26. Kawczyk-Krupka, A.; Bugaj, A. M.; Potempa, M.; Wasilewska, K.; Latos, W.;
Sieron, A. Photodiagnosis Photodyn. Ther. 2015, 12, 161–175.
27. Schmidt-Erfurth, U.; Hasan, T. Surv. Ophthalmol. 2000, 45, 195–214.
28. Dai, T.; Huang, Y.-Y.; Hamblin, M. R. Photodiagnosis Photodyn. Ther. 2009, 6, 170–188.
29. Gad, F.; Zahra, T.; Francis, K. P.; Hasan, T.; Hamblin, M. R. Photochem. Photobiol. Sci.
2004, 3, 451–458.
30. Geilich, B. M.; van de Ven, A. L.; Singleton, G. L.; Sepulveda, L. J.; Sridhar, S.;
Webster, T. J. Nanoscale 2015, 7, 3511–3519.
31. Hamblin, M. R. Curr. Opin. Microbiol. 2016, 33, 67–73.
32. Hamblin, M. R.; Hasan, T. Photochem. Photobiol. Sci. 2004, 3, 436–450.
33. Huang, L.; Zhiyentayev, T.; Xuan, Y.; Azhibek, D.; Kharkwal, G. B.; Hamblin, M. R.
Lasers Surg. Med. 2011, 43, 313–323.
34. Huang, Y.-Y.; Choi, H.; Kushida, Y.; Bhayana, B.; Wang, Y.; Hamblin, M. R. Anti-
microb. Agents Chemother. 2016, 60, 5445–5453.
35. Vecchio, D.; Dai, T.; Huang, L.; Fantetti, L.; Roncucci, G.; Hamblin, M. R.
J. Biophotonics 2013, 6, 733–742.
36. Vecchio, D.; Gupta, A.; Huang, L.; Landi, G.; Avci, P.; Rodas, A.; Hamblin, M. R.
Antimicrob. Agents Chemother. 2015, 59, 5203–5212.
37. Vera, D. M. A.; Haynes, M. H.; Ball, A. R.; Dai, T.; Astrakas, C.; Kelso, M. J.;
Hamblin, M. R.; Tegos, G. P. Photochem. Photobiol. 2012, 88, 499–511.
38. Yin, R.; Agrawal, T.; Khan, U.; Gupta, G. K.; Rai, V.; Huang, Y.-Y.; Hamblin, M. R.
Nanomedicine 2015, 10, 2379–2404.
39. Yin, R.; Dai, T.; Avci, P.; Jorge, A. E. S.; de Melo, W. C.; Vecchio, D.; Huang, Y.-Y.;
Gupta, A.; Hamblin, M. R. Curr. Opin. Pharmacol. 2013, 13, 731–762.
40. Abels, C. Photochem. Photobiol. Sci. 2004, 3, 765–771.
41. Arnaut, L. G.; Pereira, M. M.; Da˛browski, J. M.; Silva, E. F.; Schaberle, F. A.;
Abreu, A. R.; Rocha, L. B.; Barsan, M. M.; Urba nska, K.; Stochel, G. Chem.
A Eur. J. 2014, 20, 5346–5357.
42. Castano, A. P.; Demidova, T. N.; Hamblin, M. R. Photodiagnosis Photodyn. Ther. 2004,
1, 279–293.
43. Dougherty, T. J.; Gomer, C. J.; Henderson, B. W.; Jori, G.; Kessel, D.; Korbelik, M.;
Moan, J.; Peng, Q. J. Nat. Cancer Inst. 1998, 90, 889–905.
44. Ethirajan, M.; Chen, Y.; Joshi, P.; Pandey, R. K. Chem. Soc. Rev. 2011, 40, 340–362.
45. Da˛browski, J. M.; Pucelik, B.; Regiel-Futyra, A.; Brindell, M.; Mazuryk, O.;
Kyzioł, A.; Stochel, G.; Macyk, W.; Arnaut, L. G. Coord. Chem. Rev. 2016, 325,
67–101.
46. Garg, A. D.; Maes, H.; Romano, E.; Agostinis, P. Photochem. Photobiol. Sci. 2015, 14,
1410–1424.
388 Janusz M. Dąbrowski
47. Edinger, A. L.; Thompson, C. B. Curr. Opinion Cell Biol. 2004, 16, 663–669.
48. Kessel, D.; Oleinick, N. L. Method Enzymol. 2009, 453, 1–16.
49. Kessel, D. H.; Price, M.; Reiners, J.; John, J. Autophagy 2012, 8, 1333–1341.
50. Schmidt-Erfurth, U.; Hasan, T.; Gragoudas, E.; Michaud, N.; Flotte, T. J.;
Birngruber, R. Ophthalmology 1994, 101, 1953–1961.
51. Dolmans, D. E. J. G. J.; Kadambi, A.; Hill, J. S.; Waters, C. A.; Robinson, B. C.;
Walker, J. P.; Fukumura, D.; Jain, R. K. Cancer Res. 2002, 62, 2151–2156.
52. Azzouzi, A.-R.; Lebdai, S.; Benzaghou, F.; Stief, C. World J. Urol. 2015, 33, 937–944.
53. Chen, B.; Pogue, B. W.; Hoopes, P. J.; Hasan, T. Int. J. Radiat. Oncol. Biol. Phys. 2005,
61, 1216–1226.
54. Krammer, B. Anticancer Res 2001, 21, 4271–4277.
55. Maeda, H.; Wu, J.; Sawa, T.; Matsumura, Y.; Hori, K. J. Control. Release 2000, 65,
271–284.
56. Preise, D.; Scherz, A.; Salomon, Y. Photochem. Photobiol. Sci. 2011, 10, 681–688.
57. Zilberstein, J.; Schreiber, S.; Bloemers, M. C. W. M.; Bendel, P.; Neeman, M.;
Schechtman, E.; Kohen, F.; Scherz, A.; Salomon, Y. Photochem. Photobiol. 2001, 73,
257–266.
58. Krzykawska-Serda, M.; Da˛browski, J. M.; Arnaut, L. G.; Szczygieł, M.; Urba nska, K.;
Stochel, G.; Elas, M. Free Radic. Biol. Med. 2014, 73, 239–251.
59. Mroz, P.; Szokalska, A.; Wu, M. X.; Hamblin, M. R. PLoS One 2010, 5, e15194.
60. Gollnick, S. O.; Brackett, C. M. Immunol. Res. 2010, 46, 216–226.
61. Garg, A. D.; Nowis, D.; Golab, J.; Agostinis, P. Apoptosis 2010, 15, 1050–1071.
62. Allison, R. R.; Downie, G. H.; Cuenca, R.; Hu, X.-H.; Childs, C. J.; Sibata, C. H.
Photodiagnosis Photodyn. Ther. 2004, 1, 27–42.
63. Davia, K.; King, D.; Hong, Y. L.; Swavey, S. Inorg. Chem. Commun. 2008, 11,
584–586.
64. Derycke, A. S. L.; de Witte, P. A. M. Adv. Drug Deliv. Rev. 2004, 56, 17–30.
65. Ethirajan, M.; Saenz, C.; Gupta, A.; Dobhal, M.; Pandey, R. Advances in Photodynamic
Therapy: Basic, Translational, and Clinical. Artech House: Boston, 2008;13–39.
66. Rocha, L. B.; Schaberle, F.; Da˛browski, J. M.; Simões, S.; Arnaut, L. G. Int. J. Mol. Sci.
2015, 16, 29236–29249.
67. Saavedra, R.; Rocha, L. B.; Da˛browski, J. M.; Arnaut, L. G. ChemMedChem 2014, 9,
390–398.
68. Hamblin, M. R.; Newman, E. L. J. Photochem. Photobiol. B 1994, 23, 3–8.
69. Castano, A. P.; Demidova, T. N.; Hamblin, M. R. Photodiagnosis Photodyn. Ther. 2005,
2, 91–106.
70. Szaciłowski, K.; Macyk, W.; Drzewiecka-Matuszek, A.; Brindell, M.; Stochel, G.
Chem. Rev. 2005, 105, 2647–2694.
71. Stochel, G.; Brindell, M.; Macyk, W.; Stasicka, Z.; Szaciłowski, K. Bioinorganic Photo-
chemistry. John Wiley & Sons Ltd: Chichester, 2009, 382.
72. Hu, J.; Tang, Y. a.; Elmenoufy, A. H.; Xu, H.; Cheng, Z.; Yang, X. Small 2015, 11,
5860–5887.
73. Smith, A. M.; Mancini, M. C.; Nie, S. Nat. Nanotechnol. 2009, 4, 710.
74. Luo, S.; Zhang, E.; Su, Y.; Cheng, T.; Shi, C. Biomaterials 2011, 32, 7127–7138.
75. Farrell, T. J.; Wilson, B. C.; Patterson, M. S.; Chow, R. Optics, Electro-Optics, and
Laser Applications in Science and Engineering. SPIE (International Society for Optics
and Electronics): Bellingham, USA, 1991, pp 146–155.
76. Niedre, M. J.; Secord, A. J.; Patterson, M. S.; Wilson, B. C. Cancer Res. 2003, 63,
7986–7994.
77. Idris, N. M.; Jayakumar, M. K. G.; Bansal, A.; Zhang, Y. Chem. Soc. Rev. 2015, 44,
1449–1478.
78. Zhou, J.; Liu, Q.; Feng, W.; Sun, Y.; Li, F. Chem. Rev. 2015, 115, 395–465.
Reactive Oxygen Species in Photodynamic Therapy 389
79. Chen, G.; Qiu, H.; Prasad, P. N.; Chen, X. Chem. Rev. 2014, 114, 5161–5214.
80. Brancaleon, L.; Moseley, H. Lasers Med. Sci. 2002, 17, 173–186.
81. Mitsunaga, M.; Ogawa, M.; Kosaka, N.; Rosenblum, L. T.; Choyke, P. L.;
Kobayashi, H. Nat. Med. 2011, 17, 1685–1691.
82. Damoiseau, X.; Schuitmaker, H. J.; Lagerberg, J. W. M.; Hoebeke, M. J. Photochem.
Photobiol. B 2001, 60, 50–60.
83. Kong, G.; Anyarambhatla, G.; Petros, W. P.; Braun, R. D.; Colvin, O. M.;
Needham, D.; Dewhirst, M. W. Cancer Res. 2000, 60, 6950–6957.
84. Łapok, Ł.; Cyza, M.; Gut, A.; Ke˛pczy nski, M.; Szewczyk, G.; Sarna, T.;
Nowakowska, M. J. Photochem. Photobiol. A 2014, 286, 55–63.
85. Morgan, J.; Lottman, H.; Abbou, C. C.; Chopin, D. K. Photochem. Photobiol. 1994, 60,
486–496.
86. Namiki, Y.; Namiki, T.; Date, M.; Yanagihara, K.; Yashiro, M.; Takahashi, H.
Pharmacol. Res. 2004, 50, 65–76.
87. Nunes, S. M. T.; Sguilla, F. S.; Tedesco, A. C. Braz. J. Med. Biol. Res. 2004, 37,
273–284.
88. Puri, A. Pharmaceutics 2014, 6, 1–25.
89. Reddi, E. J. Photochem. Photobiol. B. 37, 189–195.
90. Reddi, E.; Zhou, C.; Biolo, R.; Menegaldo, E.; Jori, G. Br. J. Cancer 1990, 61,
407–411.
91. Sadasivam, M.; Avci, P.; Gupta, G. K.; Lakshmanan, S.; Chandran, R.; Huang, Y.-Y.;
Kumar, R.; Hamblin, M. R. Eur. J. Nanomed. 2013, 5. http://dx.doi.org/10.1515/
ejnm-2013-0010.
92. Thompson, D. H.; Gerasimov, O. V.; Wheeler, J. J.; Rui, Y.; Anderson, V. C. Biochim.
Biophys. Acta—Biomembranes 1996, 1279, 25–34.
93. Krysko, D. V.; Garg, A. D.; Kaczmarek, A.; Krysko, O.; Agostinis, P.;
Vandenabeele, P. Nat. Rev. Cancer 2012, 12, 860–875.
94. DeRosa, M. C.; Crutchley, R. J. Coord. Chem. Rev. 2002, 233–234, 351–371.
95. Yang, S. I.; Seth, J.; Strachan, J.-P.; Gentemann, S.; Kim, D.; Holten, D.; Lindsey, J. S.;
Bocian, D. F. J. Porphyr. Phthalocya. 1999, 03, 117–147.
96. Hamblin, M. R.; Huang, Y. Y. Handbook of Photomedicine. CRC Press: Boca Raton,
2014, p 854.
97. Kadish, K. M.; Smith, K. M.; Guilard, R. The Porphyrin Handbook: Inorganic, Organo-
metallic and Coordination Chemistry; Vol. 3. Elsevier: San Diego, 2000; Vol. 3.
98. Da˛browski, J. M.; Pucelik, B.; Pereira, M. M.; Arnaut, L. G.; Macyk, W.; Stochel, G.
RSC Adv. 2015, 5, 93252–93261.
99. Silva, M.; Azenha, M.; Pereira, M.; Burrows, H.; Sarakha, M.; Forano, C.;
Ribeiro, M.; Fernandes, A. Appl Catal B 2010, 100, 1–9.
100. Pinto, S. M.; Henriques, C. A.; Tome, V. A.; Vinagreiro, C. S.; Calvete, M. J.;
Da˛browski, J. M.; Piñeiro, M.; Arnaut, L. G.; Pereira, M. M. J. Porphyr. Phthalocya.
2016, 20, 45–60.
101. Giuntini, F.; Dumoulin, F.; Daly, R.; Ahsen, V.; Scanlan, E. M.; Lavado, A. S. P.;
Aylott, J. W.; Rosser, G. A.; Beeby, A.; Boyle, R. W. Nanoscale 2012, 4, 2034–2045.
102. Jurow, M.; Schuckman, A. E.; Batteas, J. D.; Drain, C. M. Coord. Chem. Rev. 2010,
254, 2297–2310.
103. Berenbaum, M.; Akande, S.; Bonnett, R.; Kaur, H.; Ioannou, S.; White, R.;
Winfield, U. Br. J. Cancer 1986, 54, 717.
104. Da˛browski, J. M.; Arnaut, L. G.; Pereira, M. M.; Urbanska, K.; Simoes, S.; Stochel, G.;
Cortes, L. Free Radic. Biol. Med. 2012, 52, 1188–1200.
105. Silva, E. F. F.; Serpa, C.; Da˛browski, J. M.; Monteiro, C. J. P.; Formosinho, S. J.;
Stochel, G.; Urba nska, K.; Simões, S.; Pereira, M. M.; Arnaut, L. G. Chem. A Eur.
J. 2010, 16, 9273–9286.
390 Janusz M. Dąbrowski
106. Pineiro, M.; Pereira, M. M.; Formosinho, S. J.; Arnaut, L. G. J. Phys. Chem. A 2002,
106, 3787–3795.
107. Yang, E.; Diers, J. R.; Huang, Y. Y.; Hamblin, M. R.; Lindsey, J. S.; Bocian, D. F.;
Holten, D. Photochem. Photobiol. 2013, 89, 605–618.
108. Da˛browski, J. M.; Arnaut, L. G.; Pereira, M. M.; Monteiro, C. J.; Urba nska, K.;
Simões, S.; Stochel, G. ChemMedChem 2010, 5, 1770–1780.
109. Da˛browski, J. M.; Urbanska, K.; Arnaut, L. G.; Pereira, M. M.; Abreu, A. R.;
Simões, S.; Stochel, G. ChemMedChem 2011, 6, 465–475.
110. Da˛browski, J. M.; Krzykawska, M.; Arnaut, L. G.; Pereira, M. M.; Monteiro, C. J.;
Simões, S.; Urbanska, K.; Stochel, G. ChemMedChem 2011, 6, 1715–1726.
111. Silva, E. F. F.; Schaberle, F. A.; Monteiro, C. J. P.; Da˛browski, J. M.; Arnaut, L. G.
Photochem. Photobiol. Sci. 2013, 12, 1187–1192.
112. Da˛browski, J. M.; Pereira, M. M.; Arnaut, L. G.; Monteiro, C. J. P.; Peixoto, A. F.;
Karocki, A.; Urba nska, K.; Stochel, G. Photochem. Photobiol. 2007, 83, 897–903.
113. Pucelik, B.; G€ urol, I.; Ahsen, V.; Dumoulin, F.; Da˛browski, J. M. Eur. J. Med. Chem.
2016, 124, 284–298.
114. Topal, S. Z.; Isci, U.; Kumru, U.; Atilla, D.; Gurek, A. G.; Hirel, C.; Durmus, M.;
Tommasino, J.-B.; Luneau, D.; Berber, S.; Dumoulin, F.; Ahsen, V. Dalton Trans.
2014, 43, 6897–6908.
115. Pereira, M. M.; Monteiro, C. J. P.; Simões, A. V. C.; Pinto, S. M. A.; Abreu, A. R.;
Sá, G. F. F.; Silva, E. F. F.; Rocha, L. B.; Da˛browski, J. M.; Formosinho, S. J.;
Simões, S.; Arnaut, L. G. Tetrahedron. 2010, 66, 9545–9551.
116. Arnaut, L. G. In Design of porphyrin-based photosensitizers for photodynamic therapy; van
Eldik, R., Stochel, G., Eds.; Advances in Inorganic Chemistry, Vol. 63, Elsevier
Academic Press: San Diego, 2011; pp 187–233.
117. Aydın Tekdaş, D.; Kumru, U.; G€ urek, A. G.; Durmuş, M.; Ahsen, V.; Dumoulin, F.
Tetrahedron Lett. 2012, 53, 5227–5230.
118. Simões, A. V. C.; Adamowicz, A.; Da˛browski, J. M.; Calvete, M. J. F.; Abreu, A. R.;
Stochel, G.; Arnaut, L. G.; Pereira, M. M. Tetrahedron 2012, 68, 8767–8772.
119. Da˛browski, J. M.; Pucelik, B.; Pereira, M. M.; Arnaut, L. G.; Stochel, G. J. Coord.
Chem. 2015, 68, 3116–3134.
120. Aydın Tekdaş, D.; Garifullin, R.; Şent€ urk, B.; Zorlu, Y.; Gundogdu, U.; Atalar, E.;
Tekinay, A. B.; Chernonosov, A. A.; Yerli, Y.; Dumoulin, F.; Guler, M. O.;
Ahsen, V.; G€ urek, A. G. Photochem. Photobiol. 2014, 90, 1376–1386.
121. Dumoulin, F.; Ali, H.; Ahsen, V.; van Lier, J. E. Tetrahedron Lett. 2011, 52, 4395–4397.
122. Dumoulin, F.; Durmuş, M.; Ahsen, V.; Nyokong, T. Coord. Chem. Rev. 2010, 254,
2792–2847.
123. Zorlu, Y.; Dumoulin, F.; Bouchu, D.; Ahsen, V.; Lafont, D. Tetrahedron Lett. 2010, 51,
6615–6618.
124. Zorlu, Y.; Dumoulin, F.; Durmuş, M.; Ahsen, V. Tetrahedron 2010, 66, 3248–3258.
125. Hong, G.; Diao, S.; Chang, J.; Antaris, A. L.; Chen, C.; Zhang, B.; Zhao, S.;
Atochin, D. N.; Huang, P. L.; Andreasson, K. I. Nat. Photonics 2014, 8, 723–730.
126. Chen, C.-Y.; Sun, E.; Fan, D.; Taniguchi, M.; McDowell, B. E.; Yang, E.; Diers, J. R.;
Bocian, D. F.; Holten, D.; Lindsey, J. S. Inorg. Chem. 2012, 51, 9443–9464.
127. Huang, L.; Krayer, M.; Roubil, J. G.; Huang, Y.-Y.; Holten, D.; Lindsey, J. S.;
Hamblin, M. R. J. Photochem. Photobiol. B. 2014, 141, 119–127.
128. Huang, Y. Y.; Balasubramanian, T.; Yang, E.; Luo, D.; Diers, J. R.; Bocian, D. F.;
Lindsey, J. S.; Holten, D.; Hamblin, M. R. ChemMedChem 2012, 7, 2155–2167.
129. Jiang, J.; Yang, E.; Reddy, K. R.; Niedzwiedzki, D. M.; Kirmaier, C.; Bocian, D. F.;
Holten, D.; Lindsey, J. S. New J. Chem. 2015, 39, 5694–5714.
130. Krayer, M.; Yang, E.; Kim, H.-J.; Kee, H. L.; Deans, R. M.; Sluder, C. E.; Diers, J. R.;
Kirmaier, C.; Bocian, D. F.; Holten, D.; Lindsey, J. S. Inorg. Chem. 2011, 50, 4607–4618.
Reactive Oxygen Species in Photodynamic Therapy 391
131. Huang, Y.-Y.; Mroz, P.; Zhiyentayev, T.; Sharma, S. K.; Balasubramanian, T.; Ruzie, C.;
Krayer, M.; Fan, D.; Borbas, K. E.; Yang, E. J. Med. Chem. 2010, 53, 4018–4027.
132. Dabrowski, J. M.; Arnaut, L. G.; Pereira, M. M.; Urbanska, K.; Stochel, G.
Medchemcomm 2012, 3, 502–505.
133. Fukuzumi, S.; Ohkubo, K.; Zheng, X.; Chen, Y.; Pandey, R. K.; Zhan, R.;
Kadish, K. M. J. Phys. Chem. B 2008, 112, 2738–2746.
134. Garcia-Diaz, M.; Huang, Y.-Y.; Hamblin, M. R. Methods 2016, 109, 158–166.
135. Price, M.; Kessel, D. J. Biomed. Opt. 2010, 15, 051605.
136. Price, M.; Reiners, J. J.; Santiago, A. M.; Kessel, D. Photochem. Photobiol. 2009, 85,
1177–1181.
137. Setsukinai, K.-I.; Urano, Y.; Kakinuma, K.; Majima, H. J.; Nagano, T. J. Biol. Chem.
2003, 278, 3170–3175.
138. Azenha, E.; Serra, A. C.; Pineiro, M.; Pereira, M. M.; Seixas de Melo, J.; Arnaut, L. G.;
Formosinho, S. J.; Rocha Gonsalves, A. M. d. A. Chem. Phys 2002, 280, 177–190.
139. Wilkinson, F.; Abdel-Shafi, A. J. Phys. Chem. A 1997, 101, 5509–5516.
140. Boyer, R. F.; McCleary, C. J. Free Radic. Biol. Med. 1987, 3, 389–395.
141. Gutteridge, J. M.; Maidt, L.; Poyer, L. Biochem. J. 1990, 269, 169–174.
142. Rizzi, C.; Samouilov, A.; Kutala, V. K.; Parinandi, N. L.; Zweier, J. L.; Kuppusamy, P.
Free Radic. Biol. Med. 2003, 35, 1608–1618.
143. Ershov, B.; Gordeev, A. Radiat. Phys. Chem. 2008, 77, 928–935.
144. Nandi, D.; Krishnakumar, E.; Rosa, A.; Schmidt, W.-F.; Illenberger, E. Chem. Phys.
Lett. 2003, 373, 454–459.
145. Evans, M. K.; Tovmasyan, A.; Batinic-Haberle, I.; Devi, G. R. Free Radic. Biol. Med.
2014, 68, 302–314.
146. Chen, Q.; Espey, M. G.; Krishna, M. C.; Mitchell, J. B.; Corpe, C. P.; Buettner, G. R.;
Shacter, E.; Levine, M. Proc. Natl. Acad. Sci. U.S.A. 2005, 102, 13604–13609.
147. Kehrer, J. P. Toxicology 2000, 149, 43–50.
148. Bielski, B. H. J.; Cabelli, D. E.; Arudi, R. L.; Ross, A. B. J. Phys. Chem. Ref. Data 1985,
14, 1041–1100.
149. Kramarenko, G. G.; Wilke, W. W.; Dayal, D.; Buettner, G. R.; Schafer, F. Q. Free
Radic. Biol. Med. 2006, 40, 1615–1627.
150. Bacellar, I. O.; Tsubone, T. M.; Pavani, C.; Baptista, M. S. Int. J. Mol. Sci. 2015, 16,
20523–20559.
151. Plaetzer, K.; Krammer, B.; Berlanda, J.; Berr, F.; Kiesslich, T. Lasers Med. Sci. 2009, 24,
259–268.
152. da Silva, E. F. F.; Pimenta, F. M.; Pedersen, B. W.; Blaikie, F. H.; Bosio, G. N.;
Breitenbach, T.; Westberg, M.; Bregnhoj, M.; Etzerodt, M.; Arnaut, L. G.;
Ogilby, P. R. Integr. Biol. 2016, 8, 177–193.
153. da Silva, E. F.; Pedersen, B. W.; Breitenbach, T.; Toftegaard, R.; Kuimova, M. K.;
Arnaut, L. G.; Ogilby, P. R. J. Phys. Chem. B 2011, 116, 445–461.
154. Berg, K.; Moan, J. Photochem. Photobiol. 1997, 65, 403–409.
155. Chowdhary, R. K.; Chansarkar, N.; Sharif, I.; Hioka, N.; Dolphin, D. Photochem. Pho-
tobiol. 2003, 77, 299–303.
156. Gelderblom, H.; Verweij, J.; Nooter, K.; Sparreboom, A. Eur. J. Cancer 2001, 37,
1590–1598.
157. Pucelik, B.; Paczy nski, R.; Dubin, G.; Pereira, M. M.; Arnaut, L. G.; Da˛browski, J. M.
J. Photobiol. Photochem. B., 2017, submitted.
158. Tije, A. J.; Verweij, J.; Loos, W. J.; Sparreboom, A. Clin. Pharmacokinet. 2012, 42,
665–685.
159. Vilsinski, B. H.; Gerola, A. P.; Enumo, J. A.; Campanholi, K. D. S. S.;
Pereira, P. C. D. S.; Braga, G.; Hioka, N.; Kimura, E.; Tessaro, A. L.; Caetano, W.
Photochem. Photobiol. 2015, 91, 518–525.
392 Janusz M. Dąbrowski
160. Jori, G. In CRC Handbook of Organic Photochemistry and Photobiology, Horspool, W. M.,
Lenci, F., Eds. 2nd ed.; CRC Press: Boca Raton (Florida), 2004, pp 146.1–14610.
161. Mojzisova, H.; Bonneau, S.; Vever-Bizet, C.; Brault, D. Biochim. Biophys. Acta—
Biomembranes 1768, 2007, 2748–2756.
162. Juarranz, A.; Villanueva, A.; Dı́az, V.; Cañete, M. J. Photochem. Photobiol. B, 1995, 27,
47–53.
163. Kuimova, M. K.; Balaz, M.; Anderson, H. L.; Ogilby, P. R. J. Am. Chem. Soc. 2009,
131, 7948–7949.
164. Mroz, P.; Huang, Y.-Y.; Szokalska, A.; Zhiyentayev, T.; Janjua, S.; Nifli, A.-P.;
Sherwood, M. E.; Ruzie, C.; Borbas, K. E.; Fan, D.; Krayer, M.;
Balasubramanian, T.; Yang, E.; Kee, H. L.; Kirmaier, C.; Diers, J. R.; Bocian, D. F.;
Holten, D.; Lindsey, J. S.; Hamblin, M. R. FASEB J. 2010, 24, 3160–3170.
165. Hsieh, Y.-J.; Wu, C. C.; Chang, C. J.; Yu, J. S. J. Cell. Physiol. 2003, 194, 363–375.
166. Hsieh, Y.-J.; Yu, J.-S.; Lyu, P.-C. J. Cell. Biochem. 2010, 111, 821–833.
167. Marchal, S.; François, A.; Dumas, D.; Guillemin, F.; Bezdetnaya, L. Br. J. Cancer 2007,
96, 944–951.
168. Runnels, J. M.; Chen, N.; Ortel, B.; Kato, D.; Hasan, T. Br. J. Cancer 1999, 80,
946–953.
169. Osaki, T.; Takagi, S.; Hoshino, Y.; Okumura, M.; Fujinaga, T. Cancer Lett. 2006, 243,
281–292.
170. Tada-Oikawa, S.; Oikawa, S.; Hirayama, J.; Hirakawa, K.; Kawanishi, S. Photochem.
Photobiol. 2009, 85, 1391–1399.
171. Moor, A. C. J. Photochem. Photobiol. B, 2000, 57, 1–13.
172. Ashur, I.; Goldschmidt, R.; Pinkas, I.; Salomon, Y.; Szewczyk, G.; Sarna, T.;
Scherz, A. J. Phys. Chem. A 2009, 113, 8027–8037.
173. Oleinick, N. L.; Morris, R. L.; Belichenko, I. Photochem. Photobiol. Sci. 2002, 1, 1–21.
174. Mroz, P.; Yaroslavsky, A.; Kharkwal, G. B.; Hamblin, M. R. Cancer 2011, 3, 2516.
175. Martinou, J.-C.; Desagher, S.; Antonsson, B. Nat. Cell Biol. 2000, 2, E41–E43.
176. Varnes, M. E.; Chiu, S.-M.; Xue, L.-Y.; Oleinick, N. L. Biochem. Biophys. Res.
Commun. 1999, 255, 673–679.
177. Xue, L. Y.; Chiu, S. M.; Oleinick, N. L. Exp. Cell Res. 2001, 263, 145–155.
178. Teiten, M. H.; Marchal, S.; D’Hallewin, M.; Guillemin, F.; Bezdetnaya, L. Photochem.
Photobiol. 2003, 78, 9–14.
179. Reiners, J., Jr.; Caruso, J.; Mathieu, P.; Chelladurai, B.; Yin, X.; Kessel, D. Cell Death
Differ. 2002, 9, 934.
180. Chiu, S.; Oleinick, N. Br. J. Cancer 2001, 84, 1099.
181. Vantieghem, A.; Xu, Y.; Declercq, W.; Vandenabeele, P.; Denecker, G.;
Vandenheede, J. R.; Merlevede, W.; De Witte, P. A.; Agostinis, P. Photochem. Photo-
biol. 2001, 74, 133–142.
182. Kessel, D. Photochem. Photobiol. 2008, 84, 809–814.
183. Proskuryakov, S. Y.; Konoplyannikov, A. G.; Gabai, V. L. Exp. Cell Res. 2003, 283,
1–16.
184. Pucelik, B.; Arnaut, L. G.; Stochel, G.; Da˛browski, J. M. ACS Appl. Mater. Interfaces
2016, 8, 22039–22055.
185. Coupienne, I.; Fettweis, G.; Rubio, N.; Agostinis, P.; Piette, J. Photochem. Photobiol.
Sci. 2011, 10, 1868–1878.
186. Wirawan, E.; Berghe, T. V.; Lippens, S.; Agostinis, P.; Vandenabeele, P. Cell Res.
2012, 22, 43–61.
187. Kroemer, G.; Levine, B. Nat. Rev. Mol. Cell Biol. 2008, 9, 1004–1010.
188. Scherz-Shouval, R.; Shvets, E.; Fass, E.; Shorer, H.; Gil, L.; Elazar, Z. EMBO J. 2007,
26, 1749–1760.
189. Pattingre, S.; Levine, B. Cancer Res. 2006, 66, 2885–2888.
Reactive Oxygen Species in Photodynamic Therapy 393
190. Xue, L. Y.; Chiu, S. M.; Azizuddin, K.; Joseph, S.; Oleinick, N. L. Autophagy 2008, 4,
125–127.
191. Andrzejak, M.; Price, M.; Kessel, D. H. Autophagy 2011, 7, 979–984.
192. Krzykawska, M.; Dabrowski, J. M.; Szczygiel, M.; Stochel, G.; Arnaut, L. G.;
Pereira, M. M.; Urbanska, K.; Elas, M. Eur. J. Cancer 2012, 48, S193.
193. Reginato, E.; Wolf, P.; Hamblin, M. R. World J. Immunol. 2014, 4, 1–11.
194. Nowis, D.; Stokłosa, T.; Legat, M.; Issat, T.; Jakóbisiak, M.; Goła˛b, J. Photodiagnosis
Photodyn. Ther. 2005, 2, 283–298.
195. Anzengruber, F.; Avci, P.; de Freitas, L. F.; Hamblin, M. R. Photochem. Photobiol. Sci.
2015, 14, 1492–1509.
196. Kousis, P. C.; Henderson, B. W.; Maier, P. G.; Gollnick, S. O. Cancer Res. 2007, 67,
10501–10510.
197. Bonnett, R.; McGarvey, D. J.; Harriman, A.; Land, E. J.; Truscott, T. G.;
Winfield, V. J. Photochem. Photobiol. 1988, 48, 271.
198. Schmidt, R.; Tanielian, C.; Dunsbach, R.; Wolff, C. J. Photochem. Photobiol. A 1994,
79, 11–17.
199. Vakrat-Haglili, Y.; Weiner, L.; Brumfeld, V.; Brandis, A.; Salomon, Y.; McLlroy, B.;
Wilson, B. C.; Pawlak, A.; Rozanowska, M.; Sarna, T.; Scherz, A. J. Am. Chem. Soc.
2005, 127, 6487–6497.
200. Zielonka, J.; Kalyanaraman, B. Free Radic. Biol. Med. 2010, 48, 983–1001.
201. Flors, C.; Fryer, M. J.; Waring, J.; Reeder, B.; Bechtold, U.; Mullineaux, P. M.;
Nonell, S.; Wilson, M. T.; Baker, N. R. J. Exp. Bot. 2006, 57, 1725–1734.
202. Gollmer, A.; Arnbjerg, J.; Blaikie, F. H.; Pedersen, B. W.; Breitenbach, T.;
Daasbjerg, K.; Glasius, M.; Ogilby, P. R. Photochem. Photobiol. 2011, 87, 671–679.
203. Dabrowski, J. M.; Silva, E.; Krzykawski, M.; Rocha, L.; Urbanska, K.; Pereira, M. M.;
Stochel, G.; Arnaut, L. G. Free Radic. Biol. Med. 2012, 53, S18.
204. Golab, J.; Nowis, D.; Skrycki, M.; Czocsot, H.; Baranczyk-Kuzma, A.;
Wilczynski, G. M.; Makowski, M.; Mroz, P.; Kozar, K.; Kaminski, R.; Jalili, A.;
Kopec, M.; Grzela, T.; Jakobisiak, M. J. Biol. Chem. 2003, 278, 407–414.
205. Price, M.; Terlecky, S. R.; Kessel, D. Photochem. Photobiol. 2009, 85, 1491–1496.
206. Miller, A. C.; Henderson, B. W. Radiat. Res. 1986, 107, 83–94.
207. Bachor, R.; Scholz, M.; Shea, C. R.; Hasan, T. Cancer Res. 1991, 51, 4410–4414.
208. Jiang, F.; Robin, A. M.; Katakowski, M.; Tong, L.; Espiritu, M.; Singh, G.; Chopp, M.
Lasers Med. Sci. 2003, 18, 128–133.
209. Oberdanner, C. B.; Plaetzer, K.; Kiesslich, T.; Krammer, B. Photochem. Photobiol. 2005,
81, 609–613.
210. Kimani, S. G.; Phillips, J. B.; Bruce, J. I.; MacRobert, A. J.; Golding, J. P. Photochem.
Photobiol. 2012, 88, 175–187.
211. Huang, P.; Feng, L.; Oldham, E. A.; Keating, M. J.; Plunkett, W. Nature 2000, 407,
390–395.
212. Bechet, D.; Couleaud, P.; Frochot, C.; Viriot, M.-L.; Guillemin, F.; Barberi-Heyob,
M. Trends Biotechnol. 26, 612–621.
213. Chatterjee, D. K.; Fong, L. S.; Zhang, Y. Adv. Drug Deliv. Rev. 2008, 60, 1627–1637.
214. Park, H.; Na, K. Biomaterials 2013, 34, 6992–7000.
215. Zhang, C.; Shi, G.; Zhang, J.; Niu, J.; Huang, P.; Wang, Y.; Wang, W.; Li, C.;
Kong, D. Nanoscale 2017, 9, 3304–3314.
216. Ding, H.; Yu, H.; Dong, Y.; Tian, R.; Huang, G.; Boothman, D. A.; Sumer, B. D.;
Gao, J. J. Control. Release 2011, 156, 276–280.
217. Jesenská, S.; Plı́štil, L.; Kubat, P.; Lang, K.; Brožová, L.; Popelka, Š.; Szatmáry, L.;
Mosinger, J. J. Biomed. Mater. Res. A 2011, 99, 676–683.
218. Hu, Y.; Kanka, J.; Liu, K.; Yang, Y.; Wang, H.; Du, H. RSC Adv. 2016, 6,
104819–104826.
394 Janusz M. Dąbrowski
Contents
1. Introduction 396
2. Liquid Organic Hydrogen Carriers 397
3. Recent Organic Materials for LOHC 398
4. Formic Acid for LOHC 401
5. Homogeneous Catalytic Dehydrogenation of Formic Acid 404
6. Cp* With Iridium Complex for H2 Generation From Formic Acid 408
7. High-Pressure H2 Generation 417
8. Application for Fuel Cell Batteries 421
9. Conclusion 424
References 425
Abstract
Formic acid is considered as one of the promising organic liquid hydrogen carriers for
the next generation; it can offer a viable method for safe hydrogen transport. In this
chapter, we introduce the potential of formic acid in terms of thermodynamics and
mechanism as described in earlier work in this area, as well as homogeneous catalysts
providing a viable method for the production of molecular hydrogen as a sustainable
fuel source through dehydrogenation. In addition, pentamethylcyclopentadienyl irid-
ium (Cp*Ir) catalysts are also focused upon for this reaction and shown as a strategy
to improve catalyst activity by introducing hydroxyl groups to increase turnover num-
bers. One of the major advantages of using formic acid as a hydrogen source is the
regeneration of formic acid through the interaction with carbon dioxide, thus
maintaining a continuous cycle, and offers a possibility for high energy output appli-
cations. The developed catalyst, Cp*Ir has potential to produce hydrogen gas with
very high pressure, 120 MPa, without facing the problem of decomposition. The gen-
erated gas pressure is sufficient for feeding a fuel cell vehicle, which requires 75 MPa,
1. INTRODUCTION
The increasing demand of energy especially in the transportation sec-
tor is diminishing fossil fuel supplies, and there are escalating environmental
concerns such as global warming (1). Recently renewable energy resources,
such as solar and wind power, geothermal energy, biomass energy, and
ocean energy, are receiving considerable attention in order to develop a sus-
tainable system (2). However, many researchers are focusing on these
renewable energy systems as there is not yet any widely applicable, practical
resolution. Nowadays, hydrogen gas (H2) can be considered as one of the
promising alternative clean fuels to replace conventional fossil fuels, and it
can be produced from any primary energy source. As a fuel, H2 can be used
either through direct introduction to an internal combustion engine or to a
fuel cell, and produces only water as a by-product (3,4). Thus, hydrogen can
be considered as one contender for zero-emission technology, which would
improve air quality especially of urbanized areas (5).
In Europe, a Strategic Research Agenda by the European Hydrogen and
Fuel Cell Technology Platform was published in 2004 for the development
of the necessity of hydrogen technologies in production, storage, transport,
and application in stationary and mobile systems (6). A development strategy
was also reported in 2004 for the technical, socioeconomic, and political
challenges of deploying world-class, competitive hydrogen technology
and fuel cell applications, and recommended courses of action (7).
In the United States, the Department of Energy published a hydrogen
and fuel cell program plan in September, 2011 (8), and clear technology
development targets are set, and progress is frequently assessed. In Califor-
nia, demonstration fleets of fuel cell vehicles are in use on the roads, and
state legislation on emissions represents a strong driving force for clean
vehicles.
Formic Acid as a Hydrogen Carrier for Fuel Cells 397
In Japan, after the Great East Japan Earthquake and the accident at the
Tokyo Electric Power Company (TEPCO)’s Fukushima Daiichi Nuclear
Power Plants in 2011, the energy situation changed drastically, both domes-
tically and abroad. Then in 2014, METI (the Ministry of Economy, Trade
and Industry, Japan) produced the fourth Strategic Energy Plan for Japan’s
new direction of energy policy. Within the plan a strategic road map for
hydrogen and fuel cells was published in June, 2014. This was to enable
the rapid expansion of hydrogen utilization such as hydrogen power gener-
ation, establishment of a large-scale hydrogen supply system, and a totally
carbon dioxide-free hydrogen supply system to form a “hydrogen society.”
still in its infancy because of the associated difficulties, particularly, its low
volumetric energy density and gaseous properties (10,11). To overcome
these difficulties, several methods were developed considering: (1) hydrogen
compression under high-pressure conditions, (2) hydrogen liquefaction at
low temperature, (3) hydrogen adsorption in metal hydrides, (4) cryogenic
storage with hydrogen adsorbing materials, and (5) hydrogen storage in liq-
uid organic hydrides.
Among these methods, hydrogen storage in liquid organic hydrides has
several beneficial aspects in terms of environmental, economical, technical,
and social usage. The concept of using liquid organic hydrides is preferred
because of the advantage of the capability of catalytic hydrogenation and
dehydrogenation in a cyclic manner. This concept has been investigated
in the Euro-Quebec Hydro Hydrogen Project regarding liquid hydrogen
and methyl cyclohexane; in addition various other liquid organic hydrides
were developed (12–14).
ð7Þ
ð8Þ
ð9Þ
ð10Þ
ð11Þ
Formic Acid as a Hydrogen Carrier for Fuel Cells 401
ð12Þ
The worldwide production of formic acid was about 621,000 t/a in 2012.
One of the main industrial routes is the carbonylation of methanol (Eq. 12)
and subsequent hydrolysis of methyl formate (Eq. 13). BASF (Germany,
BASF process), Kemira (Finland, Kemira-Leonard Process), Feicheng Acid
Chemicals (China), and Luxi Chemical Group (China) produce formic acid
by this route
ð14Þ
Fig. 1 A photo of a plastic bottle for formic acid, commercially available in Japan.
energy is required for H2 production from formic acid and could, there-
fore, be a more attractive H2 storage material. Moreover, carbon dioxide
(CO2), which is the coproduct of formic acid dehydrogenation, can be
allowed to hydrogenate back to formic acid in water or organic solvents
on the catalyst surface or in the presence of specific homogenous catalysts
(52–55). Therefore, formic acid can be shown to be a renewable chemical
for H2 storage (56–65) (Fig. 3).
Fig. 3 Schematic of a cycle for sustainable hydrogen generation and storage with
formic acid.
Fig. 4 Time course of evolved gas volume from the catalysis of formic acid conversion.
Formic Acid as a Hydrogen Carrier for Fuel Cells 409
Scheme 1 The acid–base equilibrium between the hydroxy and oxyanion forms, and
the resonance structures of the oxyanion form.
Fig. 6 Hammett type plot of log(TOFR/TOFH) vs σ p+ values of substituent (R) in the cat-
alyst at 60°C in 1 M aqueous formic acid solution (10 mL).
Fig. 8 The pH dependence of the solubility of Cp* catalyst with PHDP ligand and 4DHBP
ligand. Solid squares represent DHBP and open circles represent PHDP.
Fig. 10 Reaction mechanism for the dehydrogenation of formic acid catalyzed by Cp*Ir
catalyst.
Scheme 2 H2 generation from formic acid enhanced by the pendant base effect
through a proton relay (proton transfer) in step (B).
Fig. 11 Structure of the Cp*Ir complex with THBP, TH4BPM, and THBPM ligands.
are shown in Table 6. Introducing four hydroxy groups at ortho and para
positions, the catalytic activity of THBP was improved with the high
TOF (3890 h1) and TON (7650) values compared to these of 4DHBP
and 6DHBP containing species (Table 6, entry 2). Interestingly, when a
pyrimidine-based ligand was introduced, cited as TH4BPM in Fig. 11,
TOF and TON were drastically improved over 10 times (39,500 h1)
and 2 times, respectively, than the values for the 4DHBP complex. In addi-
tion, a dinuclear complex, (Cp*Ir)2(THBPM), showed further higher activ-
ity with the TOF of 228,000 h1 at 90°C and TON of 308,000 at 80°C
under the optimal reaction conditions (54).
The Cp*Ir(THBPM) catalyst has four OH groups at the ortho and para
positions to activate the catalyst. When THBPM was used as a ligand, much
faster gas generation compared to the case for 4DHBP as ligand was
observed, as shown in Fig. 12. For the optimization of the catalyst, the
pH dependence of the reaction was investigated, and the maximum can
be seen at pH 3.5 with TOF of 31,600 h1 (Fig. 13), which is close to
the pKa of the catalyst (pKa 3.8) and to the pKa of formic acid (pKa
3.75). These data suggest the OH groups on the THBPM ligand play
not only the “pendant base” role, but also other critical roles in the
dehydrogenation.
416 Hajime Kawanami et al.
7. HIGH-PRESSURE H2 GENERATION
Formic acid dehydrogenation is thermodynamically favorable, so that
high-pressure H2 is generated easily from formic acid rather than other H2
storage chemicals. Thus, there is the possibility of high-pressure gas gener-
ation by the decomposition of formic acid to the mixture of gas with H2 and
CO2. The first example was demonstrated by Laurenczy et al., in aqueous
solution using hydrophilic ruthenium-based catalysts, generated from the
highly water-soluble ligand meta-trisulfonated triphenylphosphine with
either [Ru(H2O)6]2+ or, more conveniently, commercially available RuCl3.
The generated H2/CO2 pressure was typically between 1 and 220 bar, but
no inhibition of catalytic activity was observed up to a pressure of 75 MPa
(Fig. 14). The total conversion did not reach 100% because 10% of SF added
for the activation of the catalyst remained unconverted; however, all the
formic acid was consumed. Notably, the decomposition of formic acid
under high-pressure conditions prevents the generation of CO and H2O
as confirmed by the analysis of a gas sample using FTIR spectroscopy (detec-
tion limit of 3 ppm). The continuous evolution of gases from formic acid
was also evaluated under high-pressure conditions (typically 5–25 MPa),
which was systematically verified after prolonged addition of formic acid.
The maximum gas out flow produced was nearly 600 mL min1 at 120°C
Fig. 14 Kinetic trace of formic acid decomposition in a closed system with a pressure
increase to 75 MPa.
418 Hajime Kawanami et al.
with [Ru(H2O)6]2+ (1.5 mmol) as the precatalyst. The catalyst’s life time
is over 1 month with the TOF of 230 5 h1, and the TON exceeded
40,000 cycles without any deactivation (53,57).
Seven years after the first report on high-pressure gas generation from
formic acid, Iguchi and Kawanami et al. reported very high-pressure gas
generation, over 120 MPa, from the decomposition of formic acid in the
presence of a water-soluble iridium catalyst at a moderate temperature of less
than 80°C (86,91). They used the Cp*Ir complex bearing 4DHBP as the
catalyst and obtained 123 MPa maximally (Fig. 15), but thermodynamic cal-
culations predicted the possibility of the generation of high-pressure gas at
225 MPa, using the method that had been developed. The TON was
37,000–38,000 in one batch with 92–93 mol% of high conversion at
40 MPa. The TOF value was decreased with the generated pressure from
9100 h1 at 0.1 MPa to 5700 h1 (2/3) at 10 MPa and 2500 h1 (1/4) at
40 MPa, respectively. Despite the successful generation of high-pressure
gas, the Cp*Ir catalyst was gradually decomposed. The catalyst undergoes
partial hydrogenolysis due to the presence of high-pressure H2 in the system,
resulting in an insoluble compound, which then precipitates after the reac-
tion. The deactivation mechanism predicted that the BPY ligand might be
Fig. 16 Images of the reactant (catalyst 2.8 mmol; water, 3 mL; FA (100%), 1 mL) during
the reaction at different stages: (A) before the reaction at RT (20°C), pH 6.8;
(B) dissolution of the catalyst at the initial stage in aqueous FA solution at 50°C under
high pressure (22 MPa), pH 0.9; (C) during reaction at 50°C under high pressure
(22 MPa), pH 0.9; (D) after the reaction; and (E) the precipitation of catalyst after cooling
down to RT (20°C), pH 1.9.
420 Hajime Kawanami et al.
30
25.8 MPa
25
20
Pressure (MPa)
15
10
H2:CO2 = 1:1
5
CO (<6 vol ppm)
0
0 1 2 3 4 5 6
Time (h)
Fig. 17 Time-dependent gas evolution through FA decomposition in the presence of Ru
catalyst bearing 2,20 -biimidazoline ligand. The reaction was carried out at 80°C in an
autoclave (internal volume is 7.0 mL) with 2 MPa of He gas, FA aqueous solution
(6.5 mol L1, 4.0 mL), and catalyst (8.0 mol, 2.0 mmol L1).
Table 7 Gas Contents of the Separated Gas Generated From the Decomposition of
FA at Various Temperatures of the Separator at 30 MPaa
Initial Gas Initial H2
Separator XH2 XCO Flow Rate Production
Entry Temp. (°C) (mol%) (mol%) (L h21)b Rate (h21)c
1 35 51 n.d.d 0.93 2560
2 0 58 n.d. 0.86 2620
3 15 69 n.d. 0.75 2790
4 40 80 n.d. 0.73 3030
5 51 85 n.d. 0.69 3050
a
Gas generation condition: 80°C, 30 MPa. Gas separation condition: 51°C to 35°C, 30 MPa. Aqueous
solution of FA: 8 mol L1, 40 mL, catalyst ([Cp*lr(4DHBP)(H2O)][HSO4]): 0.2 mmol L1, 7–8 μmol.
b
Average gas rate for initial 1 h.
c
Average rate of H2 gas per mole of the catalyst.
d
Not detected (less than 6 vol ppm).
H2/CO2
Air
humidification
(H2O)
Fuel cell
Cleaning unit
(charcoal)
Reaction vessel
Fig. 19 The hydrogen generation unit with a polymer electrolyte membrane fuel cell
(PEMFC).
Formic Acid as a Hydrogen Carrier for Fuel Cells 423
50
40
30
P (mW)
20
10
0
4
6
17
19
21
23
25 t (h)
27
29
46
52
0 69
200 400 600 800 1000
U (mV)
Fig. 20 Power output as a function of time.
1.0
0.8
0.9
0.6
Voltage (V)
H2 (UHP, cylinder)/O2
0.8
H2 (UHP, cylinder)/air
0.4
0.7
0.2
0.6
0.0 0.2 0.4 0.6 0.8 1.0
0.0
0.0 0.2 0.4 0.6 0.8 1.0
Time (h)
Fig. 22 Fuel cell performance comparison (H2/CO2 from formic acid and H2/air).
H2/O2 or H2/air fuel cell (Fig. 22). The durability of the system was assessed
in a longer duration experiment; the fuel cell maintained its voltage (0.85 V)
at a current value of 1.0 A, for the entire 14 h.
A group of students in Eindhoven “Team FAST” built successfully a
400 W model car that can carry 45 kg at approximately 8 km h1, and fur-
ther developed buses powered by formic acid. According to their website,
they will start to run a bus in the city for test purposes in 2017 (http://www.
teamfast.nl/).
9. CONCLUSION
In 2014, the Toyota Motor Cooperation started to sell the fuel cell
vehicle, Mirai, globally, followed by Honda selling the FCV, Clarity Fuel
Cell, in March, 2016. Even though FCVs are available commercially, the
overall program is still in its infancy considering the technologies as well
as the infrastructure to utilize FCVs; issues relating to the production, trans-
portation, storage, and feeding of hydrogen, especially at high-pressure, over
35 MPa up to 70 MPa, remain to be solved. As described in this chapter,
formic acid as a hydrogen storage material has immense potential that offers
many benefits to develop a sustainable society. We believe that formic acid
will be one of the promising hydrogen carriers for the next generation
throughout the world.
Formic Acid as a Hydrogen Carrier for Fuel Cells 425
REFERENCES
1. Schlapbach, L. Nature 2009, 460, 3.
2. Dresselhaus, M. S.; Thomas, I. L. Nature 2001, 414, 6.
3. Nikolaidis, P.; Poullikkas, A. Renew. Sustain. Energy Rev. 2017, 67, 597–611.
4. Marbán, G.; Valdes-Solı́s, T. Int. J. Hydrogen Energy 2007, 32, 1625–1637.
5. Schlapbach, L.; Z€ uttel, A. Nature 2001, 414, 6.
6. European Hydrogen & Fuel Cell Technology Platform, Development Strategy, August
2005.
7. Barrett, S. Fuel Cells Bull. 2005, 2005, 12–19.
8. Office of Energy Efficiency and Renewable Energy, U.S. Department Energy, Hydro-
gen and Fuel Cells Program Plan, September 2011.
9. Kothari, R.; Buddhi, D.; Sawhney, R. L. Renew. Sustain. Energy Rev. 2008, 12,
553–563.
10. Armaroli, N.; Balzani, V. ChemSusChem 2011, 4, 21–36.
11. Teichmann, D.; Arlt, W.; Wasserscheid, P.; Freymann, R. Energ. Environ. Sci. 2011, 4,
2767–2773.
12. Scherer, G. W. H.; Newson, E. Int. J. Hydrogen Energy 1998, 23, 19–25.
13. Zhao, H. Y.; Oyama, S. T.; Naeemi, E. D. Catal. Today 2010, 149, 172–184.
14. Giacomazzi, G.; Gretz, J. Cryogenics 1993, 33, 767–771.
15. Eberle, U.; Felderhoff, M.; Sch€ uth, F. Angew. Chem. Int. Ed. 2009, 48, 6608–6630.
16. Dalebrook, A. F.; Gan, W.; Grasemann, M.; Moret, S.; Laurenczy, G. Chem. Commun.
2013, 49, 8735–8751.
17. Biniwale, R.; Rayalu, S.; Devotta, S.; Ichikawa, M. Int. J. Hydrogen Energy 2008, 33,
360–365.
18. Pradhan, A. U.; Shukla, A.; Pande, J. V.; Karmarkar, S.; Biniwale, R. B. Int. J. Hydrogen
Energy 2011, 36, 680–688.
19. Shukla, A.; Karmakar, S.; Biniwale, R. B. Int. J. Hydrogen Energy 2012, 37, 3719–3726.
20. Alhumaidan, F.; Cresswell, D.; Garforth, A. Energy Fuel 2011, 25, 4217–4234.
21. Zhu, Q.-L.; Xu, Q. Energ. Environ. Sci. 2015, 8, 478–512.
22. Makowski, P.; Thomas, A.; Kuhn, P.; Goettmann, F. Energ. Environ. Sci. 2009, 2,
480–490.
23. Chaouki, J.; Klavana, D. Chem. Eng. Sci. 1994, 49, 4639–4646.
24. Shukla, A. A.; Gosavi, P. V.; Pande, J. V.; Kumar, V. P.; Chary, K. V. R.;
Biniwale, R. B. Int. J. Hydrogen Energy 2010, 35, 4020–4026.
25. Okada, Y.; Sasaki, E.; Watanabe, E.; Hyodo, S.; Nishijima, H. Int. J. Hydrogen Energy
2006, 31, 1348–1356.
26. Kariya, N.; Fukuoka, A.; Utagawa, T.; Sakuramoto, M.; Goto, Y.; Ichikawa, M. Appl.
Catal. Gen. 2003, 247, 247–259.
27. Hodoshima, S. Int. J. Hydrogen Energy 2003, 28, 1255–1262.
28. Kustov, L. M.; Tarasov, A. L.; Tarasov, B. P. Int. J. Hydrogen Energy 2013, 38,
5713–5716.
29. Lázaro, M. P.; Garcı́a-Bordeje, E.; Sebastián, D.; Lázaro, M. J.; Moliner, R. Catal. Today
2008, 138, 203–209.
30. Preuster, P.; Papp, C.; Wasserscheid, P. Acc. Chem. Res. 2017, 50, 74–85.
31. Liu, D.; Men, Y.; Wang, J.; Kolb, G.; Liu, X.; Wang, Y.; Sun, Q. Int. J. Hydrogen Energy
2016, 41, 21990–21999.
32. Sá, S.; Silva, H.; Brandão, L.; Sousa, J. M.; Mendes, A. Appl. Catal. Environ. 2010, 99,
43–57.
33. Palo, D. R.; Dagle, R. A.; Holladay, J. D. Chem. Rev. 2007, 107, 3992–4021.
34. Dobscn, A.; Robinson, S. D. J. Organomet. Chem. 1975, 87, C52–C53.
35. Dobson, A.; Robinson, S. D. Inorg. Chem. 1977, 16, 137–142.
426 Hajime Kawanami et al.
36. Rodrı́guez-Lugo, R. E.; Trincado, M.; Vogt, M.; Tewes, F.; Santiso-Quinones, G.;
Gr€utzmacher, H. Nat. Chem. 2013, 5, 342–347.
37. Stephan, D. W. Nature 2013, 495, 54–55.
38. Verendel, J. J.; Diner, P. ChemCatChem 2013, 5, 2795–2797.
39. Yang, X. ACS Catal. 2014, 4, 1129–1133.
40. Nielsen, M.; Alberico, E.; Baumann, W.; Drexler, H. J.; Junge, H.; Gladiali, S.;
Beller, M. Nature 2013, 495, 85–89.
41. Alberico, E.; Sponholz, P.; Cordes, C.; Nielsen, M.; Drexler, H. J.; Baumann, W.;
Junge, H.; Beller, M. Angew. Chem. Int. Ed. Engl. 2013, 52, 14162–14166.
42. Anderez-Fernandez, M.; Vogt, L. K.; Fischer, S.; Zhou, W.; Jiao, H.; Garbe, M.;
Elangovan, S.; Junge, K.; Junge, H.; Ludwig, R.; Beller, M. Angew. Chem. Int. Ed.
2017, 56, 559–562.
43. Alberico, E.; Lennox, A. J.; Vogt, L. K.; Jiao, H.; Baumann, W.; Drexler, H. J.;
Nielsen, M.; Spannenberg, A.; Checinski, M. P.; Junge, H.; Beller, M. J. Am. Chem.
Soc. 2016, 138, 14890–14904.
44. Gibson, H. W. Chem. Rev. 1969, 69, 673–692.
45. Hietala, J.; Vuori, A.; Johnsson, P.; Pollari, I.; Reutemann, W.; Kieczka, H. Formic Acid.
Wiley-VCH Verlag GmbH & Co: KGaA, Weinheim, 2016.
46. Wagman, D. D.; Evans, W. H.; Parker, V. B.; Schumm, R. H.; Halow, I.; Bailey, S. M.;
Churney, K. L.; Nuttall, R. L. J. Phys. Chem. Ref. Data Monogr. 1982, 11, 2–84.
47. Scott, D. W.; Guthrie, G. B.; Messerly, J. F.; Todd, S. S.; Berg, W. T.; Hossenlopp, I. A.;
McCullough, J. P. J. Phys. Chem. 1962, 66, 911–914.
48. Roux, M. V.; Temprado, M.; Chickos, J. S.; Nagano, Y. J. Phys. Chem. Ref. Data
Monogr. 2008, 37, 1855–1996.
49. Prosen, E. J.; Johnson, W. H.; Rossini, F. D. J. Res. Natl. Bur. Stand. 1946, 37, 51–56.
50. Douslin, D. R.; Huffman, H. M. J. Am. Ceram. Soc. 1946, 68, 173–176.
51. Trimm, D. L. Appl. Catal. A. 2005, 296, 1–11.
52. Sordakis, K.; Beller, M.; Laurenczy, G. ChemCatChem 2014, 6, 96–99.
53. Fellay, C.; Yan, N.; Dyson, P. J.; Laurenczy, G. Chem. A Eur. J. 2009, 15, 3752–3760.
54. Hull, J. F.; Himeda, Y.; Wang, W.-H.; Hashiguchi, B.; Periana, R.; Szalda, D. J.;
Muckerman, J. T.; Fujita, E. Nat. Chem. 2012, 4, 383–388.
55. Inoue, Y.; Izumida, H.; Sasaki, Y.; Hashimoto, H. Chem. Lett. 1976, 1976, 863–864.
56. Chen, H.-T.; Chang, J.-G.; Chen, H.-L. J. Phys. Chem. A 2008, 112, 8093–8099.
57. Fellay, C.; Dyson, P. J.; Laurenczy, G. Angew. Chem. Int. Ed. 2008, 47, 3966–3968.
58. Fukuzumi, S.; Kobayashi, T.; Suenobu, T. ChemSusChem 2008, 1, 827–834.
59. Inaba, S. J. Phys. Chem. A 2014, 118, 3026–3038.
60. Loges, B.; Boddien, A.; Junge, H.; Beller, M. Angew. Chem. Int. Ed. Engl. 2008, 47,
3962–3965.
61. Ojeda, M.; Iglesia, E. Angew. Chem. Int. Ed. Engl. 2009, 48, 4800–4803.
62. Boddien, A.; Mellmann, D.; G€artner, F.; Jackstell, R.; Junge, H.; Dyson, P. J.;
Laurenczy, G.; Ludwig, R.; Beller, M. Science 2011, 333, 1733–1736.
63. Tedsree, K.; Li, T.; Jones, S.; Chan, C. W. A.; Yu, K. M. K.; Bagot, P. A. J.;
Marquis, E. A.; Smith, G. D. W.; Tsang, S. C. E. Nat. Nanotechnol. 2011, 6, 302–307.
64. Bi, Q. Y.; Du, X. L.; Liu, Y. M.; Cao, Y.; He, H. Y.; Fan, K. N. J. Am. Chem. Soc. 2012,
134, 8926–8933.
65. Moret, S.; Dyson, P. J.; Laurenczy, G. Nat. Commun. 2014, 5, http://dx.doi.org/
10.1038/ncomms5017.
66. Coffey, R. S. Chem. Commun. 1967, 923–924.
67. Yoshida, T.; Ueda, Y.; Otsuka, S. J. Am. Chem. Soc. 1978, 100, 3941–3942.
68. Strauss, S. H.; Whitmire, K. H.; Shriver, D. F. J. Organomet. Chem. 1979, 174,
C59–C62.
69. Paonessa, R. S.; Trogler, W. C. J. Am. Chem. Soc. 1982, 104, 3529–3530.
Formic Acid as a Hydrogen Carrier for Fuel Cells 427
70. King, R. B.; Bhattacharyya, N. K. Inorg. Chim. Acta 1995, 237, 65–69.
71. Gao, Y.; Kuncheria, J.; Yapb, G. P. A.; Puddephatt, R. J. Chem. Commun. 1998,
2365–2366.
72. Gao, Y.; Kuncheria, J. K.; Jenkins, H. A.; Puddephatt, R. J.; Yap, G. P. A. J. Chem. Soc.
Dalton Trans. 2000, 3212–3217.
73. Forster, D.; Deck, G. J. Chem. Soc. D 1971, 18, 1072.
74. Boddien, A.; Loges, B.; Gartner, F.; Torborg, C.; Fumino, K.; Junge, H.; Ludwig, R.;
Beller, M. J. Am. Chem. Soc. 2010, 132, 8924–8934.
75. Boddien, A.; Gartner, F.; Jackstell, R.; Junge, H.; Spannenberg, A.; Baumann, W.;
Ludwig, R.; Beller, M. Angew. Chem. Int. Ed. Engl. 2010, 49, 8993–8996.
76. Montandon-Clerc, M.; Dalebrook, A. F.; Laurenczy, G. J. Catal. 2016, 343, 62–67.
77. Zell, T.; Butschke, B.; Ben-David, Y.; Milstein, D. Chemistry 2013, 19, 8068–8072.
78. Bielinski, E. A.; Lagaditis, P. O.; Zhang, Y.; Mercado, B. Q.; W€ urtele, C.;
Bernskoetter, W. H.; Hazari, N.; Schneider, S. J. Am. Chem. Soc. 2014, 136,
10234–10237.
79. Himeda, Y. Green Chem. 2009, 11, 2018–2022.
80. Deng, J.; Wang, Y.; Pan, T.; Xu, Q.; Guo, Q. X.; Fu, Y. ChemSusChem 2013, 6,
1163–1167.
81. Tomas-Mendivil, E.; Dıez, J.; Cadierno, V. Cat. Sci. Technol. 2011, 1, 1605.
82. Klein, S.; Dougherty, W. G.; Kassel, W. S.; Dudley, T. J.; Paul, J. J. Inorg. Chem. 2011,
50, 2754–2763.
83. Himeda, Y.; Onozawa-Komatsuzaki, N.; Miyazawa, S.; Sugihara, H.; Hirose, T.;
Kasuga, K. Chem. A Eur. J. 2008, 14, 11076–11081.
84. Himeda, Y.; Miyazawa, S.; Hirose, T. ChemSusChem 2011, 4, 487–493.
85. Himeda, Y.; Onozawa-Komatsuzaki, N.; Sugihara, H.; Kasuga, K. J. Am. Chem. Soc.
2005, 127, 13118–13119.
86. Iguchi, M.; Himeda, Y.; Manaka, Y.; Kawanami, H. ChemSusChem 2016, 9,
2749–2753.
87. Suna, Y.; Ertem, M. Z.; Wang, W.-H.; Kambayashi, H.; Manaka, Y.; Muckerman, J. T.;
Fujita, E.; Himeda, Y. Organometallics 2014, 33, 6519–6530.
88. Wang, W.-H.; Xu, S.; Manaka, Y.; Suna, Y.; Kambayashi, H.; Muckerman, J. T.;
Fujita, E.; Himeda, Y. ChemSusChem 2014, 7, 1976–1983.
89. Wang, W.-H.; Hull, J. F.; Muckerman, J. T.; Fujita, E.; Hirose, T.; Himeda, Y. Chem.
A Eur. J. 2012, 18, 9397–9404.
90. Wang, W.-H.; Hull, J. F.; Muckerman, J. T.; Fujita, E.; Himeda, Y. Energ. Environ. Sci.
2012, 5, 7923–7926.
91. Iguchi, M.; Himeda, Y.; Manaka, Y.; Matsuoka, K.; Kawanami, H. ChemCatChem
2016, 8, 886–890.
92. Guan, C.; Zhang, D. D.; Pan, Y.; Iguchi, M.; Ajitha, M. J.; Hu, J.; Li, H.; Yao, C.;
Huang, M. H.; Min, S.; Zheng, J.; Himeda, Y.; Kawanami, H.; Huang, K. W. Inorg.
Chem. 2017, 56, 438–445.
93. Boddien, A.; Loges, B.; Junge, H.; Beller, M. ChemSusChem 2008, 1, 751–758.
94. Grasemann, M.; Laurenczy, G. Energ. Environ. Sci. 2012, 5, 8171–8181.
95. Zhang, X.; Galindo, H. M.; Garces, H. F.; Baker, P.; Wang, X.; Pasaogullari, U.;
Suib, S. L.; Molter, T. J. Electrochem. Soc. 2010, 157, B409.
96. Czaun, M.; Kothandaraman, J.; Goeppert, A.; Yang, B.; Greenberg, S.; May, R. B.;
Olah, G. A.; Prakash, G. K. S. ACS Catal. 2016, 6, 7475–7484.
INDEX
Note: Page numbers followed by “f ” indicate figures, “t” indicate tables, and “s” indicate
schemes.
A (2-[6-(40 -Amino)phenoxy-3H-xanthen-
π-Acceptor effect 3-on-9-yl]benzoic acid) (APF),
ancillary substituent effect, 262–264 374–378, 376f
cationic square-planar Pt(II) complexes, Ancillary ligands, 335–336
246f Antitumor immune response, 371–372
and donor atom effect, 252–259 Apoptosis, 366–367
N-donor chelates, 269–272 Aromatic C–F bonds, 153–158
vs. σ-donor effect, 246–251 Arylplatinum compounds, 197
extended ring conjugation, 259–261 Ascorbate, 361–362
Pt(II) complexes, 254f, 255–256 ASM. See Activation strain model (ASM)
second-order rate constants, 248–249t Autophagy, 369
in square-planar Pt(II) complexes, Avantes spectrophotometer, 50
245–246
substituent effect, 261–262
terpy and analogous chelates, 253f B
tridentate nitrogen-donor ligands, 250f Bacteriochlorins, in cells, 362–366
Activation strain model (ASM) Bcis-type intermediates
adc and dmad reactions, 328–330, 329t C-H activation, 232t
analysis, 328–332, 329f chelating N(amino)-N(imine) ligands,
of chemical reactivity, 320–322 233–239
Acylperoxoiron(III) compounds, 87–97 monodentate N(imine) ligands, 228–233
Adamantane, oxidation, 129f, 142 stability, 225–227
Adsorption kinetics, 53–54 Benzene, oxidation, 136–139, 144–145,
Advanced oxidation processes (AOPs), 3–4 144f
Aldehyde deformylation, 185–190, 186f Bioinorganic chemistry, 68
Alkanes Bioinspired catalysis, 108–109
C–H bonds of, 91, 145 Bioinspired model systems, 65–67
single-turnover oxidation of, 129t Biomimetic manganese(V)-oxo complexes,
AlkB, 169–170 181–184
Alkylaromatic compounds, 147–149 Biomimetic models, 172–175,
Alkyne 177–178
in acetonitrile, 336t Bis(iminopyridyl/isoquinolyl)isoindoline,
activation strain analysis, 328–332, 329f 264–269
ASM analysis, 329t Bis(pyrazolyl)pyridine/benzene,
effect, 324–332 incorporating, 264–269
free energies, activation and reaction, Bleomycin, 174
328t Bond dissociation energies
HOMO and LUMO orbitals, 330–331, (BDE), 286
330f Btrans-type intermediates, 225–227
structural changes, 327t Buthionine sulfoximine (BSO),
transition state, 324–328, 325f 378–379
429
430 Index
N O
Nanoformulation, of photosensitizers, O2 activation, 64–65
379–382 copper- and iron-based proteins in,
Necrosis, 367–369 64–65
Nitric oxide (NO) dicopper model complexes, 68–69
crosstalk, 278–280 by metalloenzymes, 65s
signaling cascade, 278 Olefins, hydroacylation of, 151f, 151t
μ-Nitrido diiron macrocyclic complexes O–O cleavage
emission spectroscopies, 119–120 in dinuclear copper systems, 67–78
EXAFS method, 115–116 C–F bonds, hydroxylation, 72–78
Fe–Fe distances, 112–115 dicopper model complexes, 68–69
iron oxidation state determination, tyrosinase-like activity, 69–72
116–119 in iron-oxygen species
mass spectrometry, 116 acylperoxoiron(III) compounds,
oxidation properties, 121–122 87–97
oxo species, mononuclear and binuclear cytochrome P450, 79–80
platforms, 121f FeOOR species, 84–97
preparation and spectroscopic hydroperoxoiron(III) compounds,
characterization, 111–122 85–87
structural parameters, 114t iron-containing enzymes, 79–83
structures, 111f nonheme iron catalysts, 83–84
X-ray absorption, 119–120 Rieske oxygenases, 81–83
X-ray diffraction, 112–115 spectroscopically characterized
Nitrogen-/carbon-donor tridentate ligands oxoiron(V) species, 97–99
(N^C/N^N/C) Oxidative addition, 197
π-acceptor vs. σ-donor effect, concentration-tuned reactions, 210s
246–251 cyclometallated PtIV complexes, 216s
chloride substitution from deprotonated relevant kinetic and activation parameters,
phenyl ring, 257–258t 212t
mercurial structural property, Oxidative stress, in cells, 347f
245–246 Oxoiron(V) species, 97–99
Pt(II) complexes, pull-and-push effects, Oxone, 23
252–272 Oxyanion, 410s
S-Nitrosothiols (RSNOs) Oxychlorine species, 6–22
chemical structures, 279f
coordination chemistry, P
295–298 PDT. See Photodynamic therapy (PDT)
resonance structures of, 280f Peroxo compounds, 22–35
structure and reactivity, 280–282 Peroxodisulfate salts (PDS), 22–23
transnitrosation, 292–295 Peroxomonosulfate ion (PMS), 23–24
Nitroxyl (HNO), 278, 286, pathways, 25–26
289, 294 peroxo bond, 25
Nonheme complex, iron(III)-hydroperoxo, phen oxidation by, 31–32, 32s
177–181 redox reactions, 25
Nonheme iron catalysts, in hydrocarbon second-order reaction, 28
oxidation, 83–84 spontaneous decomposition, 25
Nucleophilic attack, on carbonyl group, two-electron oxidant, 26
185–186, 189–190 Peroxomonosulfate ion radical, 38–39
Index 435
Perthionitrite (S2NO–) Q
absorption spectra calculations, 289–291 Quantitative UV–vis spectrophotometry, 50
available results, 288–289
calculated spectra, 290f
coordination chemistry, 298 R
mechanistic generation routes, 292–295 Reactive oxygen species (ROS), 344–345
standard deviation for, 291t antitumor immune response, 371–372
X-ray structural data, 291–292 apoptosis, 366–367
Pheophorbide A, 380–382 ascorbate in, 361–362
Photocatalysis, 49–51 autophagy, 369
Photochemical mechanism, 355f, 378–379 biological mechanisms, 366–372
Photodynamic therapy (PDT), 348–349, cellular targets for, 366f
348f damaging aspect, 345–346
cellular approach, 351 detection in PDT, 372–378
photosensitizers for, 351–354 fluorescence, 356
ROS detection generation in PDT, 378–384
fluorescent probes, 374–378 light interactions with human tissues, 349f
1270 nm phosphorescence, molecular oxygen reduction, 344f
372–373 necrosis, 367–369
radical species, 374 penetration depth, 349–351
ROS generation photodynamic therapy, 348–349
antioxidant enzymes inhibition, photosensitizers for PDT, 351–354
378–379 phthalocyanine- and bacteriochlorin-
inorganic salts addition, 383–384 based compounds, 353f
photosensitizers nanoformulation, porphyrins, subcellular localization,
379–382 362–366
singlet oxygen-generated possible deactivation pathways, 355–357
nanomaterials, 382 redox homeostasis, 346–347
TiO2 with tetrapyrroles, 382–383 stereotypic view, 345
Photofrin®, 351, 363–365 triplet excited state, 356–357
Photoinitiated reactions, 45–46f, 46–47 Type I mechanism, 358–360
Photon, as reactant, 35–49 Type II mechanism, 357–358
Photosensitization, of titanium dioxide, vascular occlusion, 369–371
382–383 Recalcitrant pollutants, 158–160
Photosensitizer (Ps), 348f, 365–366, Redox homeostasis, in cells, 346–347, 347f
379–382 Redox reactions
Phthalocyanine, 122–124, 352–354 in aqueous solution, 2
Platinacycle, five/seven-membered chlorate–iodine reaction, 49f
from Bcis-type intermediates, 228–239 dye-covered aerogel particles, 53–54
stability, 225 general scheme of, 3s
Platinum chemistry, 197–198 heterogeneous systems, 49–55
Platinum(II) complexes, 252–272 kinetic behavior complexity, 3
Polymer electrolyte membrane fuel cell long-chain approach, 42–43
(PEMFC), 421–422, 422f oxychlorine species, 6–22
Polysulfides, 287 ozone decomposition, 3–5
Porphyrin, 124–126, 352–354, 362–366 peroxo compounds, 22–35
Potassium peroxomonosulfate, 23 photon as reactant, 35–49
Potential energy surface (PES), 320–322 stoichiometry, 4–5, 15
436 Index